000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|1502|2879|lyfalmen|V1070|1792|00|20|0|2|Vistor hf|Janssen-Cilag AB|Risperídón||1502||1502|2879 000018|G01AF0501|Pevaryl|krem/sti|0| |15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|15|0|4|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 000020|J07AL0201|Prevenar|stl|0| |0,5|ml|1|hgl||J07AL02|01.10.2002||R|K|2|0|0|0|0|WLV|0|0|0|100|USD|6759|10013|lyfalmen|||02|0|0|0|Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||6759||6759|10013 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|45572|58605|lyfsjukr|||00|2|0|24|Icepharma hf|Roche|Epóetín||45572||45572|58605 000055|B03XA0103|NeoRecormon|sts|60000|ae/rörly|1|ml|1|rörlyk|+leysir|B03XA01|01.11.2003|30.06.2009|R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|129541|163146|lyfsjukr|||00|1|0|60|Icepharma hf|Roche|Epóetín||129541||129541|163146 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|68251|86840|lyfsjukr|||00|2|0|36|Icepharma hf|Roche|Epóetín||68251||68251|86840 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|11518|16471|lyfalmen|||00|28|0|14|Icepharma hf|Eli Lilly Nederland -|Olanzapín||11518||11518|16471 000166|A07FA0201|Precosa|hylki|250|mg|20|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|SEK|1698|3145|lyfalmen|||00|20|0|5|Vistor hf|Laboratories Biocodex|Saccharomyces boulardii||1698||1698|3145 000182|A07FA0201|Precosa|hylki|250|mg|50|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|SEK|3918|6157|lyfalmen|||00|50|0|12|Vistor hf|Laboratories Biocodex|Saccharomyces boulardii||3918||3918|6157 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|34271|44852|lyfalmen|||00|28|0|42|Icepharma hf|Eli Lilly Nederland -|Olanzapín||34271||34271|44852 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|44570|57675|lyfalmen|||00|28|0|56|Icepharma hf|Eli Lilly Nederland -|Olanzapín||44570||44570|57675 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|22423|30102|lyfalmen|V0813|29544|00|28|0|28|Icepharma hf|Eli Lilly Nederland -|Olanzapín||22423||22423|30102 000211|J07AL0201|Prevenar|stl|0| |0,5|ml|1|spr|áfyllt sprauta|J07AL02|01.04.2006||R|K|2|0|0|0|0|WLV|0|0|0|100|USD|9830|14180|lyfalmen|||02|0|0|0|Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||9830||9830|14180 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|6564|9398|lyfsjukr|||00|1|0|0|Vistor hf|Ferring|Atosíban||6564||6564|9398 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|8435|16239|vetalmen|||00|100|0|0|Vistor hf|Boehringer Ingelheim|||8435||8435|16239 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|18051|24341|lyfsjukr|||00|5|0|0|Vistor hf|Ferring|Atosíban||18051||18051|24341 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|22464|30153|lyfalmen|||00|0|0|1|Vistor hf|N.V. Organon|Follitrópín beta||22464||22464|30153 000315|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5966|8542|lyfsjukr|||00|3000|0|3|Icepharma hf|Fresenius Kabi|Elektrólýtar||5966||5966|8542 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|44559|57661|lyfalmen|||00|1|0|6|Vistor hf|N.V. Organon|Follitrópín beta||44559||44559|57661 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|þpakki||N02CC04|01.03.1999||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5919|8873|lyfalmen|||00|6|0|6|Icepharma hf|M.S.D.|Rizatriptan||5919||5919|8873 000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2534|3628|lyfsjukr|||00|10|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3628 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2175|3114|lyfsjukr|||00|5|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3114 000448|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3536|5639|lyfalmen|||0|100|0|100|Vistor hf|Schering-Plough|Mómetasón||||3536|5639 000530|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|31051|40843|lyfalmen|||02|10|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||31051||31051|40843 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2174|3791|lyfalmen|||06|5|0|0|Vistor hf|Novartis Healthcare A/S-|Ketotifen||2174||2174|3791 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|5768|8668|lyfalmen|||23|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprostadíl||5768||5768|8668 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|4462|6896|lyfalmen|||00|60|0|3|Vistor hf|Janssen-Cilag AB|Tópíramat||4462||4462|6896 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|A|2|0|0|0|0|NOH|0|0|0|100|IKR|||lyflausa|||00|8|0|0|Vistor hf|Novartis Healthcare A/S-|Ketotifen||||| 000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|5957|8924|lyfalmen|||00|24|0|0|Vistor hf|Novartis Healthcare A/S-|Ketotifen||5957||5957|8924 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|16602|22537|lyfsjukr|||00|1000|0|1|Icepharma hf|Fresenius Kabi|Fitusambönd||16602||16602|22537 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|5085|7741|lyfalmen|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||||5085|7741 000770|V08BA0104|E-Z paste|pasta|60|%|1|lbs|1|pakki|til inntöku|V08BA01|01.01.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|2590|3708|lyfsjukr|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|Baríumsúlfat||2590||2590|3708 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|4206|6548|lyfalmen|||23|2|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprostadíl||4206||4206|6548 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|2|Vistor hf|McNeil Denmark ApS|Dífenhýdramín||||| 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|1|Vistor hf|McNeil Denmark ApS|Dífenhýdramín||||| 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|178890|224586|lyfsjukr|||00|6|0|123|Gróco ehf|Serono Nordic|Interferón beta-1a||178890||178890|224586 000891|M05BA0101|Didronate|töflur|200|mg|60|stk|1|þpakki||M05BA01|01.04.1996|30.06.2009|R|A|4|0|0|E|0|PGA|0|0|0|100|DKK|14688|20472|lyfalmen|||00|60|0|30|Sofus Consulting AB|Procter & Gamble-|Etídrónsýra||14688||14688|20472 000957|H01AC0101|Genotropin|sts|0| |5|mg|1|hgl|+ leysir 1 ml|H01AC01|01.05.2001||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|32221|41983|lyfsjukr|||02|5|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sómatrópín||32221||32221|41983 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|7017|10047|lyfsjukr|||02|0|0|1|Vistor hf|N.V. Organon|Ganirelix||7017||7017|10047 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|þpakki||M01AH01|01.03.2003||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|1904|3424|lyfalmen|||00|10|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||1904||1904|3424 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|13138|18542|lyfalmen|||00|30|0|120|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||13138||13138|18542 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|25140|33484|lyfalmen|||00|100|0|400|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||25140||25140|33484 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2467|4188|lyfalmen|||43|100|0|16|Vistor hf|AstraZeneca A/S DK|Metóprólól||2467||2467|4188 001324|C09CA0201|Teveten|töflur|600|mg|98|stk|1|þpakki||C09CA02|01.08.2001||R|A|3|0|0|B|0|SOP|0|0|0|100|XEU|13055|18438|lyfalmen|||00|98|0|98|Icepharma hf|Solvay Pharmaceuticals|Eprosartan||13055||13055|18438 001337|V08CA0901|Gadovist|stl|1|mmol/ml|30|ml|10|hgl||V08CA09|01.12.2003||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|437631|546718|lyfsjukr|||02|300|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadóbútról||437631||437631|546718 001346|C09CA0201|Teveten|töflur|400|mg|56|stk|1|þpakki||C09CA02|01.10.2001||R|A|3|0|0|B|0|SOP|0|0|0|100|XEU|5170|7856|lyfalmen|||00|56|0|37|Icepharma hf|Solvay Pharmaceuticals|Eprosartan||5170||5170|7856 001386|C10AA0102|Sivacor|töflur|10|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1400|1177|lyfalmen|||00|28|0|9|Actavis Group hf|Actavis hf|Simvastatín||248||248|1177 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|36038|46735|lyfsjukr|||02|2|0|5|Vistor hf|N.V. Organon|Ganirelix||36038||36038|46735 001400|C10AA0102|Sivacor|töflur|10|mg|98|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|868|2018|lyfalmen|V0361|2018|00|98|0|33|Actavis Group hf|Actavis hf|Simvastatín||868||868|2018 001409|C10AA0102|Sivacor|töflur|20|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|928|2100|lyfalmen|||00|28|0|19|Actavis Group hf|Actavis hf|Simvastatín||928||928|2100 001422|C10AA0102|Sivacor|töflur|20|mg|98|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1050|2265|lyfalmen|V0362|2265|00|98|0|65|Actavis Group hf|Actavis hf|Simvastatín||1050||1050|2265 001431|C10AA0102|Sivacor|töflur|40|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2700|4504|lyfalmen|||00|28|0|37|Actavis Group hf|Actavis hf|Simvastatín||2700||2700|4504 001442|C10AA0102|Sivacor|töflur|40|mg|98|stk|1|plglas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1630|3052|lyfalmen|V0367|3035|00|98|0|131|Actavis Group hf|Actavis hf|Simvastatín||1630||1630|3052 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|7397|10878|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insulín aspart||7397||7397|10878 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|4795|7347|lyfalmen|||10|100|0|40|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||4795||4795|7347 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|883|2039|lyfalmen|||10|30|0|30|Actavis Group hf|Actavis hf|Flúoxetín||883||883|2039 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2456|4173|lyfalmen|||10|100|0|100|Actavis Group hf|Actavis hf|Flúoxetín||2456||2456|4173 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|29722|38871|lyfsjukr|||00|4104|0|0|Icepharma hf|Fresenius Kabi|Blöndur||29722||29722|38871 001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|A|3|0|0|E|0|VIF|0|0|1|100|CHF|14550|20300|lyfalmen|V0011|19508|00|25|0|5|Vistor hf|Vifor France SA|Járnoxíð (sykurflétta)||14550||14550|20300 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|40280|52016|lyfsjukr|||00|6160|0|6|Icepharma hf|Fresenius Kabi|Blöndur||40280||40280|52016 001622|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|2|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|27333|35897|lyfsjukr|||00|5132|0|5|Icepharma hf|Fresenius Kabi|Blöndur||27333||27333|35897 001685|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|50|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|7677|10992|lyfsjukr|||02|50|0|0|Vistor hf|Octapharma AB|Albúmín||7677||7677|10992 001693|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|100|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|12259|17130|lyfsjukr|||02|100|0|0|Vistor hf|Octapharma AB|Albúmín||12259||12259|17130 001792|N02BA0109|Alka-Seltzer|freyðit|324|mg|20|stk|1|pakki||N02BA01|01.08.2004||L|A|3|0|0|0|0|BAS|0|0|1|100|IKR|||lyflausa|||00|20|0|2|Vistor hf|Bayer A/S|Acetýlsalicýlsýra||||| 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|K|3|0|0|0|1|NOH|0|0|0|100|DKK|1439|2060|lyfsjukr|||02|10|0|10|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1439||1439|2060 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|4309|6688|lyfalmen|||06|15|0|75|K.Pétursson hf|Alcon|Brinzólamíð||4309||4309|6688 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1115|2353|lyfalmen|||00|7|0|5|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1115||1115|2353 001894|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|glas|300+150+300 mg|J05AR04|01.08.2003||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|88936|112593|lyfsjukr|||00|60|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Zídóvúdín, lamívúdín og abacavír||88936||88936|112593 001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|2358|4040|lyfalmen|V0791|4040|00|60|0|12|Actavis Group hf|Actavis hf|Risperídón||2358||2358|4040 001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|12969|18331|lyfalmen|V0795|18331|00|60|0|48|Actavis Group hf|Actavis hf|Risperídón||12969||12969|18331 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|A|3|0|0|0|0|BIG|0|0|0|100|SEK|4762|7303|lyfalmen|||00|45|0|45|Icepharma hf|Bioglan AB|Capsaicin||4762||4762|7303 001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|5475|8270|lyfalmen|V0793|8270|00|60|0|24|Actavis Group hf|Actavis hf|Risperídón||5475||5475|8270 001974|J01CA0801|Selexid|töflur|200|mg|100|stk|1|glas||J01CA08|01.10.1990||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|9989|14396|lyfalmen|V0456|14268|43|100|0|33|Vistor hf|LEO Pharma A/S|Pívmecillínam||9989||9989|14396 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4026|6304|lyfalmen|V0084|6304|00|28|0|19|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4026||4026|6304 001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|8009|11709|lyfalmen|V0794|11709|00|60|0|36|Actavis Group hf|Actavis hf|Risperídón||8009||8009|11709 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|7869|11519|lyfalmen|||0|56|0|37|Vistor hf|AstraZeneca A/S DK|Esómeprazól||7869||7869|11519 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1471|2837|lyfalmen|||00|7|0|9|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1471||1471|2837 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5508|8315|lyfalmen|V0085|8197|00|28|0|37|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5508||5508|8315 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.01.2000||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|5045|7687|lyfalmen|||00|100|0|27|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5045||5045|7687 002169|B05BA1010|Kabiven Peripheral|irþ|0| |2400|ml|2|pokar|3ja hólfa poki |B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|23734|31416|lyfsjukr|||00|4800|0|5|Icepharma hf|Fresenius Kabi|Blöndur||23734||23734|31416 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|þpakki|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6733|9977|lyfalmen|||00|50|0|33|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6733||6733|9977 002186|B05BA1010|Kabiven Peripheral|irþ|0| |1920|ml|2|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|21228|28296|lyfsjukr|||00|3840|0|4|Icepharma hf|Fresenius Kabi|Blöndur||21228||21228|28296 002194|B05BA1010|Kabiven Peripheral|irþ|0| |1440|ml|4|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|34737|45115|lyfsjukr|||00|5760|0|6|Icepharma hf|Fresenius Kabi|Blöndur||34737||34737|45115 002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|13851|19429|lyfalmen|V0087|19429|00|100|0|67|Vistor hf|AstraZeneca A/S DK|Esómeprazól||13851||13851|19429 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8785|12762|lyfalmen|||00|50|0|67|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8785||8785|12762 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|A|2|0|0|*|0|NON|0|0|0|100|DKK|3486|5571|lyfalmen|||02|10|0|25|Vistor hf|Novo-Nordisk|Insúlín aspart||3486||3486|5571 002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|19633|26628|lyfalmen|V0089|26240|00|100|0|133|Vistor hf|AstraZeneca A/S DK|Esómeprazól||19633||19633|26628 002237|D05AX0201|Daivonex|smyrsli|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001|30.06.2009|R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4377|6780|lyfalmen|||00|60|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól||4377||4377|6780 002263|D05AX0201|Daivonex|smyrsli|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001|30.06.2009|R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7157|10553|lyfalmen|||00|120|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól||7157||7157|10553 002265|D05AX0201|Daivonex|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7899|11560|lyfalmen|||00|120|0|120|Vistor hf|LEO Pharma A/S|Kalcípótríól||7899||7899|11560 002276|D05AX0201|Daivonex|krem|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4598|7080|lyfalmen|||00|60|0|60|Vistor hf|LEO Pharma A/S|Kalcípótríól||4598||4598|7080 002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|19097|25961|lyfalmen|||00|98|0|39|Icepharma hf|M.S.D.|Montelúkast||19097||19097|25961 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|107608|135839|lyfsjukr|||00|1|0|2|ZLB Behring AB|Bayer HealthCare AG-|Storkuþáttur VIII||107608||107608|135839 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|54054|69165|lyfsjukr|||00|1|0|1|ZLB Behring AB|Bayer HealthCare AG-|Storkuþáttur VIII||54054||54054|69165 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|30984|40443|lyfsjukr|||00|1|0|0|ZLB Behring AB|Bayer HealthCare AG-|Storkuþáttur VIII||30984||30984|40443 002391|G03AA1201|Yasmin|töflur|0||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.02.2001||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|2890|4762|lyfalmen|||00|63|0|84|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||||2890|4762 002405|C09AA0206|Enalapril Merck NM|töflur|2,5|mg|50|stk|1|þpakki||C09AA02|01.10.2007||R|A||0|0|B|0|PCO|0|0|0|100|IKR|510|1532|lyfalmen|||00|50|1|12|Distica|Distica - óskráð lyf|Enalapríl||510||510|1532 002413|G03AA1204|Yasmin 28|töflur|0| |84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2007||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|2890|4762|lyfalmen|||00|84|0|0|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||2890||2890|4762 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Actavis Group hf|Actavis hf|Lóratadín||||| 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Actavis Group hf|Actavis hf|Lóratadín||||| 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2079|3662|lyfalmen|V0984|3662|00|100|0|100|Actavis Group hf|Actavis hf|Lóratadín||2079||2079|3662 002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000||R|A|4|0|1|0|1|NOO|0|0|0|100|DKK|219803|275522|lyfsjukr|||00|1|0|0|Vistor hf|Novartis Ophthalmics Europe Ltd.|Verteporfin||219803||219803|275522 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|A|4|0|0|0|0|BAN|0|0|0|100|DKK|3190|5520|vetorma|||0|10|0|0|Vistor hf|Bayer Animal Health GmbH|||||3190|5520 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|7|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|A|1,5|0|0|*|0|SAO|0|0|0|100|XEU|1405|2747|lyfalmen|||07|5|0|25|Icepharma hf|Santen Oy|Tímólól||1405||1405|2747 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|K|3|0|1|0|1|ALL|0|0|0|100|SEK|31662|41287|lyfsjukr|||02|1|0|0|Vistor hf|Allergan|Clostridium botulinum toxín-A||31662||31662|41287 002966|G03GA0502|Gonal-f|sts|1050|ae|1|hgl|1|pakki|á 1,75 ml + leysir |G03GA05|01.02.2002||R|A|1|0|1|E|0|SEN|0|0|0|100|SEK|69196|88334|lyfalmen|||00|1|0|14|Gróco ehf|Serono Nordic|Follitrópín alfa||69196||69196|88334 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|15783|16752|lyfalmen|V0193|16752|00|98|0|196|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||11725||11725|16752 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|11685|16698|lyfalmen|||00|100|0|12|Vistor hf|U.C.B|Levetíracetam||11685||11685|16698 003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|K|1,5|0|1|0|1|ZEP|0|0|0|100|DKK|309118|386719|lyfsjukr|||02|2|0|0|Icepharma hf|Zeneus Pharma Limited-|Doxórúbicín||309118||309118|386719 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|20174|27302|lyfalmen|V1710|27302|00|100|0|25|Vistor hf|U.C.B|Levetíracetam||20174||20174|27302 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|39199|50988|lyfalmen|||00|100|0|50|Vistor hf|U.C.B|Levetíracetam||39199||39199|50988 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|9300|13461|lyfalmen|||00|1|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||9300||9300|13461 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|13874|19458|lyfalmen|||00|1|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||13874||13874|19458 003195|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|20821|27790|lyfsjukr|||00|2|0|9|Vistor hf|Amgen|Darbepóetín alfa||20821||20821|27790 003208|B03XA0201|Aranesp|stl|15|mcg/spr|0,375|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|31017|40484|lyfsjukr|||00|2|0|13|Vistor hf|Amgen|Darbepóetín alfa||31017||31017|40484 003230|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|32302|42083|lyfsjukr|||00|2|0|18|Vistor hf|Amgen|Darbepóetín alfa||32302||32302|42083 003238|J07AM0101|Tetavax|stl|40|ae|0,5|ml|1|lykja||J07AM01|01.03.2006||R|K||0|0|0|0|LDR|0|0|1|100|IKR|557|1596|lyfalmen|||00|0|1|0|Parlogis hf|Parlogis - óskráð lyf|||557||557|1596 003252|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|47753|61320|lyfsjukr|||00|1|0|27|Vistor hf|Amgen|Darbepóetín alfa||47753||47753|61320 003274|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|62563|79758|lyfsjukr|||00|2|0|36|Vistor hf|Amgen|Darbepóetín alfa||62563||62563|79758 003296|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|77161|97933|lyfsjukr|||00|2|0|44|Vistor hf|Amgen|Darbepóetín alfa||77161||77161|97933 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|217305|272412|lyfsjukr|||02|150|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadóbútról||217305||217305|272412 003310|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|8527|12412|lyfalmen|||0|120|0|30|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8527||8527|12412 003318|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|92667|117238|lyfsjukr|||00|1|0|53|Vistor hf|Amgen|Darbepóetín alfa||92667||92667|117238 003325|R03AK0702|Symbicort mite Turbuhaler|innúðadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7792|11415|lyfalmen|||00|120|0|15|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7792||7792|11415 003340|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|122185|153988|lyfsjukr|||00|2|0|71|Vistor hf|Amgen|Darbepóetín alfa||122185||122185|153988 003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|þpakki||L04AA10|01.04.2004||R|A|1,5|0|1|*|0|WTE|0|0|0|100|USD|69895|89204|lyfalmen|||00|100|0|33|Icepharma hf|Wyeth Europe|Sirolimus||69895||69895|89204 003355|D01AE1501|Lamisil|úðalausn|10|mg/g|15|ml|1|fl|úðalausn á húð|D01AE15|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 003362|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|150765|189570|lyfsjukr|||00|2|0|89|Vistor hf|Amgen|Darbepóetín alfa||150765||150765|189570 003386|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|225382|282468|lyfsjukr|||00|1|0|133|Vistor hf|Amgen|Darbepóetín alfa||225382||225382|282468 003395|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|spr|áfyllt sprauta|B03XA02|01.12.2003||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|112741|142230|lyfsjukr|||00|1|0|67|Vistor hf|Amgen|Darbepóetín alfa||112741||112741|142230 003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|4615|7103|lyfalmen|||00|28|0|14|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||4615||4615|7103 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3965|6221|lyfalmen|||00|60|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Mísóprostól||3965||3965|6221 003468|C09AA0208|Enalapril|töflur|2,5|mg|100|stk|1|þpakki||C09AA02|01.08.2009||R|A||0|0|B|0|PCO|0|0|0|100|SEK|1076|2301|lyfalmen|||00|100|1||Distica|Distica - óskráð lyf|Enalapríl||||1076|2301 003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|15490|21470|lyfalmen|||00|98|0|49|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||15490||15490|21470 003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|7096|10470|lyfalmen|||00|28|0|28|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||7096||7096|10470 003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|22747|30505|lyfalmen|||00|98|0|98|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||22747||22747|30505 003869|R01BA5202|Clarinase|forðatfl|10|mg|10|stk|1|pakki|þp 10+240 mg|R01BA52|01.09.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|979|2169|lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough|Pseudóefedrín í blöndum||979||979|2169 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1170|2428|lyfalmen|V0931|2428|00|28|0|28|Actavis Group hf|Actavis hf|Sertralín||1170||1170|2428 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|715|1811|lyfalmen|||67|20|0|10|Vistor hf|Novartis Healthcare A/S-|Díklófenak||715||715|1811 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|4068|6361|lyfalmen|V0933|6361|00|98|0|98|Actavis Group hf|Actavis hf|Sertralín||4068||4068|6361 003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|1|glas|80 + 20 mg/ml|J05AE06|01.08.2003||R|A|2|0|1|0|1|ABL|0|0|0|100|DKK|105549|133276|lyfsjukr|||00|60|0|8|Vistor hf|Abbott Laboratories A/S|Lopinavír||105549||105549|133276 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2389|4082|lyfalmen|V0608|2116|67|100|0|50|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2389||2389|4082 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|37223|48210|lyfsjukr|||00|50|0|10|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||37223||37223|48210 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|8891|12906|lyfalmen|||00|250|0|15|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||8891||8891|12906 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|A|5|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|100|0|2|Vistor hf|Janssen-Cilag AB|Lóperamíð||||| 004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|A|1|0|0|B|0|GSK|0|0|0|100|GBP|4601|7084|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4601||4601|7084 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|þpakki||N06AB06|01.05.2003||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|665|1743|lyfalmen|||00|7|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||665||665|1743 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|þpakki||N05CD01|01.12.2000||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|1190|2455|lyfalmen|||10|30|0|15|Vistor hf|Meda AB|Flúrazepam||1190||1190|2455 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|A|4|0|0|0|0|PFI|0|1|0|100|DKK|6947|10268|lyfalmen|||00|14|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||6947||6947|10268 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|6713|9950|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||6713||6713|9950 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|9344|13521|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9344||9344|13521 004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|842|1983|lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough|Deslóratadín||842||842|1983 004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|A|2|0|0|B|0|ORG|0|1|0|100|DKK|6658|9876|lyfalmen|||00|66|0|33|Vistor hf|N.V. Organon|Mirtazapín||6658||6658|9876 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|24992|32983|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||24992||24992|32983 004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1860|3364|lyfalmen|V1901|3364|00|30|0|30|Vistor hf|Schering-Plough|Deslóratadín||1860||1860|3364 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|9351|13530|lyfalmen|||0|10|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||9351||9351|13530 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|5203|7901|lyfalmen|V1902|7901|00|100|0|100|Vistor hf|Schering-Plough|Deslóratadín||5203||5203|7901 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|0| |5|ml|20|spr||QJ51RC25|01.12.1978||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|5130|9943|vetalmen|||16|100|0|0|Vistor hf|Boehringer Ingelheim|||5130||5130|9943 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|3648|5791|lyfalmen|||00|56|0|14|Icepharma hf|Norpharma |Tramadól||3648||3648|5791 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|þpakki||C01DA08|01.06.1980||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|680|1763|lyfalmen|||00|100|0|8|Vistor hf|Recip AB|Ísósorbíð dínítrat||680||680|1763 004468|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3583|5703|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3583||3583|5703 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|4865|7442|lyfalmen|||00|56|0|19|Icepharma hf|Norpharma |Tramadól||4865||4865|7442 004487|L01BC0301|Uft|hylki|324|mg|21|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|36895|47802|lyfsjukr|||00|21|0|0|Merck AB|Merck KgaA (M)|Tegafur||36895||36895|47802 004489|N02AX0208|Zytram|forðatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|6871|10165|lyfalmen|||00|56|0|28|Icepharma hf|Norpharma |Tramadól||6871||6871|10165 004500|N02AX0208|Zytram|forðatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|9146|13252|lyfalmen|||00|56|0|37|Icepharma hf|Norpharma |Tramadól||9146||9146|13252 004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2224|3858|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefna­vakar||2224||2224|3858 004532|L01BC0301|Uft|hylki|324|mg|35|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|61491|78424|lyfsjukr|||00|35|0|0|Merck AB|Merck KgaA (M)|Tegafur||61491||61491|78424 004543|L01BC0301|Uft|hylki|324|mg|42|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|73790|93736|lyfsjukr|||00|42|0|0|Merck AB|Merck KgaA (M)|Tegafur||73790||73790|93736 004565|L01BC0301|Uft|hylki|324|mg|28|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|49194|63114|lyfsjukr|||00|28|0|0|Merck AB|Merck KgaA (M)|Tegafur||49194||49194|63114 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|4470|6906|lyfalmen|||00|90|0|180|Vistor hf|Aventis Pharma |Glímepíríð||4470||4470|6906 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2556|4309|lyfalmen|V0926|4309|00|100|0|100|Actavis Group hf|Actavis hf|Cítalópram||2556||2556|4309 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EME|0|0|0|100|SEK|40570|52377|lyfsjukr|||00|1|0|4|MedFarm ehf|E. Merck AB|Sómatrópín||40570||40570|52377 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|A|2|0|0|0|0|AGT|0|0|1|100|DKK|2158|3769|lyfalmen|||20|25|0|25|Actavis Group hf|Actavis Group hf|Metrónídazól||2158||2158|3769 004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dæla|einnotadæl|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2882|4751|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefna­vakar||2882||2882|4751 004623|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5353|8105|lyfalmen|||51|1|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||5353||5353|8105 004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1836|3332|lyfalmen|V0927|3332|00|28|0|56|Actavis Group hf|Actavis hf|Cítalópram||1836||1836|3332 004636|N06AB0402|Oropram|töflur|40|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5188|7881|lyfalmen|V0929|7881|00|56|0|112|Actavis Group hf|Actavis hf|Cítalópram||5188||5188|7881 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5614|8459|lyfalmen|V0930|8459|00|100|0|200|Actavis Group hf|Actavis hf|Cítalópram||5614||5614|8459 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|776|1893|lyfalmen|V0921|1893|00|28|0|14|Actavis Group hf|Actavis hf|Cítalópram||776||776|1893 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2703|4508|lyfalmen|V0922|4508|00|100|0|50|Actavis Group hf|Actavis hf|Cítalópram||2703||2703|4508 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1269|2562|lyfalmen|V0923|2562|00|28|0|28|Actavis Group hf|Actavis hf|Cítalópram||1269||1269|2562 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|A|3|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|100|0|0|Vistor hf|Medic Team|Magnesíum hýdroxíð|||||1713 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|48007|61636|lyfsjukr|||00|5|0|7|Vistor hf|Biovitrum AB (publ)|Anakinra||48007||48007|61636 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1778|3253|lyfalmen|V0925|3253|00|56|0|56|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3253 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|5|Actavis Group hf|Actavis hf|Dextrómetorfan||||| 004699|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|spr||L04AC03|01.04.2007||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|184822|231971|lyfsjukr|||00|19|0|28|Vistor hf|Biovitrum AB (publ)|Anakinra||184822||184822|231971 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EME|0|0|0|100|SEK|202855|254422|lyfsjukr|||00|5|0|20|MedFarm ehf|E. Merck AB|Sómatrópín||202855||202855|254422 004746|A10AE0401|Lantus [OptiPen]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiPen|A10AE04|01.06.2004||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|10440|15008|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10440||10440|15008 004811|J01XD0105|Metronidazol Actavis|irl|5|mg/ml|100|ml|10|poki||J01XD01|01.04.1990|31.07.2009|R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|12047|16866|lyfsjukr|||00|1000|0|3|Actavis Group hf|Actavis Group hf|Metrónídazól||12047||12047|16866 004822|J01XD0105|Metronidazol Actavis|irl|5|mg/ml|200|ml|10|poki||J01XD01|01.04.1990|31.07.2009|R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|22438|29803|lyfsjukr|||00|2000|0|7|Actavis Group hf|Actavis Group hf|Metrónídazól||22438||22438|29803 004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|9889|8049|lyfalmen|V0714|6418|0|100|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||5312||5312|8049 004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|12953|10701|lyfalmen|V0715|8037|10|100|0|22|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||7266||7266|10701 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|729|1830|lyfalmen|||41|24|0|3|Actavis Group hf|Actavis Group hf|Metrónídazól||729||729|1830 004863|R03DX0501|Xolair|sts|150|mg|2|ml|1|hgl|+ leysir, lausn|R03DX05|01.01.2006||R|A|4|0|1|0|1|NOE|0|0|0|100|XEU|77428|98265|lyfsjukr|||00|2|0|9|Vistor hf|Novartis Europharm Ltd|Omalizúmab||77428||77428|98265 004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|6084|8711|lyfsjukr|||00|1|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||6084||6084|8711 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|432|1427|lyfalmen|||41|8|0|2|Actavis Group hf|Actavis Group hf|Metrónídazól||432||432|1427 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|737|1841|lyfalmen|||41|14|0|4|Actavis Group hf|Actavis Group hf|Metrónídazól||737||737|1841 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|1394|2732|lyfalmen|||41|30|0|8|Actavis Group hf|Actavis Group hf|Metrónídazól||1394||1394|2732 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 005085|J07AJ5205|Boostrix|stl|0| |0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1940|3473|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||1940||1940|3473 005089|J07AL0103|Pneumovax|stl|0||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2602|4371|lyfalmen|||00|1|0|0|Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||||2602|4371 005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|9850|7642|lyfalmen|V0437|6955|00|90|0|90|Vistor hf|Yamanouchi Europe|Tamsúlósín||5012||5012|7642 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1864|lyfalmen|||10|30|0|4|Actavis Group hf|Actavis hf|Díkloxacillín||754||754|1864 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|763|1876|lyfalmen|||10|20|0|5|Actavis Group hf|Actavis hf|Díkloxacillín||763||763|1876 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1076|2301|lyfalmen|||10|30|0|8|Actavis Group hf|Actavis hf|Díkloxacillín||1076||1076|2301 005241|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|25580|34032|lyfalmen|||00|360|0|90|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||25580||25580|34032 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2002||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|46334|59871|lyfalmen|||00|100|0|75|Vistor hf|AstraZeneca UK Ltd|Quetíapín||46334||46334|59871 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|A|2,5|0|0|E|0|ASZ|0|0|0|100|SEK|3056|4988|lyfalmen|||00|10|0|4|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3056||3056|4988 005330|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Icepharma hf|Napp|Joð/pólývídón||||| 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|A|2|0|0|E|0|LEP|0|0|1|100|DKK|1265|2557|lyfalmen|||00|2|0|0|Vistor hf|LEO Pharma A/S|Fúsidínsýra||1265||1265|2557 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|glas|+ dæla|L02AE03|01.04.1996||R|A|3|0|1|*|0|ASZ|0|0|0|100|SEK|63887|81724|lyfalmen|||00|1|0|84|Vistor hf|AstraZeneca UK Ltd|Góserelín||63887||63887|81724 005380|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.04.2004||R|K|1|0|1|*|0|PHO|0|0|0|100|NOK|41816|54246|lyfalmen|||00|2|0|0|Icepharma hf|PhotoCure ASA|Metýlamínólevúlínat||41816||41816|54246 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|1669|3105|lyfalmen|||24|200|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1669||1669|3105 005503|N05AH0301|Zyprexa|húðuðtfl|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|33202|18183|lyfalmen|V0815|16911|00|28|0|42|Icepharma hf|Eli Lilly Nederland -|Olanzapín||12850||12850|18183 005507|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|4|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5956|8923|lyfalmen|||00|4|0|28|Icepharma hf|M.S.D.|Alendrónsýra||5956||5956|8923 005526|N05AH0301|Zyprexa|húðuðtfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|42227|54758|lyfalmen|||00|28|0|56|Icepharma hf|Eli Lilly Nederland -|Olanzapín||42227||42227|54758 005538|G03AA0702|Microgyn|töflur|0| |63|stk|1|þpakki||G03AA07|01.06.1977||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1122|2363|lyfalmen|||23|63|0|84|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1122||1122|2363 005565|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|14779|20585|lyfalmen|V0718|7727|00|12|0|84|Icepharma hf|M.S.D.|Alendrónsýra||14779||14779|20585 005576|R05CA1002|Tussol|mixtúra|0| |150|ml|1|glas||R05CA10|01.10.2001||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||01|150|0|0|Actavis Group hf|Actavis hf|Blöndur||||| 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|7029|10379|lyfalmen|V2110|10379|00|30|0|30|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||7029||7029|10379 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|7407|10892|lyfalmen|V0985|10892|0|30|0|30|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||7407||7407|10892 005606|J07AH0703|NeisVac-C|bóluefni|0| |0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|K|3,5|0|0|0|0|BAX|0|0|0|100|USD|4331|6718|lyfalmen|||00|0|0|0|Icepharma hf|Baxter|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4331||4331|6718 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|1794|3275|lyfalmen|||00|30|0|6|Icepharma hf|Servier|Glíklazíð||1794||1794|3275 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|3127|5084|lyfalmen|||00|60|0|11|Icepharma hf|Servier|Glíklazíð||3127||3127|5084 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|8303|12108|lyfalmen|||00|180|0|34|Icepharma hf|Servier|Glíklazíð||8303||8303|12108 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|4563|7033|lyfalmen|||00|90|0|17|Icepharma hf|Servier|Glíklazíð||4563||4563|7033 005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|A|2|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|100|0|100|Actavis Group hf|Actavis hf|Asetýlsalicýlsýra||||| 005747|G03CA0317|Aerodiol|nefúði|150|mcg/sk|180|skammtar|1|pakki|60 skammtar x 3|G03CA03|01.01.2003||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|6907|10214|lyfalmen|||00|180|0|90|Icepharma hf|Servier|Estradíól||6907||6907|10214 005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|2007|3564|lyfalmen|||00|28|0|14|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||2007||2007|3564 005766|H01CC0201|Cetrotide|sts|0,25|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|4840|6930|lyfsjukr|||00|1|0|0|Gróco ehf|Serono Nordic|Cetrorelix||4840||4840|6930 005782|L01BB0501|Fludara|filmhtfl|10|mg|15|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|73921|93899|lyfsjukr|||00|15|0|0|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||73921||73921|93899 005787|H01CC0201|Cetrotide|sts|0,25|mg/hgl|7|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|37948|49113|lyfsjukr|||00|7|0|0|Gróco ehf|Serono Nordic|Cetrorelix||37948||37948|49113 005789|H01CC0201|Cetrotide|sts|3|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|37948|49113|lyfsjukr|||00|1|0|0|Gróco ehf|Serono Nordic|Cetrorelix||37948||37948|49113 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|8178|11938|lyfalmen|||00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||8178||8178|11938 005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|3538|5642|lyfalmen|V0939|5594|00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||3538||3538|5642 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|18561|32121|vetorma|||16|5|0|0|Vistor hf|Merial (MSD)|||18561||18561|32121 005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|7208|10622|lyfalmen|||00|56|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||7208||7208|10622 005836|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|82416|104475|lyfsjukr|||00|20|0|0|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||82416||82416|104475 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|11866|16943|lyfalmen|||00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||11866||11866|16943 005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|5684|8554|lyfalmen|||00|28|0|42|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5684||5684|8554 005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|3529|5629|lyfalmen|||00|28|0|28|Vistor hf|Boehringer Ingelheim International |||3529||3529|5629 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|þpakki||P01BC02|01.01.1993||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|3350|5386|lyfalmen|||59|8|0|2|Icepharma hf|Roche|Meflókvín||3350||3350|5386 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|991|2185|lyfalmen|||00|1|0|1|Icepharma hf|Eli Lilly Nederland -|Olanzapín||991||991|2185 005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|11547|16510|lyfalmen|||00|98|0|98|Vistor hf|Boehringer Ingelheim International |||11547||11547|16510 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|18371|25057|lyfalmen|||00|100|0|150|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||18371||18371|25057 005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|4131|6446|lyfalmen|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|Valsartan||4131||4131|6446 005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|7260|10693|lyfalmen|||00|28|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||7260||7260|10693 005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|10603|13671|lyfalmen|V1110|10942|00|98|0|98|Vistor hf|Novartis Healthcare A/S-|Valsartan||9455||9455|13671 005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|15791|21845|lyfalmen|||00|56|0|112|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||15791||15791|21845 005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|5268|7989|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|Valsartan||5268||5268|7989 005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|14411|19219|lyfalmen|V1111|15463|00|98|0|196|Vistor hf|Novartis Healthcare A/S-|Valsartan||13682||13682|19219 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|95657|120960|lyfsjukr|||00|2|0|1|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíðar||95657||95657|120960 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|6492|9650|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insulín aspart||6492||6492|9650 006026|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|35091|45556|lyfsjukr|||00|60|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||35091||35091|45556 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|138969|174884|lyfsjukr|||00|1|0|1|Icepharma hf|M.S.D.|Caspofungin||138969||138969|174884 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|A|2,5|0|0|*|0|NON|0|0|0|100|DKK|6298|9387|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insúlín aspart||6298||6298|9387 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|191449|240222|lyfsjukr|||00|3|0|2|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíðar||191449||191449|240222 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|89371|113134|lyfsjukr|||00|1|0|1|Icepharma hf|M.S.D.|Caspofungin||89371||89371|113134 006172|S01XA2007|Simplex|augnsm|0| |4|g|1|túpa|paraf+vasel án ullarf.|S01XA20|01.07.2003||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1249|2535|lyfalmen|||00|4|1|0|Parlogis hf|Parlogis - óskráð lyf|Gervitár og aðrar óvirkar sam­setningar||1249||1249|2535 006178|A10AE0402|Lantus [Optiset]|stl|100|ein/ml|3|ml|5|pennar||A10AE04|01.11.2005||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|9255|13400|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9255||9255|13400 006212|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|40499|52289|lyfsjukr|||00|1200|0|0|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||40499||40499|52289 006226|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|69630|88557|lyfsjukr|||00|2400|0|0|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||69630||69630|88557 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2604|4374|lyfalmen|||00|30|0|8|Vistor hf|Recip AB|Flúkloxacillín||||2604|4374 006346|N03AG0101|Depakine|sh-tfl|500|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|2616|4390|lyfalmen|||43|40|0|13|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||2616||2616|4390 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|9899|19027|vetalmen|||00|50|0|0|Vistor hf|Boehringer Ingelheim|||9899||9899|19027 006579|D05AX5201|Daivobet|smyrsli|0| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|8194|11960|lyfalmen|V0391|11960|00|60|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||8194||8194|11960 006637|D05AX5201|Daivobet|smyrsli|0| |120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|13893|19482|lyfalmen|V2001|19482|00|120|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||13893||13893|19482 006650|A04AA0301|Navoban|stl|1|mg/ml|5|ml|10|lykjur||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|39359|51187|lyfalmen|||02|50|0|10|Vistor hf|Novartis Healthcare A/S-|Trópísetrón||39359||39359|51187 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 006785|G03AC0303|NorLevo|töflur|750|mcg|2|stk|1|þpakki||G03AC03|01.01.2005||L|A|3|0|0|0|0|LHP|0|0|0|100|IKR|||lyflausa|||23|2|0|0|Gróco ehf|Laboratoire HRA Pharma|Levonorgestrel||||| 006825|A04AA0301|Navoban|hylki|5|mg|5|stk|1|þpakki||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|17437|23894|lyfalmen|||10|5|0|5|Vistor hf|Novartis Healthcare A/S-|Trópísetrón||17437||17437|23894 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|16418|22625|lyfalmen|||00|98|0|196|Icepharma hf|M.S.D.|Lósartan||16418||16418|22625 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4139|6457|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|||4139||4139|6457 007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|759|1870|lyfalmen|||00|100|0|2|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||759||759|1870 007123|V03AE0201|Renagel|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.01.2004||R|A|2|0|0|0|0|GZE|0|0|0|100|XEU|31516|41422|lyfalmen|||00|180|0|22|Vistor hf|Genzyme Europe B.V.|Sevelamer||31516||31516|41422 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|27174|51934|vetalmen|||27|20|0|0|Vistor hf|Boehringer Ingelheim Danmark|||27174||27174|51934 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|13168|18579|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|||13168||13168|18579 007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|1978|3525|lyfalmen|||00|100|0|8|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||1978||1978|3525 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6202|9257|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|||6202||6202|9257 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|19733|26753|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|||19733||19733|26753 007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|6400|9525|lyfalmen|||00|100|0|33|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||6400||6400|9525 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8233|12013|lyfalmen|||00|28|0|112|Vistor hf|AstraZeneca A/S DK|||8233||8233|12013 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|25454|33875|lyfalmen|||00|98|0|392|Vistor hf|AstraZeneca A/S DK|||25454||25454|33875 007223|B01AX0001|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AX00|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|164196|206292|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|Prótein C||164196||164196|206292 007268|B01AX0001|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AX00|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|290045|362974|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|Prótein C||290045||290045|362974 007278|C08CA0302|Lomir Retard|forðahlk|2,5|mg|30|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2368|4054|lyfalmen|||10|30|0|15|Vistor hf|Novartis Healthcare A/S-|Ísradipín||2368||2368|4054 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|2899|4774|lyfalmen|||00|3|0|30|Vistor hf|Allergan|Bimatóprost||2899||2899|4774 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 007337|H01CB0302|Ipstyl Autogel|stl|60|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|167803|210782|lyfsjukr|||00|1|0|20|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||167803||167803|210782 007360|H01CB0302|Ipstyl Autogel|stl|120|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|258251|323390|lyfsjukr|||00|1|0|40|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||258251||258251|323390 007363|H01CB0302|Ipstyl Autogel|stl|90|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|224523|281399|lyfsjukr|||00|1|0|30|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||224523||224523|281399 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|146507|184269|lyfsjukr|||00|3000|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Linezolíd||146507||146507|184269 007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|þpakki||A02BA02|01.09.1983||L|A|5|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||00|20|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||||| 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|369102|461399|lyfsjukr|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Linezolíd||369102||369102|461399 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|K|2|0|0|*|0|PFI|0|0|0|100|DKK|3627|5762|lyfalmen|V0988|5762|06|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tímólól í blöndum||3627||3627|5762 007448|B05XC04|Cernevit|sts|0| |5|ml|10|hgl||B05XC|01.05.2002||R|A|3|0|0|0|1|CPS|0|0|0|100|SEK|7808|11179|lyfsjukr|||02|50|0|0|Icepharma hf|Clintec parenteral SA|||7808||7808|11179 007449|V03AB0001|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB00|01.09.2003||R|A|2|0|0|0|1|OPO|0|0|0|100|XEU|135512|170580|lyfsjukr|||00|100|0|0|Swedish Orphan International AB|OPi Orphan Pharma international (S)|||135512||135512|170580 007462|N01AB0801|Sevorane|innönd.l|0| |250|ml|1|plastf||N01AB08|01.03.2002||R|A|3|0|0|0|1|ABS|0|0|0|100|DKK|27341|35907|lyfsjukr|||00|250|0|0|Vistor hf|Abbott Scandinavia AB|Sevóflúran||27341||27341|35907 007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dæla|til inntöku|QP52AA01|01.04.2002||L|A|2|0|0|0|0|BAN|0|0|0|0|DKK|||vetorma|||16|7|0|0|Vistor hf|Bayer Animal Health GmbH||||||3826 007505|G04BD0702|Detrusitol Retard|forðahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|7013|10357|lyfalmen|||00|30|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tólteródín||7013||7013|10357 007516|R03BA0701|Asmanex Twisthaler|innúðadu|200|mcg|60|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|5567|8395|lyfalmen|||00|60|0|30|Vistor hf|Schering-Plough Europe|Mometasón||5567||5567|8395 007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3304|5324|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|Candesartan||3304||3304|5324 007538|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|5567|8395|lyfalmen|||00|30|0|30|Vistor hf|Schering-Plough Europe|Mometasón||5567||5567|8395 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|A|2|0|0|0|1|BRS|0|0|0|100|DKK|10217|14588|lyfsjukr|||00|1200|0|4|Vistor hf|Bristol-Myers Squibb|Paracetamól||10217||10217|14588 007541|J07BL0101|Stamaril|bóluefni|0| |0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|24136|32234|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||24136||24136|32234 007549|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|10850|15564|lyfalmen|||00|60|0|60|Vistor hf|Schering-Plough Europe|Mometasón||10850||10850|15564 007559|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|10513|15107|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|Candesartan||10513||10513|15107 007575|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2841|4068|lyfsjukr|||02|9000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2841||2841|4068 007609|C09CA0601|Atacand|töflur|4|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2517|4256|lyfalmen|||00|28|0|14|Vistor hf|AstraZeneca A/S DK|Candesartan||2517||2517|4256 007760|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|8604|12516|lyfalmen|||00|30|0|21|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tólteródín||8604||8604|12516 007769|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|26128|34714|lyfalmen|||00|100|0|70|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tólteródín||26128||26128|34714 007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|1728|3185|lyfalmen|V1075|3185|00|60|0|6|Actavis Group hf|Actavis hf|Risperídón||1728||1728|3185 007852|G02BB0101|NuvaRing|sk-hring|0| |3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|A|3,3|0|0|0|0|ORG|0|0|0|100|DKK|4493|6938|lyfalmen|||00|3|0|84|Vistor hf|N.V. Organon|Skeiðarinnleg með progestógeni og östrógeni||4493||4493|6938 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|0| |50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|A|1,5|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||00|2500|0|0|Icepharma hf|Baxter Medical AB|||||| 007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|0| |100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|A|1,5|0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa|||00|5000|0|0|Icepharma hf|Baxter|||||| 007920|S01EX0601|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EX06|01.02.2004||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|2438|4149|lyfalmen|||00|2|0|0|K.Pétursson hf|Alcon|||2438||2438|4149 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|1376|2708|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|Ólópatadín||1376||1376|2708 007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|178830|224511|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|Drotrecogin alfa (virkjað)||178830||178830|224511 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|15|0|15|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||||| 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|24977|32964|lyfsjukr|||00|10|0|0|Ísaga ehf|AGA AB|Nituroxíð||24977||24977|32964 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|729|1830|lyfalmen|||00|30|1|10|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||729||729|1830 008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|45060|57967|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|Drotrecogin alfa (virkjað)||45060||45060|57967 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|627|1691|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|Metformín||627||627|1691 008028|J05AH0201|Tamiflu|mixtduft|12|mg/ml|1|stk|1|fl|750 mg í flösku|J05AH02|01.11.2002||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|3979|6240|lyfalmen|||00|1|0|5|Icepharma hf|Roche Registration Limited|Oseltamivír||3979||3979|6240 008058|B05BA1011|Oliclinomel N4 550E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|26569|34946|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||26569||26569|34946 008069|B05BA1011|Oliclinomel N4 550E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|33212|43216|lyfsjukr|||00|8000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||33212||33212|43216 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|þpakki||N02CC04|01.03.2003||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|7567|11109|lyfalmen|||00|6|0|3|Icepharma hf|M.S.D.|Rizatriptan||7567||7567|11109 008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|103846|131156|lyfsjukr|||00|4|0|27|Vistor hf|Schering-Plough|Peginterferón alfa 2b||103846||103846|131156 008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|208774|261791|lyfsjukr|||00|4|0|53|Vistor hf|Schering-Plough|Peginterferón alfa 2b||208774||208774|261791 008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|151394|190353|lyfsjukr|||00|4|0|43|Vistor hf|Schering-Plough|Peginterferón alfa 2b||151394||151394|190353 008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|172460|216580|lyfsjukr|||00|4|0|64|Vistor hf|Schering-Plough|Peginterferón alfa 2b||172460||172460|216580 008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|260148|325752|lyfsjukr|||00|4|0|80|Vistor hf|Schering-Plough|Peginterferón alfa 2b||260148||260148|325752 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||||| 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2281|3936|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||2281||2281|3936 008197|R06AX2701|Aerius|saft|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2002||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1304|2610|lyfalmen|||00|120|0|12|Vistor hf|Schering-Plough|Deslóratadín||1304||1304|2610 008219|D07AC0101|Betnovat|áburður|1|mg/ml|20|ml|1|glas||D07AC01|01.12.1980||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|314|1266|lyfalmen|||20|20|0|20|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||314||314|1266 008223|B05BA1013|Oliclinomel N6 900E|irl|0| |1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|34989|45429|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||34989||34989|45429 008234|B05BA1013|Oliclinomel N6 900E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|27321|35882|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||27321||27321|35882 008243|D07AC0101|Betnovat|áburður|1|mg/g|30|ml|1|glas|í hársvörð|D07AC01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|516|1541|lyfalmen|||33|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||516||516|1541 008245|B05BA1013|Oliclinomel N6 900E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|34239|44495|lyfsjukr|||00|8000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||34239||34239|44495 008300|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|7759|11370|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca A/S DK|Candesartan||7759||7759|11370 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|1321|2633|lyfalmen|V0733|2633|00|20|0|7|Actavis Group hf|Actavis hf|Tramadól||1321||1321|2633 008318|C09CA0601|Atacand|töflur|8|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2703|4508|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|Candesartan||2703||2703|4508 008326|D07AC0101|Betnovat|áburður|1|mg/g|100|ml|1|glas|í hársvörð|D07AC01|01.07.1988||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1359|2685|lyfalmen|||33|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1359||1359|2685 008334|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|8604|12516|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|Candesartan||8604||8604|12516 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|5171|7858|lyfalmen|V0734|7858|00|100|0|33|Actavis Group hf|Actavis hf|Tramadól||5171||5171|7858 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|7936|11610|lyfalmen|V0736|11610|00|100|0|50|Actavis Group hf|Actavis hf|Tramadól||7936||7936|11610 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|10449|15020|lyfalmen|V0738|15020|00|100|0|67|Actavis Group hf|Actavis hf|Tramadól||10449||10449|15020 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|K|3|0|1|0|1|GEZ|0|0|0|100|XEU|232261|291032|lyfsjukr|||02|2|0|0|Vistor hf|Genzyme BV|Thýrótrópín||232261||232261|291032 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MAC|0|0|0|100|XEU|874|2026|lyfalmen|V0431|2026|00|100|0|33|Actavis Group PTC ehf|Merck KgaA (A) |Levótýroxínnatríum||874||874|2026 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MAC|0|0|0|100|XEU|739|1843|lyfalmen|V0430|1843|00|100|0|67|Actavis Group PTC ehf|Merck KgaA (A) |Levótýroxínnatríum||739||739|1843 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|5306|9182|vetorma|||00|1000|0|0|Icepharma hf|Chanelle Pharmaceuticals |||5306||5306|9182 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|12245|23496|vetalmen|||00|50|0|0|Icepharma hf|Chanelle Pharmaceuticals |||12245||12245|23496 008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||||| 008523|R06AX2201|Kestine|töflur|10|mg|100|stk|1|þpakki||R06AX22|01.04.1998||R|A|3|0|0|E|0|ALF|0|0|1|100|NOK|4974|7590|lyfalmen|||00|100|0|100|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||4974||4974|7590 008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||||| 008545|G03FB0506|NovoFem|filmhtfl|0| |84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3245|5244|lyfalmen|||23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3245||3245|5244 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|147564|185585|lyfsjukr|||00|2|0|0|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||147564||147564|185585 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|145529|183051|lyfsjukr|||00|2|0|28|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||145529||145529|183051 008785|QP52AC1303|Zerofen, vet.|mixtúra|10|%|500|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|2718|4704|vetorma|||00|500|0|0|Icepharma hf|Chanelle Pharmaceuticals |||2718||2718|4704 008831|D11AX1501|Elidel|krem|1|%|15|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3455|5529|lyfalmen|||00|15|0|15|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||3455||3455|5529 008888|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3304|5324|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||3304||3304|5324 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburður, lausn|D10AF01|01.01.1994||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|2569|4327|lyfalmen|||20|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2569||2569|4327 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6787|10051|lyfalmen|V1350|9866|00|4|0|8|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6787|10051 008938|H02AB0104|Betapred|stl|4|mg/ml|1|ml|5|lykjur||H02AB01|01.07.2004||R|A||0|0|0|0|LVE|0|0|1|100|IKR|950|2130|lyfalmen|||02|5|1|13|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||950||950|2130 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|13370|18831|lyfalmen|V1351|18497|00|8|0|16|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13370|18831 009065|D11AX1501|Elidel|krem|1|%|30|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|5830|8752|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||5830||5830|8752 009079|D11AX1501|Elidel|krem|1|%|100|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|18096|24714|lyfalmen|||00|100|0|100|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||18096||18096|24714 009192|M01AH0401|Dynastat|sts|40|mg/hgl|5|hgl|1|pakki|+leysir 2ml/lykju |M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|8249|12035|lyfalmen|||03|5|0|5|Vistor hf|Pfizer Limited|Parekoxíb||8249||8249|12035 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|15658|21679|lyfalmen|||03|10|0|10|Vistor hf|Pfizer Limited|Parekoxíb||15658||15658|21679 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|68420|87050|lyfsjukr|||00|30|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||68420||68420|87050 009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|400|0|0|Icepharma hf|Fresenius Kabi||||||1769 009285|D11AX1401|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|6231|9296|lyfalmen|||00|30|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||6231||6231|9296 009340|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|400|0|0|Icepharma hf|Fresenius Kabi|||||| 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1529|2915|lyfalmen|||23|8|0|21|Vistor hf|Novartis Healthcare A/S-|Estradíól||1529||1529|2915 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1643|3070|lyfalmen|||23|8|0|28|Vistor hf|Novartis Healthcare A/S-|Estradíól||1643||1643|3070 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1936|3468|lyfalmen|||23|8|0|42|Vistor hf|Novartis Healthcare A/S-|Estradíól||1936||1936|3468 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2227|3863|lyfalmen|||23|8|0|56|Vistor hf|Novartis Healthcare A/S-|Estradíól||2227||2227|3863 009522|N02BE0101|Panodil|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||04|10|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|273308|342136|lyfsjukr|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||273308||273308|342136 009649|D11AX1401|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|6391|9513|lyfalmen|||00|30|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||6391||6391|9513 009672|J05AB0102|Zovir|töflur|400|mg|55|stk|1|þpakki||J05AB01|01.09.2003|30.06.2009|R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|10207|14692|lyfalmen|||00|55|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10207||10207|14692 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|78948|100158|lyfsjukr|||00|30|0|30|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||78948||78948|100158 009688|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|10511|15104|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||10511||10511|15104 009830|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|1|spr||B03XA01|01.05.2006||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|46384|59616|lyfsjukr|||00|1|0|20|Icepharma hf|Roche|Epóetín||46384||46384|59616 009881|A10BD0201|Glucovance|filmhtfl|502,5|mg|30|stk|1|þpakki|500+2,5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|944|2121|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|Metformin og súlfónamíð||944||944|2121 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7382|10858|lyfalmen|||02|180|0|0|Vistor hf|Dentsply Limited|Mepívakaín||7382||7382|10858 009905|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7247|10675|lyfalmen|||00|180|0|0|Vistor hf|Dentsply Limited|||7247||7247|10675 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8589|12496|lyfalmen|||17|180|0|0|Vistor hf|Dentsply Limited|||8589||8589|12496 009913|N06AX1102|Remeron Smelt|munndr.t|15|mg|6|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|616|1676|lyfalmen|||00|6|0|3|Vistor hf|N.V. Organon|Mirtazapín||616||616|1676 009942|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7819|11451|lyfalmen|||00|180|0|0|Vistor hf|Dentsply Limited|||7819||7819|11451 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8620|12538|lyfalmen|||17|180|0|0|Vistor hf|Dentsply Limited|||8620||8620|12538 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6632|9840|lyfalmen|||02|180|0|0|Vistor hf|Dentsply Limited|Mepívakaín||6632||6632|9840 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|2617|4392|lyfalmen|V1151|3122|00|30|0|15|Vistor hf|N.V. Organon|Mirtazapín||2617||2617|4392 010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|4644|7143|lyfalmen|V1152|4545|00|30|0|30|Vistor hf|N.V. Organon|Mirtazapín||4644||4644|7143 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|9918|14300|lyfalmen|||00|30|0|45|Vistor hf|N.V. Organon|Mirtazapín||9918||9918|14300 010070|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|áfyllt sprauta, lausn|L03AA13|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|191112|239802|lyfsjukr|||00|1|0|20|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||191112||191112|239802 010102|G03GA0502|Gonal-f|sts|75|ae|1|hgl|1|pakki|(5,5 mcg) + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|4956|7566|lyfalmen|||00|1|0|1|Gróco ehf|Serono Europe|Follitrópín alfa||4956||4956|7566 010135|A10BD0201|Glucovance|filmhtfl|505|mg|30|stk|1|þpakki|500+5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|1352|2675|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|Metformin og súlfónamíð||1352||1352|2675 010159|G03GA0502|Gonal-f|sts|75|ae|10|hgl|1|pakki|(5,5 mcg) + leysir |G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|50916|65575|lyfalmen|||00|10|0|10|Gróco ehf|Serono Europe|Follitrópín alfa||50916||50916|65575 010164|G03GA0502|Gonal-f|sts|450|ae|1|hgl|1|pakki|á 0,75ml + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|30552|40222|lyfalmen|||00|1|0|6|Gróco ehf|Serono Europe|Follitrópín alfa||30552||30552|40222 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|A|3|0|0|0|1|RRL|0|0|0|100|DKK|272518|341152|lyfsjukr|||00|60|0|30|Icepharma hf|Roche Registration Limited|Valgancíklóvír||272518||272518|341152 010187|H01AX0101|Somavert|sts|10|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|471068|588347|lyfsjukr|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegvisómant||471068||471068|588347 010203|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt sprauta|B03XA02|01.04.2005||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|182056|228527|lyfsjukr|||00|1|0|111|Vistor hf|Amgen|Darbepóetín alfa||182056||182056|228527 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|9198|13169|lyfsjukr|||00|1|0|0|Icepharma hf|M.S.D.|Ertapenem||9198||9198|13169 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|14415|20132|lyfalmen|V1153|14023|00|96|0|96|Vistor hf|N.V. Organon|Mirtazapín||14415||14415|20132 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|20324|27488|lyfalmen|||00|96|0|144|Vistor hf|N.V. Organon|Mirtazapín||20324||20324|27488 010312|N06DX0101|Ebixa|töflur|10|mg|30|stk|1|þpakki||N06DX01|01.10.2002|30.06.2009|R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|9153|13261|lyfalmen|||00|30|0|15|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||9153||9153|13261 010323|N06DX0101|Ebixa|töflur|10|mg|50|stk|1|þpakki||N06DX01|01.10.2002|30.06.2009|R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|14950|20798|lyfalmen|||00|50|0|25|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||14950||14950|20798 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|26044|34610|lyfalmen|||00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||26044||26044|34610 010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|4362|6760|lyfalmen|||00|28|0|56|Vistor hf|Boehringer Ingelheim International |||4362||4362|6760 010348|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|10037|14461|lyfalmen|||51|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||10037||10037|14461 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|14090|19727|lyfalmen|||00|98|0|196|Vistor hf|Boehringer Ingelheim International |||14090||14090|19727 010437|QI09AB1301|Stellamune One|stl|0| |100|ml|10|glös|fleyti|QI09AB13|01.09.2008||R|K|3|0|0|0|0|PZR|0|0|0|100|DKK|83142|158544|vetalmen|||00|1000|0|0|Icepharma hf|Pfizer A/S (Í)|||83142||83142|158544 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.01.2003||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|6931|10246|lyfalmen|||00|60|0|32|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||6931||6931|10246 010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|BAM|0|0|0|100|SEK|13344|18481|lyfsjukr|||00|2500|0|0|Icepharma hf|Baxter Medical AB|Elektrólýtar||13344||13344|18481 010534|B05BA0108|Vaminolac|irl|0| |100|ml|10|fl||B05BA01|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9384|13436|lyfsjukr|||00|1000|0|1|Icepharma hf|Fresenius Kabi|Amínósýrur||9384||9384|13436 010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|A|3|0|0|0|0|SAO|0|0|1|100|XEU|1494|2868|lyfalmen|||00|5|0|0|Icepharma hf|Santen Oy|Levófloxacín||1494||1494|2868 010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|5326|8068|lyfalmen|||00|4|0|28|Vistor hf|Sanofi-aventis Norge AS|||5326||5326|8068 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7069|10121|lyfsjukr|||00|7500|0|8|Icepharma hf|Baxter Medical AB|Kolvetni||7069||7069|10121 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|12963|18006|lyfsjukr|||00|5000|0|5|Icepharma hf|Baxter Medical AB|Kolvetni||12963||12963|18006 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4934|7064|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Kolvetni||4934||4934|7064 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2827|4048|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Kolvetni||2827||2827|4048 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|8062|11781|lyfalmen|||00|9|0|90|Vistor hf|Allergan|Bimatóprost||8062||8062|11781 010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|12963|18006|lyfsjukr|||00|5000|0|5|Icepharma hf|Baxter Medical AB|Elektrólýtar||12963||12963|18006 010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7116|10188|lyfsjukr|||00|7500|0|8|Icepharma hf|Baxter Medical AB|Elektrólýtar||7116||7116|10188 010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4744|6792|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Elektrólýtar||4744||4744|6792 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|13811|19380|lyfalmen|V1080|19380|00|12|0|84|Vistor hf|Sanofi-aventis Norge AS|||13811||13811|19380 010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2633|3770|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Elektrólýtar||2633||2633|3770 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|SEK|469567|586478|lyfsjukr|||00|56|0|14|Swedish Orphan International AB|Actelion Registration Ltd. (S)|Bósentan||469567||469567|586478 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|SEK|439618|549192|lyfsjukr|||00|56|0|28|Swedish Orphan International AB|Actelion Registration Ltd. (S)|Bósentan||439618||439618|549192 010837|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|704036|878392|lyfsjukr|||00|30|0|45|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegvisómant||704036||704036|878392 010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|936996|1168428|lyfsjukr|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegvisómant||936996||936996|1168428 010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|1358|2672|lyfalmen|||10|28|0|28|Actavis Group hf|Actavis hf|Ómeprazól||1350||1350|2672 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|300|0|20|Icepharma hf|GlaxoSmithKline CH A/S|Klórhexidín||||| 010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|6037|7550|lyfalmen|V2171|7550|10|100|0|100|Actavis Group hf|Actavis hf|Ómeprazól||4944||4944|7550 010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|3384|4259|lyfalmen|V2170|4259|10|56|0|56|Actavis Group hf|Actavis hf|Ómeprazól||2519||2519|4259 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|K|3,5|0|1|0|1|BAM|0|0|0|100|SEK|51447|65919|lyfsjukr|||03|10|0|0|Icepharma hf|Baxter Medical AB|Bleómýcín||51447||51447|65919 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|A|3|0|0|0|1|REP|0|0|0|100|SEK|2959|4237|lyfsjukr|||03|10|0|5|Vistor hf|Recip AB|Kloxacillín||2959||2959|4237 010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|SEK|3115|5068|lyfalmen|||00|28|0|14|Icepharma hf|Wyeth AB|Lansóprazól||3115||3115|5068 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|24970|33273|lyfalmen|||00|28|0|19|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||24970||24970|33273 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|24970|33273|lyfalmen|||00|28|0|28|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||24970||24970|33273 010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|50|0|17|Icepharma hf|GlaxoSmithKline CH A/S|Klórhexidín||||| 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|38723|50395|lyfalmen|V1702|50395|00|56|0|37|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||38723||38723|50395 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|38459|50066|lyfalmen|V1703|50066|00|56|0|56|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||38459||38459|50066 011163|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|18956|25785|lyfalmen|||00|100|0|33|Vistor hf|AstraZeneca A/S DK|Búdesóníð||18956||18956|25785 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|5072|7723|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|Etoríkoxíb||5072||5072|7723 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|5270|7992|lyfalmen|||00|28|0|42|Icepharma hf|M.S.D.|Etoríkoxíb||5270||5270|7992 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|22854|30638|lyfalmen|V2172|30638|00|100|0|200|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||22854||22854|30638 011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|992|2187|lyfalmen|V0195|2187|00|28|0|7|Actavis Group hf|Actavis hf|Lósartan||992||992|2187 011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|13843|19420|lyfalmen|||02|5|0|167|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||13843||13843|19420 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1427|2777|lyfalmen|||00|28|0|28|Actavis Group hf|Actavis hf|Lósartan||1427||1427|2777 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|4069|5469|lyfalmen|V0197|5469|00|98|0|98|Actavis Group hf|Actavis hf|Lósartan||3411||3411|5469 011409|R03AK0703|Symbicort forte Turbuhaler|innúðadu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|8503|12379|lyfalmen|||00|60|0|30|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8503||8503|12379 011453|G04BE0901|Levitra|filmhtfl|5|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|13090|18482|lyfalmen|||00|12|0|6|Vistor hf|Bayer AG-|Vardenafíl||13090||13090|18482 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|7029|10379|lyfalmen|||00|30|0|18|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7029||7029|10379 011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|8257|11822|lyfsjukr|||02|10000|0|0|Icepharma hf|Baxter Medical AB|Mannitól||8257||8257|11822 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|2718|3891|lyfsjukr|||00|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Esketamín||2718||2718|3891 011547|M01AH0501|Arcoxia|filmhtfl|120|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|6627|9834|lyfalmen|||00|28|0|56|Icepharma hf|M.S.D.|Etoríkoxíb||6627||6627|9834 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|9183|13302|lyfalmen|||00|30|0|36|Vistor hf|Janssen-Cilag AB|Metýlfenídat||9183||9183|13302 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|A|5|0|0|0|0|CHP|1|0|0|100|USD|1710|3374|vetalmen|||00|25|0|0|Icepharma hf|Chanelle Pharmaceuticals |||1710||1710|3374 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|5435|7782|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Esketamín||5435||5435|7782 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|með skammtadælu|G03CA03|01.03.2000||R|A|2|0|0|E|0|OLF|0|0|0|100|SEK|1453|2812|lyfalmen|||00|64|0|29|Gróco ehf|Oy Leiras Finland Ab|Estradíól||1453||1453|2812 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|112325|141712|lyfsjukr|||00|168|0|34|Icepharma hf|Roche Registration Limited|Ribavirin||112325||112325|141712 011810|D11AX1501|Elidel|krem|1|%|60|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|11599|16581|lyfalmen|||00|60|0|60|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||11599||11599|16581 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2003|3559|lyfalmen|V0935|3559|00|28|0|56|Actavis Group hf|Actavis hf|Sertralín||2003||2003|3559 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|7008|10351|lyfalmen|V0937|10351|00|98|0|196|Actavis Group hf|Actavis hf|Sertralín||7008||7008|10351 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4339|6212|lyfsjukr|||02|20|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||4339||4339|6212 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3941|5643|lyfsjukr|||02|20|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3941||3941|5643 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|þpakki||N06DX01|01.06.2009||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|8997|13050|lyfalmen|||00|28|0|14|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|Memantín||||8997|13050 011986|C10AA0403|Lescol depot|forðatfl|80|mg|28|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|5030|7666|lyfalmen|||00|28|0|37|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||5030||5030|7666 011997|C10AA0403|Lescol depot|forðatfl|80|mg|98|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|17313|23740|lyfalmen|||00|98|0|131|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||17313||17313|23740 012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|48220|61901|lyfsjukr|||00|30|0|30|Icepharma hf|M.S.D.|Efavirenz||48220||48220|61901 012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|12556|17817|lyfalmen|||00|90|0|90|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríð||12556||12556|17817 012260|R01AC0301|Lastin|nefúði|1|mg/ml|20|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1372|2702|lyfalmen|||00|20|0|36|Vistor hf|Meda AB|Azelastínum||1372||1372|2702 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6764|10019|lyfalmen|||00|4|0|4|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6764||6764|10019 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|4|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012309|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|6004|10390|vetorma|||00|20|0|0|Icepharma hf|Icepharma hf|||6004||6004|10390 012310|A10BB1201|Amaryl|töflur|1|mg|30|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|888|2045|lyfalmen|||00|30|0|15|Vistor hf|Aventis Pharma |Glímepíríð||888||888|2045 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|10883|15609|lyfalmen|||00|30|0|54|Vistor hf|Janssen-Cilag AB|Metýlfenídat||10883||10883|15609 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012640|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|28217|48831|vetorma|||00|100|0|0|Icepharma hf|Icepharma hf|||28217||28217|48831 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|7|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|A|3|0|1|0|1|WTE|0|0|0|100|USD|530043|661771|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|Díbótermín alfa||530043||530043|661771 012770|G04BE0901|Levitra|filmhtfl|5|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|4667|7174|lyfalmen|||00|4|0|2|Vistor hf|Bayer AG-|Vardenafíl||4667||4667|7174 012792|G04BE0901|Levitra|filmhtfl|10|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|5164|7848|lyfalmen|||00|4|0|4|Vistor hf|Bayer AG-|Vardenafíl||5164||5164|7848 012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|10|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012816|G04BE0901|Levitra|filmhtfl|10|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|15213|21125|lyfalmen|||00|12|0|12|Vistor hf|Bayer AG-|Vardenafíl||15213||15213|21125 012838|G04BE0901|Levitra|filmhtfl|20|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|6402|9528|lyfalmen|||00|4|0|8|Vistor hf|Bayer AG-|Vardenafíl||6402||6402|9528 012860|G04BE0901|Levitra|filmhtfl|20|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|18511|25231|lyfalmen|||00|12|0|24|Vistor hf|Bayer AG-|Vardenafíl||18511||18511|25231 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|718|1815|lyfalmen|||08|80|0|4|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|1815 012921|G03AA1301|Evra|forðapl|0| |9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|A|2|0|0|0|0|JCI|0|0|0|100|SEK|4357|6753|lyfalmen|||00|9|0|0|Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og östrógen||4357||4357|6753 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|A|3|0|0|E|0|LBI|0|0|0|100|SEK|6736|9981|lyfalmen|||00|30|0|30|Icepharma hf|Laboratoires Besins International|Testósterón||6736||6736|9981 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|6948|10269|lyfalmen|||00|30|0|20|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||6948||6948|10269 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|7619|14684|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||7619||7619|14684 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|10489|15074|lyfalmen|||00|30|0|40|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||10489||10489|15074 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1976|3899|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||1976||1976|3899 013097|A02BC0301|Lanzo|munndr.t|15|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|1341|2660|lyfalmen|||00|14|0|7|Icepharma hf|Wyeth AB|Lansóprazól||1341||1341|2660 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|24977|32964|lyfsjukr|||00|2|0|0|Ísaga ehf|AGA AB|Nituroxíð||24977||24977|32964 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|K|3|0|0|0|1|ZLB|0|0|0|100|SEK|9650|13816|lyfsjukr|||17|2|0|0|Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||9650||9650|13816 013259|B02BD0901|BeneFIX|sts|0| |250|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|35039|45491|lyfsjukr|||00|250|0|1|Icepharma hf|Wyeth Europe|Storkuþáttur IX||35039||35039|45491 013270|B02BD0901|BeneFIX|sts|0| |500|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|70081|89118|lyfsjukr|||00|500|0|1|Icepharma hf|Wyeth Europe|Storkuþáttur IX||70081||70081|89118 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|5004|9703|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||5004||5004|9703 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|12026|23079|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||12026||12026|23079 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1262|2490|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||1262||1262|2490 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BAL|0|0|0|100|SEK|197954|248320|lyfsjukr|||00|1|0|3|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||197954||197954|248320 013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|32992|42943|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||32992||32992|42943 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|131969|166169|lyfsjukr|||00|1|0|2|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||131969||131969|166169 013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|64267|81880|lyfsjukr|||00|1|0|2|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||64267||64267|81880 013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.05.2003||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|21169|28540|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|Ezetimíb||21169||21169|28540 013544|L04AB0401|Humira|stl|40|mg/spr|0,8|ml|2|spr||L04AB04|01.12.2003||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|190997|239659|lyfsjukr|||00|2|0|28|Vistor hf|Abbott|Adalimumab||190997||190997|239659 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|A||1|0|0|0|NOP|0|0|0|100|DKK|1373|2704|lyfalmen|||00|5|0|2|Icepharma hf|Norpharma|Oxýcódon||||1373|2704 013593|A01AA3001|Xerodent|munnstfl|0| |90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|A|2|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||00|90|0|0|Actavis Group hf|Actavis Group hf|Blöndur|||||1367 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|A||1|0|0|0|NOP|0|0|0|100|DKK|2637|4419|lyfalmen|||00|5|0|3|Icepharma hf|Norpharma|Oxýcódon||||2637|4419 013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1369|2698|lyfalmen|||00|40|0|5|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||1369||1369|2698 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|503|1523|lyfalmen|||00|30|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||503||503|1523 013718|M05BA0801|Zometa|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|47832|61418|lyfsjukr|||00|5|0|1|Vistor hf|Novartis Europharm Ltd|||47832||47832|61418 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|B|0|NOH|0|0|0|100|DKK|5289|8018|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||5289||5289|8018 013767|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|98|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|B|0|NOH|0|0|0|100|DKK|15977|22076|lyfalmen|||00|98|0|196|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||15977||15977|22076 013802|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.08.2009||R|A||0|0|B|0|SPL|0|0|1|100|DKK|1087|2315|lyfalmen|||00|1|0|5|Vistor hf|Schering-Plough Europe|Betametasón||||1087|2315 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2003||R|A|3|0|0|0|0|GSK|0|0|1|100|IKR|1215|2489|lyfalmen|V0465|2489|00|20|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2489 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|7832|11469|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín (manna)||7832||7832|11469 013909|A10AB0107|Actrapid NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AB01|01.08.2003||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|6084|9097|lyfalmen|||51|15|0|38|Vistor hf|Novo-Nordisk|Insúlín (manna)||6084||6084|9097 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2981|4886|lyfalmen|||51|10|0|25|Vistor hf|Novo-Nordisk|Insúlín (manna)||2981||2981|4886 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5220|7924|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín (manna)||5220||5220|7924 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|233694|292817|lyfsjukr|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|Imatiníb||233694||233694|292817 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|406259|507660|lyfsjukr|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|Imatiníb||406259||406259|507660 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2955|4850|lyfalmen|||71|10|0|25|Vistor hf|Novo-Nordisk|Insúlín (manna)||2955||2955|4850 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|A|2|0|0|0|1|AZD|0|0|0|100|SEK|15778|21511|lyfsjukr|||00|50|0|13|Vistor hf|AstraZeneca A/S DK|Esómeprazól||15778||15778|21511 014081|N03AX1401|Keppra|mixtúra|100|mg|300|ml|1|glas||N03AX14|01.12.2006||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|26419|35077|lyfalmen|||00|300|0|20|Vistor hf|U.C.B|Levetíracetam||26419||26419|35077 014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|K|2|0|0|0|0|ELD|0|0|0|100|XEU|64442|82415|lyfalmen|||AC|3|0|38|Icepharma hf|Eli Lilly Nederland -|Teriparatíð||64442||64442|82415 014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|40483|52269|lyfsjukr|||00|5908|0|0|Icepharma hf|Fresenius Kabi|Blöndur||40483||40483|52269 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|3|hylki|320+9 mcg/sk|R03AK07|01.08.2009||R|A||0|0|B|0|AZD|0|0|0|100|SEK|25508|33942|lyfalmen|||00|180|0|90|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||25508|33942 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1393|2731|lyfalmen|||00|30|0|30|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1393||1393|2731 014285|B05BA1020|StructoKabiven elektrolyfri|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|24938|32915|lyfsjukr|||00|3940|0|0|Icepharma hf|Fresenius Kabi|Blöndur||24938||24938|32915 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|A|2|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||29|4|0|0|Vistor hf|Janssen-Cilag AB|Levókabastín||||| 014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|27395|35974|lyfsjukr|||00|3944|0|0|Icepharma hf|Fresenius Kabi|Blöndur||27395||27395|35974 014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|35724|46344|lyfsjukr|||00|5908|0|0|Icepharma hf|Fresenius Kabi|Blöndur||35724||35724|46344 014372|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|24938|32915|lyfsjukr|||00|3940|0|0|Icepharma hf|Fresenius Kabi|Blöndur||24938||24938|32915 014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|flaska||P01AB01|01.08.2009||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2314|3981|lyfalmen|||00|100|1||Distica|Distica - óskráð lyf|Metrónídazól||||2314|3981 014435|QM01AE03  |Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|A|3|0|0|0|0|VET|0|0|0|100|XEU|2581|5088|vetalmen|||00|45|0|0|Dýraheilsa ehf|Vetcare Ltd.|||||2581|5088 014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|A|3|0|0|0|0|SCH|0|0|0|100|SEK|16756|23046|lyfalmen|||23|1|0|1825|Icepharma hf|Schering Oy|Plast lyfjalykkja (IUD) með prógestógen||16756||16756|23046 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|A|2|0|1|0|1|GIS|0|0|0|100|DKK|93195|117895|lyfsjukr|||0|30|0|30|Gilead Sience Sweden AB|Gilead Science International ltd.|||||93195|117895 014541|QA02BX1201|Orbeseal|spenalyf|2,6|g/dælu|24|dælur|1|pakki||QA02BX12|01.04.2005||R|A|5|0|0|0|0|PFI|0|0|0|100|XEU|6416|12393|vetalmen|||16|24|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6416||6416|12393 014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|318697|398645|lyfsjukr|||00|60|0|0|Icepharma hf|Roche Registration Limited|Enfúvirtíð||318697||318697|398645 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2715|4525|lyfalmen|||10|28|0|2|Icepharma hf|Norpharma |Oxýcódon||2715||2715|4525 014702|C09CA0601|Atacand|töflur|32|mg|28|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|4703|7223|lyfalmen|||00|28|0|112|Vistor hf|AstraZeneca A/S DK|Candesartan||4703||4703|7223 014713|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|14769|20572|lyfalmen|||00|98|0|392|Vistor hf|AstraZeneca A/S DK|Candesartan||14769||14769|20572 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|76335|96905|lyfsjukr|||00|2|0|4|Vistor hf|Amgen Europe B.V.|Fílgrastím||76335||76335|96905 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|119440|150570|lyfsjukr|||00|2|0|7|Vistor hf|Amgen Europe B.V.|Fílgrastím||119440||119440|150570 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|21748|29261|lyfalmen|||00|60|0|10|Icepharma hf|Novartis Healthcare A/S|Everolímus||21748||21748|29261 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|65626|83889|lyfalmen|||00|60|0|30|Icepharma hf|Novartis Healthcare A/S|Everolímus||65626||65626|83889 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|43683|56570|lyfalmen|||00|60|0|20|Icepharma hf|Novartis Healthcare A/S|Everolímus||43683||43683|56570 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|90|0|24|Icepharma hf|Pharma Nord ApS|Glúkósamín||||| 015230|R01AC0301|Lastin|nefúði|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|699|1789|lyfalmen|||00|10|0|18|Vistor hf|Meda AB|Azelastínum||699||699|1789 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|270|0|72|Icepharma hf|Pharma Nord ApS|Glúkósamín||||| 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|4886|7471|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Mirtazapín||4886||4886|7471 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|9690|13990|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín detemír||9690||9690|13990 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|2563|4318|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|Mirtazapín||2563||2563|4318 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|2760|4586|lyfalmen|||00|100|1|33|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||2760||2760|4586 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1228|2507|lyfalmen|||23|8|0|14|Vistor hf|Novartis Healthcare A/S-|Estradíól||1228||1228|2507 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2084|3442|lyfalmen|V0832|3442|00|6|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1917||1917|3442 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3042|4556|lyfalmen|V0831|4556|00|12|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||2738||2738|4556 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|11931|17031|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín detemír||11931||11931|17031 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|389439|486719|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||389439||389439|486719 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|103511|130739|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||103511||103511|130739 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6906|10212|lyfalmen|||00|30|0|3|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6906||6906|10212 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|15219|21133|lyfalmen|V1732|21133|00|100|0|11|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15219||15219|21133 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6906|10212|lyfalmen|||00|30|0|10|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6906||6906|10212 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|16452|22668|lyfalmen|V1731|22668|00|100|0|33|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||16452||16452|22668 015677|N05CF0201|Stilnoct|töflur|10|mg|1000|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|36510|47640|lyfalmen|||00|1000|0|1000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||36510||36510|47640 015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|90092|114032|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||90092||90092|114032 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|90092|114032|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||90092||90092|114032 015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|90092|114032|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||90092||90092|114032 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6906|10212|lyfalmen|||00|30|0|7|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6906||6906|10212 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|15059|20933|lyfalmen|V1730|20932|00|100|0|22|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15059||15059|20933 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|90092|114032|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||90092||90092|114032 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|31283|41132|lyfalmen|||00|120|0|10|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||31283||31283|41132 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|54407|69922|lyfalmen|||00|120|0|22|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||54407||54407|69922 015800|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA04|01.01.1977||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|1027|2234|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Cýklópentólat||1027||1027|2234 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3591|6214|vetorma|||16|2|0|0|Vistor hf|Bayer HealthCare AG|||3591||3591|6214 015833|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A|3|0|0|0|1|VIL|0|0|0|100|NOK|4106|5879|lyfsjukr|||00|750|0|0|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||||4106|5879 015844|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A|3|0|0|0|1|VIL|0|0|0|100|NOK|7855|11246|lyfsjukr|||00|1500|0|0|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||||7855|11246 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|5046|8732|vetorma|||16|12|0|0|Vistor hf|Bayer HealthCare AG|||5046||5046|8732 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3204|5545|vetorma|||16|1|0|0|Vistor hf|Bayer HealthCare AG|||3204||3204|5545 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|4017|6952|vetorma|||16|3|0|0|Vistor hf|Bayer HealthCare AG|||4017||4017|6952 015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|þpakki||M01CC01|01.05.1978||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|5118|7786|lyfalmen|||10|50|0|25|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||5118||5118|7786 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|4500|7787|vetorma|||16|8|0|0|Vistor hf|Bayer HealthCare AG|||4500||4500|7787 015912|D11AX1401|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AX14|01.03.2009||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|2262|3910|lyfalmen|||0|10|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||||2262|3910 015923|D11AX1401|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AX14|01.10.2007||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|2540|4287|lyfalmen|||00|10|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||2540||2540|4287 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1712|3164|lyfalmen|||02|10|0|3|Icepharma hf|Martindale Pharmaceuticals|Morfín||1712||1712|3164 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3591|6214|vetorma|||16|1|0|0|Vistor hf|Bayer HealthCare AG|||3591||3591|6214 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|A|3|0|0|B|0|GSK|0|1|0|100|GBP|1647|3075|lyfalmen|||00|28|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1647||1647|3075 015985|C09AA0401|Coversyl|töflur|8|mg|90|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|17457|23919|lyfalmen|||00|90|0|180|Icepharma hf|Servier|Perindópríl||17457||17457|23919 016000|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|5362|8117|lyfalmen|||00|6|0|6|Vistor hf|Laboratorios Almirall S.A.|Almótriptan||5362||5362|8117 016003|C09AA0401|Coversyl|töflur|8|mg|30|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|5872|8809|lyfalmen|||00|30|0|60|Icepharma hf|Servier|Perindópríl||5872||5872|8809 016011|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|7591|11142|lyfalmen|||00|9|0|9|Vistor hf|Laboratorios Almirall S.A.|Almótriptan||7591||7591|11142 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|13447|18926|lyfalmen|||00|100|0|100|Vistor hf|AstraZeneca A/S DK|||13447||13447|18926 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1272|2567|lyfalmen|||02|10|0|1|Icepharma hf|Martindale Pharmaceuticals|Petidín||1272||1272|2567 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|20146|27267|lyfalmen|||00|100|0|200|Vistor hf|AstraZeneca A/S DK|||20146||20146|27267 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1348|2670|lyfalmen|||02|20|0|2|Icepharma hf|Martindale Pharmaceuticals|Petidín||1348||1348|2670 016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|2768|4597|lyfalmen|||00|3|0|3|Vistor hf|Laboratorios Almirall S.A.|Almótriptan||2768||2768|4597 016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.10.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 016125|M02AA1001|Orudis|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.03.2000||L|A|2|0|0|0|0|SNO|0|0|1|100|IKR|||lyflausa|||00|60|0|0|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||||| 016178|A10BD0301|Avandamet|filmhtfl|502|mg|112|stk|1|þpakki|500+2mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|8865|12871|lyfalmen|||00|112|0|56|GlaxoSmithKline ehf|SmithKline Beecham PLC|Metformín og rosiglítazón||8865||8865|12871 016209|N05AX0801|Risperdal|töflur|2|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.09.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|8042|11754|lyfalmen|||00|28|0|11|Vistor hf|Janssen-Cilag AB|Risperídón||8042||8042|11754 016239|A10BD0301|Avandamet|filmhtfl|501|mg|112|stk|1|þpakki|500+1mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|4959|7570|lyfalmen|||00|112|0|56|GlaxoSmithKline ehf|SmithKline Beecham PLC|Metformín og rosiglítazón||4959||4959|7570 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3704|5867|lyfalmen|||00|14|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3704||3704|5867 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|7542|11075|lyfalmen|||00|56|0|14|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7542||7542|11075 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|K|2|0|1|E|0|SEE|0|0|0|100|SEK|5002|7628|lyfalmen|||00|0|0|1|Gróco ehf|Serono Europe|Chóríógónadótrópín alfa||5002||5002|7628 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|11437|16361|lyfalmen|||00|56|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11437||11437|16361 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2488|4217|lyfalmen|||00|14|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2488||2488|4217 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|16615|22871|lyfalmen|||00|56|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||16615||16615|22871 016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|12580|17847|lyfalmen|||10|100|0|100|Vistor hf|Novartis Healthcare A/S-|Ísradipín||12580||12580|17847 016353|N05AX0801|Risperdal|töflur|1|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.08.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|4530|6988|lyfalmen|||00|28|0|6|Vistor hf|Janssen-Cilag AB|Risperídón||4530||4530|6988 016363|L01BC0108|Cytarabine Pfizer|stl/irl|20|mg/ml|5|ml|5|hgl||L01BC01|01.11.2000||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|5226|7482|lyfsjukr|||00|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cýtarabín||5226||5226|7482 016364|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|2|ml|5|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|6616|9472|lyfsjukr|||00|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metótrexat||6616||6616|9472 016374|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|20|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|19216|25791|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cýtarabín||19216||19216|25791 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|A|1,5|0|0|0|1|PFI|0|0|0|100|DKK|158438|199123|lyfsjukr|||00|70|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||158438||158438|199123 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|9609|13758|lyfsjukr|||00|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cýtarabín||9609||9609|13758 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2948|4841|lyfalmen|||00|56|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2948||2948|4841 016396|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|8885|12721|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metótrexat||8885||8885|12721 016474|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|5|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|30120|39367|lyfsjukr|||00|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Karbóplatín||30120||30120|39367 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016506|N07BA0111|Nicorette Classic|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016516|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|45|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|252946|316785|lyfsjukr|||00|225|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Karbóplatín||252946||252946|316785 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016534|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|15|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|88712|112314|lyfsjukr|||00|75|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Karbóplatín||88712||88712|112314 016561|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|19823|26865|lyfalmen|V1701|26865|00|28|0|6|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19823||19823|26865 016605|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016622|A06AG1101|Microlax|innhl|0| |5|ml|50|túpa||A06AG11|01.09.2005||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|250|0|50|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||7749 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|38723|50395|lyfalmen|||00|56|0|12|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||38723||38723|50395 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1026|2233|lyfalmen|V0466|2233|00|12|0|12|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1026||1026|2233 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|270780|338989|lyfsjukr|||00|2|0|180|Icepharma hf|Roche|Epóetín||270780||270780|338989 016686|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|3|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|236724|296589|lyfsjukr|||00|6|0|0|Icepharma hf|Ipsen Ltd.|Sómatrópín||236724||236724|296589 016699|A10BA0202|Glucophage (Lyfjaver)|töflur|500|mg|400|stk|1|plglas||A10BA02|01.09.2003||R|A|5|0|0|*|0|LVR|0|0|0|100|NOK|2993|4902|lyfalmen|||00|400|0|100|Lyfjaver ehf|Lyfjaver ehf|Metformín||2993||2993|4902 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|8837|12833|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||8837||8837|12833 016728|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|1|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|78908|100108|lyfsjukr|||00|2|0|0|Icepharma hf|Ipsen Ltd.|Sómatrópín||78908||78908|100108 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|4203|6544|lyfalmen|V0789|5536|10|200|0|40|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||4203||4203|6544 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|7663|11239|lyfalmen|V0713|9508|10|200|0|80|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||7663||7663|11239 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|72719|92720|lyfalmen|||00|28|0|28|Vistor hf|Amgen Europe B.V.|Cinacalcet||72719||72719|92720 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|107489|136009|lyfalmen|||00|28|0|42|Vistor hf|Amgen Europe B.V.|Cinacalcet||107489||107489|136009 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|34979|45734|lyfalmen|||00|28|0|0|Vistor hf|Amgen Europe B.V.|Cinacalcet||34979||34979|45734 016892|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|57133|73316|lyfalmen|||00|2|0|12|Gróco ehf|Serono Europe|Follitrópín alfa||57133||57133|73316 016927|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|21854|29393|lyfalmen|||00|0|0|4|Gróco ehf|Serono Europe|Follitrópín alfa||21854||21854|29393 016938|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|32778|42994|lyfalmen|||00|1|0|6|Gróco ehf|Serono Europe|Follitrópín alfa||32778||32778|42994 016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|2486|4214|lyfalmen|||00|14|0|14|Icepharma hf|Wyeth AB|Lansóprazól||2486||2486|4214 016954|A02BC0301|Lanzo|munndr.t|30|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|4823|7385|lyfalmen|||00|28|0|28|Icepharma hf|Wyeth AB|Lansóprazól||4823||4823|7385 016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|9393|13587|lyfalmen|||00|98|0|49|Icepharma hf|Wyeth AB|Lansóprazól||9393||9393|13587 016965|A02BC0301|Lanzo|munndr.t|30|mg|56|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|7578|11124|lyfalmen|||00|56|0|56|Icepharma hf|Wyeth AB|Lansóprazól||7578||7578|11124 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|A|3|0|1|0|1|GIS|0|0|0|100|XEU|45446|58448|lyfsjukr|||00|30|0|30|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||45446||45446|58448 016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|16578|22825|lyfalmen|||00|98|0|98|Icepharma hf|Wyeth AB|Lansóprazól||16578||16578|22825 016979|N02AE0103|Norspan|forðapl|5|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|3922|6163|lyfalmen|||00|4|0|17|Icepharma hf|Norpharma |Búprenorfín||3922||3922|6163 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.12.2006||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|21245|40640|vetalmen|||16|60|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||21245||21245|40640 017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|36758|47631|lyfsjukr|||00|4824|0|0|Icepharma hf|Fresenius Kabi|Blöndur||36758||36758|47631 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1730|3188|lyfalmen|||03|3|0|21|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Medroxýprógesterón||1730||1730|3188 017111|A09AA0201|Combizym|töflur|0| |100|stk|1|þpakki||A09AA02|01.07.1988||R|A|2|0|0|E|0|DSG|0|0|0|100|XEU|1750|3215|lyfalmen|||10|100|0|25|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1750||1750|3215 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|K|2|0|1|0|1|SKY|0|0|0|100|DKK|325597|407236|lyfsjukr|||00|5|0|0|Icepharma hf|SkyPharma PLC|Cýtarabín||325597||325597|407236 017145|C08DB0102|Cardizem Retard|forðatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|A|2|0|0|B|0|FRO|0|0|0|100|DKK|7838|11477|lyfalmen|||10|60|0|45|Vistor hf|Ferrosan A/S|Diltíazem||7838||7838|11477 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|A|3|0|1|0|1|JCI|0|0|0|100|SEK|175840|220788|lyfsjukr|||00|1|0|0|Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||175840||175840|220788 017203|M05BA0601|Bondronat|irþ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|51333|65777|lyfsjukr|||00|6|0|1|Icepharma hf|Roche|||51333||51333|65777 017204|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|3|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|37992|49168|lyfsjukr|||00|5712|0|0|Icepharma hf|Fresenius Kabi|Blöndur||37992||37992|49168 017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|1543|2934|lyfalmen|V0221|2934|00|100|0|33|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||1543||1543|2934 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|K|2|0|1|0|1|BIN|0|0|0|100|XEU|154725|194500|lyfsjukr|||00|2|0|28|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||154725||154725|194500 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|57287|73507|lyfalmen|||00|28|0|0|Icepharma hf|Roche|||57287||57287|73507 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|170991|215069|lyfalmen|||00|84|0|0|Icepharma hf|Roche|||170991||170991|215069 017266|N02AE0103|Norspan|forðapl|10|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|6943|10262|lyfalmen|||00|4|0|33|Icepharma hf|Norpharma |Búprenorfín||6943||6943|10262 017294|N03AX1202|Gabapentin NM Pharma|hylki|300|mg|100|stk|1|glas||N03AX12|01.10.2007||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|4110|6418|lyfalmen|V0714|6418|00|100|0|17|Actavis Group PTC ehf|Merck NM AB|Gabapentín||4110||4110|6418 017326|N02AE0103|Norspan|forðapl|20|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|12966|18328|lyfalmen|||00|4|0|67|Icepharma hf|Norpharma |Búprenorfín||12966||12966|18328 017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|3051|4981|lyfalmen|||00|100|0|67|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||3051||3051|4981 017331|A04AD1201|Emend|hylki|0| |3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|A|2,5|0|0|0|1|MSD|0|0|0|100|XEU|12903|17932|lyfsjukr|||00|3|0|0|Icepharma hf|M.S.D.|Aprepitant||12903||12903|17932 017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|792|1915|lyfalmen|||00|20|0|5|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||792||792|1915 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|A|2|0|0|E|0|REP|0|0|1|100|SEK|3115|5068|lyfalmen|||00|30|0|150|Vistor hf|Recip AB|Prednisón||3115||3115|5068 017541|N07CA0101|Betaserc|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.06.1999||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|8181|11942|lyfalmen|||00|100|0|67|Medico ehf|Solvay Duphar |Betahistín||8181||8181|11942 017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1215|2489|lyfalmen|V0465|2489|00|20|0|12|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1215||1215|2489 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|7582|14614|vetalmen|||00|100|0|0|Vistor hf|Boehringer Ingelheim|||7582||7582|14614 017763|N06DA0401|Reminyl|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|38302|49871|lyfalmen|V1371|49871|00|84|0|84|Vistor hf|Janssen-Cilag AB|Galantamín||38302||38302|49871 017773|N06DA0401|Reminyl|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|11986|17106|lyfalmen|V1370|17106|00|28|0|14|Vistor hf|Janssen-Cilag AB|Galantamín||11986||11986|17106 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12688|17982|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eplerenón||12688||12688|17982 017809|N06DA0401|Reminyl|forðahlk|24|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|48206|62201|lyfalmen|||00|84|0|126|Vistor hf|Janssen-Cilag AB|Galantamín||48206||48206|62201 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|10778|15467|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eplerenón||10778||10778|15467 018044|D06BX0103|Rozex|hlaup|7,5|mg/g|30|g|1|túpa||D06BX01|01.01.1998||R|A||0|0|0|0|LDR|0|0|1|100|IKR|1373|2704|lyfalmen|||00|30|1|30|Parlogis hf|Parlogis - óskráð lyf|Metrónídazól||1373||1373|2704 018268|G03FA1701|Angemin|töflur|0| |84|stk|1|þpakki|2+1 mg|G03FA17|01.06.2005||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|6508|9672|lyfalmen|||00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrogen||6508||6508|9672 018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|3059|4992|lyfalmen|||00|28|0|14|Gróco ehf|Daiichi Sankyo Europe GmbH-|||3059||3059|4992 018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|4517|6970|lyfalmen|||00|28|0|56|Gróco ehf|Daiichi Sankyo Europe GmbH-|||4517||4517|6970 018453|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|1|spr||L02BA03|01.06.2004||R|K|3|0|1|0|1|ASZ|0|0|0|100|SEK|65983|84016|lyfsjukr|||00|5|0|0|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||65983||65983|84016 018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|14146|19797|lyfalmen|||00|98|0|196|Gróco ehf|Daiichi Sankyo Europe GmbH-|||14146||14146|19797 018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|9936|14324|lyfalmen|||00|98|0|49|Gróco ehf|Daiichi Sankyo Europe GmbH-|||9936||9936|14324 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|3520|5617|lyfalmen|||02|0|0|0|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin með blóðmaur||3520||3520|5617 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|3845|6058|lyfalmen|||02|0|0|0|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin með blóðmaur||3845||3845|6058 018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|11669|16676|lyfalmen|||00|98|0|98|Gróco ehf|Daiichi Sankyo Europe GmbH-|||11669||11669|16676 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1499|2875|lyfalmen|||00|42|0|4|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1499||1499|2875 018558|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|5|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|17699|23903|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||17699||17699|23903 018569|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|87517|110826|lyfsjukr|||00|25|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||87517||87517|110826 018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|3799|5996|lyfalmen|||00|28|0|28|Gróco ehf|Daiichi Sankyo Europe GmbH-|||3799||3799|5996 018591|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|35649|46251|lyfsjukr|||00|17|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||35649||35649|46251 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|9356|13537|lyfalmen|||00|30|0|60|Vistor hf|Astellas Pharma A/S|Sólífenacín||9356||9356|13537 018663|J01DD0401|Rocephalin|stþ|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|15484|21145|lyfsjukr|||03|5|0|2|Icepharma hf|Roche|Ceftríaxón||15484||15484|21145 018670|C09CA0301|Diovan|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|1652|3082|lyfalmen|||00|14|0|7|Vistor hf|Novartis Healthcare A/S-|Valsartan||1652||1652|3082 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|22926|30728|lyfalmen|||00|90|0|180|Vistor hf|Astellas Pharma A/S|Sólífenacín||22926||22926|30728 018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|3306|5327|lyfalmen|||00|28|0|14|Vistor hf|Novartis Healthcare A/S-|Valsartan||3306||3306|5327 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|11.06.2004||R|A|3|0|0|B|0|MAC|0|0|1|100|XEU|1256|2545|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck KgaA (A) |Prednisólón||1256||1256|2545 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|7381|10857|lyfalmen|||00|30|0|30|Vistor hf|Astellas Pharma A/S|Sólífenacín||7381||7381|10857 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|18666|25424|lyfalmen|||00|90|0|90|Vistor hf|Astellas Pharma A/S|Sólífenacín||18666||18666|25424 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|42300|54848|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eplerenón||42300||42300|54848 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|147043|184936|lyfsjukr|||00|28|0|0|Vistor hf|Teva Pharmaceuticals Limited|Glatíramer acetat||||147043|184936 018894|N06DA0202|Aricept (Lyfjaver)|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.01.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|54268|69185|lyfalmen|V0375|43136|00|98|0|65|Lyfjaver ehf|Lyfjaver ehf|Dónepezíl||53815||53815|69185 018908|N06DA0202|Aricept (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.01.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|58909|74676|lyfalmen|V0376|48147|00|98|0|131|Lyfjaver ehf|Lyfjaver ehf|Dónepezíl||58226||58226|74676 018927|M05BA0402|Fosamax (Lyfjaver)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.03.2004||R|A|2|0|0|E|0|LVR|0|0|0|100|XEU|16517|22749|lyfalmen|V0718|7727|00|12|0|84|Lyfjaver ehf|Lyfjaver ehf|Alendrónsýra||16517||16517|22749 018956|R06AX2201|Kestine|töflur|20|mg|30|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|3524|5623|lyfalmen|||00|30|0|60|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||3524||3524|5623 018967|R06AX2201|Kestine|töflur|20|mg|100|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|10901|15634|lyfalmen|||00|100|0|200|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||10901||10901|15634 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|65544|83470|lyfsjukr|||43|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|Fosamprenavír||65544||65544|83470 018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|674|1755|lyfalmen|||00|100|0|50|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||674||674|1755 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1248|2463|vetalmen|||27|100|0|0|Icepharma hf|Kela Laboratoria NV|||1248||1248|2463 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|11983|17102|lyfalmen|V1052|15357|00|5|0|62|Vistor hf|Janssen-Cilag AB|Fentanýl||11983||11983|17102 019065|N06DA0302|Exelon (Lyfjaver)|hylki|6|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|16638|22899|lyfalmen|||00|56|0|37|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||16638||16638|22899 019079|N06DA0302|Exelon (Lyfjaver)|hylki|4,5|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|16638|22899|lyfalmen|||00|56|0|28|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||16638||16638|22899 019082|N06DA0302|Exelon (Lyfjaver)|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|16310|21715|lyfalmen|V1372|21713|00|56|0|19|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||15687||15687|21715 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|8619|12537|lyfalmen|V1051|11214|00|5|0|42|Vistor hf|Janssen-Cilag AB|Fentanýl||8619||8619|12537 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27592|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27592 019102|N06DA0302|Exelon (Lyfjaver)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|8319|12130|lyfalmen|||00|28|0|5|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||8319||8319|12130 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|4663|7168|lyfalmen|V1050|6228|00|5|0|21|Vistor hf|Janssen-Cilag AB|Fentanýl||4663||4663|7168 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30654|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30654 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||13480||13480|18650 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||15297||15297|20912 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|14766|20569|lyfalmen|V1053|18194|00|5|0|83|Vistor hf|Janssen-Cilag AB|Fentanýl||14766||14766|20569 019293|B02BC0001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC00|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|DKK|64407|82054|lyfsjukr|||00|1|0|0|Gróco ehf|Nycomed Danmark A/S|||64407||64407|82054 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|XEU|839706|1047301|lyfsjukr|||00|10|0|0|Gróco ehf|Nycomed Danmark A/S|Bívalirúdín||839706||839706|1047301 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7723|11321|lyfalmen|||00|56|0|0|Icepharma hf|Eli Lilly Nederland -|||7723||7723|11321 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|67208|85541|lyfsjukr|||AC|4|0|0|Icepharma hf|Roche Registration Limited|Bevacizúmab||67208||67208|85541 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7723|11321|lyfalmen|||00|56|0|0|Icepharma hf|Eli Lilly Nederland -|||7723||7723|11321 019491|N06AX2102|Yentreve|hylki|40|mg|140|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|19005|25846|lyfalmen|||00|140|0|0|Icepharma hf|Eli Lilly Nederland -|||19005||19005|25846 019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|677|1759|lyfalmen|||00|100|0|100|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||677||677|1759 019589|C09CA0401|Aprovel|filmhtfl|150|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|4000|6269|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||4000||4000|6269 019600|C09CA0401|Aprovel|filmhtfl|150|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|9995|14404|lyfalmen|||00|98|0|98|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||9995||9995|14404 019611|C09CA0401|Aprovel|filmhtfl|300|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|5702|8578|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||5702||5702|8578 019622|C09CA0401|Aprovel|filmhtfl|300|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|15331|21272|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||15331||15331|21272 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|0|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019699|C09DA0401|CoAprovel|filmhtfl|162,5|mg|28|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|4000|6269|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||4000||4000|6269 019710|C09DA0401|CoAprovel|filmhtfl|162,5|mg|98|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|13968|19575|lyfalmen|||00|98|0|98|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||13968||13968|19575 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|6839|9792|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||6839||6839|9792 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019721|C09DA0401|CoAprovel|filmhtfl|312,5|mg|28|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|5702|8578|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||5702||5702|8578 019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019732|C09DA0401|CoAprovel|filmhtfl|312,5|mg|98|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|16197|22350|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||16197||16197|22350 019739|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|708|1801|lyfalmen|||00|250|0|250|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||708||708|1801 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|33157|43148|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||33157||33157|43148 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|224056|280817|lyfsjukr|||AC|16|0|0|Icepharma hf|Roche Registration Limited|Bevacizúmab||224056||224056|280817 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019786|J01CA0410|Amoxicillin Merck NM|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1014|2216|lyfalmen|||10|20|0|10|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1014||1014|2216 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|A|2|0|1|0|1|ELD|0|0|0|100|XEU|243834|305441|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|Pemetrexed||243834||243834|305441 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13739|19290|lyfalmen|||00|28|0|4|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13739||13739|19290 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13739|19290|lyfalmen|||00|28|0|6|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13739||13739|19290 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|62907|80504|lyfalmen|||00|1|0|12|Vistor hf|N.V. Organon|Follitrópín beta||62907||62907|80504 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13739|19290|lyfalmen|||00|28|0|9|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13739||13739|19290 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13739|19290|lyfalmen|||00|28|0|14|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13739||13739|19290 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13739|19290|lyfalmen|||00|28|0|21|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13739||13739|19290 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|K|4|0|1|0|1|BIA|0|0|0|100|DKK|888017|1107449|lyfsjukr|||02|6|0|9|Vistor hf|Biovitrum AB (publ)|Palifermín||888017||888017|1107449 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|433|1428|lyfalmen|||00|12|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||433||433|1428 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|74273|94337|lyfsjukr|||00|30|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||74273||74273|94337 019968|J01CA0410|Amoxicillin Merck NM|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1518|2900|lyfalmen|||10|30|0|15|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1518||1518|2900 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||43|100|0|50|Vistor hf|AstraZeneca A/S DK|Ferrósúlfat||||| 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0|0|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||| 020134|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 020180|C03CC0101|Edecrin|sts|0| |50|mg|1|hgl||C03CC01|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|26861|35309|lyfsjukr|||00|50|1|1|Parlogis hf|Parlogis - óskráð lyf|||26861||26861|35309 020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 020238|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|30|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|5036|7674|lyfalmen|||00|30|0|30|Vistor hf|Astellas Pharma A/S|Tamsúlósín||5036||5036|7674 020244|J07CA0204|Boostrix Polio|stl|0| |0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|28959|38239|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mænusótt, stífkrampi||28959||28959|38239 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stil|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|A|5|0|0|0|0|LVR|0|0|0|100|NOK|2655|4443|lyfalmen|||04|50|0|50|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2655||2655|4443 020277|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.02.2007||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|858|2005|lyfalmen|V0953|1604|00|7|0|3|Icepharma hf|Wyeth AB|Venlafaxín||858||858|2005 020338|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|90|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|11071|15864|lyfalmen|||00|90|0|90|Vistor hf|Astellas Pharma A/S|Tamsúlósín||11071||11071|15864 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|60014|76902|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|Leuprórelín||60014||60014|76902 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|4556|7023|lyfalmen|||00|84|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||4556||4556|7023 020398|N06AB1001|Cipralex|dropar|10|mg/ml|28|ml|1|glas||N06AB10|01.11.2005||R|A|2|0|0|B|0|LBK|0|1|0|100|DKK|4099|6403|lyfalmen|||00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4099||4099|6403 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|13170|18582|lyfalmen|||00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||13170||13170|18582 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|27826|36828|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|Leuprórelín||27826||27826|36828 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|819|1952|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||819||819|1952 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|7818|11450|lyfalmen|||00|28|0|28|Icepharma hf|Servier|Strontíum ranelat||7818||7818|11450 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2389|4082|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2389||2389|4082 020494|N03AX1102|Topimax (Lyfjaver)|töflur|25|mg|60|stk|1|plglas||N03AX11|01.08.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|4692|6391|lyfalmen|V0709|6391|00|60|0|5|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||4090||4090|6391 020510|N03AX1102|Topimax (Lyfjaver)|töflur|50|mg|60|stk|1|plglas||N03AX11|01.07.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|6837|9980|lyfalmen|V0710|9977|00|60|0|10|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||6735||6735|9980 020516|N03AX1102|Topimax (Lyfjaver)|töflur|100|mg|60|stk|1|plglas||N03AX11|01.09.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|13629|17324|lyfalmen|V0711|17324|00|60|0|20|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||12160||12160|17324 020523|N06AB1002|Cipralex (D.A.C.)|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.07.2004||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|3565|5594|lyfalmen|V0939|5594|00|28|0|28|D.A.C. ehf|D.A.C. ehf|Escítalópram||3503||3503|5594 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|22936|30740|lyfalmen|||00|84|0|84|Icepharma hf|Servier|Strontíum ranelat||22936||22936|30740 020616|G03CA0319|Vagifem (D.A.C.)|sk-tfl|25|mcg|15|stk|1|þpakki||G03CA03|01.07.2004|31.05.2009|R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|2051|3624|lyfalmen|||5|15|0|15|D.A.C. ehf|D.A.C. ehf|Estradíól||2051||2051|3624 020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|þpakki||R06AX22|01.10.2005||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|20|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||||| 020649|N03AX1203|Neurontin (D.A.C.)|hylki|300|mg|50|stk|1|þpakki||N03AX12|01.07.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK||4446|lyfalmen|||10|50|0|8|D.A.C. ehf|D.A.C. ehf|Gabapentín||2657||2657|4446 020711|G03AC0302|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AC03|01.01.2007||L|A|4|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||23|1|0|0|Icepharma hf|Medimpex UK Limited|Levonorgestrel||||| 020763|R03AK0704|Symbicort Turbuhaler (D.A.C.)|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.08.2004|31.05.2009|R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|7715|11310|lyfalmen|||0|120|0|30|D.A.C. ehf|D.A.C. ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7715||7715|11310 020770|QP54AA5101|Eqvalan Duo|pasta|0| |7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|A|3|0|0|0|0|MES|0|0|0|100|XEU|2510|4344|vetorma|||16|8|0|0|Vistor hf|Merial SAS|||2510||2510|4344 020774|L04AB0101|Enbrel|sts|0| |50|mg|4|hgl|+ leysir|L04AB01|01.10.2005||R|K|3|0|1|0|1|WTE|0|0|0|100|USD|216218|271059|lyfsjukr|||00|200|0|29|Icepharma hf|Wyeth Europe|Etanercept||216218||216218|271059 020826|N06AX1601|Efexor|töflur|37,5|mg|28|stk|1|þpakki||N06AX16|01.10.1996|30.06.2009|R|A|3|0|0|B|0|WLN|0|1|0|100|USD|2554|4306|lyfalmen|||00|28|0|10|Icepharma hf|Wyeth Lederle Nordiska|Venlafaxín||||2554|4306 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|A|2|0|0|0|0|DAC|0|0|1|100|DKK|3112|5064|lyfalmen|V0429|4704|00|3|0|5|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||3112||3112|5064 021031|R05CB0102|Mucomyst|lausn|200|mg/ml|10|ml|10|hgl|innöndunarvökvi|R05CB01|01.11.2006|31.05.2009|R|K|3|0|0|E|0|BIP|0|0|0|100|SEK|5510|8318|lyfalmen|||00|100|0|0|Vistor hf|BioPhausia AB|Acetýlcýstein||5510||5510|8318 021048|R03DC0301|Singulair|filmhtfl|10|mg|28|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|6814|10087|lyfalmen|||63|28|0|28|Icepharma hf|M.S.D.|Montelúkast||6814||6814|10087 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|2332|4005|lyfalmen|||00|60|0|60|Icepharma hf|Galderma Nordic AB|Adapalen||2332||2332|4005 021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|þpakki|500+125 mg|J01CR02|01.05.2005||R|A|2|0|0|0|0|DAC|0|0|1|100|IKR|714|1809|lyfalmen|||00|12|0|8|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|1809 021091|S01ED5107|Xalacom (D.A.C.)|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.11.2004||R|K|2|0|0|*|0|DAC|0|0|0|100|DKK|3896|6127|lyfalmen|V0988|5762|06|2|0|0|D.A.C. ehf|D.A.C. ehf|Tímólól í blöndum||3896||3896|6127 021107|N05AH0403|Seroquel (D.A.C.)|töflur|100|mg|60|stk|1|þpakki||N05AH04|01.05.2005||R|A|3|0|0|*|0|DAC|0|1|0|100|SEK|9953|12628|lyfalmen|||00|60|0|15|D.A.C. ehf|D.A.C. ehf|Quetíapín||8686||8686|12628 021120|N03AX1103|Topamax (D.A.C.)|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.11.2004|31.05.2009|R|A|3|0|0|E|0|DAC|0|0|0|100|SEK|11974|15545|lyfalmen|||00|60|0|20|D.A.C. ehf|D.A.C. ehf|Tópíramat||10836||10836|15545 021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|þpakki|875+125 mg|J01CR02|01.05.2005||R|A|1,5|0|0|0|0|DAC|0|0|1|100|IKR|1093|2233|lyfalmen|V0466|2233|00|12|0|12|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||1026||1026|2233 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|453|1436|lyfalmen|V0609|1424|00|30|0|15|Actavis Group hf|Actavis hf|Díklófenak||439||439|1436 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|A|2|0|0|E|0|GEM|0|0|0|100|XEU|1148|2398|lyfalmen|||00|10|0|0|Actavis Group hf|Gerhard Mann|Dexpantenól||1148||1148|2398 021221|R03AC0303|Terbasmin Turbuhaler (D.A.C.)|innönddu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.11.2004|31.05.2009|R|A|2|0|0|B|0|DAC|0|0|1|100|SEK|1705|3154|lyfalmen|||23|200|0|50|D.A.C. ehf|D.A.C. ehf|Terbútalín||1705||1705|3154 021226|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.09.2007||R|A|5|0|0|B|0|DAC|0|1|0|100|DKK|4383|3736|lyfalmen|V0931|2428|00|28|0|28|D.A.C. ehf|D.A.C. ehf|Sertralín||2134||2134|3736 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1187|2451|lyfalmen|V0610|2451|00|100|0|50|Actavis Group hf|Actavis hf|Díklófenak||1187||1187|2451 021232|N06AB0603|Zoloft (D.A.C.)|filmhtfl|100|mg|28|stk|1|þpakki||N06AB06|01.11.2004||R|A|5|0|0|B|0|DAC|0|1|0|100|DKK|6839|5696|lyfalmen|V0935|3559|00|28|0|56|D.A.C. ehf|D.A.C. ehf|Sertralín||3578||3578|5696 021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|16783|23080|lyfalmen|||02|4|0|56|Icepharma hf|Bayer Schering Pharma AG|Testósterón||16783||16783|23080 021278|S01EE0102|Xalatan (D.A.C.)|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2009||R|K|3|0|0|*|0|DAC|0|0|0|100|DKK|3078|5017|lyfalmen|V1989|4751|0|2|0|25|D.A.C. ehf|D.A.C. ehf|Latanóprost||||3078|5017 021325|R03BB0402|Spiriva (D.A.C.)|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.11.2004||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|7972|10892|lyfalmen|V0985|10892|0|30|0|30|D.A.C. ehf|D.A.C. ehf|Tíótrópíumbrómíð||7407||7407|10892 021341|R03AK0603|Seretide Diskus (Lyfjaver)|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2009||R|A|1,5|0|0|B|0|LVR|0|0|0|100|GBP|9810|14153|lyfalmen|V0993|14153|23|60|0|30|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||9810|14153 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|19453|26404|lyfalmen|||63|98|0|98|Icepharma hf|M.S.D.|Montelúkast||19453||19453|26404 021365|R03AK0603|Seretide Diskus (Lyfjaver)|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2009||R|A|1,5|0|0|B|0|LVR|0|0|0|100|GBP|7494|11010|lyfalmen|V0992|11010|23|60|0|30|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||7494|11010 021373|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.04.2006||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|5421|8197|lyfalmen|V0085|8197|00|28|0|37|D.A.C. ehf|D.A.C. ehf|Esómeprazól||5421||5421|8197 021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|þpakki||M01AB05|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|20|0|2|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||| 021398|L02BB0303|Casodex (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.11.2004||R|A|5|0|0|*|0|DAC|0|0|0|100|XEU|20449|23178|lyfalmen|V0560|23178|00|30|0|30|D.A.C. ehf|D.A.C. ehf|Bíkalútamíð||16862||16862|23178 021417|R01AD0504|Rhinocort (D.A.C.)|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.11.2004|31.05.2009|R|A|2|0|0|E|0|DAC|0|0|1|100|SEK|1377|2709|lyfalmen|||24|120|0|38|D.A.C. ehf|D.A.C. ehf|Búdesóníð||1377||1377|2709 021426|N04BX0203|Comtan (D.A.C.)|filmhtfl|200|mg|100|stk|1|glas||N04BX02|01.11.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|13723|17776|lyfalmen|V0729|17776|0|100|0|20|D.A.C. ehf|D.A.C. ehf|Entakapón||12523||12523|17776 021428|A06AB0201|Dulcolax|eþ-stil|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|A|5|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||04|6|0|6|Vistor hf|Boehringer Ingelheim|Bisakódýl||||| 021447|N04BC0402|Requip (D.A.C.)|töflur|2|mg|84|stk|1|plglas||N04BC04|01.11.2004||R|A|2|0|0|E|0|DAC|0|0|0|100|GBP|13015|18389|lyfalmen|V0728|18389|00|84|0|28|D.A.C. ehf|D.A.C. ehf|Rópíníról||13015||13015|18389 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|25505|33939|lyfalmen|||63|98|0|49|Icepharma hf|M.S.D.|Montelúkast||25505||25505|33939 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3091|4426|lyfsjukr|||02|100|0|0|Icepharma hf|Fresenius Kabi|Própófól||3091||3091|4426 021548|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|200|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|3142|5104|lyfalmen|||23|100|0|25|D.A.C. ehf|D.A.C. ehf|Búdesóníð||3142||3142|5104 021559|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|400|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|5143|7820|lyfalmen|||23|100|0|50|D.A.C. ehf|D.A.C. ehf|Búdesóníð||5143||5143|7820 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|5248|7962|lyfalmen|||00|30|0|4|Vistor hf|Ferring Lægemidler A/S|Desmópressín||5248||5248|7962 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|16583|22831|lyfalmen|||00|100|0|15|Vistor hf|Ferring Lægemidler A/S|Desmópressín||16583||16583|22831 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|13169|18580|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca A/S DK|||13169||13169|18580 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FAB|0|0|0|100|DKK|9779|14111|lyfalmen|||00|30|0|9|Vistor hf|Ferring AB, Svíþjóð|Desmópressín||9779||9779|14111 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|30489|39826|lyfsjukr|||02|1000|0|0|Icepharma hf|Fresenius Kabi|Própófól||30489||30489|39826 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|25933|34472|lyfalmen|||00|100|0|30|Vistor hf|Ferring Lægemidler A/S|Desmópressín||25933||25933|34472 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|41171|53125|lyfsjukr|||02|500|0|0|Icepharma hf|Fresenius Kabi|Própófól||41171||41171|53125 021659|V01AA0304|Alutard SQ, derm. pter.|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|27472|36388|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||27472||27472|36388 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4139|6457|lyfalmen|||00|28|0|14|Vistor hf|AstraZeneca A/S DK|||4139||4139|6457 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|19376|25991|lyfsjukr|||02|500|0|0|Icepharma hf|Fresenius Kabi|Própófól||19376||19376|25991 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|5179|7415|lyfsjukr|||02|50|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tranexamsýra||5179||5179|7415 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|21994|29568|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||21994||21994|29568 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|4325|6710|lyfalmen|V1951|6710|00|28|0|14|Icepharma hf|Eli Lilly Nederland -|||4325||4325|6710 021862|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.02.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|5421|8197|lyfalmen|V0085|8197|00|28|0|37|D.A.C. ehf|D.A.C. ehf|Esómeprazól||5421||5421|8197 021950|B05AA0705|HyperHAES|irl|0| |250|ml|10|pokar||B05AA07|01.07.2005||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|28868|37808|lyfsjukr|||00|2500|0|2|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||28868||28868|37808 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|5977|8951|lyfalmen|||00|28|0|28|Icepharma hf|Eli Lilly Nederland -|||5977||5977|8951 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|20597|27828|lyfalmen|||00|98|0|98|Icepharma hf|Eli Lilly Nederland -|||20597||20597|27828 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|21994|29568|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||21994||21994|29568 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|102502|129482|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|Erlótiníb||102502||102502|129482 022087|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.10.1995||R|A|5|0|0|0|0|LAH|0|0|0|100|DKK|803|1585|vetalmen|||16|20|0|0|Vistor hf|LEO Animal Health A/S|||803||803|1585 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|200|0|45|Actavis Group hf|Actavis Group hf|Natríumflúoríð||||| 022132|C10BA0201|Inegy|töflur|30|mg|98|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|27054|35867|lyfalmen|||00|98|0|131|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||27054||27054|35867 022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|31569|41488|lyfalmen|||00|98|0|261|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||31569||31569|41488 022181|C10BA0201|Inegy|töflur|90|mg|98|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|32535|42691|lyfalmen|||00|98|0|523|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||32535||32535|42691 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|354538|443267|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|Erlótiníb||354538||354538|443267 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|365765|457245|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|Erlótiníb||365765||365765|457245 022215|N06AB0504|Paxetin|töflur|20|mg|20|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|584|1424|lyfalmen|V0917|1424|00|20|0|20|Actavis Group hf|Actavis hf|Paroxetín||430||430|1424 022218|QP52AA5102|Drontal Comp.vet.|töflur|0| |24|stk|1|þpakki||QP52AA51|01.01.2006||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|11590|20057|vetorma|||00|24|0|0|Vistor hf|Bayer Animal Health GmbH|||11590||11590|20057 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|K|2|0|1|0|0|ALL|0|0|0|100|SEK|26198|34801|lyfalmen|||02|1|0|0|Vistor hf|Allergan|Clostridium botulinum toxín-A||26198||26198|34801 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|2563|4435|vetorma|||00|2|0|0|Vistor hf|Bayer HealthCare AG|||2563||2563|4435 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|3292|5308|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||3292||3292|5308 022281|QP52AA5102|Drontal Comp.vet.|töflur|0| |2|stk|1|þpakki||QP52AA51|01.10.1991||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|||vetorma|||00|2|0|0|Vistor hf|Bayer Animal Health GmbH||||||2135 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|4403|4981|lyfalmen|V0308|3043|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||3051||3051|4981 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|7610|7422|lyfalmen|V0310|4428|00|100|0|200|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||4850||4850|7422 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|2427|4200|vetorma|||00|1|0|0|Vistor hf|Bayer HealthCare AG|||2427||2427|4200 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|839|1979|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||839||839|1979 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2439|4150|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2439||2439|4150 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|1571|2719|vetorma|||00|1|0|0|Vistor hf|Bayer HealthCare AG|||1571||1571|2719 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|5288|8016|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||5288||5288|8016 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2400|3240|lyfalmen|V0919|3240|00|100|0|100|Actavis Group hf|Actavis hf|Paroxetín||1768||1768|3240 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1554|2385|lyfalmen|V0918|2385|00|60|0|60|Actavis Group hf|Actavis hf|Paroxetín||1138||1138|2385 022585|L04AX0304|Metotrexato Lederle (D.A.C.)|töflur|2,5|mg|50|stk|1|glas||L04AX03|01.08.2005||R|A|3|0|0|*|0|DAC|0|0|0|100|USD|1483|2853|lyfalmen|||00|50|0|50|D.A.C. ehf|D.A.C. ehf|Metótrexat||1483||1483|2853 022609|A07EC0205|Pentasa (D.A.C)|forðatfl|500|mg|60|stk|1|þpakki||A07EC02|01.08.2006||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|4435|5692|lyfalmen|||10|60|0|20|D.A.C. ehf|D.A.C. ehf|Mesalazín (5-amínósalicýlsýra)||3575||3575|5692 022708|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|15336|21278|lyfalmen|V0192|19556|00|98|0|196|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||15336||15336|21278 022802|L01XC0401|MabCampath|irþ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|K|2|0|1|0|1|GEU|0|0|0|100|SEK|247949|310564|lyfsjukr|||00|3|0|0|Icepharma hf|Genzyme Europe B.V. (I)|Alemtuzumab||247949||247949|310564 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|A|3|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar sam­setningar|||||2966 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|1407|2750|lyfalmen|||67|30|0|10|Actavis Group hf|Actavis hf|Ísótretínóín||1407||1407|2750 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|2450|4165|lyfalmen|||67|30|0|20|Actavis Group hf|Actavis hf|Ísótretínóín||2450||2450|4165 022962|V01AA1104|Alutard SQ, hrossaværur|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|27472|36388|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|dýr||27472||27472|36388 022970|V01AA1104|Alutard SQ, hrossaværur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|21994|29568|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||21994||21994|29568 023036|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|pakki|þp+M-úðari|R03BB01|01.07.1992||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|4447|6875|lyfalmen|||19|100|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||4447||4447|6875 023047|G04BD1001|Emselex|forðatfl|7,5|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|6394|9517|lyfalmen|||00|28|0|28|Vistor hf|Novartis Europharm Ltd|Darífenacín||6394||6394|9517 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|135890|171051|lyfsjukr|||00|30|0|0|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||135890||135890|171051 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|29074|38382|lyfalmen|||00|90|0|20|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||29074||29074|38382 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|45392|58698|lyfalmen|||00|90|0|30|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||45392||45392|58698 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|22987|30804|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Darífenacín||22987||22987|30804 023146|G04BD1001|Emselex|forðatfl|15|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|6458|9604|lyfalmen|||00|28|0|56|Vistor hf|Novartis Europharm Ltd|Darífenacín||6458||6458|9604 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|23220|31094|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Darífenacín||23220||23220|31094 023325|V03AB2501|Lanexat|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.07.1989||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|23570|31212|lyfsjukr|||02|25|0|0|Icepharma hf|Roche|Flúmazeníl||23570||23570|31212 023376|N03AX1204|Gabapentin Merck NM|hylki|400|mg|100|stk|1|glas||N03AX12|01.05.2004||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|5303|8037|lyfalmen|V0715|8037|00|100|0|22|Actavis Group PTC ehf|Merck NM AB|Gabapentín||5303||5303|8037 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|A|3|0|0|0|0|DED|0|0|1|100|XEU|18648|25402|lyfalmen|||00|34|0|0|Vistor hf|Dentsply DeTrey GmbH|Blöndur||18648||18648|25402 023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|9715|13909|lyfsjukr|||00|0|0|4|Vistor hf|Amgen|Darbepóetín alfa||9715||9715|13909 023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|38241|49478|lyfsjukr|||00|0|0|18|Vistor hf|Amgen|Darbepóetín alfa||38241||38241|49478 023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|28943|37902|lyfsjukr|||00|0|0|13|Vistor hf|Amgen|Darbepóetín alfa||28943||28943|37902 023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|68899|87647|lyfsjukr|||00|0|0|33|Vistor hf|Amgen|Darbepóetín alfa||68899||68899|87647 023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|46000|59138|lyfsjukr|||00|0|0|22|Vistor hf|Amgen|Darbepóetín alfa||46000||46000|59138 023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|9051|12959|lyfsjukr|||00|10|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||9051||9051|12959 023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|137710|173316|lyfsjukr|||00|1|0|67|Vistor hf|Amgen|Darbepóetín alfa||137710||137710|173316 023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|22628|30039|lyfsjukr|||00|25|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||22628||22628|30039 023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|18917|25419|lyfsjukr|||00|0|0|9|Vistor hf|Amgen|Darbepóetín alfa||18917||18917|25419 023468|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|14246|19921|lyfalmen|||00|10|0|20|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||14246||14246|19921 023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|45256|58211|lyfsjukr|||00|50|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||45256||45256|58211 023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|90511|114554|lyfsjukr|||00|100|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||90511||90511|114554 023479|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|9973|14374|lyfalmen|||00|3|0|14|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||9973||9973|14374 023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|220250|276079|lyfsjukr|||00|1|0|111|Vistor hf|Amgen|Darbepóetín alfa||220250||220250|276079 023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|181024|227242|lyfsjukr|||00|200|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||181024||181024|227242 023491|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|19944|27015|lyfalmen|||00|6|0|28|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||19944||19944|27015 023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|14958|20808|lyfalmen|||00|4|0|21|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||14958||14958|20808 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|157588|198065|lyfsjukr|||00|120|0|30|Vistor hf|Boehringer Ingelheim International |Tipranavír||157588||157588|198065 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|26035|34599|lyfalmen|||00|100|0|100|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||26035||26035|34599 023544|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|4854|7427|lyfalmen|||00|4|0|7|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||4854||4854|7427 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|A|2,5|0|0|*|0|SAO|0|0|0|100|XEU|4075|6370|lyfalmen|||00|12|0|60|Icepharma hf|Santen Oy|Tímólól||4075||4075|6370 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|69806|88776|lyfsjukr|||00|120|0|100|Icepharma hf|Roche|Saquínavír||69806||69806|88776 023809|A10AE0404|Lantus [OptiClik]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiClik|A10AE04|01.04.2007||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|10435|15001|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10435||10435|15001 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|A|5|0|1|0|1|PFL|0|0|0|100|DKK|106609|134596|lyfsjukr|||00|90|0|36|Vistor hf|Pfizer Limited|Síldenafíl||106609||106609|134596 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|3426|5490|lyfalmen|||00|100|0|17|Icepharma hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||3426||3426|5490 024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007||R|A|1,5|0|0|0|1|WTE|0|0|0|100|USD|92163|116610|lyfsjukr|||00|10|0|5|Icepharma hf|Wyeth Europe|Tigecýklín||92163||92163|116610 024037|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.09.2005||R|A|2|0|0|0|1|NOM|0|0|0|100|IKR|5443|7793|lyfsjukr|||03|10|0|3|Icepharma hf|NordMedica ApS|Cefazólín||5443||5443|7793 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|3217|5206|lyfalmen|||00|5|0|10|Vistor hf|Janssen-Cilag AB|Fentanýl||3217||3217|5206 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|22337|29995|lyfalmen|||00|30|0|30|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||22337||22337|29995 024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|0| |1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2259|3234|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Elektrólýtar||2259||2259|3234 024147|A10BD0301|Avandamet|filmhtfl|1002|mg|112|stk|1|þpakki|1000+2mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|9987|14393|lyfalmen|||00|112|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Metformín og rosiglítazón||9987||9987|14393 024169|A10BD0301|Avandamet|filmhtfl|1004|mg|112|stk|1|þpakki|1000+4mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|17124|23504|lyfalmen|||00|112|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Metformín og rosiglítazón||17124||17124|23504 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|74457|94884|lyfalmen|||00|100|0|100|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||74457||74457|94884 024307|V01AA1105|Alutard SQ, hundahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|27472|36388|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|dýr||27472||27472|36388 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8648|12576|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8648||8648|12576 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|404|1389|lyfalmen|||00|100|0|2|Vistor hf|AstraZeneca A/S DK|Terbútalín||404||404|1389 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8648|12576|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8648||8648|12576 024504|V04CL0003|Soluprick SQ ALK106 - Rauðölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14572|20327|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14572||14572|20327 024510|V04CL0004|Soluprick SQ ALK107 - Gráölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14572|20327|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14572||14572|20327 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviður|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14596|20357|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14596||14596|20357 024532|V04CL0007|Soluprick SQ ALK203 - Háliðagras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14572|20327|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14572||14572|20327 024559|V04CL0008|Soluprick SQ ALK214 -Axhnoðapunktur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14572|20327|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14572||14572|20327 024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14746|20544|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14746||14746|20544 024576|V04CL0010|Soluprick SQ ALK223 - Vallarrýgresi|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14572|20327|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14572||14572|20327 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8648|12576|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8648||8648|12576 024589|V04CL0012|Soluprick SQ ALK228 - Vallarsveifgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14572|20327|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14572||14572|20327 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|A|3|0|1|E|0|NOE|0|0|0|100|DKK|82318|104671|lyfalmen|||00|100|0|125|Vistor hf|Novartis Europharm Ltd|||82318||82318|104671 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14746|20544|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14746||14746|20544 024603|V04CL0001|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1776|3250|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1776||1776|3250 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8648|12576|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8648||8648|12576 024644|V04CL0015|Soluprick SQ ALK552 - Hrossaværur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8648|12576|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8648||8648|12576 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8648|12576|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8648||8648|12576 024681|V04CL0002|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1776|3250|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1776||1776|3250 025093|C01BD0102|Trangorex (D.A.C.)|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.08.2006||R|A|3|0|0|B|0|DAC|0|0|0|100|NOK|1122|2149|lyfalmen|V0143|2149|70|30|0|30|D.A.C. ehf|D.A.C. ehf|Amíódarón||964||964|2149 025126|M05BB0301|Fosavance|töflur|0| |4|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|E|0|MSD|0|0|0|100|XEU|6504|9667|lyfalmen|||00|4|0|0|Icepharma hf|M.S.D.|Alendrónsýra og kólekalsíferól||6504||6504|9667 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|1037|2248|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1037||1037|2248 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|21994|29568|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||21994||21994|29568 025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2966|4865|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2966||2966|4865 025180|R03BA0201|Pulmicort|innúðal|100|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1980|3527|lyfalmen|||0|120|0|15|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1980||1980|3527 025191|R03BA0201|Pulmicort|innúðal|200|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|3768|5954|lyfalmen|||0|120|0|30|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3768||3768|5954 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|21994|29568|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||21994||21994|29568 025300|J01DB0101|Keflex|mixtúrud|50|mg/ml|100|ml|1|glas||J01DB01|01.03.1983||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|959|2142|lyfalmen|||08|100|0|2|Icepharma hf|NordMedica A/S|Cefalexín||959||959|2142 025306|M05BB0301|Fosavance|töflur|0| |12|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|E|0|MSD|0|0|0|100|XEU|15593|21598|lyfalmen|||00|12|0|0|Icepharma hf|M.S.D.|Alendrónsýra og kólekalsíferól||15593||15593|21598 025311|J01DB0101|Keflex|töflur|500|mg|14|stk|1|þpakki||J01DB01|01.07.1988||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|794|1918|lyfalmen|||00|14|0|4|Icepharma hf|NordMedica A/S|Cefalexín||794||794|1918 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|113131|142716|lyfsjukr|||00|30|0|60|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||113131||113131|142716 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|111843|141112|lyfsjukr|||00|30|0|30|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||111843||111843|141112 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|10898|20930|vetalmen|||00|20|0|0|Vistor hf|Boehringer Ingelheim|||10898||10898|20930 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|20189|27320|lyfalmen|||00|30|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||20189||20189|27320 025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|24555|32756|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|Valsartan||24555||24555|32756 025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|7162|10560|lyfalmen|||00|28|0|112|Vistor hf|Novartis Healthcare A/S-|Valsartan||7162||7162|10560 025471|N06AB1002|Cipralex (D.A.C.)|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.12.2006|30.06.2009|R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|7232|10655|lyfalmen|||00|28|0|56|D.A.C. ehf|D.A.C. ehf|Escítalópram||7232||7232|10655 025555|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|31776|41746|lyfalmen|||00|1|0|28|Vistor hf|Janssen-Cilag AB|Risperídón||31776||31776|41746 025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.01.2007||R|A|2|0|0|*|0|DAC|0|0|0|100|XEU|2127|3727|lyfalmen|V1090|3727|06|5|0|17|D.A.C. ehf|D.A.C. ehf|Dorzólamíð||2127||2127|3727 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|5968|8939|lyfalmen|||00|1|0|30|Icepharma hf|Roche Registration Limited|||5968||5968|8939 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|15565|21563|lyfalmen|||00|3|0|90|Icepharma hf|Roche Registration Limited|||15565||15565|21563 025676|L01CB0201|Vumon|stl|10|mg/ml|5|ml|10|lykjur||L01CB02|01.05.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|34429|44732|lyfsjukr|||00|50|1|0|Distica|Distica - óskráð lyf|||34429||34429|44732 025677|S01ED5109|Cosopt (D.A.C.)|augndr|5|mg/ml|5|ml|1|glas||S01ED51|01.04.2006|31.07.2009|R|A|2|0|0|*|0|DAC|0|0|0|100|XEU|3002|4401|lyfalmen|||06|5|0|0|D.A.C. ehf|D.A.C. ehf|Tímólól í blöndum||2624||2624|4401 025698|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|16964|23305|lyfalmen|||00|1|0|14|Vistor hf|Janssen-Cilag AB|Risperídón||16964||16964|23305 025709|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|24536|32732|lyfalmen|||00|1|0|21|Vistor hf|Janssen-Cilag AB|Risperídón||24536||24536|32732 025725|R01AD0505|Rhinocort Turbuhaler (D.A.C.)|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.2007|31.05.2009|R|A|2|0|0|E|0|DAC|0|0|1|100|SEK|3623|5757|lyfalmen|||23|200|0|100|D.A.C. ehf|D.A.C. ehf|Búdesóníð||3623||3623|5757 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|63031|80659|lyfalmen|||00|100|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||63031||63031|80659 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|6754|9670|lyfsjukr|||02|25|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||6754||6754|9670 025841|V01AA1106|Alutard SQ, kattahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|27472|36388|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|dýr||27472||27472|36388 025958|M01AE0215|Naproxen Merck NM|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|920|2089|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||920||920|2089 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|3970|6870|vetorma|||16|1|0|0|Vistor hf|Merial (MSD)|||3970||3970|6870 025985|M01AE0215|Naproxen Merck NM|töflur|500|mg|50|stk|1|þpakki||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|948|2127|lyfalmen|||00|50|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||948||948|2127 025994|M01AE0215|Naproxen Merck NM|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|1691|3135|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Naproxen||1691||1691|3135 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|8984|15547|vetorma|||16|2|0|0|Vistor hf|Merial (MSD)|||8984||8984|15547 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|21994|29568|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||21994||21994|29568 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1898|3416|lyfalmen|||00|100|0|25|Vistor hf|Recip AB|Nítrófúrantóín||1898||1898|3416 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|395|1376|lyfalmen|||00|50|0|1|Vistor hf|Recip AB|Nítrófúrantóín||395||395|1376 027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|þpakki||M01CC01|01.06.1982||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|3071|5008|lyfalmen|||10|50|0|15|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||3071||3071|5008 027235|G03HA0103|Cyproteron Merck NM|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|7594|11146|lyfalmen|||00|50|0|25|Actavis Group PTC ehf|Merck NM AB|Cýpróterón||7594||7594|11146 027281|N06DA0204 |Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|33599|44016|lyfalmen|V0375|44016|00|100|0|67|Actavis Group hf|Actavis hf|Dónepezíl||||33599|44016 027305|N06DA0204 |Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|37707|49130|lyfalmen|V0376|49130|00|100|0|133|Actavis Group hf|Actavis hf|Dónepezíl||||37707|49130 027362|L01AX0302 |Temodal (Lyfjaver)|hylki|20|mg|20|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|73856|93818|lyfsjukr|||00|20|0|0|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||73856|93818 027373|L01AX0302 |Temodal (Lyfjaver)|hylki|100|mg|5|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|90293|114282|lyfsjukr|||00|5|0|0|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||90293|114282 027385|L01AX0302 |Temodal (Lyfjaver)|hylki|250|mg|5|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|194887|244502|lyfsjukr|||00|5|0|0|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||194887|244502 027397|G02CX0102 |Tractocile (Lyfjaver)|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.05.2009||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|5910|8462|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Lyfjaver ehf|Atosíban||||5910|8462 027408|G02CX0102 |Tractocile (Lyfjaver)|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.05.2009||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|17604|23784|lyfsjukr|||00|5|0|0|Lyfjaver ehf|Lyfjaver ehf|Atosíban||||17604|23784 027559|N03AX1501|Zonegran|hylki|25|mg|14|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|1930|3459|lyfalmen|||00|14|0|2|Vistor hf|Eisai Ltd|||1930||1930|3459 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|7721|11318|lyfalmen|||00|56|0|7|Vistor hf|Eisai Ltd|||7721||7721|11318 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|10334|14864|lyfalmen|||00|56|0|14|Vistor hf|Eisai Ltd|||10334||10334|14864 027604|N03AX1501|Zonegran|hylki|100|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|13650|19179|lyfalmen|||00|56|0|28|Vistor hf|Eisai Ltd|||13650||13650|19179 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|1002|2200|lyfalmen|V0431|2026|00|100|0|33|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||1002||1002|2200 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|955|2136|lyfalmen|V0430|1843|00|100|0|67|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||955||955|2136 027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|140055|176236|lyfsjukr|||00|105|0|1|Icepharma hf|SP Europe|Posacónazól||140055||140055|176236 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|26956|35745|lyfalmen|||00|28|0|19|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||26956||26956|35745 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|26956|35745|lyfalmen|||00|28|0|28|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||26956||26956|35745 028168|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|28|stk|1|þpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4472|6909|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||||4472|6909 028179|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|98|stk|1|þpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|15545|21539|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||||15545|21539 028190|C09XA5201|Rasilez HCT|filmhtfl|175|mg|28|stk|1|þpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4472|6909|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||||4472|6909 028201|C09XA5201|Rasilez HCT|filmhtfl|175|mg|98|stk|1|þpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|15545|21539|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||||15545|21539 028212|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|28|stk|1|þpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|5154|7835|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||||5154|7835 028224|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|98|stk|1|þpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|17930|24508|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||||17930|24508 028235|C09XA5201|Rasilez HCT|filmhtfl|325|mg|28|stk|1|þpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|5154|7835|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||||5154|7835 028246|C09XA5201|Rasilez HCT|filmhtfl|325|mg|98|stk|1|þpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|17930|24508|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||||17930|24508 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2875|4742|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefna­vakar||2875||2875|4742 028351|J07BL0101|Stamaril|sts|0| |0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|24136|32234|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||24136||24136|32234 028360|J07BG0101|Rabies - Imovax|bóluefni|0| |1|ml|1|hgl||J07BG01|01.01.1996||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|9236|13374|lyfalmen|||02|1|0|0|Icepharma hf|Aventis Pasteur MSD A/S|Hundaæði, dauð veira||9236||9236|13374 028387|M03BX0104|Baklofen Merck NM|töflur|25|mg|50|stk|1|glas|0|M03BX01|01.10.2008||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|1363|2690|lyfalmen|V0712|2690|00|50|0|25|Actavis Group PTC ehf|Merck NM AB|Baklófen||1363||1363|2690 028405|M01AE0216|Naproxen-E Merck NM|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|1941|3474|lyfalmen|||10|50|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||1941||1941|3474 028498|C08DB0102|Cardizem Retard|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|3736|5910|lyfalmen|V0351|3898|10|60|0|30|Vistor hf|Ferrosan A/S|Diltíazem||3736||3736|5910 028575|N03AX0901 |Lamictal|dreifit.|5|mg|56|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1278|2575|lyfalmen|||00|56|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2575 028586|N03AX0901 |Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|5812|8728|lyfalmen|||00|98|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||5812|8728 028597|D07BB0401|Locoidol|krem|0| |30|g|1|túpa||D07BB04|01.01.1990||R|A|4|0|0|B|0|ASP|0|0|1|100|XEU|1026|2233|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat og sýkla­eyðandi lyf||1026||1026|2233 028598|N03AX0901 |Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|10358|14897|lyfalmen|||00|98|0|65|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||10358|14897 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|A|3|0|0|0|0|OCO|0|0|0|100|DKK|9045|17401|vetalmen|||27|10|0|0|Icepharma hf|Orion Corporation (I)|||9045||9045|17401 028761|A03FA0101|Primperan|stl|5|mg/ml|2|ml|12|lykjur||A03FA01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|989|2182|lyfalmen|||02|24|0|4|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||989||989|2182 028787|A04AA0201|Kytril|töflur|1|mg|10|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|13506|19000|lyfalmen|||00|10|0|5|Icepharma hf|Roche as|Granisetrón||13506||13506|19000 029025|D07AC0301|Ibaril|smyrsli|2,5|mg/g|50|g|1|túpa||D07AC03|01.12.1978||R|A|1,5|0|0|B|0|SNO|0|0|1|100|NOK|2266|3915|lyfalmen|||20|50|0|50|Vistor hf|Sanofi-aventis Norge AS|Desoxímetasón||2266||2266|3915 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|1205|2476|lyfalmen|||24|16|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1205|2476 029116|A03FA0101|Primperan|töflur|10|mg|40|stk|1|þpakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|586|1636|lyfalmen|||00|40|0|13|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||586||586|1636 029287|C03DB0105 |Amiloride|töflur|5|mg|28|stk|1|þpakki||C03DB01|01.04.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|282|1223|lyfalmen|||00|28|0|14|Actavis Group hf|Actavis UK Ltd.|||||282|1223 029307|A07EA0603|Entocort enema (D.A.C.)|endaþ.dr|0,02|mg/ml|7|stk|1|þpakki||A07EA06|01.01.2007||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|7702|11292|lyfalmen|||0|7|0|0|D.A.C. ehf|D.A.C. ehf|Búdesóníð||||7702|11292 029352|C10AA0103|Zocor (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|9510|6435|lyfalmen|||00|98|0|33|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||4123||4123|6435 029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|8607|10171|lyfalmen|||00|98|0|65|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||6876||6876|10171 029370|C10AA0103|Zocor (Lyfjaver)|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|13525|13757|lyfalmen|V0367|3035|00|98|0|131|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||9518||9518|13757 029379|C10AA0103|Zocor (Lyfjaver)|töflur|80|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|1,5|0|0|0|0|LVR|0|0|0|100|XEU|19020|25865|lyfalmen|||00|98|0|261|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||19020||19020|25865 029517|L01BB0503 |Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|A|2|0|1|0|1|AGP|0|0|0|100|XEU|35671|46278|lyfsjukr|||00|50|0|0|Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||||35671|46278 029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|K|3|0|1|0|1|AGP|0|0|0|100|XEU|22957|30449|lyfsjukr|||00|5|0|0|Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||||22957|30449 029574|L01XX1904 |Irinotecan Actavis|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|A|3|0|1|0|1|AGT|0|0|0|100|XEU|22995|30496|lyfsjukr|||00|5|0|0|Actavis Group hf|Actavis Group hf|Írinótekan||||22995|30496 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 030054|J05AE0302|Norvir (D.A.C.)|hylki|100|mg|84|stk|1|glas|mjúk hylki|J05AE03|01.12.2008||R|K|2|0|1|0|1|DAC|0|0|0|100|DKK|21354|28453|lyfsjukr|||00|84|0|7|D.A.C. ehf|D.A.C. ehf|Ritonavír||||21354|28453 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|23876|31911|lyfalmen|||00|98|0|49|Vistor hf|Eisai Ltd|||23876||23876|31911 030361|D07AB0101|Emovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AB01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|536|1568|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasón||536||536|1568 030387|D07AB0101|Emovat|smyrsli|0,5|mg/g|100|g|1|túpa||D07AB01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|2111|3705|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasón||2111||2111|3705 030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.07.2006||L|A|3|0|0|0|0|NAV|0|0|1|100|IKR|||lyflausa|||00|60|0|25|Icepharma hf|Navamedic ASA|Glúkósamín||||| 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|10512|15106|lyfalmen|V1400|15106|00|100|0|33|Vistor hf|Novartis Healthcare A/S-|Klózapín||10512||10512|15106 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|3353|5391|lyfalmen|V1401|5391|00|100|0|8|Vistor hf|Novartis Healthcare A/S-|Klózapín||3353||3353|5391 030754|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|770|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|770|0|0|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||| 030765|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|11000|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|11000|0|0|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||| 030940|C07AB0207|Metoprolol Merck NM|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|909|2074|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB|Metóprólól||909||909|2074 031039|C07AB0207|Metoprolol Merck NM|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|1326|2640|lyfalmen|||00|100|0|67|Actavis Group PTC ehf|Merck NM AB|Metóprólól||1326||1326|2640 031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||R|A|2|0|0|E|0|NHE|0|0|1|100|DKK|949|2128|lyfalmen|||23|2|0|2|Artasan ehf|Novartis Healthcare A/S-A|Skópólamín||949||949|2128 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|3590|5712|lyfalmen|||17|10|0|25|Icepharma hf|Eli Lilly Nederland -|Insúlín lispró||3590||3590|5712 031261|A10AB0604|Apidra [opticlik]|stl|100|ein/ml|3|ml|5|rörlyk||A10AB06|01.04.2007||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|5036|7674|lyfalmen|||02|15|0|38|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5036||5036|7674 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2128|3728|lyfalmen|||00|100|0|33|Vistor hf|Recip AB|Ísósorbíð dínítrat||2128||2128|3728 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|7147|10539|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insúlín aspart||7147||7147|10539 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|A|3|0|0|0|1|FEL|0|0|0|100|DKK|42085|54263|lyfsjukr|||00|5|0|0|Vistor hf|Ferring Lægemidler A/S|Terlípressín||42085||42085|54263 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1858|3362|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Sótalól||1858||1858|3362 032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|10973|15529|lyfsjukr|||0|4|0|0|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||10973|15529 032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|16039|21836|lyfsjukr|||0|10|0|0|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||16039|21836 032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|55497|70961|lyfsjukr|||0|50|0|0|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||55497|70961 032190|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|1|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|1|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032202|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|2|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|2|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032236|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|4|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032247|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|5|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032258|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|10|0|0|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||| 032270|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|20|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032281|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|50|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032304|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|600|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|K|2|0|0|*|0|OTS|0|1|0|100|DKK|27992|37035|lyfalmen|||00|150|0|10|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||27992||27992|37035 032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|4329|7492|vetorma|||27|50|0|0|Vistor hf|Merial (MSD)|||4329||4329|7492 032660|L03AB0702|Rebif|stl|0||0,5|ml|12|áf.spr|8,88+22 mcg|L03AB07|01.02.2009||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|141766|178366|lyfsjukr|||0|6|0|0|Gróco ehf|Serono Nordic|Interferón beta-1a||||141766|178366 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|15395|26642|vetorma|||27|200|0|0|Vistor hf|Merial (MSD)|||15395||15395|26642 033159|S01FA0103|Isopto Atropin 1 %|augndr|1|%|5|ml|1|glas||S01FA01|01.05.1983||R|A|3|0|0|E|0|ALC|0|0|0|100|USD|497|1515|lyfalmen|||06|5|0|0|K.Pétursson hf|Alcon|Atrópín||497||497|1515 033251|S01CA0102|Tobradex|augndr|0| |5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|1330|2645|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|Dexametasón||1330||1330|2645 033918|L04AC0501|Stelara|stl|45|mg/hgl|0,5|ml|1|hgl||L04AC05|01.06.2009||R|K|1|0|1|0|1|JCI|0|0|0|100|SEK|565532|705955|lyfsjukr|||AC|0|0|0|Vistor hf|Janssen-Cilag International N.V.|||||565532|705955 034033|QJ01M0001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2828|5558|vetalmen|||0|10|0|0|Vistor hf|Bayer Animal Health GmbH|||||2828|5558 034157|J07AM5104|Diftavax|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|K|3|0|0|0|0|SPM|0|0|1|100|XEU|851|1995|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíð í blöndum með barnaveikistoxóíðum||851||851|1995 034616|N05CM0201|Heminevrin|mixtúra|50|mg/ml|300|ml|1|glas||N05CM02|01.07.2006||R|K|2|0|0|0|0|ARA|0|0|1|100|SEK|2172|3788|lyfalmen|||00|300|0|10|Vistor hf|Astra|Clómetíazól||2172||2172|3788 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|2090|3677|lyfalmen|||00|6|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2090||2090|3677 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3583|5703|lyfalmen|||00|12|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||3583||3583|5703 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|10105|14448|lyfsjukr|||02|25|0|0|Vistor hf|LEO Pharma A/S|Prótamín||10105||10105|14448 035099|C02CA0404 |Carduran CR (D.A.C.)|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|10447|15017|lyfalmen|V2120|5882|00|100|0|100|D.A.C. ehf|D.A.C. ehf|Doxazósín||||10447|15017 035155|N03AX1403 |Keppra (D.A.C.)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.05.2009||R|A|3|0|1|E|0|DAC|0|0|0|100|DKK|21543|27302|lyfalmen|V1710|27302|00|100|0|25|D.A.C. ehf|D.A.C. ehf|Levetíracetam||20174||20174|27302 035177|N03AX1203 |Neurontin (D.A.C.)|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|6826|8049|lyfalmen|V0714|6418|10|100|0|17|D.A.C. ehf|D.A.C. ehf|Gabapentín||5312||5312|8049 035200|N03AX1203 |Neurontin (D.A.C.)|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|19049|25901|lyfalmen|V2160|25901|00|100|0|33|D.A.C. ehf|D.A.C. ehf|Gabapentín||||19049|25901 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|18249|24905|lyfalmen|||10|300|0|100|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||18249||18249|24905 035222|N06DA0403 |Reminyl (D.A.C.)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|SEK|12289|17106|lyfalmen|V1370|17106|00|28|0|14|D.A.C. ehf|D.A.C. ehf|Galantamín||11986||11986|17106 035234|M01AB5502 |Arthrotec (D.A.C.)|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|5842|8327|lyfalmen|V2130|8327|0|100|0|50|D.A.C. ehf|D.A.C. ehf|Díklófenaknatríum í blöndum||5517||5517|8327 035506|N03AX0903|Lamotrin|dreifit.|25|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1435|2788|lyfalmen|||00|56|0|5|Actavis Group hf|Actavis hf|Lamótrigín||1435||1435|2788 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1844|3343|lyfalmen|V0703|3343|00|56|0|9|Actavis Group hf|Actavis hf|Lamótrigín||1844||1844|3343 035524|N03AX0903|Lamotrin|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3321|5347|lyfalmen|V0705|5347|00|56|0|19|Actavis Group hf|Actavis hf|Lamótrigín||3321||3321|5347 035533|N03AX0903|Lamotrin|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|5919|8873|lyfalmen|V0706|8873|00|56|0|37|Actavis Group hf|Actavis hf|Lamótrigín||5919||5919|8873 035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006||R|A|1,5|0|1|0|1|PFI|0|0|0|100|DKK|137323|172835|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegaptaníb||137323||137323|172835 035824|C01AA0503|Lanoxin|stl|0,25|mg/ml|2|ml|5|lykjur||C01AA05|01.07.2000||R|A||0|0|0|1|PCO|0|0|0|100|IKR|926|1326|lyfsjukr|||00|10|1|0|Distica|Distica - óskráð lyf|Digoxín||926||926|1326 035832|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|fl||B05BA02|01.08.1980||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|51438|65908|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Fitusambönd||51438||51438|65908 035840|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.03.1978||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|1060|2279|lyfalmen|||00|60|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Digoxín||1060||1060|2279 035865|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.08.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|565|1607|lyfalmen|||00|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Digoxín||565||565|1607 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|5857|8789|lyfalmen|||00|60|0|60|Vistor hf|Meda AS|Tenoxíkam||5857||5857|8789 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|249538|312542|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|Sunitíníb||249538||249538|312542 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|445689|556750|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|Sunitíníb||445689||445689|556750 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|890948|1111098|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|Sunitíníb||890948||890948|1111098 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|829|1965|lyfalmen|||00|20|0|8|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||829||829|1965 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1325|2638|lyfalmen|||08|60|0|3|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1325||1325|2638 036541|A03AX1301|Minifom|dropar|0| |30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|S|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|30|0|6|Vistor hf|AstraZeneca A/S DK|Silíkonsambönd||||| 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2615|4389|lyfalmen|||08|125|0|6|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2615||2615|4389 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|793|1917|lyfalmen|||00|30|0|12|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||793||793|1917 037278|N04BC0404|Requip Depot|forðatfl|2|mg|42|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|7568|11111|lyfalmen|||00|42|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||7568||7568|11111 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|15135|21028|lyfalmen|||00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||15135||15135|21028 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|29684|39142|lyfalmen|||00|84|0|56|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||29684||29684|39142 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|58314|74786|lyfalmen|||00|84|0|112|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||58314||58314|74786 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|A|4|0|0|E|0|ROC|0|0|0|100|DKK|2870|4735|lyfalmen|||00|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2870||2870|4735 037531|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1275|2571|lyfalmen|||0|30|0|30|Vistor hf|Schering-Plough|Mómetasón||1275||1275|2571 037754|J01EA0102|Monotrim|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.1980||R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|767|1881|lyfalmen|||00|30|0|8|Vistor hf|Hexal A/S|Trímetóprím||767||767|1881 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|100|0|25|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||2282 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|250|0|62|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||3864 037929|J01EA0102|Monotrim|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.1980||R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|2064|3641|lyfalmen|||00|100|0|25|Vistor hf|Hexal A/S|Trímetóprím||2064||2064|3641 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|664|1489|lyfalmen|V0917|1424|00|20|0|20|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||478||478|1489 038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|1766|2556|lyfalmen|V0918|2385|00|60|0|60|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1264||1264|2556 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|2667|3506|lyfalmen|V0919|3240|00|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1964||1964|3506 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|1188|2453|lyfalmen|||00|50|0|50|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1188||1188|2453 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|243204|304656|lyfsjukr|||00|1|0|0|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||243204||243204|304656 038828|C09AA0401|Coversyl|töflur|4|mg|90|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|7093|10466|lyfalmen|||00|90|0|90|Icepharma hf|Servier|Perindópríl||7093||7093|10466 038877|N07CA0101|Betaserc|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.1982||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|5004|7631|lyfalmen|||00|100|0|33|Medico ehf|Solvay Duphar |Betahistín||5004||5004|7631 038915|J01FA1004|Zitromax UNO|forðakyr|0| |2|g|1|fl||J01FA10|01.10.2007||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|3382|5430|lyfalmen|||00|2|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||3382||3382|5430 039005|L01XA0301|Eloxatin|irþ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|41555|53603|lyfsjukr|||00|10|0|0|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||41555||41555|53603 039014|L01XA0301|Eloxatin|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|72309|91892|lyfsjukr|||00|20|0|0|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||72309||72309|91892 039575|D01AE1503 |Lamisil (D.A.C.)|krem|10|mg/g|15|g|1|túpa||D01AE15|01.05.2009||L|A|5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|15|0|15|D.A.C. ehf|D.A.C. ehf|Terbínafín||||| 039669|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|glas||C01BA03|01.05.1983||R|A|1|0|0|B|0|SNO|0|0|0|100|NOK|5331|8075|lyfalmen|||10|100|0|62|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||5331||5331|8075 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1677|3116|lyfalmen|||00|15|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||1677||1677|3116 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2572|4331|lyfalmen|||00|22|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||2572||2572|4331 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|389|557|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||389||389|557 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|0|0|AGP|0|0|0|100|IKR|1630|3052|lyfalmen|V0367|3035|00|98|0|131|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||||1630|3052 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|892|1277|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||892||892|1277 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|1582|2265|lyfsjukr|||02|1|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1582||1582|2265 040287|N03AF0104|Tegretol|töflur|200|mg|200|stk|1|þpakki||N03AF01|01.04.1993||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|3447|5518|lyfalmen|||00|200|0|40|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3447||3447|5518 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|A|4|0|0|E|0|ALC|0|0|0|100|IKR|||lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Gervitár og aðrar óvirkar sam­setningar|||||1579 041059|J07BH0101|Rotarix|mixtduft|0| |1|hgl|1|pakki|+áf.munnspr.m/leysi|J07BH01|01.07.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|9808|14150|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Rota-veira, veikluð veira||9808||9808|14150 041423|G03AA1203|Yasminelle|töflur|0||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.12.2006||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|3059|4992|lyfalmen|||00|63|0|0|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||3059||3059|4992 041488|N06AB1002 |Cipralex (D.A.C.)|filmhtfl|20|mg|98|stk|1|þpakki||N06AB10|01.05.2009||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|25961|30070|lyfalmen|V2172|30025|00|98|0|196|D.A.C. ehf|D.A.C. ehf|Escítalópram||22398||22398|30070 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|4996|8646|vetorma|||AA|100|0|0|Icepharma hf|Intervet International B.V.|||4996||4996|8646 041795|M02AA1503 |Voltaren Emulgel (D.A.C.)|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|100|0|0|D.A.C. ehf|D.A.C. ehf|Díklófenak||||| 041815|V08CA1101|Vasovist|stl|0,25|mmol/ml|10|ml|10|hgl|lausn|V08CA11|01.12.2006||R|A|3|0|0|0|0|SAG|0|0|0|100|SEK|187850|236058|lyfalmen|||02|100|0|0|Icepharma hf|Schering AG|Gadófosveset||187850||187850|236058 041996|A06AG1101|Microlax|innhl|0| |5|ml|4|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||56|20|0|4|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum||||| 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1407|2750|lyfalmen|||02|25|0|0|Vistor hf|AstraZeneca A/S DK|Metóprólól||1407||1407|2750 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|11841|16610|lyfsjukr|||00|500|0|0|Vistor hf|AstraZeneca A/S DK|Rópívakaín||11841||11841|16610 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4142|5930|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||4142||4142|5930 042309|N01BB0902|Naropin|stl/irl|2|mg/ml|200|ml|5|plpok||N01BB09|01.07.2009||R|A||0|0|0|1|AZD|0|0|0|100|SEK|21178|28234|lyfsjukr|||00|1000|0|0|Vistor hf|AstraZeneca A/S DK|Rópívakaín||||21178|28234 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5223|7478|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||5223||5223|7478 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4937|7069|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||4937||4937|7069 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7484|10715|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||7484||7484|10715 042346|N07BA0137 |Nicorette (D.A.C.)|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|42|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 042357|N07BA0141 |Nicotinell Fruktsmak (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|8592|12302|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||8592||8592|12302 042368|A06AB0602 |Senokot|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.04.2009||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|2515|4253|lyfalmen|||00|500|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||||2515|4253 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BA03|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9397|13454|lyfsjukr|||00|4000|0|4|Icepharma hf|Fresenius Kabi|Kolvetni||9397||9397|13454 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4990|7144|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||4990||4990|7144 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3661|5242|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||3661||3661|5242 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3156|4519|lyfsjukr|||02|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3156||3156|4519 042442|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|40|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|11030|15600|lyfsjukr|||00|2000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||11030||11030|15600 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|3363|4815|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||3363||3363|4815 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|2490|3565|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||2490||2490|3565 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BB01|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7918|11337|lyfsjukr|||00|4000|0|4|Icepharma hf|Fresenius Kabi|Elektrólýtar||7918||7918|11337 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2554|3657|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||2554||2554|3657 042549|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|1|dæla|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|879|2033|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||879||879|2033 042551|B05BB0209 |Glucos 100 mg/ml med Na40 + K20 Fres|irl|0||1000|ml|10|plpok||B05BB02|01.04.2009||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3576|5120|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||||3576|5120 042556|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|16790|23089|lyfalmen|||02|10|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||16790||16790|23089 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3879|5554|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3879||3879|5554 042669|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|4000|0|0|Icepharma hf|Fresenius Kabi|||||| 043232|N05CD0305|Flunitrazepam Merck NM|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|348|1313|lyfalmen|||00|30|0|30|Actavis Group PTC ehf|Merck NM AB|Flúnítrazepam||348||348|1313 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3294|4716|lyfsjukr|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|Rópívakaín||3294||3294|4716 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|4206|6548|lyfalmen|||24|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||4206||4206|6548 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|6054|8668|lyfsjukr|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|Rópívakaín||6054||6054|8668 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|641|1710|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tríazólam||641||641|1710 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.07.1989||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|1370|2700|lyfalmen|||10|30|0|30|Vistor hf|N.V. Organon|Estríól||1370||1370|2700 043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0|Icepharma hf|Fresenius Kabi|||||| 043935|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Icepharma hf|Fresenius Kabi|||||| 044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|A|3|0|0|E|0|LVR|0|0|1|100|NOK|14220|19508|lyfalmen|V0011|19508|00|25|0|5|Lyfjaver ehf|Lyfjaver ehf|Járnoxíð (sykurflétta)||13914||13914|19508 044624|G04BE0303|Viagra (D.A.C.)|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.11.2006||R|A|5|0|0|0|0|DAC|0|0|0|100|DKK|6301|9391|lyfalmen|V1300|9391|00|4|0|8|D.A.C. ehf|D.A.C. ehf|Síldenafíl||6301||6301|9391 045013|L01XX1902|Campto|irþ|20|mg/ml|5|ml|1|hgl||L01XX19|01.01.1999||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|43043|55456|lyfsjukr|||00|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Írinótekan||43043||43043|55456 045104|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|1488|2860|lyfalmen|||10|50|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Azatíóprín||1488||1488|2860 045379|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045385|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|10|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|8394|12231|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||8394||8394|12231 045388|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045397|N07BA0127|Nicorette Mint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045406|N07BA0127|Nicorette Mint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1050|2265|lyfalmen|V0362|2265|00|98|0|65|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||||1050|2265 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|868|2018|lyfalmen|V0361|2018|00|98|0|33|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||||868|2018 045578|N07BA0122|Nicorette (Lyfjaver)|nefúði|500|mcg/sk|200|skammtar|1|glas||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|200|0|3|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045587|N07BA0122|Nicorette (Lyfjaver)|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045596|N07BA0122|Nicorette (Lyfjaver)|innsogsl|10|mg|18|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|18|0|3|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045605|N07BA0122|Nicorette (Lyfjaver)|innsogsl|10|mg|42|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|42|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045614|N07BA0123|Nicotinell (Lyfjaver)|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|21|0|32|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045896|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045905|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045915|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|11|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045924|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045933|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045942|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045951|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|11|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045960|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|K|2|0|0|0|0|PFV|0|0|0|100|DKK|24032|45949|vetalmen|||27|10|0|0|Icepharma hf|Pfizer vet.|||24032||24032|45949 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1943|3477|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Ramipríl||1943||1943|3477 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|IKR|5076|7729|lyfalmen|V1088|7729|02|10|0|1|Icepharma hf|Vian SA|Ondansetrón||5076||5076|7729 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|769|1884|lyfalmen|V0001|1884|00|90|0|45|Actavis Group hf|Actavis hf|Glímepíríð||769||769|1884 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1215|2489|lyfalmen|V0002|2489|00|90|0|90|Actavis Group hf|Actavis hf|Glímepíríð||1215||1215|2489 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1622|3042|lyfalmen|V0003|3042|00|90|0|135|Actavis Group hf|Actavis hf|Glímepíríð||1622||1622|3042 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|IKR|8305|12111|lyfalmen|V1089|12111|02|20|0|2|Icepharma hf|Vian SA|Ondansetrón||8305||8305|12111 047042|L04AB0101|Enbrel|stl|0| |25|mg|4|áf.spr|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|USD|87908|111313|lyfsjukr|||00|100|0|14|Icepharma hf|Wyeth Europe|Etanercept||87908||87908|111313 047159|C07AA0704|Sotalol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|938|2113|lyfalmen|||00|100|0|25|Actavis Group PTC ehf|Merck NM AB|Sótalól||938||938|2113 047340|J01CA0406|Flemoxin Solutab|lausnart|500|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1255|2543|lyfalmen|||23|14|0|7|Vistor hf|Astellas Pharma A/S|Amoxicillín||1255||1255|2543 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|13388|18536|lyfsjukr|||00|10|0|0|Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|18536 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|47555|61073|lyfsjukr|||00|50|0|0|Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|61073 047560|L04AB0101|Enbrel|stl|0| |50|mg|4|áf.spr|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|USD|223554|280192|lyfsjukr|||00|200|0|29|Icepharma hf|Wyeth Europe|Etanercept||223554||223554|280192 047563|R03DC0101|Accolate|töflur|20|mg|98|stk|1|þpakki||R03DC01|01.04.1998||R|A|3|0|0|B|0|ASZ|0|0|0|100|SEK|9552|13803|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca UK Ltd|Zafírlúkast||9552||9552|13803 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4874|6978|lyfsjukr|||02|250|0|0|Icepharma hf|Baxter Medical AB|Albúmín||4874||4874|6978 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7693|11014|lyfsjukr|||02|100|0|0|Icepharma hf|Baxter Medical AB|Albúmín||7693||7693|11014 048199|A03CA0201|Librax|töflur|0| |100|stk|1|glas||A03CA02|01.12.1972||R|A|5|0|0|E|0|MAB|0|0|0|100|DKK|1331|2647|lyfalmen|||00|100|0|0|Vistor hf|Meda AB|Klídín og geðlyf||1331||1331|2647 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|15783|21835|lyfalmen|||00|98|0|196|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||15783||15783|21835 048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|4333|6720|lyfalmen|||00|100|0|67|Vistor hf|Recip AB|Ísósorbíð dínítrat||4333||4333|6720 048447|G03AA0901|Marvelon|töflur|0| |63|stk|1|þpakki||G03AA09|01.07.1986||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2040|3609|lyfalmen|||23|63|0|84|Vistor hf|N.V. Organon|Desógestrel og östrógen||2040||2040|3609 048452|M01AE5101|Ibukod|töflur|0| |30|stk|1|glas|10+200 mg|M01AE51|01.11.2006||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|650|1722|lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf|Íbúprófen í blöndum||650||650|1722 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|73786|94049|lyfalmen|||00|150|0|38|Icepharma hf|Roche|Mýcófenólsýra||73786||73786|94049 048611|N04BD0104|Selegilin Merck NM|töflur|10|mg|100|stk|1|glas||N04BD01|01.07.1994||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|9042|13111|lyfalmen|||00|100|0|200|Actavis Group PTC ehf|Merck NM AB|Selegilín||9042||9042|13111 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|A|4|0|0|0|0|GCH|0|0|1|100|DKK|548|1584|lyfalmen|V0772|1355|00|100|0|17|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||548||548|1584 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3269|5277|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Ranitidín||3269||3269|5277 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|21707|29210|lyfalmen|||00|3|0|0|Icepharma hf|Roche Registration Limited|||21707||21707|29210 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2960|4857|lyfalmen|||00|100|0|25|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2960||2960|4857 049502|D01AC0801|Fungoral|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1993||L|A|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||23|60|0|60|Vistor hf|Janssen-Cilag AB|Ketókónazól||||| 049524|S01ED5110|Duotrav|augndr|0| |2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|3747|5925|lyfalmen|||00|2|0|0|K.Pétursson hf|Alcon|Tímólól í blöndum||3747||3747|5925 049533|S01ED5110|Duotrav|augndr|0| |2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|11027|15805|lyfalmen|||00|8|0|0|K.Pétursson hf|Alcon|Tímólól í blöndum||11027||11027|15805 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|A|3|0|0|0|0|GAN|0|0|1|100|CHF|8921|12947|lyfalmen|||23|5|0|5|Icepharma hf|Galderma Nordic AB|Amorolfín||8921||8921|12947 049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1059|2277|lyfalmen|V0361|2277|00|98|0|33|Portfarma ehf|Portfarma|Simvastatín||1059||1059|2277 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1154|2265|lyfalmen|V0362|2265|00|98|0|65|Portfarma ehf|Portfarma|Simvastatín||1050||1050|2265 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|1827|3097|lyfalmen|V0367|3097|00|100|0|133|Portfarma ehf|Portfarma|Simvastatín||1663||1663|3097 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|8006|4829|lyfalmen|V0343|4435|00|28|0|28|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|4829 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2519|4259|lyfalmen|||00|100|0|200|Actavis Group hf|Actavis hf|Ramipríl||2519||2519|4259 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||R|A|5|0|0|0|0|NHE|0|0|1|100|DKK|2297|3958|lyfalmen|||00|30|0|30|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||2297||2297|3958 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|4132|6448|lyfalmen|||00|100|0|400|Actavis Group hf|Actavis hf|Ramipríl||4132||4132|6448 049750|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|25|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|5704|8141|lyfalmen|||10|30|0|3|D.A.C. ehf|D.A.C. ehf|Ciklospórín||5380||5380|8141 049760|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|100|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|20930|27068|lyfalmen|||10|30|0|12|D.A.C. ehf|D.A.C. ehf|Ciklospórín||19986||19986|27068 049778|M05BA0405|Fosamax (D.A.C.)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2006||R|A|3|0|0|E|0|DAC|0|0|0|100|XEU|17086|22749|lyfalmen|V0718|7727|00|12|0|84|D.A.C. ehf|D.A.C. ehf|Alendrónsýra||16517||16517|22749 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|89497|113609|lyfalmen|||00|300|0|38|Icepharma hf|Roche|Mýcófenólsýra||89497||89497|113609 050179|N01AF0301|Pentothal Natrium|sts|2,5|g|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|9066|12980|lyfsjukr|||02|12|0|0|Vistor hf|Hospira Enterprises B.V.|Tíópentalnatríum||9066||9066|12980 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.12.2006||R|A|2,5|0|1|0|1|BHC|0|0|0|100|SEK|606761|734901|lyfsjukr|||00|112|0|0|Vistor hf|Bayer HealthCare AG|Sorafeníb||588782||588782|734901 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|4265|6628|lyfalmen|||00|14|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4265||4265|6628 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|15213|21125|lyfalmen|||00|56|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||15213||15213|21125 050651|C02CA0402|Carduran Retard|forðatfl|4|mg|30|stk|1|þpakki||C02CA04|01.01.2007|30.06.2009|R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|3355|5393|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxazósín||3355||3355|5393 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|3715|5882|lyfalmen|V2120|5882|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxazósín||3715||3715|5882 050914|N02BE0101|Panodil|eþ-stil|1|g|10|stk|1|pakki||N02BE01|01.10.1989||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|543|1577|lyfalmen|||04|10|0|3|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||543||543|1577 051011|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.07.1994||L|A|2|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|2|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Acíklóvír||||| 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1935|3466|lyfalmen|||10|100|0|10|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1935||1935|3466 051058|M02AA1002|Orudis (D.A.C.)|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.01.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|60|0|0|D.A.C. ehf|D.A.C. ehf|Ketóprófen||||| 051076|D05AX5202|Daivobet (D.A.C.)|smyrsli|0| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2007||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|10307|14827|lyfalmen|V0391|11960|00|60|0|0|D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||10307||10307|14827 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|2328|4000|lyfalmen|||10|100|0|20|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2328||2328|4000 051193|R05CB0102|Mucomyst|freyðit|200|mg|25|stk|1|glas||R05CB01|01.01.1986|31.05.2009|R|A|2|0|0|E|0|BIP|0|0|1|100|SEK|466|1473|lyfalmen|||72|25|0|10|Vistor hf|BioPhausia AB|Acetýlcýstein||466||466|1473 051331|R06AX2602|Nefoxef|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|1098|2330|lyfalmen|V1910|2330|00|30|0|30|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1098||1098|2330 051340|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|3309|5331|lyfalmen|V1911|5331|00|100|0|100|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3309||3309|5331 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|1691|3135|lyfalmen|V1912|3135|00|30|0|45|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1691||1691|3135 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|4890|7476|lyfalmen|V1913|7476|00|100|0|150|Actavis Group PTC ehf|Mylan AB|Fexófenadín||4890||4890|7476 051425|R05CB0102|Mucomyst|freyðit|200|mg|100|stk|1|glas||R05CB01|01.01.1986|31.05.2009|R|A|2|0|0|E|0|BIP|0|0|1|100|SEK|1764|3234|lyfalmen|||72|100|0|40|Vistor hf|BioPhausia AB|Acetýlcýstein||1764||1764|3234 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|A|2|0|1|0|1|UCB|0|0|0|100|DKK|39814|51436|lyfsjukr|||00|50|0|3|Vistor hf|U.C.B|Levetíracetam||39814||39814|51436 051713|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.04.2006||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|4108|6304|lyfalmen|V0084|6304|00|28|0|19|D.A.C. ehf|D.A.C. ehf|Esómeprazól||4026||4026|6304 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|1909|3043|lyfalmen|V0308|3043|00|100|0|100|Portfarma ehf|Portfarma|Amlódipín||1623||1623|3043 051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|3111|4428|lyfalmen|V0310|4428|00|100|0|200|Portfarma ehf|Portfarma|Amlódipín||2644||2644|4428 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|438438|547723|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||438438||438438|547723 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|A||0|0|0|0|RAN|0|0|0|100|SEK|329|1287|lyfalmen|V0856|1287|00|20|0|10|Actavis Group PTC ehf|Mylan AB|Alprazólam||||329|1287 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|A||0|0|0|0|RAN|0|0|0|100|SEK|815|1946|lyfalmen|V0855|1946|00|100|0|25|Actavis Group PTC ehf|Mylan AB|Alprazólam||||815|1946 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|883381|1101677|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||883381||883381|1101677 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|893485|1114256|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||893485||893485|1114256 052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|2|0|2|D.A.C. ehf|D.A.C. ehf|Acíklóvír||||| 052498|V03AF0302|Rescuvolin|sts|15|mg|1|stk|25|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|37677|48775|lyfsjukr|||63|25|0|6|Actavis Group hf|Pharmachemie|Kalsíumfólínat||37677||37677|48775 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|46469|59721|lyfsjukr|||00|8212|0|8|Icepharma hf|Fresenius Kabi|Blöndur||46469||46469|59721 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|37335|48350|lyfsjukr|||00|7698|0|8|Icepharma hf|Fresenius Kabi|Blöndur||37335||37335|48350 052522|V03AF0302|Rescuvolin|sts|50|mg|1|stk|10|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|50302|64493|lyfsjukr|||63|10|0|8|Actavis Group hf|Pharmachemie|Kalsíumfólínat||50302||50302|64493 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|43200|55652|lyfsjukr|||00|7680|0|8|Icepharma hf|Fresenius Kabi|Blöndur||43200||43200|55652 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|30318|39613|lyfsjukr|||00|7200|0|7|Icepharma hf|Fresenius Kabi|Blöndur||30318||30318|39613 052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|48659|62448|lyfsjukr|||00|7880|0|8|Icepharma hf|Fresenius Kabi|Blöndur||48659||48659|62448 052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|45270|58229|lyfsjukr|||00|7616|0|8|Icepharma hf|Fresenius Kabi|Blöndur||45270||45270|58229 053006|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|100|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|2743|4563|lyfalmen|V0903|4563|00|100|0|100|Actavis Group PTC ehf|Mylan AB|Zolpidem||2743||2743|4563 053025|G03HB0102|Diane mite|töflur|0| |63|stk|1|þpakki||G03HB01|01.07.1989||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|2261|3909|lyfalmen|||23|63|0|63|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2261||2261|3909 053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|A|2|0|1|0|1|ABT|0|0|0|100|DKK|86987|110166|lyfsjukr|||00|120|0|30|Vistor hf|Abbott Laboratories Ltd|Lopinavír||86987||86987|110166 053231|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|6776|10036|lyfalmen|||02|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||6776||6776|10036 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|37617|49018|lyfalmen|||00|100|0|50|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||37617||37617|49018 053397|L04AA1301|Arava|töflur|20|mg|30|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|11655|16657|lyfalmen|||00|30|0|30|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||11655||11655|16657 053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|35987|46989|lyfalmen|||00|100|0|100|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||35987||35987|46989 053546|L04AA1301|Arava|töflur|100|mg|3|stk|1|þpakki||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|5591|8428|lyfalmen|||00|3|0|20|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||5591||5591|8428 053680|J05AE1001|Prezista|filmhtfl|300|mg|120|stk|1|plglas||J05AE10|01.04.2007||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|112500|141930|lyfsjukr|||43|120|0|30|Vistor hf|Janssen-Cilag International N.V.|||112500||112500|141930 053689|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|20|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|584|1633|lyfalmen|V0902|1633|00|20|0|20|Actavis Group PTC ehf|Mylan AB|Zolpidem||584||584|1633 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|A|2|1|0|0|0|MAP|0|0|0|100|GBP|17314|23741|lyfalmen|||00|10|0|50|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||17314||17314|23741 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburður, lausn|D10AF01|01.07.1985||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|1317|2628|lyfalmen|||20|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||1317||1317|2628 054148|J01CA0405|Flemoxin|dropar|100|mg/ml|20|ml|1|glas||J01CA04|01.11.1979||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|909|2074|lyfalmen|||28|20|0|2|Vistor hf|Astellas Pharma A/S|Amoxicillín||909||909|2074 054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|2976|4879|lyfalmen|||02|0|0|0|Icepharma hf|Aventis Pasteur MSD A/S|Haemophilus influenzae B||2976||2976|4879 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|1|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|4|0|0|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|74890|95106|lyfsjukr|||00|56|0|22|Icepharma hf|Roche Registration Limited|Ribavirin||74890||74890|95106 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|2|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|A|3|0|0|0|0|UCN|0|0|1|100|SEK|1360|2686|lyfalmen|||00|200|0|5|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1360||1360|2686 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|949|2128|lyfalmen|V0914|2128|10|30|0|30|Actavis Group hf|Actavis hf|Flúoxetín||949||949|2128 054601|QB03AC9001|Idofer, vet.|stl|200|mg/ml|100|ml|5|fl|plastfl.|QB03AC90|01.05.1999||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|14667|28110|vetalmen|||27|500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||14667||14667|28110 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|8868|15347|vetorma|||16|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||8868||8868|15347 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|765|1879|lyfalmen|||10|20|0|5|Vistor hf|Recip AB|Erýtrómýcín||765||765|1879 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|13417|18889|lyfalmen|||10|100|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||13417||13417|18889 055392|J04AK0102|Pyrazinamid|töflur|500|mg|100|stk|1|glas||J04AK01|01.04.2005||R|A||0|0|E|0|LDR|0|0|0|100|IKR|3734|5908|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||3734||3734|5908 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|1|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|4359|6756|lyfalmen|V0337|6756|00|100|0|50|Actavis Group hf|Actavis hf|Atorvastatín||4359||4359|6756 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|6185|9234|lyfalmen|V0338|9234|00|100|0|100|Actavis Group hf|Actavis hf|Atorvastatín||6185||6185|9234 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|7867|11516|lyfalmen|V0339|11516|00|100|0|200|Actavis Group hf|Actavis hf|Atorvastatín||7867||7867|11516 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1247|2533|lyfalmen|||10|40|0|10|Vistor hf|Recip AB|Erýtrómýcín||1247||1247|2533 056879|V07AY02|Palacos cum Gentamicin (Paranova)|sement|500|mg|40,5|g|2|pakkar|+ leysir|V07AY|01.06.1997||R|A|4|0|0|0|1|PAN|0|0|0|100|DKK|30097|39338|lyfsjukr|||00|81|0|0|xxxxx|Paranova A/S|||30097||30097|39338 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|K|4|0|1|0|1|EPI|0|0|0|100|XEU|277965|347934|lyfsjukr|||00|15|0|30|Icepharma hf|Elan Pharma International|Natalizumab||277965||277965|347934 056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|76579|97208|lyfsjukr|||00|30|0|30|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl||76579||76579|97208 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|K|4|0|1|0|1|NOH|0|0|0|100|DKK|21434|28553|lyfsjukr|||02|5|0|1|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||21434||21434|28553 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|11390|16048|lyfsjukr|||02|5|0|1|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||11390||11390|16048 057422|B05XA3102|Tracel|irþ|0| |10|ml|20|plastl||B05XA31|01.01.1987||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7416|10618|lyfsjukr|||00|200|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||7416||7416|10618 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|6131|8778|lyfsjukr|||02|5|0|0|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||6131||6131|8778 057703|J01DD0401|Rocephalin|irþ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|28549|37411|lyfsjukr|||00|5|0|5|Icepharma hf|Roche|Ceftríaxón||28549||28549|37411 057924|C09DA0401|CoAprovel|filmhtfl|325|mg|28|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|B|0|SBM|0|0|0|100|NOK|5457|8246|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||5457||5457|8246 057933|C09DA0401|CoAprovel|filmhtfl|325|mg|98|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|B|0|SBM|0|0|0|100|NOK|19416|26358|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||19416||19416|26358 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|23240|31119|lyfalmen|||0|112|0|56|Vistor hf|Pfizer Limited|||||23240|31119 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|491|1507|lyfalmen|||02|5|0|2|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||491||491|1507 058283|QI01AD040|Avipro Thymovac|frþlyf|||500|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|186735|323154|vetorma|||00|5000|0|0|Icepharma hf|Lohmann Animal Health|||||186735|323154 058397|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|23169|31030|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||23169||23169|31030 058503|J01EA0105|Trimetoprim AstraZeneca|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|947|2126|lyfalmen|||00|100|0|2|Vistor hf|Recip AB|Trímetóprím||947||947|2126 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|130482|164318|lyfsjukr|||00|210|0|21|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||130482||130482|164318 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|1587|2994|lyfalmen|||43|100|0|75|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1587||1587|2994 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|2502|4236|lyfalmen|||43|100|0|150|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||2502||2502|4236 058924|QI01AD040|Avipro Thymovac|frþlyf|||1000|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|283669|490903|vetorma|||00|10000|0|0|Icepharma hf|Lohmann Animal Health|||||283669|490903 058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07CA06|01.03.1999||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|4794|7346|lyfalmen|||51|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||4794||4794|7346 059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1581|2986|lyfalmen|||00|250|0|21|Vistor hf|Recip AB|Ísósorbíð dínítrat||1581||1581|2986 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|119427|150872|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|Leuprórelín||119427||119427|150872 059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|10|spr||J07CA06|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|36600|47752|lyfalmen|||51|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||36600||36600|47752 059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|131814|165976|lyfsjukr|||00|30|0|0|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl og emtrícítabín||131814||131814|165976 059823|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.05.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|8331|11928|lyfsjukr|||00|28|0|7|Vistor hf|Schering-Plough|Búprenorfín í blöndum||8331||8331|11928 059824|C07AB0310|Atenolol Merck NM|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|512|1535|lyfalmen|V0290|1535|00|98|0|33|Actavis Group PTC ehf|Merck NM AB|Atenólól||512||512|1535 059842|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|18889|25384|lyfsjukr|||00|28|0|28|Vistor hf|Schering-Plough|Búprenorfín í blöndum||18889||18889|25384 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|450552|563122|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|Deferasírox||450552||450552|563122 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|228173|286260|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|Deferasírox||228173||228173|286260 060578|V03AC0301|Exjade|dreifit.|125|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|114087|144223|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|Deferasírox||114087||114087|144223 060848|N06AA0402|Anafranil Retard|forðatfl|75|mg|100|stk|1|þpakki||N06AA04|01.10.1989||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|8770|12742|lyfalmen|||10|100|0|75|Vistor hf|Novartis Healthcare A/S-|Klómípramín||8770||8770|12742 060905|C01DA0204|Nitromex|tungur.t|0,5|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|24|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||2028 060913|C01DA0204|Nitromex|tungur.t|0,25|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|12|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||2028 061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|3165|6200|vetalmen|||0|4|0|0|Icepharma hf|Pfizer Animal Health|||||3165|6200 061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|1658|3272|vetalmen|||0|4|0|0|Icepharma hf|Pfizer Animal Health|||||1658|3272 061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|1|0|0|100|DKK|9796|18831|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Animal Health|||||9796|18831 061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|8615|11856|lyfalmen|V1030|11856|00|84|0|84|D.A.C. ehf|D.A.C. ehf|Tíbólón||8117||8117|11856 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|IKR|||lyflausa|||23|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam||||| 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|8117|11856|lyfalmen|V1030|11856|00|84|0|84|Vistor hf|N.V. Organon|Tíbólón||8117||8117|11856 061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|1|spr||QP52AF02|01.04.1992||L|A|1|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|26|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||2110 061715|L01XE0901|Torisel|irþ|25|mg/ml|1|hgl|1|pakki||L01XE09|01.05.2008||R|A|2|0|1|0|1|WTE|0|0|0|100|USD|189148|237357|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|Temsirolímus||189148||189148|237357 061762|N02BA0106|Magnyl|töflur|500|mg|50|stk|1|þpakki||N02BA01|01.12.1983||L|A|1|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|50|0|8|Actavis Group hf|Actavis hf|Acetýlsalicýlsýra||||| 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|7593|10871|lyfsjukr|||00|10|0|2|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||7593||7593|10871 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|19948|26703|lyfsjukr|||00|1|0|1|Vistor hf|Novartis Europharm Ltd|Daptomýcín||19948||19948|26703 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|28235|37020|lyfsjukr|||00|1|0|2|Vistor hf|Novartis Europharm Ltd|Daptomýcín||28235||28235|37020 062117|N05BA1204|Tafil Retard|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|583|1632|lyfalmen|||10|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||583||583|1632 062343|A10BD0401|Avaglim|filmhtfl|0| |28|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|5564|8391|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||5564||5564|8391 062379|A10BD0401|Avaglim|filmhtfl|0| |28|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|8324|12136|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||8324||8324|12136 062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|8066|11548|lyfsjukr|||02|20|0|0|Icepharma hf|Wyeth AB|Metótrexat||8066||8066|11548 062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|567|812|lyfsjukr|||02|1|0|0|Icepharma hf|Wyeth AB|Metótrexat||567||567|812 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|1227|2505|lyfalmen|||10|60|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1227||1227|2505 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|A|5|0|0|E|0|AGT|0|0|1|100|XEU|2353|4034|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis Group hf|Cyanocobalamin||2353||2353|4034 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|20734|35881|vetorma|||16|1000|0|0|Vistor hf|Bayer Animal Health GmbH|||20734||20734|35881 062935|G03AA1005|Harmonet|töflur|0| |63|stk|1|pakki|þp 20+75 mcg|G03AA10|01.11.1998||R|A|3|0|0|0|0|WEM|0|0|0|100|USD|2098|3687|lyfalmen|||23|63|0|63|Icepharma hf|Wyeth Medica|Gestóden og östrógen||2098||2098|3687 062987|J07BM0201|Cervarix|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|18417|25114|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||18417||18417|25114 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|5913|8865|lyfalmen|||00|10|0|2|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||5913||5913|8865 063453|J01CA0406|Flemoxin Solutab|lausnart|750|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2385|4077|lyfalmen|||23|14|0|10|Vistor hf|Astellas Pharma A/S|Amoxicillín||2385||2385|4077 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|A|2|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|500|0|50|Vistor hf|Medic Team|Laktúlósa|||||3089 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|glas||D01BA02|01.11.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2649|4435|lyfalmen|V0343|4435|00|28|0|28|Actavis Group hf|Actavis hf|Terbínafín||2649||2649|4435 063706|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.11.2006||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|2384|3364|lyfalmen|V1901|3364|00|30|0|30|D.A.C. ehf|D.A.C. ehf|Deslóratadín||1860||1860|3364 063715|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|5593|7901|lyfalmen|V1902|7901|00|100|0|100|D.A.C. ehf|D.A.C. ehf|Deslóratadín||5203||5203|7901 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|K|2,5|0|0|0|1|OCT|0|0|0|100|DKK|11803|16562|lyfsjukr|||17|2|0|0|Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||11803||11803|16562 063923|QP54AB5207|Equest Pramox vet|hlaup|0| |11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|A|2|0|0|0|0|FDV|0|0|0|100|XEU|2918|5050|vetorma|||16|12|0|0|Vistor hf|Fort Dodge Veterinär GmbH|||2918||2918|5050 063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|1227|2505|lyfalmen|||10|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1227||1227|2505 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2496|4228|lyfalmen|||10|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||2496||2496|4228 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|1248692|1556489|lyfsjukr|||00|1|0|12|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1248692|1556489 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|499476|623715|lyfsjukr|||00|1|0|5|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||499476|623715 064170|N05BA1204|Tafil Retard|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|2699|4503|lyfalmen|||10|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||2699||2699|4503 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|4994769|6220355|lyfsjukr|||00|1|0|47|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4994769|6220355 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|2497385|3111112|lyfsjukr|||00|1|0|23|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2497385|3111112 064733|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|1005|2204|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||1005||1005|2204 065032|D10AF5101|Duac|hlaup|0| |25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|A|1,5|0|0|0|0|SLL|0|0|0|100|DKK|2248|3891|lyfalmen|||38|25|0|0|Vistor hf|Stiefel Laboratories (UK) Ltd.|Klindamýcín í blöndum||2248||2248|3891 065060|J07BD5202|MMR II|bóluefni|0| |0,5|ml|10|hgl|+ leysir|J07BD52|01.11.1998||R|K|2|0|0|0|0|MEX|0|0|0|100|XEU|15041|20911|lyfalmen|||51|5|0|0|Icepharma hf|Aventis Pasteur MSD A/S|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||15041||15041|20911 065094|V08AB0901|Visipaque|stl|150|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996|31.07.2009|R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5486|7855|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||5486||5486|7855 065314|G01AF0201|Canesten|sk-stil|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|A|4|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||25|6|0|6|Vistor hf|Bayer A/S|Klótrímazól||||| 065332|G01AF0201|Canesten|sk-stil|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|A|5|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||25|1|0|5|Vistor hf|Bayer A/S|Klótrímazól||||| 065540|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996|31.07.2009|R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||15297||15297|20912 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|K|3|0|0|*|0|PFI|0|0|0|100|DKK|2882|4751|lyfalmen|V1989|4751|06|2|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Latanóprost||2882||2882|4751 065722|S01EE0101 |Xalatan|augndr|50|mcg/ml|2,5|ml|3|glas||S01EE01|01.05.2009||R|K|3|0|0|*|0|PFI|0|0|0|100|DKK|8639|12564|lyfalmen|||06|8|0|75|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Latanóprost||||8639|12564 065979|C09CA0101|Cozaar|töflur|12,5|mg|28|stk|1|þpakki||C09CA01|01.03.1999||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|2455|4172|lyfalmen|V0195|2187|00|28|0|7|Icepharma hf|M.S.D.|Lósartan||2455||2455|4172 066241|C03EA0103|Hydramil|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|238|1163|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Hýdróklórtíazíð og kalíumsparandi lyf||238||238|1163 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|8294|12096|lyfalmen|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíð||8294||8294|12096 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|A|5|0|0|0|1|FRP|0|0|0|100|DKK|33618|43722|lyfsjukr|||00|10000|0|10|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||33618||33618|43722 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|10|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|21|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|32|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 066548|QG03FA0401|Prid, vet.|lykkja|10|mg|10|stk|1|pakki|m. hylki|QG03FA04|01.08.1984||R|A|2|0|0|0|0|CES|1|0|0|100|XEU|24082|46044|vetalmen|||16|10|0|0|Icepharma hf|Ceva Sante Animale|||24082||24082|46044 066563|N06AA0405|Klomipramin Merck NM|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|946|2124|lyfalmen|||00|100|0|10|Actavis Group PTC ehf|Merck NM AB|Klómípramín||946||946|2124 066621|N06AA0405|Klomipramin Merck NM|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|873|2025|lyfalmen|V0908|2025|00|100|0|25|Actavis Group PTC ehf|Merck NM AB|Klómípramín||873||873|2025 066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4575|6550|lyfsjukr|||02|120|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6550 066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|K|5|0|0|B|0|DAC|0|0|0|100|NOK|2519|3313|lyfalmen|V0144|3313|70|30|0|15|D.A.C. ehf|D.A.C. ehf|Amíódarón||1822||1822|3313 067025|J01CA0406|Flemoxin Solutab|lausnart|125|mg|20|stk|1|þpakki||J01CA04|01.01.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|740|1845|lyfalmen|||23|20|0|2|Vistor hf|Astellas Pharma A/S|Amoxicillín||740||740|1845 067124|N07CA0101|Betaserc|töflur|16|mg|84|stk|1|þpakki||N07CA01|01.04.1993||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|8181|11942|lyfalmen|||00|84|0|56|Medico ehf|Solvay Duphar |Betahistín||8181||8181|11942 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|þpakki||N05BB01|01.07.1994||R|A|5|0|0|0|0|UCN|0|0|0|100|SEK|1360|2686|lyfalmen|||00|100|0|33|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1360||1360|2686 067632|QN05CM9501|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM95|01.05.2009||R|A|3|0|0|0|0|LAS|1|0|0|100|XEU|7833|15092|vetalmen|||0|10|0|0|Dýraheilsa ehf|Laboratorios SYVA S.A.|||||7833|15092 067641|N05CD0204|Mogadon (D.A.C.)|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.11.2006||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|871|2022|lyfalmen|V0901|2022|00|50|0|50|D.A.C. ehf|D.A.C. ehf|Nítrazepam||871||871|2022 067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1740|3202|lyfalmen|V0551|3202|10|7|0|2|Actavis Group hf|Actavis hf|Flúkónazól||1740||1740|3202 067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|7143|10534|lyfalmen|V0552|10534|10|30|0|8|Actavis Group hf|Actavis hf|Flúkónazól||7143||7143|10534 067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1864|lyfalmen|V0554|1864|10|1|0|1|Actavis Group hf|Actavis hf|Flúkónazól||754||754|1864 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1441|2796|lyfalmen|V0555|2796|10|2|0|2|Actavis Group hf|Actavis hf|Flúkónazól||1441||1441|2796 067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|2500|4233|lyfalmen|V0556|4233|10|4|0|3|Actavis Group hf|Actavis hf|Flúkónazól||2500||2500|4233 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|26738|35474|lyfalmen|V0557|35474|10|30|0|30|Actavis Group hf|Actavis hf|Flúkónazól||26738||26738|35474 068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|A|2,5|1|0|0|0|VEQ|1|0|0|100|XEU|7022|13547|vetalmen|||27|50|0|0|Icepharma hf|Vétoquinol AG|||7022||7022|13547 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|2287|3944|lyfalmen|||00|20|0|10|Vistor hf|Meda AB (V)|Flekaíníð||2287||2287|3944 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|6456|9601|lyfalmen|||00|100|0|50|Vistor hf|Meda AB (V)|Flekaíníð||6456||6456|9601 068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Actavis Group hf|Braun|||||| 068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0|0|Actavis Group hf|Braun|||||| 068951|V07AB09|Sterilt Vann B. Braun|leysir|0||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0|0|Actavis Group hf|Braun|||||| 068960|V07AB09|Sterilt Vann B. Braun|leysir|0||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0|0|Actavis Group hf|Braun|||||| 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|A|5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 069807|D01BA0201|Lamisil|töflur|250|mg|14|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|4952|3211|lyfalmen|||00|14|0|14|Vistor hf|Novartis Healthcare A/S-|Terbínafín||1747||1747|3211 069815|D01BA0201|Lamisil|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|31896|16993|lyfalmen|||00|98|0|98|Vistor hf|Novartis Healthcare A/S-|Terbínafín||11903||11903|16993 069833|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|3033|4956|lyfalmen|||00|40|0|10|Icepharma hf|NordMedica A/S|Cefalexín||3033||3033|4956 069842|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|1516|2898|lyfalmen|||00|20|0|5|Icepharma hf|NordMedica A/S|Cefalexín||1516||1516|2898 070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|44276|56991|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||44276||44276|56991 070359|L01DB0701|Novantrone|irþ|2|mg/ml|10|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|33865|44029|lyfsjukr|||00|10|0|0|Icepharma hf|Wyeth AB|Mítoxantrón||33865||33865|44029 070514|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|6212|8894|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||6212||6212|8894 070523|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|5796|8298|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||5796||5796|8298 070533|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|10178|14539|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||10178||10178|14539 070542|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6477|9273|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||6477||6477|9273 070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|A|2|0|0|0|0|PSW|1|0|0|100|SEK|5472|10595|vetalmen|||27|100|0|0|Vistor hf|Pharmaxim Sweden AB|||5472||5472|10595 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|17247|23657|lyfalmen|||00|100|0|20|Vistor hf|Janssen-Cilag AB|Risperídón||17247||17247|23657 071076|QA12CE9902|Selevitan, vet.|kyrni|0| |1250|g|1|plbrús||QA12CE99|01.12.2006||R|A|3|0|0|0|0|PSW|0|0|0|100|SEK|5794|11208|vetalmen|||16|1250|0|0|Vistor hf|Pharmaxim Sweden AB|||5794||5794|11208 071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|A|5|0|0|*|0|ACA|0|1|0|100|IKR|728|1828|lyfalmen|||00|100|0|22|Actavis Group hf|Actavis hf|Litíum||728||728|1828 071217|C03EA0104|Hydramil mite|töflur|27,5|mg|100|stk|1|glas|2.5+25 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|158|1055|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Hýdróklórtíazíð og kalíumsparandi lyf||158||158|1055 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|61179|78035|lyfsjukr|||00|1|0|8|Vistor hf|Eisai Ltd|Ziconotíð||61179||61179|78035 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|305895|382707|lyfsjukr|||00|5|0|42|Vistor hf|Eisai Ltd|Ziconotíð||305895||305895|382707 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|A|3|0|0|0|0|ORF|1|0|0|100|DKK|8961|17241|vetalmen|||27|5|0|0|Vistor hf|Orion-Farmos|||8961||8961|17241 072371|A04AA0201|Kytril|stl|1|mg/ml|3|ml|5|lykjur||A04AA02|01.04.1993||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|15682|21709|lyfalmen|||00|15|0|5|Icepharma hf|Roche as|Granisetrón||15682||15682|21709 072520|V01AA1104|Alutard SQ, hrossaværur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|21994|29568|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||21994||21994|29568 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|615|881|lyfsjukr|||02|10|0|0|Vistor hf|Janssen-Cilag AB|Súfentaníl||615||615|881 072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|190997|239659|lyfsjukr|||00|2|0|28|Vistor hf|Abbott|Adalimumab||190997||190997|239659 072892|N01AH0301|Sufenta|stl|50|mcg/ml|1|ml|5|lykjur||N01AH03|01.10.1992||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1883|2696|lyfsjukr|||02|5|0|0|Vistor hf|Janssen-Cilag AB|Súfentaníl||1883||1883|2696 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELN|0|0|0|100|XEU|17126|23507|lyfalmen|||00|1|0|20|Icepharma hf|Eli Lilly Nederland|Exenatíð||17126||17126|23507 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELN|0|0|0|100|XEU|17126|23507|lyfalmen|||00|2|0|40|Icepharma hf|Eli Lilly Nederland|Exenatíð||17126||17126|23507 073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1503|2880|lyfalmen|||00|100|0|8|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1503||1503|2880 073224|A09AA0205|Creon|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.01.2008||R|A|2|0|0|E|0|SOY|0|0|0|100|XEU|4428|5874|lyfalmen|||10|100|0|100|Medico ehf|Solvay Pharmaceuticals GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||3709||3709|5874 073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1883|3396|lyfalmen|||00|100|0|17|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1883||1883|3396 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|351|1317|lyfalmen|||00|20|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||351||351|1317 073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|946|2124|lyfalmen|||00|50|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||946||946|2124 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1370|2700|lyfalmen|V0855|1946|00|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1370||1370|2700 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|593|1645|lyfalmen|V0856|1287|00|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||593||593|1645 073866|N05BA1203|Tafil|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1030|2238|lyfalmen|||00|50|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1030||1030|2238 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|2044|3614|lyfalmen|||00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||2044||2044|3614 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|4130|6445|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4130||4130|6445 074051|C09DB0101|Exforge|filmhtfl|85|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|12026|17157|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||12026||12026|17157 074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|5269|7991|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||5269||5269|7991 074069|C09DB0101|Exforge|filmhtfl|165|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|15509|21494|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||15509||15509|21494 074078|C09DB0101|Exforge|filmhtfl|170|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|5269|7991|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||5269||5269|7991 074087|C09DB0101|Exforge|filmhtfl|170|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|17408|23858|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||17408||17408|23858 074229|A08AA1001|Reductil|hylki|10|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|6311|9405|lyfalmen|||00|28|0|28|Vistor hf|Abbott Laboratories A/S|Sibutramin||6311||6311|9405 074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|22740|30179|lyfsjukr|||00|50|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||22740||22740|30179 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|264|1199|lyfalmen|||00|25|0|12|Actavis Group hf|Actavis Group hf|Díazepam||264||264|1199 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|535|1566|lyfalmen|||00|50|0|25|Actavis Group hf|Actavis Group hf|Díazepam||535||535|1566 074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|0| |1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|K|2|0|0|0|0|SCA|1|0|0|100|DKK|23814|41211|vetorma|||58|25|0|0|Vistor hf|Scan Vet Animal Health AS|||23814||23814|41211 074674|D06BB0401|Condyline|áburður|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.07.1988||R|A|2|0|0|0|0|GAN|0|0|1|100|XEU|2504|4238|lyfalmen|||23|4|0|4|Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2504||2504|4238 074732|A08AA1001|Reductil|hylki|15|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|6311|9405|lyfalmen|||00|28|0|42|Vistor hf|Abbott Laboratories A/S|Sibutramin||6311||6311|9405 074922|R06AX2601|Telfast|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1507|2519|lyfalmen|V1910|2330|00|30|0|30|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1237||1237|2519 075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|þpakki||J02AB02|01.01.1985||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|1561|2959|lyfalmen|||69|10|0|10|Vistor hf|Janssen-Cilag AB|Ketókónazól||1561||1561|2959 075068|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1|Vistor hf|McNeil Denmark ApS|Nikótín||||| 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2131|3423|lyfalmen|V1912|3135|00|30|0|45|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1903||1903|3423 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6|Vistor hf|McNeil Denmark ApS|Nikótín||||| 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|IKR|1500|2876|lyfalmen|||00|300|0|50|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||1500||1500|2876 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|NOK|2689|4489|lyfalmen|||00|300|0|300|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||2689||2689|4489 075305|N02BE0108|Paratabs Retard|forðatfl|500|mg|300|stk|1|plglas||N02BE01|01.10.2007||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|1536|2925|lyfalmen|||10|300|0|50|Actavis Group hf|Actavis hf|Paracetamól||1536||1536|2925 075382|V04CL0030|Soluprick SQ, rauðölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8538|12427|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||8538||8538|12427 075408|V04CL0022|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8538|12427|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||8538||8538|12427 075424|V04CL0019|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8538|12427|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||8538||8538|12427 075440|V04CL0026|Soluprick SQ, hesliviður|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8538|12427|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||8538||8538|12427 075465|V04CL0024|Soluprick SQ, haliðagras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8538|12427|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8538||8538|12427 075481|V04CL0023|Soluprick SQ, hafrar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8538|12427|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8538||8538|12427 075507|V04CL0018|Soluprick SQ, axhnoðapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8538|12427|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8538||8538|12427 075523|V04CL0025|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8538|12427|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8538||8538|12427 075549|V04CL0033|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8538|12427|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8538||8538|12427 075564|V04CL0032|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8538|12427|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8538||8538|12427 075580|V04CL0034|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8538|12427|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8538||8538|12427 075606|V04CL0031|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8538|12427|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8538||8538|12427 075663|V04CL0021|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8538|12427|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||8538||8538|12427 075689|V04CL0027|Soluprick SQ, hrossaværur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8538|12427|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|dýr||8538||8538|12427 075705|V04CL0028|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8538|12427|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|dýr||8538||8538|12427 075721|V04CL0029|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8538|12427|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|dýr||8538||8538|12427 075724|B02BD0901|BeneFIX|sts|0| |1000|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|140161|176368|lyfsjukr|||00|1000|0|3|Icepharma hf|Wyeth Europe|Storkuþáttur IX||140161||140161|176368 075787|QS02CA0102|Canaural|eyrnadr|0| |25|ml|1|glas||QS02CA01|01.12.1982||R|A|3|0|0|0|0|VEX|0|0|0|100|DKK|2393|4722|vetalmen|||13|25|0|0|Vistor hf|VetXX A/S|||2393||2393|4722 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|A|3|0|0|*|0|MSD|0|0|0|100|XEU|26029|34591|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|Sítagliptín||26029||26029|34591 076281|R01AX0301|Atrovent|nefúði|21|mcg/sk|30|ml|1|stauk|380 sk.|R01AX03|01.01.2000||R|A|2|0|0|E|0|BOI|0|0|1|100|DKK|2947|4840|lyfalmen|||24|30|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð||2947||2947|4840 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|738|1792|lyfalmen|V1070|1792|00|20|0|2|Portfarma ehf|Portfarma|Risperídón||701||701|1792 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2033|3185|lyfalmen|V1075|3185|00|60|0|6|Portfarma ehf|Portfarma|Risperídón||1728||1728|3185 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2876|4040|lyfalmen|V0791|4040|00|60|0|12|Portfarma ehf|Portfarma|Risperídón||2358||2358|4040 076533|N05AB0301 |Trilafon|filmhtfl|2|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1023|2229|lyfalmen|||00|100|0|7|Vistor hf|Schering-Plough|Perfenazín||||1023|2229 076542|N05AB0301 |Trilafon|filmhtfl|4|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1418|2765|lyfalmen|||00|100|0|13|Vistor hf|Schering-Plough|Perfenazín||||1418|2765 076551|N05AB0301 |Trilafon|filmhtfl|8|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|2021|3583|lyfalmen|||00|100|0|27|Vistor hf|Schering-Plough|Perfenazín||||2021|3583 076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|8196|14184|vetorma|||27|100|0|0|Vistor hf|Merial (MSD)|||8196||8196|14184 077215|A06AH0101|Relistor|stl|20|mg/ml|0,6|ml|1|hgl|lausn|A06AH01|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|USD|6791|10056|lyfalmen|||0|12|0|0|Icepharma hf|Wyeth Europe|Metýlnaltrexónbrómíð||6791||6791|10056 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|200|1112|lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||200||200|1112 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|505|1526|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||505||505|1526 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|788|1910|lyfalmen|||02|10|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||788||788|1910 077951|M01AB0514|Voltfast (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.04.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|IKR|955|1424|lyfalmen|V0609|1424|10|30|0|15|D.A.C. ehf|D.A.C. ehf|Díklófenak||430||430|1424 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|489|1504|lyfalmen|||00|20|0|2|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||489||489|1504 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|744|1850|lyfalmen|||00|40|0|5|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||744||744|1850 078709|N06AB0303|Serol|töflur|10|mg|30|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|100|IKR|1226|2504|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|Flúoxetín||1226||1226|2504 078717|N06AB0303|Serol|töflur|10|mg|100|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|100|IKR|4110|6418|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|Flúoxetín||4110||4110|6418 078741|N06AX0306|Mianserin Merck NM|töflur|30|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|3059|4992|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Míanserín||3059||3059|4992 078782|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|5770|8261|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||5770||5770|8261 078790|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|16998|23030|lyfsjukr|||00|15|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||16998||16998|23030 078824|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|18876|25368|lyfsjukr|||00|45|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||18876||18876|25368 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|A|2|0|1|0|1|SAG|0|0|0|100|SEK|146569|184346|lyfsjukr|||00|15|0|30|Icepharma hf|Schering AG|Interferón beta-1b||146569||146569|184346 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|10203|6644|lyfalmen|V0197|5469|00|98|0|98|Icepharma hf|M.S.D.|Lósartan||4277||4277|6644 079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|2210|3164|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Ífosfamíð||2210||2210|3164 079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|3815|5462|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Ífosfamíð||3815||3815|5462 079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|6854|9813|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Ífosfamíð||6854||6854|9813 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|þpakki||J05AH02|01.11.2002||R|A|5|0|0|0|0|RRL|0|0|0|100|DKK|3843|6056|lyfalmen|||00|10|0|5|Icepharma hf|Roche Registration Limited|Oseltamivír||3843||3843|6056 079236|L01CA0206|Vincristine Mayne|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|7712|11042|lyfsjukr|||02|5|0|0|Icepharma hf|Mayne Pharma Plc|Vínkristín||7712||7712|11042 079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|A|3|0|0|*|0|SCP|0|1|0|100|DKK|21155|28523|lyfalmen|||02|10|0|155|Vistor hf|Schering-Plough|Perfenazín||21155||21155|28523 079616|L01CA0206|Vincristine Mayne|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|12070|16895|lyfsjukr|||02|10|0|0|Icepharma hf|Mayne Pharma Plc|Vínkristín||12070||12070|16895 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2375|3400|lyfsjukr|||03|5|0|2|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2375||2375|3400 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|393|1374|lyfalmen|V0514|1374|00|10|0|2|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1374 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|638|1706|lyfalmen|V0518|1706|00|20|0|5|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1706 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|647|1718|lyfalmen|V0522|1718|00|10|0|5|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1718 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1168|2425|lyfalmen|V0526|2425|00|20|0|10|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2425 080424|G01AF0502|Pevaryl Depot|sk-stil|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||05|1|0|2|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2577|4337|lyfalmen|||00|100|0|67|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2577||2577|4337 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|6875|10170|lyfalmen|||00|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||6875||6875|10170 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|3707|5871|lyfalmen|||00|30|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||3707||3707|5871 080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|34887|60374|vetorma|||27|500|0|0|Vistor hf|Merial (MSD)|||34887||34887|60374 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|27555|36173|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ídarúbicín||27555||27555|36173 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|45783|58867|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ídarúbicín||45783||45783|58867 081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.11.1998||R|A|3,5|0|0|E|0|AZD|0|0|0|100|SEK|39449|51299|lyfalmen|||02|12|0|35|Vistor hf|AstraZeneca A/S DK|Natríumhýalúrónat||39449||39449|51299 081507|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.05.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|XEU|6651|9866|lyfalmen|V1350|9866|00|4|0|8|D.A.C. ehf|D.A.C. ehf|Tadalafíl||||6651|9866 081525|V03AN0101|Conoxia|innö.gas|100|%|10|l|1|hylki|MO10|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|10|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081534|V03AN0101|Conoxia|innö.gas|100|%|20|l|1|hylki|MO20|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|20|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081543|V03AN0101|Conoxia|innö.gas|100|%|50|l|1|hylki|Mo50|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|50|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081552|V03AN0101|Conoxia|innö.gas|100|%|5|l|1|hylki|MO5|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|5|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081561|V03AN0101|Conoxia|innö.gas|100|%|50|l|12|hylki|MS5I|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|600|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081571|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081589|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081598|V03AN0101|Conoxia|innö.gas|100|%|2,5|l|1|hylki|MO2,5c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081625|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081634|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4b|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081671|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081680|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081689|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|2369|3392|lyfsjukr|||02|10|0|3|Icepharma hf|Roche|Mídazólam||2369||2369|3392 081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.05.2007||R|A|3|0|0|*|0|DAC|0|1|0|100|XEU|21975|29544|lyfalmen|V0813|29544|00|28|0|28|D.A.C. ehf|D.A.C. ehf|Olanzapín||21975||21975|29544 081987|A10AB0602|Apidra [solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áflylltir|A10AB06|01.01.2008||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|5633|8485|lyfalmen|||02|15|0|38|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5633||5633|8485 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap||A10AE04|01.01.2008||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|9533|13777|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9533||9533|13777 082040|D07XC0101|Diprosalic|áburður|0||100|ml|1|glas||D07XC01|01.01.1987||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3808|6008|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||||3808|6008 082233|V03AN0101|Conoxia|innö.gas|100|%|36|l|1|hylki|Hemlox|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|36|0|0|Ísaga ehf|AGA AB|Súrefni||||| 082685|R03BA0502|Flixotide Diskus|innúðadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|3525|5624|lyfalmen|||23|60|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3525||3525|5624 082701|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|60|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|645|1716|lyfalmen|||00|60|0|3|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||645||645|1716 082719|R03BA0502|Flixotide Diskus|innúðadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|5758|8654|lyfalmen|||23|60|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5758||5758|8654 082792|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|1008|2208|lyfalmen|||00|125|0|6|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1008||1008|2208 082842|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|200|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|1612|3028|lyfalmen|||00|200|0|10|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1612||1612|3028 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5065|7714|lyfalmen|||00|100|0|6|Vistor hf|AstraZeneca A/S DK|Búdesóníð||5065||5065|7714 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5566|8394|lyfalmen|||00|40|0|12|Vistor hf|AstraZeneca A/S DK|Búdesóníð||5566||5566|8394 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|15018|20882|lyfalmen|||00|56|0|9|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||15018||15018|20882 083113|L02BG0301|Arimidex|töflur|1|mg|28|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|17642|24149|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca UK Ltd|Anastrózól||17642||17642|24149 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|15685|21713|lyfalmen|V1372|21713|00|56|0|19|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||15685||15685|21713 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7077|10444|lyfalmen|||00|40|0|25|Vistor hf|AstraZeneca A/S DK|Búdesóníð||7077||7077|10444 083360|G03GA0501|Gonal-F|sts|75|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|48511|62581|lyfalmen|||03|10|0|10|Gróco ehf|Serono Nordic|Follitrópín alfa||48511||48511|62581 083451|G03GA0501|Gonal-F|sts|150|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|98561|124893|lyfalmen|||03|10|0|20|Gróco ehf|Serono Nordic|Follitrópín alfa||98561||98561|124893 083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|K|0,5|0|1|0|1|ABL|0|0|0|100|DKK|87653|110995|lyfsjukr|||00|450|0|30|Vistor hf|Abbott Laboratories A/S|Ritonavír||87653||87653|110995 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|34036|44560|lyfalmen|||00|112|0|75|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||34036||34036|44560 083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|8634|12362|lyfsjukr|||02|11|0|7|Vistor hf|Sanofi-aventis Norge AS|Búserelín||8634||8634|12362 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|307|1257|lyfalmen|||02|10|0|2|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||307||307|1257 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|592|1644|lyfalmen|||02|20|0|5|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||592||592|1644 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|72481|92106|lyfsjukr|||00|0|0|38|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||72481||72481|92106 084673|P01BC0103|Kinin Actavis|töflur|100|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1161|2416|lyfalmen|||00|100|0|7|Actavis Group hf|Actavis hf|Kínín||1161||1161|2416 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|94515|119539|lyfsjukr|||00|0|0|50|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||94515||94515|119539 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|112687|142163|lyfsjukr|||00|0|0|62|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||112687||112687|142163 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|24309|32132|lyfsjukr|||00|0|0|12|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||24309||24309|32132 084699|P01BC0103|Kinin Actavis|töflur|250|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|2458|4176|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|Kínín||2458||2458|4176 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|36376|47156|lyfsjukr|||00|0|0|19|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||36376||36376|47156 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|48389|62112|lyfsjukr|||00|0|0|25|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||48389||48389|62112 084751|B03XA0301 |Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|14426|19828|lyfsjukr|||00|0|0|8|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||14426|19828 084778|B03XA0301 |Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|54990|70330|lyfsjukr|||00|0|0|30|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||54990|70330 084787|B03XA0301 |Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|169364|212726|lyfsjukr|||00|0|0|90|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||169364|212726 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|1037|2248|lyfalmen|||00|10|0|1|Vistor hf|Eisai Ltd|Rúfínamíð||1037||1037|2248 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|11989|17110|lyfalmen|||00|60|0|3|Vistor hf|Eisai Ltd|Rúfínamíð||11989||11989|17110 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|39969|51946|lyfalmen|||00|100|0|29|Vistor hf|Eisai Ltd|Rúfínamíð||39969||39969|51946 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|22251|29887|lyfalmen|||10|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||22251||22251|29887 085105|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|98|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|6411|7407|lyfalmen|||0|98|0|49|Actavis Group hf|Actavis Group hf|Ómeprazól||4839||4839|7407 085132|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|2540|4287|lyfalmen|V2170|4287|0|56|0|56|Actavis Group hf|Actavis Group hf|Ómeprazól||||2540|4287 085141|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|98|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|4530|6988|lyfalmen|V2171|6988|0|98|0|98|Actavis Group hf|Actavis Group hf|Ómeprazól||||4530|6988 085160|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|28|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|0|0|AGT|0|0|0|100|IKR|3291|5306|lyfalmen|||0|28|0|56|Actavis Group hf|Actavis Group hf|Ómeprazól||||3291|5306 085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|A|2|0|0|0|0|SAO|0|0|1|100|XEU|3466|5544|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Levófloxacín||3466||3466|5544 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|34036|44560|lyfalmen|||00|112|0|56|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||34036||34036|44560 085407|R03AC0206|Ventoline|lausn|1|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|867|2017|lyfalmen|||00|50|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||867||867|2017 085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl|með rotvörn|B01AB04|01.04.1993||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|14940|20468|lyfsjukr|||00|4|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||14940||14940|20468 085542|G03GA0202|Menopur|sts|0| |75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|23162|31022|lyfalmen|||00|375|0|12|Vistor hf|Ferring Lægemidler A/S|Menótrópín||23162||23162|31022 085551|G03GA0202|Menopur|sts|0| |75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|41208|53489|lyfalmen|||00|750|0|25|Vistor hf|Ferring Lægemidler A/S|Menótrópín||41208||41208|53489 085829|S01EB0104|Pilokarpin|augndr|2|%|0,15|ml|20|skammt|án rotvarnar|S01EB01|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1929|3458|lyfalmen|||00|3|1|8|Parlogis hf|Parlogis - óskráð lyf|Pílókarpín||1929||1929|3458 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5233|5901|lyfalmen|V1911|5331|00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3729||3729|5901 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|6293|8322|lyfalmen|V1913|7476|00|100|0|150|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||5513||5513|8322 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|9604|13751|lyfsjukr|||03|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||9604||9604|13751 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|15859|21612|lyfsjukr|||03|5|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||15859||15859|21612 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|K|2|0|1|0|1|BSP|0|0|0|100|DKK|72437|92052|lyfsjukr|||00|1|0|9|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||72437||72437|92052 087014|J05AF1101|Sebivo|filmhtfl|600|mg|28|stk|1|þpakki||J05AF11|01.07.2008||R|A|2|0|1|0|1|NOH|0|0|0|100|DKK|84530|107107|lyfsjukr|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|||84530||84530|107107 087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|3689|5847|lyfalmen|||00|28|0|28|Vistor hf|N.V. Organon|Tíbólón||3689||3689|5847 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|30|0|14|Vistor hf|Janssen-Cilag AB|Silíkonsambönd||||| 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|183385|230182|lyfsjukr|||00|60|0|15|Vistor hf|Pfizer Limited|Maravíroc||183385||183385|230182 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|281|1222|lyfalmen|||00|10|0|10|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||281||281|1222 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|247|1176|lyfalmen|V0886|1165|00|30|0|30|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||247||247|1176 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|2927|4812|lyfalmen|||00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||2927||2927|4812 087445|A02BX1301|Gaviscon|mixtúra|0| |500|ml|1|glas||A02BX13|01.08.1984||L|A|2|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||01|500|0|0|Vistor hf|Nordic Drugs AB|Algínsýra||||| 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|þpakki||G03GB02|01.07.1986||R|A|5|0|0|E|0|EME|0|0|0|100|SEK|806|1934|lyfalmen|||00|5|0|28|MedFarm ehf|E. Merck AB|Klómífen||806||806|1934 087760|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087769|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2004||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087778|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087787|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087796|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087805|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087814|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087823|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.09.2007||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|16862|23178|lyfalmen|V0560|23178|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||16862||16862|23178 087932|A02BX1301|Gaviscon|tuggutfl|0| |20|stk|1|þpakki||A02BX13|01.10.1993||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||00|20|0|0|Vistor hf|Nordic Drugs AB|Algínsýra|||||1633 088006|N07BA0126|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 088015|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 088051|L03AB0503|IntronA (Lyfjaver)|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|27307|35865|lyfsjukr|||00|1|0|9|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||27307||27307|35865 088224|L03AB0503|IntronA (Lyfjaver)|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|44478|57243|lyfsjukr|||00|1|0|15|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||44478||44478|57243 088233|L03AB0503|IntronA (Lyfjaver)|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|91042|115215|lyfsjukr|||00|1|0|30|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||91042||91042|115215 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|sk|1|glas||R01AD12|01.04.2008||R|A|3|0|0|E|0|GGL|0|0|1|100|GBP|1510|2890|lyfalmen|||00|120|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1510||1510|2890 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1695|3141|lyfalmen|||14|20|0|20|Vistor hf|Meda AB|Nabúmeton||1695||1695|3141 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|8402|12242|lyfalmen|||14|100|0|100|Vistor hf|Meda AB|Nabúmeton||8402||8402|12242 088393|A03FA0101|Primperan|eþ-stil|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|514|1538|lyfalmen|||04|6|0|4|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||514||514|1538 088632|C09CA0302|Diovan (D.A.C.)|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.05.2007||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|17060|18882|lyfalmen|V1111|15463|00|98|0|196|D.A.C. ehf|D.A.C. ehf|Valsartan||13411||13411|18882 088723|L01XE0701|Tyverb|filmhtfl|250|mg|70|stk|1|þpakki||L01XE07|01.11.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|186489|234046|lyfsjukr|||00|70|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||||186489|234046 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.12.2008||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|56117|59697|lyfalmen|V0561|59697|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||46194||46194|59697 089003|G03CA0308|Progynon|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|1346|2667|lyfalmen|V0408|1896|00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|Estradíól||1346||1346|2667 089094|A02BX1301|Gaviscon|tuggutfl|0| |120|stk|1|þpakki||A02BX13|01.01.1989||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||00|120|0|0|Vistor hf|Nordic Drugs AB|Algínsýra||||| 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|183385|230182|lyfsjukr|||00|60|0|30|Vistor hf|Pfizer Limited|Maravíroc||183385||183385|230182 090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|2368|4054|lyfalmen|V0352|1798|00|100|0|25|Vistor hf|Ferrosan A/S|Diltíazem||2368||2368|4054 090232|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MRK|0|0|0|100|XEU|46354|59578|lyfsjukr|||00|20|0|0|Vistor hf|Merck KgaA (V)|Cetúxímab||46354||46354|59578 090242|L01XC0601|Erbitux|irl|5|mg/ml|100|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MRK|0|0|0|100|XEU|231766|290416|lyfsjukr|||00|100|0|0|Vistor hf|Merck KgaA (V)|Cetúxímab||231766||231766|290416 090460|L04AB0102|Enbrel (Lyfjaver)|stl|0| |25|mg|4|áf.spr|lausn|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|88925|112579|lyfsjukr|||00|100|0|14|Lyfjaver ehf|Lyfjaver ehf|Etanercept||88925||88925|112579 090469|L04AB0102|Enbrel (Lyfjaver)|stl|0| |50|mg|4|áf.spr|lausn|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|185426|232723|lyfsjukr|||00|200|0|29|Lyfjaver ehf|Lyfjaver ehf|Etanercept||185426||185426|232723 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1714|3166|lyfalmen|||24|16|0|30|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1714||1714|3166 090688|A06AB0602|Senokot|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.1990||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|965|2150|lyfalmen|||00|60|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||965||965|2150 091360|C08DB0108|Korzem-R|forðatfl|120|mg|60|stk|1|þpakki||C08DB01|01.04.2008||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2253|3898|lyfalmen|V0351|3898|10|60|0|30|Actavis Group hf|Actavis hf|Diltíazem||2253||2253|3898 091642|L03AX1302|Copaxone (Lyfjaver)|stl|20|mg/spr|28|spr|1|pakki|lausn|L03AX13|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|146090|183750|lyfsjukr|||00|28|0|0|Lyfjaver ehf|Lyfjaver ehf|Glatíramer acetat||146090||146090|183750 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|1905|2371|lyfalmen|V0001|1884|00|90|0|45|Vistor hf|Aventis Pharma |Glímepíríð||1128||1128|2371 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3429|3269|lyfalmen|V0002|2489|00|90|0|90|Vistor hf|Aventis Pharma |Glímepíríð||1790||1790|3269 092005|N06AB1001 |Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|A|2|0|0|0|0|LBK|0|0|0|100|DKK|4393|6802|lyfalmen|||00|15|0|30|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||4393|6802 092014|L03AB0703|Rebif (Lyfjaver)|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|146110|183774|lyfsjukr|||00|6|0|61|Lyfjaver ehf|Lyfjaver ehf|Interferón beta-1a||146110||146110|183774 092024|L03AB0703|Rebif (Lyfjaver)|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|188148|236112|lyfsjukr|||00|6|0|123|Lyfjaver ehf|Lyfjaver ehf|Interferón beta-1a||188148||188148|236112 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|8296|15974|vetalmen|||16|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||8296||8296|15974 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|7630|11195|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||7630||7630|11195 092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|A|5|0|0|*|0|DAC|0|1|0|100|DKK|11684|15106|lyfalmen|V1400|15106|00|100|0|33|D.A.C. ehf|D.A.C. ehf|Klózapín||10512||10512|15106 092769|C09DA0305|Diovan Comp 320/12,5 mg|filmhtfl|332,5|mg|98|stk|1|þpakki|320/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|30048|39595|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||||30048|39595 092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|þpakki|320/25 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|30048|39595|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||||30048|39595 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|5982|8958|lyfalmen|||00|1|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||5982||5982|8958 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|30004|51923|vetorma|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||30004||30004|51923 093625|B03AA0702|Ferlen-R|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.04.1993|31.07.2009|L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|100|0|50|Actavis Group hf|Actavis hf|Ferrósúlfat||||| 093708|L01DB0701|Novantrone|irþ|2|mg/ml|5|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|17075|23126|lyfsjukr|||00|5|0|0|Icepharma hf|Wyeth AB|Mítoxantrón||17075||17075|23126 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|20097|27206|lyfalmen|||10|28|0|30|Icepharma hf|Norpharma |Oxýcódon||20097||20097|27206 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|66260|84679|lyfalmen|||10|98|0|261|Icepharma hf|Norpharma |Oxýcódon||66260||66260|84679 093823|S01EC0102|Diamox Depot|forðahlk|250|mg|100|stk|1|hylki||S01EC01|01.04.1998||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|2226|3861|lyfalmen|||10|100|0|33|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||2226||2226|3861 093824|N06AB0403|Cipramil (D.A.C.)|filmhtfl|20|mg|28|stk|1|þpakki||N06AB04|01.03.2009||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|3607|3894|lyfalmen|V0923|2562|0|28|0|28|D.A.C. ehf|D.A.C. ehf|Cítalópram||2250||2250|3894 093849|S01EC0102|Diamox Depot|forðahlk|500|mg|100|stk|1|hylki||S01EC01|01.12.1972||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|4453|6883|lyfalmen|||10|100|0|67|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||4453||4453|6883 093969|G03FB0507|Trisekvens (D.A.C.)|töflur|0| |84|stk|1|skífup||G03FB05|01.05.2007||R|A|4|0|0|E|0|DAC|0|0|0|100|DKK|2973|4875|lyfalmen|V0385|4875|23|84|0|84|D.A.C. ehf|D.A.C. ehf|Noretísterón og östrógen||2973||2973|4875 094132|QM01A0001|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|2021|3988|vetalmen|||00|8|0|0|Vistor hf|Boehringer Ingelheim|||2021||2021|3988 094287|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|14748|20546|lyfalmen|||00|50|0|5|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||14748||14748|20546 094296|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|21126|28487|lyfalmen|||00|50|0|10|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||21126||21126|28487 094305|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|95059|120533|lyfalmen|||00|50|0|50|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||95059||95059|120533 094933|A06AH0101|Relistor|stl|20|mg/ml|0,6|ml|7|hgl|lausn|A06AH01|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|USD|47489|61309|lyfalmen|||0|84|0|0|Icepharma hf|Wyeth Europe|Metýlnaltrexónbrómíð||47489||47489|61309 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1577|2980|lyfalmen|||00|100|1|50|Distica|Distica - óskráð lyf|||1577||1577|2980 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|0|100|DKK|3751|5931|lyfalmen|||00|50|0|100|Actavis Group hf|Actavis Group hf|Dísúlfíram||3751||3751|5931 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|16391|22592|lyfalmen|||00|28|0|14|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||16391||16391|22592 095662|N05AX1301|Invega|forðatfl|3|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|39473|51329|lyfalmen|||00|56|0|28|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||39473||39473|51329 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|16391|22592|lyfalmen|||00|28|0|28|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||16391||16391|22592 095689|N05AX1301|Invega|forðatfl|6|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|35770|46719|lyfalmen|||00|56|0|56|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||35770||35770|46719 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|16391|22592|lyfalmen|||00|28|0|42|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||16391||16391|22592 095716|N05AX1301|Invega|forðatfl|9|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|62979|80594|lyfalmen|||00|56|0|84|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||62979||62979|80594 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|4127|8033|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4127||4127|8033 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|5446|10545|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5446||5446|10545 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|9917|19062|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9917||9917|19062 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|2543|3641|lyfsjukr|||02|60|0|0|Icepharma hf|Baxter Medical AB|Mesna||2543||2543|3641 096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|15505|21171|lyfsjukr|||17|10|0|0|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||15505||15505|21171 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|155050|194905|lyfsjukr|||17|100|0|0|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||155050||155050|194905 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|A|2|0|0|0|0|GGL|0|0|1|100|GBP|1602|3014|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||1602||1602|3014 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|18233|24885|lyfalmen|||00|30|0|15|Vistor hf|Novartis Europharm Ltd|Rívastigmín||18233||18233|24885 096351|S01AA1302|Fucithalmic (D.A.C.)|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.06.2007||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|895|1921|lyfalmen|V1500|1921|07|5|0|0|D.A.C. ehf|D.A.C. ehf|Fúsidínsýra||796||796|1921 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|1099055|1370191|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||1099055|1370191 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|1009109|1258208|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||1009109|1258208 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|1061891|1323922|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||1061891|1323922 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|1166043|1453591|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||1166043|1453591 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|18233|24885|lyfalmen|||00|30|0|30|Vistor hf|Novartis Europharm Ltd|Rívastigmín||18233||18233|24885 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|1744|3207|lyfalmen|||00|30|0|18|Icepharma hf|Servier|Indapamíð||1744||1744|3207 096688|N06DA0301|Exelon|forðapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|36468|47588|lyfalmen|||00|60|0|60|Vistor hf|Novartis Europharm Ltd|Rívastigmín||36468||36468|47588 096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|100556|127060|lyfsjukr|||00|1|0|1|Vistor hf|Pfizer Limited|Anidulafungin||100556||100556|127060 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|3892|4129|lyfalmen|V0426|4129|00|20|0|5|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2423||2423|4129 097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1259|2549|lyfalmen|||00|120|0|12|Vistor hf|Schering-Plough|Deslóratadín||1259||1259|2549 097297|L02BG0402|Femar (D.A.C.)|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.06.2007||R|A|5|0|0|*|0|DAC|0|0|0|100|DKK|69998|80194|lyfalmen|V0563|80194|00|100|0|100|D.A.C. ehf|D.A.C. ehf|Letrózól||62658||62658|80194 097442|L01CB0101|Vepesid|hylki|50|mg|20|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|13690|18912|lyfsjukr|||00|20|1|0|Distica|Distica - óskráð lyf|||13690||13690|18912 097642|J07AJ5201|Infanrix|bóluefni|0| |0,5|ml|1|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1991|3542|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||1991||1991|3542 097790|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.04.1995||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|7967|8049|lyfalmen|V0714|6418|10|100|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||5312||5312|8049 097816|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.04.1995||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|12953|10701|lyfalmen|V0715|8037|10|100|0|22|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||7266||7266|10701 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|4451|4051|lyfalmen|V0003|3042|00|90|0|135|Vistor hf|Aventis Pharma |Glímepíríð||2366||2366|4051 097887|N02CC0104|Sumacta|húðuðtfl|50|mg|12|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|2738|4556|lyfalmen|V0831|4556|00|12|0|12|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||2738||2738|4556 097896|N02CC0104|Sumacta|húðuðtfl|100|mg|6|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1917|3442|lyfalmen|V0832|3442|00|6|0|12|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1917||1917|3442 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|1681|3122|lyfalmen|V1151|3122|00|30|0|15|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1681||1681|3122 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|7444|10942|lyfalmen|V1110|10942|00|98|0|98|Actavis Group hf|Actavis hf|Valsartan||7444||7444|10942 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|10775|15463|lyfalmen|V1111|15463|00|98|0|196|Actavis Group hf|Actavis hf|Valsartan||10775||10775|15463 098228|J07AJ5201|Infanrix|bóluefni|0| |0,5|ml|10|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|19364|26293|lyfalmen|||02|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||19364||19364|26293 098459|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|30|stk|1|þpakki||N06AB03|01.05.2009||R|A|2|0|0|B|0|DAC|0|1|0|100|XEU|3592|5715|lyfalmen|||00|30|0|30|D.A.C. ehf|D.A.C. ehf|Flúoxetín||||3592|5715 098468|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|100|stk|1|þpakki||N06AB03|01.05.2009||R|A|2|0|0|B|0|DAC|0|1|0|100|XEU|11955|17064|lyfalmen|||00|100|0|100|D.A.C. ehf|D.A.C. ehf|Flúoxetín||||11955|17064 098486|G03GA002|Pergoveris|sts|225|ae|1|hgl|1|pakki|+ leysir|G03GA00|01.03.2009||R|A|3|0|1|E|0|SEE|0|0|0|100|SEK|12734|18039|lyfalmen|||0|1|0|0|Gróco ehf|Serono Europe|||||12734|18039 098504|G03GA002|Pergoveris|sts|225|ae|10|hgl|1|pakki|+ leysir|G03GA00|01.03.2009||R|A|3|0|1|E|0|SEE|0|0|0|100|SEK|118120|149244|lyfalmen|||0|1|0|0|Gróco ehf|Serono Europe|||||118120|149244 098582|S01ED0201|Betoptic|augndr|5|mg/ml|5|ml|1|glas||S01ED02|01.04.2006||R|A|3|0|0|*|0|PCO|0|0|0|100|IKR|1186|2450|lyfalmen|||06|5|1|25|Distica|Distica - óskráð lyf|||1186||1186|2450 098722|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|22927|30729|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||22927||22927|30729 099242|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.04.1988||R|A|3|0|0|E|0|LEP|0|0|1|100|DKK|811|1941|lyfalmen|V1500|1921|07|5|0|0|Vistor hf|LEO Pharma A/S|Fúsidínsýra||811||811|1941 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|5665|8528|lyfalmen|V0725|8528|00|100|0|6|Actavis Group PTC ehf|Merck NM AB (A)|Quetíapín||5665||5665|8528 099485|N05AH0404|Quetiapin Merck NM|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|12936|18290|lyfalmen|V0726|18290|00|100|0|25|Actavis Group PTC ehf|Merck NM AB (A)|Quetíapín||12936||12936|18290 099494|N05AH0404|Quetiapin Merck NM|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|20933|28247|lyfalmen|V0727|28247|00|100|0|50|Actavis Group PTC ehf|Merck NM AB (A)|Quetíapín||20933||20933|28247 099620|N02AX0210|Nobligan (D.A.C.)|hylki|50|mg|20|stk|1|pakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|647|1718|lyfalmen|V0730|1238|10|20|0|3|D.A.C. ehf|D.A.C. ehf|Tramadól||647||647|1718 099705|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Icepharma hf|Mundipharma|Joð/pólývídón||||| 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Icepharma hf|Mundipharma|Joð/pólývídón||||| 099746|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 099755|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 100008|V08AB0501|Ultravist|stl/irl|300|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|47447|60939|lyfsjukr|||02|500|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||47447||47447|60939 100016|V08AB0501|Ultravist|stl/irl|300|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|70235|89310|lyfsjukr|||02|1000|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||70235||70235|89310 100024|V08AB0501|Ultravist|stl/irl|370|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|51375|65829|lyfsjukr|||02|500|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||51375||51375|65829 100032|V08AB0501|Ultravist|stl/irl|370|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|114070|143885|lyfsjukr|||02|1000|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||114070||114070|143885 100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|14869|20697|lyfalmen|||00|28|0|7|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||14869|20697 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|14869|20697|lyfalmen|||00|28|0|14|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||14869|20697 100305|G03GA0701|Luveris|sts|75|ae/hgl|1|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|13719|19265|lyfalmen|||00|1|0|1|Gróco ehf|Ares-Serono|Lutropin alfa||13719||13719|19265 100412|M01AC0101|Felden|töflur|20|mg|30|stk|1|þpakki||M01AC01|01.01.1997|31.05.2009|R|A|4|0|0|E|0|PFI|0|0|1|100|DKK|2089|3675|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam||2089||2089|3675 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|19438|26385|lyfalmen|V2160|25901|0|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||19438||19438|26385 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|32767|42980|lyfalmen|||0|100|0|44|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||32767||32767|42980 101386|R06AX1301|Clarityn|saft|1|mg/ml|100|ml|1|glas||R06AX13|01.10.1995||L|A|2|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|100|0|10|Vistor hf|Schering-Plough|Lóratadín||||| 101543|G03GA0701|Luveris|sts|75|ae/hgl|3|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|41155|53423|lyfalmen|||00|3|0|3|Gróco ehf|Ares-Serono|Lutropin alfa||41155||41155|53423 101550|G03GA0701|Luveris|sts|75|ae/hgl|10|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|137187|172983|lyfalmen|||00|10|0|10|Gróco ehf|Ares-Serono|Lutropin alfa||137187||137187|172983 101691|C08CA0502|Adalat Oros|forðatfl|20|mg|28|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|2048|3620|lyfalmen|||00|28|0|19|Vistor hf|Bayer HealthCare AG|Nífedipín||2048||2048|3620 101709|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|6426|9561|lyfalmen|||00|98|0|65|Vistor hf|Bayer HealthCare AG|Nífedipín||6426||6426|9561 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|2730|4545|lyfalmen|V1152|4545|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||2730||2730|4545 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|9714|14023|lyfalmen|V1153|14023|00|96|0|96|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||9714||9714|14023 101769|N02AX0211|Nobligan Retard (D.A.C.)|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|9972|14373|lyfalmen|V0736|11610|00|100|0|50|D.A.C. ehf|D.A.C. ehf|Tramadól||9972||9972|14373 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|12471|23927|vetalmen|||0|250|0|0|Vistor hf|Boehringer Ingelheim|||||12471|23927 102863|C01DA1401|Imdur|forðatfl|60|mg|28|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1492|2865|lyfalmen|||43|28|0|42|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||1492||1492|2865 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3415|5475|lyfalmen|V0139|2746|43|98|0|147|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||3415||3415|5475 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1994||R|A|2|0|0|0|1|ASZ|0|0|0|100|SEK|2383|3412|lyfsjukr|||02|50|0|0|Vistor hf|AstraZeneca UK Ltd|Própófól||2383||2383|3412 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1988||R|A|2|0|0|0|1|ASZ|0|0|0|100|SEK|4944|7079|lyfsjukr|||00|50|0|0|Vistor hf|AstraZeneca UK Ltd|Própófól||4944||4944|7079 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|XEU|8025|10450|lyfalmen|V0198|10450|00|98|0|98|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||7081||7081|10450 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|XEU|13287|16752|lyfalmen|V0193|16752|00|98|0|196|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||11725||11725|16752 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|4295|5469|lyfalmen|V0197|5469|00|98|0|98|Portfarma ehf|Portfarma|Lósartan||3411||3411|5469 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|2797|4086|lyfalmen|V0507|4086|00|10|0|2|Portfarma ehf|Portfarma|Valacíklóvír||2392||2392|4086 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|11626|14320|lyfalmen|V0508|14279|00|40|0|7|Portfarma ehf|Portfarma|Valacíklóvír||9933||9933|14320 103678|N06AX1604|Venlafaxin Portfarma|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|USD|15583|17139|lyfalmen|V0955|13473|00|100|0|75|Portfarma ehf|Portfarma|Venlafaxín||12011||12011|17139 103687|N06AX1604|Venlafaxin Portfarma|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|USD|29657|27117|lyfalmen|V0956|21381|00|100|0|150|Portfarma ehf|Portfarma|Venlafaxín||20026||20026|27117 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||56|25|0|5|Vistor hf|Orion Pharma|Bisakódýl|||||1885 103952|A06AG0201|Toilax|innhl/tf|0| |1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|A|2|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||00|1|0|1|Vistor hf|Orion Pharma|Bisakódýl||||| 104034|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996|31.07.2009|R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||13480||13480|18650 104179|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.05.2009||R|A|5|0|0|B|0|DAC|0|1|0|30|DKK|13191|10296|lyfalmen|V0933|6361|00|98|0|98|D.A.C. ehf|D.A.C. ehf|Sertralín||6968||6968|10296 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|K|3|0|0|E|0|FEL|0|0|0|100|DKK|4206|6548|lyfalmen|||23|2|0|10|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4206||4206|6548 104498|N05CH0101|Circadin|forðatfl|2|mg|21|stk|1|þpakki||N05CH01|01.11.2007||R|A|5|0|0|0|0|NEU|0|0|1|100|DKK|2903|4780|lyfalmen|||00|21|0|21|Gróco ehf|Neurim Pharmaceuticals EEC Ltd|Melatonin||2903||2903|4780 104760|A07EC0202|Pentasa|eþ-stil|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|9377|13565|lyfalmen|||04|28|0|19|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||9377||9377|13565 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|6158|9197|lyfalmen|||56|700|0|5|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||6158||6158|9197 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|5959|8927|lyfalmen|||10|100|0|33|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5959||5959|8927 105023|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|fl||V08AB09|01.01.1996|31.07.2009|R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5432|7777|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||5432||5432|7777 105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|4108|6304|lyfalmen|V0084|6304|00|28|0|19|D.A.C. ehf|D.A.C. ehf|Esómeprazól||4026||4026|6304 105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|14312|19431|lyfalmen|V0087|19429|00|100|0|67|D.A.C. ehf|D.A.C. ehf|Esómeprazól||13852||13852|19431 105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|19321|26240|lyfalmen|V0089|26240|00|100|0|133|D.A.C. ehf|D.A.C. ehf|Esómeprazól||19321||19321|26240 105315|G03AA0705 |Microgynon (D.A.C.)|töflur|0||63|stk|1|þpakki||G03AA07|01.05.2009||R|A|5|0|0|0|0|DAC|0|0|0|100|SEK|1099|2332|lyfalmen|||23|63|0|84|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og östrógen||||1099|2332 105379|N03AG0601|Gabitril|töflur|10|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|21377|28799|lyfalmen|||00|100|0|33|Icepharma hf|Cephalon France|Tíagabín||21377||21377|28799 105387|N03AG0601|Gabitril|töflur|15|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|17636|24142|lyfalmen|||00|50|0|25|Icepharma hf|Cephalon France|Tíagabín||17636||17636|24142 105395|N03AG0601|Gabitril|töflur|15|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|32067|42108|lyfalmen|||00|100|0|50|Icepharma hf|Cephalon France|Tíagabín||32067||32067|42108 105403|N03AG0601|Gabitril|töflur|5|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|8818|12807|lyfalmen|||00|50|0|8|Icepharma hf|Cephalon France|Tíagabín||8818||8818|12807 105437|N03AG0601|Gabitril|töflur|5|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|16033|22146|lyfalmen|||00|100|0|17|Icepharma hf|Cephalon France|Tíagabín||16033||16033|22146 105445|N03AG0601|Gabitril|töflur|10|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|11757|16795|lyfalmen|||00|50|0|17|Icepharma hf|Cephalon France|Tíagabín||11757||11757|16795 105586|C09XA02|Rasilez|filmhtfl|150|mg|28|stk|1|þpakki||C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4472|6909|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||4472||4472|6909 105597|C09XA02|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|15545|21539|lyfalmen|||00|98|0|98|Vistor hf|Novartis Europharm Ltd|||15545||15545|21539 105608|C09XA02|Rasilez|filmhtfl|300|mg|28|stk|1|þpakki||C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|5154|7835|lyfalmen|||00|28|0|56|Vistor hf|Novartis Europharm Ltd|||5154||5154|7835 105620|C09XA02|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|17930|24508|lyfalmen|||00|98|0|196|Vistor hf|Novartis Europharm Ltd|||17930||17930|24508 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2410|4111|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2410||2410|4111 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2625|4403|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2625||2625|4403 106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|3777|5966|lyfalmen|||63|14|0|7|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||3777||3777|5966 106486|C09AA0207|Enalapril Portfarma|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|802|1929|lyfalmen|V0167|1929|0|100|0|50|Portfarma ehf|Portfarma|Enalapríl||802||802|1929 106497|C09AA0207|Enalapril Portfarma|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|1153|2405|lyfalmen|V0168|2405|0|100|0|100|Portfarma ehf|Portfarma|Enalapríl||1153||1153|2405 106508|C09AA0207|Enalapril Portfarma|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|2725|4538|lyfalmen|V0169|4538|0|100|0|200|Portfarma ehf|Portfarma|Enalapríl||2725||2725|4538 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|20554|27457|lyfsjukr|||00|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||20554||20554|27457 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|11367|16019|lyfsjukr|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||11367||11367|16019 106963|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|þpakki||M05BA02|01.03.2004||R|A|3|0|0|E|0|LEI|0|0|0|100|SEK|18330|25006|lyfalmen|||10|30|0|15|Icepharma hf|Leiras Oy|Klódrónsýra||18330||18330|25006 107050|A10BD0401|Avaglim|filmhtfl|0| |84|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|16484|22708|lyfalmen|||00|84|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||16484||16484|22708 107061|A10BD0401|Avaglim|filmhtfl|0| |84|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|24817|33082|lyfalmen|||00|84|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||24817||24817|33082 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|2026|3590|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Súlfasalazín||2026||2026|3590 107268|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|glas||M05BA02|01.01.1997||R|A|3|0|0|E|0|LEI|0|0|0|100|SEK|18330|25006|lyfalmen|||10|30|0|15|Icepharma hf|Leiras Oy|Klódrónsýra||18330||18330|25006 107532|N02BE0106|Parasupp|eþ-stil|60|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||04|10|0|0|Actavis Group hf|Actavis hf|Paracetamól||||| 107583|N03AF0202 |Trileptal (D.A.C.)|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|6095|8326|lyfalmen|V2150|8326|00|100|0|30|D.A.C. ehf|D.A.C. ehf|Oxkarbazepín||5516||5516|8326 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|A|2|0|0|0|0|ICV|0|0|0|100|XEU|||vetorma|||16|6|0|0|Icepharma hf|Icevet ehf||||||3020 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1117|2356|lyfalmen|||00|60|0|30|Actavis Group hf|Actavis hf|Ranitidín||1117||1117|2356 108209|N02BE0106|Parasupp|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.06.1984|31.05.2009|L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||04|10|0|2|Actavis Group hf|Actavis hf|Paracetamól||||| 108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.01.1991||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|3145|5108|lyfalmen|||63|100|0|33|Vistor hf|Bayer HealthCare AG|Nífedipín||3145||3145|5108 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|4951|7559|lyfalmen|||00|30|0|15|Vistor hf|Novartis Europharm Ltd|Vildagliptín||4951||4951|7559 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|13504|18997|lyfalmen|||00|90|0|45|Vistor hf|Novartis Europharm Ltd|Vildagliptín||13504||13504|18997 108803|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|12|hgl|20mg/ml+36mcg/ml|QN01BB52|01.12.2003|31.07.2009|R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1238|2443|vetalmen|||27|1200|0|0|Icepharma hf|Kela Laboratoria NV|||1238||1238|2443 108845|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1074|2298|lyfalmen|||24|120|0|19|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1074||1074|2298 108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1633|3056|lyfalmen|||24|120|0|38|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1633||1633|3056 108860|N02AX0203|Tramol|hylki|50|mg|20|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|293|1238|lyfalmen|V0730|1238|00|20|0|3|Actavis Group hf|Actavis hf|Tramadól||293||293|1238 108878|N02AX0203|Tramol|hylki|50|mg|100|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|504|1524|lyfalmen|V0731|1524|00|100|0|17|Actavis Group hf|Actavis hf|Tramadól||504||504|1524 109207|N02AA5901|Panocod|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|237|1162|lyfalmen|V0775|1151|00|20|0|7|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||237||237|1162 109223|N02AA5901|Panocod|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|1|0|0|0|SNO|0|0|1|100|NOK|905|2069|lyfalmen|V0780|2048|00|100|0|33|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||905||905|2069 109421|V01AA0303|Alutard SQ, derm.farinae|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|27472|36388|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||27472||27472|36388 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|21994|29568|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||21994||21994|29568 109462|V04CL0020|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8538|12427|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||8538||8538|12427 109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.1983||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3|Actavis Group hf|Actavis hf|Paracetamól||||| 109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.07.1992||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|5|Actavis Group hf|Actavis hf|Paracetamól||||| 109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|379|1355|lyfalmen|V0772|1355|00|100|0|17|Actavis Group hf|Actavis hf|Paracetamól||379||379|1355 110072|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|723|1822|lyfalmen|||06|5|0|25|Icepharma hf|Santen Oy|Tímólól||723||723|1822 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|807|1936|lyfalmen|||06|5|0|25|Icepharma hf|Santen Oy|Tímólól||807||807|1936 110242|V03AN0101|Conoxia|innö.gas|100|%|3|l|1|hylki|MO3c|V03AN01|01.04.2008||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|3|0|0|Ísaga ehf|AGA AB|Súrefni||||| 110395|G03AA0902|Mercilon|töflur|0| |63|stk|1|þpakki||G03AA09|01.07.1990||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1742|3204|lyfalmen|||23|63|0|84|Vistor hf|N.V. Organon|Desógestrel og östrógen||1742||1742|3204 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|A|4|0|0|B|0|ORC|0|0|0|100|DKK|5104|7767|lyfalmen|||10|100|0|83|Vistor hf|Orion Corporation|Verapamíl||5104||5104|7767 111505|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.10.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|XEU|13102|18497|lyfalmen|V1351|18497|00|8|0|16|D.A.C. ehf|D.A.C. ehf|Tadalafíl||||13102|18497 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|848|1991|lyfalmen|||00|100|0|33|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||848||848|1991 112359|S01AA1101|Garamycin|augndr|3|mg/ml|5|ml|1|glas||S01AA11|01.03.1977||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|912|2078|lyfalmen|||06|5|0|0|Vistor hf|Schering-Plough|Gentamícín||912||912|2078 112441|A10BB0701|Mindiab|töflur|2,5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|1449|2807|lyfalmen|||68|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Glípízíð||1449||1449|2807 112615|C01DA0201|Discotrine|forðapl|15|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3917|6156|lyfalmen|||23|30|0|90|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3917||3917|6156 112641|M05BA0407 |Alendronat Ranbaxy|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2009||R|A|2|0|0|E|0|RAN|0|0|0|100|XEU|9296|7727|lyfalmen|V0718|7727|00|12|0|84|Gróco ehf|Ranbaxy (UK) Ltd|Alendrónsýra||5075||5075|7727 113394|A10BD0801|Eucreas|filmhtfl|0||60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|10916|15654|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||||10916|15654 113403|A10BD0801|Eucreas|filmhtfl|0||180|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|30048|39595|lyfalmen|||00|180|0|0|Vistor hf|Novartis Europharm Ltd|||||30048|39595 113412|A10BD0801|Eucreas|filmhtfl|0||60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|10916|15654|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||||10916|15654 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|3635|5773|lyfalmen|||00|2|0|10|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3635||3635|5773 113421|A10BD0801|Eucreas|filmhtfl|0||180|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|30048|39595|lyfalmen|||00|180|0|0|Vistor hf|Novartis Europharm Ltd|||||30048|39595 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5895|8840|lyfalmen|||00|4|0|20|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||5895||5895|8840 113796|L01XC0602|Erbitux (Lyfjaver)|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2008||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|38871|50262|lyfsjukr|||00|20|0|0|Lyfjaver ehf|Lyfjaver ehf|Cetúxímab||38871||38871|50262 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|833270|1039289|lyfsjukr|||00|112|0|0|Vistor hf|Novartis Europharm Ltd|Nilotiníb||833270||833270|1039289 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|657|1732|lyfalmen|||00|20|0|10|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||657||657|1732 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|959|2142|lyfalmen|||00|30|0|15|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||959||959|2142 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1273|2568|lyfalmen|||00|40|0|20|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1273||1273|2568 114033|R03AC0210|Ventolin Diskus|innúðadu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|871|2022|lyfalmen|||23|60|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||871||871|2022 114395|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|100|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|2160|3240|lyfalmen|V0919|3240|00|100|0|100|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||1768||1768|3240 114406|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|60|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|1390|2385|lyfalmen|V0918|2385|00|60|0|60|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||1138||1138|2385 114417|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|20|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|526|1424|lyfalmen|V0917|1424|00|20|0|20|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||430||430|1424 114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíð 20 mg|S01ED51|01.03.1999||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2663|4454|lyfalmen|||06|5|0|0|Icepharma hf|M.S.D.|Tímólól í blöndum||2663||2663|4454 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|4696|7213|lyfalmen|||0|750|0|3|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||4696||4696|7213 115285|J01CA0410|Amoxicillin Merck NM|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1852|3354|lyfalmen|||00|20|0|15|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1852||1852|3354 115318|B01AE0701|Pradaxa|hylki|75|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|14077|19711|lyfalmen|||0|2250|0|10|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||14077||14077|19711 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|28155|37238|lyfalmen|||0|4500|0|20|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||28155||28155|37238 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|4696|7213|lyfalmen|||0|1100|0|5|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||4696||4696|7213 115353|B01AE0701|Pradaxa|hylki|110|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|14077|19711|lyfalmen|||0|3300|0|15|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||14077||14077|19711 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|28155|37238|lyfalmen|||0|6600|0|30|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||28155||28155|37238 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2172|3788|lyfalmen|V1090|3727|06|5|0|17|Icepharma hf|M.S.D.|Dorzólamíð||2172||2172|3788 115808|R06AX0201|Periactin|töflur|4|mg|100|stk|1|þpakki||R06AX02|01.10.2005||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|1374|2705|lyfalmen|||00|100|0|33|Icepharma hf|M.S.D.|Cýpróheptadín||1374||1374|2705 115931|R03AC1202|Serevent Diskus|innúðadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|4023|6300|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||4023||4023|6300 115980|P03AX0301|Prioderm|húðlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|A|3|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|55|0|0|Icepharma hf|Norpharma |Malatíón||||| 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|4316|6179|lyfsjukr|||03|5|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||4316||4316|6179 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|2256|3230|lyfsjukr|||03|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2256||2256|3230 116244|D11AF01|Verucid|áburður|0| |10|ml|1|glas||D11AF|01.11.1981||L|K|2|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|10|0|10|Icepharma hf|Galderma Nordic AB|||||| 116327|D07AC1301 |Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3389|5439|lyfalmen|||0|100|0|100|Vistor hf|Schering-Plough|Mómetasón||||3389|5439 116418|D07AC1301 |Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3389|5439|lyfalmen|||0|100|0|100|Vistor hf|Schering-Plough|Mómetasón||||3389|5439 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3|Actavis Group hf|Actavis hf|Íbúprófen||||| 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|10|Actavis Group hf|Actavis hf|Íbúprófen||||| 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|þpakki||M01AE01|01.08.2008||R|A|5|0|0|E|0|ACA|0|0|1|100|XEU|895|2055|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|Íbúprófen||895||895|2055 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|501|1520|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|Íbúprófen||501||501|1520 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|þpakki||M01AE01|01.05.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|1211|2484|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|Íbúprófen||1211||1211|2484 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|20615|27851|lyfalmen|||00|84|0|84|Vistor hf|Pfizer Limited|||||20615|27851 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|7296|10741|lyfalmen|||00|28|0|28|Vistor hf|Pfizer Limited|||||7296|10741 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|7749|11356|lyfalmen|||00|28|0|56|Vistor hf|Pfizer Limited|||||7749|11356 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|23350|31256|lyfalmen|||00|84|0|168|Vistor hf|Pfizer Limited|||||23350|31256 116985|N06AX1607 |Efexor Depot (D.A.C.)|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.05.2009||R|A|3|0|0|B|0|DAC|0|1|0|100|USD|18121|24213|lyfalmen|V0955|13204|00|98|0|74|D.A.C. ehf|D.A.C. ehf|Venlafaxín||17693||17693|24213 116997|N05AX1203|Abilify (Lyfjaver)|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|DKK|41788|54211|lyfalmen|V1702|50395|00|56|0|37|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||41788||41788|54211 117008|N05AX1203|Abilify (Lyfjaver)|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|DKK|41788|54211|lyfalmen|V1703|50066|00|56|0|56|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||41788||41788|54211 117408|QA12AX0001|Calcimag vet. Kela|irl|0| |500|ml|12|plastf||QA12AX00|01.04.2004||R|A|2|0|0|0|0|KEL|1|0|0|100|NOK|10109|19427|vetalmen|||00|6000|0|0|Icepharma hf|Kela Laboratoria NV|||10109||10109|19427 117515|M01AE0303|Orudis|forðahlk|200|mg|100|stk|1|hylki||M01AE03|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|8633|12556|lyfalmen|||10|100|0|133|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||8633||8633|12556 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|6605|9804|lyfalmen|||00|100|0|33|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||6605||6605|9804 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|13531|19031|lyfalmen|||00|100|0|12|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||13531|19031 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|23915|31959|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||23915|31959 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2723|4536|lyfalmen|||10|100|0|8|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2723||2723|4536 117573|N05AH0405|Seroquel Prolong|forðatfl|300|mg|10|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|4135|6452|lyfalmen|||00|10|0|8|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4135|6452 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|41352|53668|lyfalmen|||00|100|0|75|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||41352|53668 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|47830|61733|lyfalmen|||00|100|0|100|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||47830|61733 117721|D11AF01|Verucid|hlaup|0| |5|g|1|túpa||D11AF|01.08.1984||L|A|3|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|5|0|5|Icepharma hf|Galderma Nordic AB|||||| 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|11001|19038|vetorma|||00|250|0|0|Vistor hf|Bayer Animal Health GmbH|||11001||11001|19038 117788|C08CA0502|Adalat Oros|forðatfl|30|mg|28|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|2882|4751|lyfalmen|||61|28|0|28|Vistor hf|Bayer HealthCare AG|Nífedipín||2882||2882|4751 117796|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|5070|7721|lyfalmen|||61|98|0|98|Vistor hf|Bayer HealthCare AG|Nífedipín||5070||5070|7721 117820|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|8242|12025|lyfalmen|||61|98|0|196|Vistor hf|Bayer HealthCare AG|Nífedipín||8242||8242|12025 117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|7062|13623|vetalmen|||00|1200|0|0|Icepharma hf|Kela Laboratoria NV|||7062||7062|13623 117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|12385|23763|vetalmen|||00|6000|0|0|Icepharma hf|Kela Laboratoria NV|||12385||12385|23763 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|4521|4570|lyfalmen|V0809|4570|00|28|0|7|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2748||2748|4570 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|6426|5724|lyfalmen|V0810|5724|00|28|0|14|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3599||3599|5724 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|24920|21485|lyfalmen|V0812|21485|00|56|0|56|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||15502||15502|21485 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|19038|16911|lyfalmen|V0815|16911|00|28|0|42|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||11842||11842|16911 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|1943|3477|lyfalmen|||65|100|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1943||1943|3477 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|A|3|0|0|0|1|AGA|0|0|0|100|IKR|9512|13619|lyfsjukr|||00|4|0|0|Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|13619 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|30|0|15|Actavis Group hf|Actavis hf|Ranitidín||||| 118315|M01AB0505|Voltaren|eþ-stil|100|mg|5|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|805|1933|lyfalmen|||04|5|0|5|Vistor hf|Novartis Healthcare A/S-|Díklófenak||805||805|1933 118323|M01AB0505|Voltaren|eþ-stil|100|mg|50|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|8070|11792|lyfalmen|||04|50|0|50|Vistor hf|Novartis Healthcare A/S-|Díklófenak||8070||8070|11792 118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|þpakki||A02BA02|01.04.1994||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1062|2282|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|Ranitidín||1062||1062|2282 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|19592|17355|lyfalmen|V0811|17355|00|56|0|42|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||12185||12185|17355 118570|A07EC0203|Pentasa Sachets|forðakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|10403|14958|lyfalmen|||00|50|0|33|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||10403||10403|14958 118612|A07EC0203|Pentasa Sachets|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|30599|40281|lyfalmen|||00|150|0|100|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||30599||30599|40281 118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|4025|5391|lyfalmen|V1401|5391|00|100|0|8|Lyfjaver ehf|Lyfjaver ehf|Klózapín||3353||3353|5391 118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|11857|15106|lyfalmen|V1400|15106|00|100|0|33|Lyfjaver ehf|Lyfjaver ehf|Klózapín||10512||10512|15106 119031|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|K|3|0|1|0|1|AEU|0|0|0|100|DKK|95108|120277|lyfsjukr|||00|5|0|0|Vistor hf|Amgen Europe B.V.|Panitúmúmab||95108||95108|120277 119719|C09BA0801|Inhibace Comp.|töflur|17,5|mg|98|stk|1|pakki|þp ( 5+ 12,5 mg)|C09BA08|01.12.1997||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|11530|16487|lyfalmen|||00|98|0|98|Icepharma hf|Roche|Cílazapríl og þvagræsilyf||11530||11530|16487 119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.03.2008||L|A|3|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||00|30|0|10|Portfarma ehf|Portfarma|Íbúprófen||||| 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|534639|667811|lyfalmen|||00|30|0|20|GlaxoSmithKline ehf|Glaxo Group Limited|||||534639|667811 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|534639|667811|lyfalmen|||00|30|0|40|GlaxoSmithKline ehf|Glaxo Group Limited|||||534639|667811 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|1028|2235|lyfalmen|||06|10|0|0|K.Pétursson hf|Alcon|Cýklópentólat||1028||1028|2235 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|A|2|0|1|0|1|LIL|0|0|0|100|XEU|53223|68130|lyfsjukr|||00|1|0|0|Icepharma hf|Lilly ICOS Limited|Pemetrexed||||53223|68130 120341|N06DA0402|Reminyl (Lyfjaver)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|13405|17106|lyfalmen|V1370|17106|00|28|0|14|Lyfjaver ehf|Lyfjaver ehf|Galantamín||11986||11986|17106 120353|N06DA0402|Reminyl (Lyfjaver)|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|41251|50220|lyfalmen|V1371|49871|00|84|0|84|Lyfjaver ehf|Lyfjaver ehf|Galantamín||38582||38582|50220 120950|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|28|stk|1|þpakki||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|DKK|3636|5643|lyfalmen|V0939|5594|00|28|0|28|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||3539||3539|5643 120961|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|200|stk|1|plglas||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|NOK|22655|30390|lyfalmen|||00|200|0|200|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||22655||22655|30390 120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.05.2008||R|A|3|0|1|E|0|LVR|0|0|0|100|DKK|21982|29553|lyfalmen|V1710|27302|00|100|0|25|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||||21982|29553 121164|A02BC0501 |Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5533|8349|lyfalmen|||00|28|0|9|Vistor hf|AstraZeneca A/S DK|Esómeprazól||||5533|8349 121269|N05CD0505|Triazolam NM Pharma|töflur|0,25|mg|100|stk|1|glas||N05CD05|01.07.1991||R|A|4|0|0|0|0|MNA|0|0|0|100|SEK|788|1910|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Tríazólam||788||788|1910 121286|M03AC0901 |Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|11168|15772|lyfsjukr|||00|50|0|0|Vistor hf|N.V. Organon|Rókúrón, brómíð||||11168|15772 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|396|1378|lyfalmen|||24|200|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||396||396|1378 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|A|2|0|0|E|0|AUK|0|0|1|100|GBP|448|1448|lyfalmen|||00|28|0|28|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||448||448|1448 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|2267|3917|lyfalmen|V0908|2025|00|100|0|25|Vistor hf|Novartis Healthcare A/S-|Klómípramín||2267||2267|3917 121863|A07EC0204|Asacol|eþ-stil|500|mg|30|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|3420|5481|lyfalmen|||98|30|0|10|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||3420||3420|5481 123166|M01AE5101|Ibukod|töflur|0| |100|stk|1|glas|10+200 mg|M01AE51|01.10.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1507|2885|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|Íbúprófen í blöndum||1507||1507|2885 123216|N05BA0105|Stesolid|eþ-stil|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|624|1687|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis Group hf|Díazepam||624||624|1687 123224|N05BA0105|Stesolid|eþ-stil|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|973|2161|lyfalmen|||04|10|0|10|Actavis Group hf|Actavis Group hf|Díazepam||973||973|2161 123253|L02BB0301|Casodex|töflur|150|mg|28|stk|1|þpakki||L02BB03|01.06.2009||R|A|4|0|0|*|0|ASZ|0|0|0|100|SEK|55319|65550|lyfalmen|V0561|55717|00|28|0|84|Vistor hf|AstraZeneca UK Ltd|Bíkalútamíð||50896||50896|65550 123264|A07AA0904|Vancomycin Alpharma|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|13696|19236|lyfalmen|||0|28|0|2|Actavis Group hf|Alpharma ApS|Vankómýcín||||13696|19236 123273|N05BA0603|Temesta|töflur|1|mg|100|stk|1|þpakki||N05BA06|01.11.2005||R|A|3|0|0|0|0|LDR|0|0|1|100|USD|2535|4280|lyfalmen|||00|100|1|40|Parlogis hf|Parlogis - óskráð lyf|||2535||2535|4280 123275|A07AA0904|Vancomycin Alpharma|hylki|250|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|27429|36334|lyfalmen|||00|28|0|4|Actavis Group hf|Alpharma ApS|Vankómýcín||||27429|36334 123308|R03BB0404 |Spiriva (Lyfjaver)|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.05.2009||R|A|2|0|0|B|0|LVR|0|0|0|100|DKK|7687|11272|lyfalmen|V2110|10379|00|30|0|30|Lyfjaver ehf|Lyfjaver ehf|Tíótrópíumbrómíð||||7687|11272 123319|M05BA0704|Optinate Septimum (Lyfjaver)|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|NOK|14295|19982|lyfalmen|V1080|19380|00|12|0|84|Lyfjaver ehf|Lyfjaver ehf|||14295||14295|19982 123414|C01AA0504|Lanoxin mite|töflur|62,5|mcg|100|stk|1|glas||C01AA05|01.03.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|357|1325|lyfalmen|||00|100|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Digoxín||357||357|1325 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|A|3|0|0|E|0|AVS|0|0|0|100|NOK|43836|56761|lyfalmen|||00|56|0|28|Vistor hf|Aventis Pharma SA|Rílúzól||43836||43836|56761 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|A||0|0|0|0|CHP|0|0|0|100|XEU|2061|4067|vetalmen|||00|42|0|0|Icepharma hf|Chanelle Pharmaceuticals|||||2061|4067 124248|R06AD0301|Torecan|töflur|6,5|mg|20|stk|1|þpakki||R06AD03|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|974|2162|lyfalmen|||00|20|1|10|Parlogis hf|Parlogis - óskráð lyf|||974||974|2162 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1132|2377|lyfalmen|||00|30|0|19|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1132||1132|2377 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|612|1671|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|Enalapríl||612||612|1671 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1153|2405|lyfalmen|V0168|2405|00|100|0|100|Actavis Group hf|Actavis hf|Enalapríl||1153||1153|2405 125163|C01BD0104|Cordarone (Lyfjaver)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.01.2009||R|A|5|0|0|B|0|LVR|0|0|0|100|NOK|2569|3313|lyfalmen|V0144|3313|0|30|0|15|Lyfjaver ehf|Lyfjaver ehf|Amíódarón||1822||1822|3313 126163|N05AX1202|Abilify (D.A.C)|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|DAC|0|1|0|100|DKK|24470|27807|lyfalmen|V1701|26865|00|28|0|6|D.A.C. ehf|D.A.C. ehf|Aripiprazól||20580||20580|27807 126231|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|20359|21133|lyfalmen|V1732|21133|00|100|0|11|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15219||15219|21133 126242|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|18064|20932|lyfalmen|V1730|20932|00|100|0|22|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15058||15058|20932 126253|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|22919|22668|lyfalmen|V1731|22668|00|100|0|33|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||16452||16452|22668 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|þpakki||A07DA03|01.10.1991||L|A|5|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||10|16|0|3|Vistor hf|Janssen-Cilag AB|Lóperamíð||||| 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|GSK|0|0|0|100|GBP|124679|157093|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Tópótecan||||124679|157093 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|GSK|0|0|0|100|GBP|31997|41704|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Tópótecan||||31997|41704 126540|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|28691|37588|lyfsjukr|||00|1|0|1|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||28691||28691|37588 126561|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|15|mg|28|stk|1|þpakki||A02BC03|01.09.2008|30.06.2009|R|A|1,5|0|0|0|0|RAN|0|0|0|100|IKR|1607|2219|lyfalmen|||00|28|0|14|Gróco ehf|Ranbaxy (UK) Ltd|Lansóprazól||1016||1016|2219 126572|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|15|mg|56|stk|1|þpakki||A02BC03|01.09.2008|30.06.2009|R|A|1,5|0|0|E|0|RAN|0|0|0|100|IKR|3045|3598|lyfalmen|||00|56|0|28|Gróco ehf|Ranbaxy (UK) Ltd|Lansóprazól||2032||2032|3598 126583|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|30|mg|28|stk|1|þpakki||A02BC03|01.09.2008|30.06.2009|R|A|1,5|0|0|0|0|RAN|0|0|0|100|IKR|1607|2219|lyfalmen|||00|28|0|28|Gróco ehf|Ranbaxy (UK) Ltd|Lansóprazól||1016||1016|2219 126594|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|30|mg|56|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|E|0|RAN|0|0|0|100|IKR|3045|3598|lyfalmen|||00|56|0|56|Gróco ehf|Ranbaxy (UK) Ltd|Lansóprazól||2032||2032|3598 126649|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|9563|13692|lyfsjukr|||00|1|0|0|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||9563||9563|13692 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|1109|2345|lyfalmen|||10|100|0|20|Vistor hf|Janssen-Cilag AB|Lóperamíð||1109||1109|2345 126974|N06AX2104|Cymbalta (D.A.C.)|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.07.2008||R|A|3|0|0|B|0|DAC|0|1|0|100|XEU|4586|6710|lyfalmen|V1951|6710|00|28|0|14|D.A.C. ehf|D.A.C. ehf|||4325||4325|6710 127383|R02AA0302|Strepsils med honning og citron|sogtfl|0||36|stk|1|þpakki||R02AA03|01.01.2009||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|36|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|9862|6729|lyfalmen|V0810|5724|00|28|0|14|Icepharma hf|Eli Lilly Nederland -|Olanzapín||4339||4339|6729 128131|QG51BE0002|Sulfa-Streptocillin vet.|legstil|0||30|stk|1|þpakki||QG51BE00|01.03.2009||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|6863|13244|vetalmen|||0|30|0|0|Vistor hf|Boehringer Ingelheim Danmark|||||6863|13244 128173|C08DA0107|Verapamil Merck NM|töflur|40|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|506|1527|lyfalmen|||00|100|0|17|Actavis Group PTC ehf|Merck NM AB|Verapamíl||506||506|1527 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|0| |100|stk|1|glas||C03AB01|01.05.1999||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1394|2732|lyfalmen|||10|100|0|50|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1394||1394|2732 128864|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128875|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128886|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128897|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|4381|6272|lyfsjukr|||02|100|0|0|Icepharma hf|Baxter Medical AB|Mesna||4381||4381|6272 129098|N05AH0301|Zyprexa|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|33308|18648|lyfalmen|V0811|17355|00|56|0|42|Icepharma hf|Eli Lilly Nederland -|Olanzapín||13223||13223|18648 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|38644|23128|lyfalmen|V0812|21485|00|56|0|56|Icepharma hf|Eli Lilly Nederland -|Olanzapín||16822||16822|23128 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|A|5|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||00|100|0|0|Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||2862 129817|R03BB0101|Atrovent|innúðal|0,25|mg/ml|2|ml|60|plastl|í vél|R03BB01|01.04.1989||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|5283|8010|lyfalmen|||00|120|0|100|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||5283||5283|8010 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|16928|20575|lyfalmen|V0726|18290|00|100|0|25|Vistor hf|AstraZeneca UK Ltd|Quetíapín||14771||14771|20575 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|26796|31299|lyfalmen|V0727|28247|00|100|0|50|Vistor hf|AstraZeneca UK Ltd|Quetíapín||23385||23385|31299 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|K|3|0|0|0|0|MYL|0|0|1|100|SEK|2131|3732|lyfalmen|||63|10|0|20|Actavis Group PTC ehf|Mylan AB|Adrenalín tartrat||||2131|3732 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|4523|6978|lyfalmen|||02|125|0|31|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||4523||4523|6978 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|1|100|SEK|2219|3852|lyfalmen|||63|10|0|3|Actavis Group PTC ehf|Mylan AB|Atrópínsúlfat||||2219|3852 130596|N07BA0301|Champix|filmhtfl|0||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|12871|18209|lyfalmen|||0|53|0|21|Vistor hf|Pfizer Limited|||||12871|18209 130772|QI10A0001 |Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10A|01.05.2009||R|K|1,25|0|0|0|0|PHA|0|0|0|100|NOK|61889|118060|vetalmen|||0|500|0|0|Vistor hf|PHARMAQ AS|||||61889|118060 131136|R03CA0202|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||R03CA02|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|0|100|SEK|3050|4979|lyfalmen|||00|10|0|10|Actavis Group PTC ehf|Mylan AB|Efedrínhýdróklóríð||||3050|4979 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|430|1424|lyfalmen|||00|100|0|33|Vistor hf|Recip AB|Fenýtóín||430||430|1424 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|825|1960|lyfalmen|||00|100|0|15|Vistor hf|Recip AB|||825||825|1960 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|903|2066|lyfalmen|||00|100|0|50|Vistor hf|Recip AB|||903||903|2066 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|999|2196|lyfalmen|||00|100|0|100|Vistor hf|Recip AB|||999||999|2196 131565|G03CA0306|Evorel|forðapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|6026|9018|lyfalmen|||23|26|0|182|Vistor hf|Janssen-Cilag AB|Estradíól||6026||6026|9018 131729|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1|Vistor hf|McNeil Denmark ApS|Nikótín||||| 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6|Vistor hf|McNeil Denmark ApS|Nikótín||||| 131817|B01AX0601 |Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BHC|0|0|0|100|SEK|8201|11970|lyfalmen|||0|10|0|0|Vistor hf|Bayer HealthCare AG|Rivaroxaban||||8201|11970 131828|B01AX0601 |Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BHC|0|0|0|100|SEK|24604|32817|lyfalmen|||0|30|0|0|Vistor hf|Bayer HealthCare AG|Rivaroxaban||||24604|32817 131840|B01AX0601 |Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BHC|0|0|0|100|SEK|82014|104292|lyfalmen|||0|100|0|0|Vistor hf|Bayer HealthCare AG|Rivaroxaban||||82014|104292 132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|279|1132|lyfalmen|||00|28|0|4|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||215||215|1132 132240|N06AA0905|Amitriptyline|töflur|25|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|368|1252|lyfalmen|||00|28|0|9|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||303||303|1252 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|13953|19556|lyfalmen|V0192|19556|00|98|0|196|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||13953||13953|19556 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|9657|13945|lyfalmen|V0191|13945|00|98|0|98|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||9657||9657|13945 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|A|5|1|0|E|0|REP|0|0|1|100|SEK|1587|2994|lyfalmen|||00|100|0|25|Vistor hf|Recip AB|Kódein||1587||1587|2994 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|8139|11885|lyfalmen|||0|30|0|27|Vistor hf|Janssen-Cilag AB|Metýlfenídat||||8139|11885 132761|D08AG0201|Betadine|áburður|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyflausa|||23|8|0|8|Icepharma hf|Napp|Joð/pólývídón||||| 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|K|2|0|0|0|0|ALC|0|0|0|100|USD|1172|2431|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Proxýmetakaín||1172||1172|2431 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|A|3|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||00|100|0|3|Vistor hf|Abigo Medical AB|Lyfjakol||||| 132902|G03AB0402|Trinovum 28|töflur|0| |84|stk|1|þpakki||G03AB04|01.01.1993||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|902|2064|lyfalmen|||23|84|0|84|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||902||902|2064 133074|L03AA1001|Granocyte|sts|33,6|millj ae|1|stk|5|hgl|+ leysir|L03AA10|01.07.1994|31.07.2009|R|A|2|0|1|0|1|CSA|0|0|0|100|NOK|89025|112704|lyfsjukr|||02|5|0|4|Vistor hf|Chugai sanofi-aventis|Lenógrastím||89025||89025|112704 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|36024|46717|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||36024|46717 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|40248|51976|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||40248|51976 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|44720|57544|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||44720|57544 133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|SEK|9658|13947|lyfalmen|||10|100|0|25|Icepharma hf|Sandoz GmbH|Rífampicín||9658||9658|13947 134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|þpakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|124993|157484|lyfsjukr|||00|14|0|7|D.A.C. ehf|D.A.C. ehf|Voricónazól||124993||124993|157484 134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|2682|4480|lyfalmen|||00|50|0|5|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2682||2682|4480 134498|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|5|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|2880|4123|lyfsjukr|||0|5|0|0|Actavis Group hf|Actavis Group hf|Epírúbicín||||2880|4123 134509|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|10|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|4303|6161|lyfsjukr|||0|10|0|0|Actavis Group hf|Actavis Group hf|Epírúbicín||||4303|6161 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|12042|16860|lyfsjukr|||0|25|0|0|Actavis Group hf|Actavis Group hf|Epírúbicín||||12042|16860 134862|J05AR0601|Atripla|filmhtfl|0| |30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|A|2|0|1|0|1|GSI|0|0|0|100|DKK|186828|234364|lyfsjukr|||00|30|0|0|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||186744||186744|234364 135095|M01AC0101|Felden|töflur|20|mg|60|stk|1|þpakki||M01AC01|01.01.1997|31.05.2009|R|A|4|0|0|E|0|PFI|0|0|1|100|DKK|4364|6763|lyfalmen|||00|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam||4364||4364|6763 135111|H01AC0101|Genotropin|sts|0| |12|mg|1|rörlyk|tvíhólfa|H01AC01|01.04.1992||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|81484|103315|lyfsjukr|||00|12|0|18|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sómatrópín||81484||81484|103315 135319|C08DA0107|Verapamil Merck NM|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|1003|2201|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB|Verapamíl||1003||1003|2201 135434|R03BA0502|Flixotide Diskus|innúðadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2467|4188|lyfalmen|||23|60|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2467||2467|4188 136168|G03AB0401|Trinovum|töflur|0| |63|stk|1|þpakki||G03AB04|01.10.1988||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|902|2064|lyfalmen|||23|63|0|84|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||902||902|2064 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|6703|9937|lyfalmen|||00|100|0|100|Vistor hf|Recip AB|Ísóníazíð||6703||6703|9937 136564|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|10|hgl|röntgenskuggaefni|V08CA01|01.01.1993||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|110087|138926|lyfsjukr|||02|150|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||110087||110087|138926 136572|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|10|hgl|röntgenskuggaefni|V08CA01|01.06.1997||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|81519|103359|lyfsjukr|||02|100|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||81519||81519|103359 136964|L01CD0102|Paclitaxel Hospira|irþ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|17699|23903|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||17699|23903 136975|L01CD0102|Paclitaxel Hospira|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|35649|46251|lyfsjukr|||00|17|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||35649|46251 136987|L01CD0102|Paclitaxel Hospira|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|87517|110826|lyfsjukr|||00|25|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||87517|110826 136998|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|102284|129211|lyfsjukr|||00|50|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||102284|129211 137141|N02BA5102|Treo|freyðit|0| |20|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|20|0|3|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole||||| 137158|N02BA5102|Treo|freyðit|0| |60|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|60|0|10|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole||||| 137364|N05AB0301|Trilafon|töflur|4|mg|100|stk|1|þpakki||N05AB03|01.01.1986|31.07.2009|R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|1653|3084|lyfalmen|||00|100|0|13|Vistor hf|Schering-Plough|Perfenazín||1653||1653|3084 137455|N05AB0301|Trilafon|töflur|2|mg|100|stk|1|þpakki||N05AB03|01.01.1986|31.07.2009|R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|1096|2328|lyfalmen|||00|100|0|7|Vistor hf|Schering-Plough|Perfenazín||1096||1096|2328 137513|S01XA2011|Oculac|augndr|0| |10|ml|1|glas|með rotvörn|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|10|0|0|Vistor hf|Novartis Healthcare A/S-|Gervitár og aðrar óvirkar sam­setningar|||||1621 137521|S01XA2011|Oculac|augndr|0| |0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|8|0|0|Vistor hf|Novartis Healthcare A/S-|Gervitár og aðrar óvirkar sam­setningar|||||2045 137641|S01LA0401|Lucentis|stl|10|mg/ml|0,23|ml|1|hgl|lausn|S01LA04|01.03.2007||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|165484|207895|lyfsjukr|||00|0|0|0|Vistor hf|Novartis Europharm Ltd|Ranibizumab||165484||165484|207895 137679|A09AA0205|Creon|sh-hylki|0| |100|stk|1|glas|plastglas|A09AA02|01.04.1990||R|A|2|0|0|E|0|KAC|0|0|0|100|XEU|4923|7521|lyfalmen|||10|100|0|100|Medico ehf|Kali-Chemie|Hvatablöndur (lípasi, próteasi o.s.frv.)||4923||4923|7521 137809|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|31001|40464|lyfsjukr|||00|25|0|1|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||31001||31001|40464 137820|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|12785|17785|lyfsjukr|||00|10|0|0|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||12785||12785|17785 137831|M05BA0303|Pamidronatdinatrium Hospira|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|16760|22734|lyfsjukr|||00|10|0|1|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||16760||16760|22734 137842|M05BA0304|Pamidronatdinatrium Hospira|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|22021|29284|lyfsjukr|||00|10|0|2|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||22021||22021|29284 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|2424|3471|lyfsjukr|||00|500|0|0|Vistor hf|Hospira Enterprises B.V.|Vankómýcín||2424||2424|3471 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|3024|4330|lyfsjukr|||00|1|0|0|Vistor hf|Hospira Enterprises B.V.|Vankómýcín||3024||3024|4330 138560|S01ED0105|Optimol|augndr|2,5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2270|3921|lyfalmen|||00|15|0|60|Icepharma hf|Santen Oy|Tímólól||2270||2270|3921 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,5|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2411|4112|lyfalmen|||00|30|0|60|Icepharma hf|Santen Oy|Tímólól||2411||2411|4112 139410|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|250|ml|1|fl||QP52AC13|01.07.1987||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|3068|5309|vetorma|||13|250|0|0|Icepharma hf|Intervet International B.V.|||3068||3068|5309 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||R|A|5|0|0|E|0|NHE|0|0|1|100|DKK|3373|5418|lyfalmen|||00|100|0|50|Artasan ehf|Novartis Healthcare A/S-A|Klemastín||3373||3373|5418 140118|A10BA0202|Glucophage (Lyfjaver)|töflur|1000|mg|180|stk|1|glas||A10BA02|01.07.2008||R|A|3|0|0|*|0|LVR|0|0|0|100|NOK|3040|4966|lyfalmen|||00|180|0|90|Lyfjaver ehf|Lyfjaver ehf|Metformín||3040||3040|4966 140130|V03AB3501 |Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|192454|241473|lyfsjukr|||00|20|0|0|Vistor hf|N.V. Organon|||||192454|241473 140141|V03AB3501 |Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|481136|600882|lyfsjukr|||00|50|0|0|Vistor hf|N.V. Organon|||||481136|600882 140186|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|þpakki||R03BB01|01.10.1988||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|2837|4690|lyfalmen|||19|100|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||2837||2837|4690 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1919|3445|lyfalmen|||00|30|0|1|Vistor hf|Boehringer Ingelheim International |Pramipexól||1919||1919|3445 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|A|2|0|0|0|1|LBK|0|1|0|100|DKK|15908|21673|lyfsjukr|||02|10|0|33|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||15908||15908|21673 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|717|1027|lyfsjukr|||02|5|0|3|Vistor hf|Novartis Healthcare A/S-|Oxýtócín||717||717|1027 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|10|0|3|Vistor hf|McNeil Denmark ApS|Nikótín||||| 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1518|2900|lyfalmen|||03|2|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||1518||1518|2900 141164|N01BB2005|Emla (D.A.C.)|krem|5|%|5|g|5|túpa|0|N01BB20|01.11.2008||R|A|3|0|0|0|0|DAC|0|0|1|100|SEK|3325|5353|lyfalmen|V2002|5353|00|25|0|5|D.A.C. ehf|D.A.C. ehf|Blöndur||||3325|5353 141175|J01CA0409|Flemoxin (D.A.C.)|mixtúrud|50|mg/ml|100|ml|1|glas||J01CA04|01.10.2008||R|A|4|0|0|0|0|DAC|0|0|1|100|XEU|1530|2917|lyfalmen|||08|80|0|0|D.A.C. ehf|D.A.C. ehf|Amoxicillín||||1530|2917 141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|A|2|0|0|0|1|DAC|0|0|0|100|DKK|10012|14332|lyfsjukr|||00|1200|0|4|D.A.C. ehf|D.A.C. ehf|Paracetamól||10012||10012|14332 141208|B03AC0204|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.10.2008||R|A|3|0|0|E|0|DAC|0|0|1|100|CHF|15730|21769|lyfalmen|V0011|19508|00|25|0|5|D.A.C. ehf|D.A.C. ehf|Járnoxíð (sykurflétta)||15730||15730|21769 141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|30346|39648|lyfsjukr|||00|1|0|0|D.A.C. ehf|D.A.C. ehf|Voricónazól||30346||30346|39648 141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A||0|0|E|0|BII|0|0|0|100|DKK|3710|5875|lyfalmen|||00|30|0|2|Vistor hf|Boehringer Ingelheim International |Pramipexól||3710||3710|5875 141684|G03AA1205|Yaz|filmhtfl|0||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009||R|A|5|0|0|0|0|BAB|0|0|0|100|SEK|4437|5503|lyfalmen|||0|84|0|0|Icepharma hf|Bayer AB|Dróspírenón og östrógen||3436||3436|5503 141751|J01EE0106|Co-trimoxazole|töflur|480|mg|28|stk|1|glas|80+400 mg|J01EE01|01.02.2008||R|A|5|0|0|0|0|AUK|0|0|1|100|GBP|742|1847|lyfalmen|||00|28|0|7|Actavis Group hf|Actavis UK Ltd.|Súlfametoxazól og trímetóprím||||742|1847 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|9691|13992|lyfalmen|||00|100|0|7|Vistor hf|Boehringer Ingelheim International|Pramipexól||9691||9691|13992 142059|C07AA0509|Propranolol Merck NM|töflur|10|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|480|1492|lyfalmen|||00|100|0|6|Actavis Group PTC ehf|Merck NM AB|Própranólól||480||480|1492 142190|C07AA0509|Propranolol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|616|1676|lyfalmen|||00|100|0|25|Actavis Group PTC ehf|Merck NM AB|Própranólól||616||616|1676 142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|8303|11888|lyfsjukr|||02|30|0|8|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||8303||8303|11888 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1072|2295|lyfalmen|V0143|2149|70|30|0|30|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1072||1072|2295 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|A|5|0|0|0|0|MEB|0|0|1|100|SEK|2621|4397|lyfalmen|||00|100|0|50|Vistor hf|Meda AB (V)|Metenamín||2621||2621|4397 142596|C07AA0509|Propranolol Merck NM|töflur|80|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|853|1998|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Própranólól||853||853|1998 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|2313|3979|lyfalmen|||03|1|0|6|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||2313||2313|3979 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|4863|6963|lyfsjukr|||03|1|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||4863||4863|6963 143412|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.12.1972||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|822|1956|lyfalmen|||07|5|0|0|Vistor hf|Novartis Healthcare A/S-|Prednisólón||822||822|1956 143413|S01JX|Methocel 2%|lausn|20|mg/ml|30|ml|1|glas||S01|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|1370|2700|lyfalmen|||00|30|1|0|Distica|Distica - óskráð lyf|||1370||1370|2700 143511|J07BC2002|Twinrix Peadriatric|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|3810|6011|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|blöndur||3810||3810|6011 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|968|2154|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Trópíkamíð||968||968|2154 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1761|3230|lyfalmen|||00|2|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||1761||1761|3230 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|þpakki||N02CX02|01.04.1974||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2511|4248|lyfalmen|||00|100|0|25|Vistor hf|Boehringer Ingelheim|Klónidín||2511||2511|4248 143631|A10BD0701|Janumet|filmhtfl|0||56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|9769|14097|lyfalmen|||0|56|0|0|Icepharma hf|M.S.D.|||||9769|14097 143653|N06AB0403|Cipramil (D.A.C.)|töflur|20|mg|98|stk|1|glas||N06AB04|01.11.2008||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|12164|6753|lyfalmen|V0926|4223|00|98|0|98|D.A.C. ehf|D.A.C. ehf|Cítalópram||4357||4357|6753 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|1037|2248|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1037||1037|2248 143800|N05AN0101|Litarex|forðatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|A|5|0|0|*|0|AGT|0|1|0|100|DKK|1355|2679|lyfalmen|||10|100|0|25|Actavis Group hf|Actavis Group hf|Litíum||1355||1355|2679 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2847|4704|lyfalmen|V0429|4704|00|3|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||2847||2847|4704 143917|L01DB0301|Farmorubicin|stl|2|mg/ml|5|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|4754|6807|lyfsjukr|||02|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Epírúbicín||4754||4754|6807 143933|L01DB0301|Farmorubicin|stl|2|mg/ml|10|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|9136|13080|lyfsjukr|||02|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Epírúbicín||9136||9136|13080 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|A|2|0|0|E|0|MSD|0|0|0|100|XEU|2897|4772|lyfalmen|||10|100|0|17|Icepharma hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2897||2897|4772 144089|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5353|8105|lyfalmen|||51|1|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||5353||5353|8105 144105|L01DB0301|Farmorubicin|stl|2|mg/ml|25|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|16072|21877|lyfsjukr|||02|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Epírúbicín||16072||16072|21877 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|108084|136432|lyfsjukr|||AC|2|0|22|Vistor hf|Novo-Nordisk|Sómatrópín||108084||108084|136432 144330|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.02.2009||L|A|3|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|28|0|28|Actavis Group hf|Actavis Group hf|Ómeprazól||||| 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|67864|86358|lyfsjukr|||AC|2|0|15|Vistor hf|Novo-Nordisk|Sómatrópín||67864||67864|86358 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|44125|56803|lyfsjukr|||AC|2|0|7|Vistor hf|Novo-Nordisk|Sómatrópín||44125||44125|56803 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|1013|2215|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1013||1013|2215 144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|471|1480|lyfalmen|||00|24|0|8|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||471||471|1480 144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|813|1944|lyfalmen|||00|24|0|20|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||813||813|1944 145292|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3583|5703|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3583||3583|5703 145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|5559|8384|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||5559||5559|8384 145540|P02CX0101|Vanquin|mixtúra|10|mg/ml|30|ml|1|glas||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||24|30|0|0|Vistor hf|Recip AB|Pýrvín||||| 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|8|0|0|Vistor hf|Recip AB|Pýrvín||||| 145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|þpakki||P02CX01|01.01.1995||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|32|0|0|Vistor hf|Recip AB|Pýrvín||||| 145698|N05AH0301|Zyprexa|húðuðtfl|10|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|23573|31533|lyfalmen|||00|28|0|28|Icepharma hf|Eli Lilly Nederland -|Olanzapín||23573||23573|31533 146207|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|11706|16441|lyfsjukr|||0|2|0|0|Icepharma hf|Hospira UK Ltd|Írinótekan||||11706|16441 146218|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|27731|36393|lyfsjukr|||0|5|0|0|Icepharma hf|Hospira UK Ltd|Írinótekan||||27731|36393 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|838|1978|lyfalmen|||41|10|0|2|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||838||838|1978 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|5436|7783|lyfsjukr|||0|5|0|0|Icepharma hf|Mayne Pharma Plc|Cýtarabín||||5436|7783 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|4586|6566|lyfsjukr|||0|10|0|0|Icepharma hf|Mayne Pharma Plc|Cýtarabín||||4586|6566 147512|G03DA0202|Perlutex|töflur|5|mg|50|stk|1|þpakki||G03DA02|01.03.1981|30.06.2009|R|A|5|0|0|E|0|LEP|0|0|0|100|DKK|1360|2686|lyfalmen|||00|50|0|50|Vistor hf|LEO Pharma A/S|Medroxýprógesterón||1360||1360|2686 147702|B05AA0501|Macrodex 60 mg/ml med glukos|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|13352|18491|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||13352||13352|18491 147728|B05AA0508|Rheomacrodex med glukos|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|21343|28440|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||21343||21343|28440 147926|J01GB0301|Garamycin|stl|40|mg/ml|2|ml|100|hgl||J01GB03|01.12.1975||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|45723|58793|lyfsjukr|||02|200|0|33|Vistor hf|Schering-Plough|Gentamícín||45723||45723|58793 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|K|2|0|0|0|0|ROA|0|0|1|100|DKK|127283|160652|lyfalmen|||00|750|0|30|Icepharma hf|Roche as|Dornase alfa||127283||127283|160652 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|A|5|0|0|*|0|LFS|0|1|0|100|DKK|1195|2462|lyfalmen|||00|100|0|20|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||1195||1195|2462 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|A|3|0|1|0|1|HON|0|0|0|100|SEK|23274|30844|lyfsjukr|||00|1|0|0|Vistor hf|Hospira Nordic AB (V)|Raltítrexed||23274||23274|30844 148939|D05AX5202|Daivobet (D.A.C.)|smyrsli|0||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.11.2008||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|17645|21221|lyfalmen|V2001|19482|00|120|0|120|D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||15290||15290|21221 148950|N06DA0203 |Aricept (D.A.C.)|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|52739|67845|lyfalmen|V0375|43136|00|98|0|65|D.A.C. ehf|D.A.C. ehf|Dónepezíl||||52739|67845 148961|N06DA0203 |Aricept (D.A.C.)|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|57063|73228|lyfalmen|V0376|48147|00|98|0|131|D.A.C. ehf|D.A.C. ehf|Dónepezíl||||57063|73228 148972|C09DA0304|Diovan Comp 160/12,5 mg (D.A.C.)|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|17103|21277|lyfalmen|V0192|19556|00|98|0|196|D.A.C. ehf|D.A.C. ehf|Valsartan og þvagræsilyf||15335||15335|21277 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|A|3,25|0|0|0|0|BAN|1|0|0|100|DKK|4099|7979|vetalmen|||27|25|0|0|Vistor hf|Bayer Animal Health GmbH|||4099||4099|7979 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|þpakki||N05AG02|01.03.2004||R|A|5|0|0|0|0|PCO|0|1|0|100|IKR|1719|3173|lyfalmen|||00|75|1|19|Distica|Distica - óskráð lyf|||1719||1719|3173 150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|SEK|14945|20792|lyfalmen|||10|100|0|50|Icepharma hf|Sandoz GmbH|Rífampicín||14945||14945|20792 150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|4001|6270|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||4001|6270 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|8091|11820|lyfalmen|||02|10|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||8091||8091|11820 151217|G01AF0102|Flagyl|sk-stil|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1130|2374|lyfalmen|||05|10|0|10|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1130||1130|2374 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|17995|24589|lyfalmen|||00|28|0|28|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|Memantín||||17995|24589 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|55562|71360|lyfalmen|||00|28|0|98|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|Memantín||||55562|71360 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.05.2006||R|A|3|0|0|E|0|MYL|0|0|0|100|SEK|6640|6955|lyfalmen|V0437|6955|00|90|0|90|Actavis Group PTC ehf|Mylan AB|Tamsúlósín||4506||4506|6955 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1814|3302|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxepín||1814||1814|3302 151944|N06AA1201|Sinquan|hylki|10|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1251|2538|lyfalmen|||10|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxepín||1251||1251|2538 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|789|1130|lyfsjukr|||02|5|0|0|Vistor hf|Novartis Healthcare A/S-|Baklófen||789||789|1130 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|IKR|||lyflausa|||23|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam||||| 152397|R03BA0202|Pulmicort Turbuhaler|innúðadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|4143|6463|lyfalmen|||23|200|0|25|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4143||4143|6463 152413|R03BA0202|Pulmicort Turbuhaler|innúðadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|6411|9540|lyfalmen|||23|200|0|50|Vistor hf|AstraZeneca A/S DK|Búdesóníð||6411||6411|9540 152421|R03BA0202|Pulmicort Turbuhaler|innúðadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|ASZ|0|0|0|100|SEK|10736|15410|lyfalmen|||23|200|0|100|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||10736||10736|15410 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki||J02AC02|01.01.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|1743|3206|lyfalmen|||10|4|0|2|Vistor hf|Janssen-Cilag AB|Ítracónazól||1743||1743|3206 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Actavis Group hf|Actavis hf|Cetirizín||||| 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1632|3055|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||1632||1632|3055 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Actavis Group hf|Actavis hf|Cetirizín||||| 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2112|3706|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||2112||2112|3706 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1457|2818|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||1457||1457|2818 153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2214|3845|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Cetirizín||2214||2214|3845 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|A|3|0|0|0|1|GIS|0|0|0|100|DKK|418301|522652|lyfsjukr|||00|10|0|14|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||418301||418301|522652 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|5841|8767|lyfalmen|||10|15|0|8|Vistor hf|Janssen-Cilag AB|Ítracónazól||5841||5841|8767 153575|M01AH0102 |Celebra (D.A.C.)|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|15653|21202|lyfalmen|V2140|21201|00|100|0|100|D.A.C. ehf|D.A.C. ehf|Celekoxíb||15275||15275|21202 153593|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|5|lykjur||B03BA03|01.12.1972||R|A|2|0|0|E|0|HEX|0|0|1|100|DKK|7235|10659|lyfalmen|||02|5|0|250|Vistor hf|Hexal A/S|Hýdroxókóbalamín||7235||7235|10659 153734|L01CA0101|Velbe|sts|10|mg/hgl|1|sk|1|hgl||L01CA01|01.01.1998||R|K||0|1|0|1|LDR|0|0|0|100|IKR|2880|4123|lyfsjukr|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|||2880||2880|4123 154464|D05AX5203 |Xamiol|hlaup|0||30|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|5314|8052|lyfalmen|||00|30|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||||5314|8052 154475|D05AX5203 |Xamiol|hlaup|0||60|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|10176|14650|lyfalmen|||00|60|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||||10176|14650 154484|G04CA0102|Xatral Uno|forðatfl|10|mg|30|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|6132|9162|lyfalmen|||00|30|0|40|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||6132||6132|9162 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|1522|2906|lyfalmen|||10|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Díklófenaknatríum í blöndum||1522||1522|2906 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|5517|8327|lyfalmen|V2130|8327|10|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Díklófenaknatríum í blöndum||5517||5517|8327 154728|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|28|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|2246|3888|lyfalmen|V0954|3888|00|28|0|21|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||2246|3888 154732|G04CA0102|Xatral Uno|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|7070|10435|lyfalmen|V0438|10435|00|90|0|120|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||7070||7070|10435 154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|9111|13204|lyfalmen|V0955|13204|00|98|0|74|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||9111|13204 154750|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|28|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|3886|6114|lyfalmen|V0957|6114|00|28|0|42|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3886|6114 154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|15075|20953|lyfalmen|V0956|20953|00|98|0|147|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||15075|20953 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|K|3|0|0|*|0|GSK|0|0|0|100|GBP|1408|2751|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Chlorambucíl||1408||1408|2751 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|1901|3420|lyfalmen|||00|100|0|17|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1901||1901|3420 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|589|1640|lyfalmen|||00|100|0|5|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||589||589|1640 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|11051|15837|lyfalmen|||00|28|0|14|Vistor hf|Janssen-Cilag AB|Ítracónazól||11051||11051|15837 156505|A08AB0101|Xenical|hylki|120|mg|42|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|7149|10542|lyfalmen|||00|42|0|14|Icepharma hf|Roche|Orlístat||7149||7149|10542 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|9523|13764|lyfalmen|||00|84|0|28|Icepharma hf|Roche|Orlístat||9523||9523|13764 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|A|3|0|0|0|0|JAS|0|0|0|100|SEK|865|2014|lyfalmen|||00|6|0|3|Vistor hf|Janssen-Cilag AB|Mebendazól||865||865|2014 156964|N07BA0137 |Nicorette (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2.5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 156986|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 156997|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|28|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157020|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157031|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157053|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157064|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|28|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157086|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157097|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|10|spr|.|QP52AF02|01.04.1992||R|A|1|0|0|0|0|PAL|0|0|0|100|DKK|8242|14263|vetorma|||16|260|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||8242||8242|14263 157419|N07BA0134 |Nicotinell Mint (D.A.C.)|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|204|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157430|N07BA0140 |Nicorette Peppermynte (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2.5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157463|N07BA0134 |Nicotinell Mint (D.A.C.)|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|96|0|6|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157598|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|96|0|13|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157609|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|27|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157642|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157768|S01AA3001|Terramycin Polymyxin B|augnsm|0| |3,5|g|1|túpa||S01AA30|01.01.2000||R|S|5|0|0|E|0|PCO|0|0|1|100|IKR|554|1592|lyfalmen|||07|4|1|0|Distica|Distica - óskráð lyf|||554||554|1592 157909|D07XC0101|Diprosalic|áburður|0| |100|ml|1|glas||D07XC01|01.01.1987|30.06.2009|R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3615|5746|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||3615||3615|5746 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|þpakki||N03AF01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1138|2385|lyfalmen|||00|50|0|10|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1138||1138|2385 158431|B02BD0801 |NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|116936|147453|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||116936|147453 158442|B02BD0801 |NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|233874|293041|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||233874|293041 158453|B02BD0801 |NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|663143|827481|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||663143|827481 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|59756|76264|lyfsjukr|||0|1|0|0|Vistor hf|Astellas Pharma GmbH|||||59756|76264 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|94114|119039|lyfsjukr|||0|1|0|1|Vistor hf|Astellas Pharma GmbH|||||94114|119039 158683|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|K|4|0|0|E|0|NOH|0|0|0|100|DKK|1266|2558|lyfalmen|||23|5|0|13|Vistor hf|Novartis Healthcare A/S-|Oxýtócín||1266||1266|2558 158725|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|940|2116|lyfalmen|V0608|2116|10|100|0|50|Actavis Group PTC ehf|Mylan AB|Díklófenak||||940|2116 158729|C07AB0208|Selo-ZOC (D.A.C.)|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|SEK|2217|3849|lyfalmen|V2003|3849|00|98|0|31|D.A.C. ehf|D.A.C. ehf|Metóprólól||||2217|3849 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|3970|6228|lyfalmen|V1050|6228|00|5|0|21|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||3970|6228 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|7644|11214|lyfalmen|V1051|11214|00|5|0|42|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||7644|11214 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|10697|15357|lyfalmen|V1052|15357|00|5|0|62|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||10697|15357 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|12859|18194|lyfalmen|V1053|18194|00|5|0|83|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||12859|18194 159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|7345|4977|lyfalmen|V0925|3253|00|56|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3048||3048|4977 159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|29081|38391|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Exemestan||29081||29081|38391 159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|15035|13601|lyfalmen|V0929|7881|00|56|0|112|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||9403||9403|13601 159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2126|2706|lyfalmen|V0921|1893|00|28|0|14|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1375||1375|2706 159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|3680|3894|lyfalmen|V0923|2562|00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2250||2250|3894 159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|7584|5254|lyfalmen|V0927|3332|00|28|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3252||3252|5254 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|A|3|0|0|0|1|ACA|0|0|0|100|DKK|192126|241064|lyfsjukr|||00|2|0|1|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||192126||192126|241064 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|A|3|0|0|0|1|AGT|0|0|0|100|DKK|2571|3681|lyfsjukr|||02|50|0|25|Actavis Group hf|Actavis Group hf|Díazepam||2571||2571|3681 160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|45479|58489|lyfsjukr|||00|100|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||45479||45479|58489 160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|68218|86799|lyfsjukr|||00|150|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||68218||68218|86799 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|956|2138|lyfalmen|||00|100|0|5|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||956||956|2138 160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|A|5|0|0|0|0|BRS|0|0|0|100|DKK|2677|4473|lyfalmen|||42|50|0|14|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2677||2677|4473 160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|90958|115110|lyfsjukr|||00|200|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||90958||90958|115110 160739|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|30|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|355|1322|lyfalmen|||10|30|0|15|Actavis Group PTC ehf|Mylan AB|Díklófenak||||355|1322 160945|N02AA5901|Panocod|freyðit|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|373|1347|lyfalmen|||14|20|0|7|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||373||373|1347 161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|82964|105158|lyfsjukr|||0|120|0|30|Vistor hf|Janssen-Cilag International N.V.|||||82964|105158 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|A|2|0|0|B|0|PFI|0|0|1|100|DKK|866|2016|lyfalmen|||03|1|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||866||866|2016 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|2027|2902|lyfsjukr|||03|1|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón||2027||2027|2902 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|3477|4978|lyfsjukr|||03|5|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón||3477||3477|4978 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|795|1919|lyfalmen|||03|1|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón||795||795|1919 161133|G03CA0306|Evorel|forðapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5364|8120|lyfalmen|||23|26|0|136|Vistor hf|Janssen-Cilag AB|Estradíól||5364||5364|8120 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|68262|87171|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Exemestan||68262||68262|87171 161802|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|3650|5226|lyfsjukr|||00|2|0|1|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||3650||3650|5226 161901|D11AC0301|Selsun|hársápa|25|mg/ml|120|ml|1|glas||D11AC03|01.12.1972||L|A|3|0|0|0|0|CHT|0|0|0|100|IKR|||lyflausa|||01|120|0|120|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|Selensambönd||||| 162016|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|7169|10264|lyfsjukr|||00|5|0|2|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||7169||7169|10264 162305|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|22641|30056|lyfsjukr|||00|18|0|6|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||22641||22641|30056 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|2679|4476|lyfalmen|||00|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Súlfasalazín||2679||2679|4476 162929|G04CA0205 |Ranomax|forðahlk|0,4|mg|100|stk|1|þpakki||G04CA02|01.04.2009||R|A|4|0|0|E|0|RAN|0|0|0|100|XEU|5380|8141|lyfalmen|V0437|7728|00|100|0|100|Gróco ehf|Ranbaxy (UK) Ltd|Tamsúlósín||||5380|8141 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2467|4188|lyfalmen|||24|120|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2467||2467|4188 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|A|2|1|0|0|0|NOH|0|0|0|100|DKK|1297|2600|lyfalmen|||00|30|0|10|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||1297||1297|2600 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|1844|3343|lyfalmen|||41|30|0|6|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1844||1844|3343 163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|A|3|0|0|E|0|AEA|0|0|0|100|XEU|229|1151|lyfalmen|||0|20|0|20|Actavis hf|Actavis EAD|||||229|1151 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|3288|5302|lyfalmen|||24|120|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3288||3288|5302 163709|V03AE0101|Resonium|duft|0| |454|g|1|stauk||V03AE01|01.01.2000||R|A||0|0|0|0|PCO|0|0|0|100|IKR|8140|11887|lyfalmen|||00|454|1|0|Distica|Distica - óskráð lyf|||8140||8140|11887 164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|3103|5051|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Merkaptópúrín||3103||3103|5051 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|2742|4561|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Selegilín||||2742|4561 164871|A07EC0204|Asacol|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|6699|9931|lyfalmen|V0299|9931|98|60|0|20|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||6699||6699|9931 165001|C05AA0102|Proctosedyl|eþ-stil|0| |12|stk|1|pakki||C05AA01|01.12.1972||L|K|1,5|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||04|12|0|0|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón||||| 165019|C05AA0102|Proctosedyl|eþ-smyr|0| |30|g|1|túpa||C05AA01|01.03.1981||L|A|3|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||00|30|0|0|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón||||| 165431|C08CA0202|Plendil|forðatfl|2,5|mg|98|stk|1|þpakki||C08CA02|01.01.1992||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5316|8054|lyfalmen|||43|98|0|49|Vistor hf|AstraZeneca A/S DK|Felódipín||5316||5316|8054 165449|C08CA0202|Plendil|forðatfl|10|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|4641|7138|lyfalmen|V0324|3906|43|98|0|196|Vistor hf|AstraZeneca A/S DK|Felódipín||4641||4641|7138 165548|C08CA0202|Plendil|forðatfl|5|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2995|4905|lyfalmen|V0316|2769|43|98|0|98|Vistor hf|AstraZeneca A/S DK|Felódipín||2995||2995|4905 165639|H01CA0201|Synarela|nefúði|200|mcg/sk|4|ml|1|stauk|30 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|16342|22531|lyfalmen|||23|4|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Nafarelín||16342||16342|22531 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|945|2123|lyfalmen|||00|100|0|50|Vistor hf|UCB Nordic A/S|Meklózín||945||945|2123 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|335|1295|lyfalmen|||00|25|0|12|Vistor hf|UCB Nordic A/S|Meklózín||335||335|1295 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|A|5|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||00|10|0|5|Vistor hf|UCB Nordic A/S|Meklózín||||| 165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|227395|284974|lyfsjukr|||00|500|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||227395||227395|284974 165928|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|fl|plastfl.|V08AB09|01.05.1999|31.07.2009|R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||13480||13480|18650 166033|R06AB0201|Polaramin|forðatfl|6|mg|100|stk|1|þpakki||R06AB02|01.06.1980||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|2805|4647|lyfalmen|||10|100|0|100|Vistor hf|Schering-Plough|Dexklórfeníramín||2805||2805|4647 166090|N05AA0401|Plegicil|töflur|10|mg|10|stk|1|glas||N05AA04|01.03.2007||R|A|5|0|0|0|0|PSW|0|0|0|100|SEK|980|2170|lyfalmen|||00|10|0|1|Vistor hf|Pharmaxim Sweden AB|Aceprómazín||980||980|2170 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|2537|4283|lyfalmen|||00|100|0|39|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||2537||2537|4283 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|17227|23633|lyfalmen|||23|8|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Nafarelín||17227||17227|23633 166272|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|fl|plastfl.|V08AB09|01.05.1999|31.07.2009|R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||15297||15297|20912 166709|G04CA0103|Alfuzosin Ranbaxy|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.07.2009||R|A||0|0|E|0|RAN|0|0|0|100|XEU|11197|16035|lyfalmen|V0438|10435|00|90|0|120|Gróco ehf|Ranbaxy (UK) Ltd|Alfúzósín||||11197|16035 166918|J02AA0102|Amphocil|irs|50|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|27676|36324|lyfsjukr|||00|1|0|1|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|Amfóterícín||27676||27676|36324 167007|J02AA0102|Amphocil|irs|100|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|55351|70779|lyfsjukr|||00|1|0|3|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|Amfóterícín||55351||55351|70779 167319|N06AX1608|Venlafaxin Actavis|forðahlk|37,5|mg|7|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|563|1604|lyfalmen|V0953|1604|00|7|0|3|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||563|1604 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.06.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|686|1771|lyfalmen|||00|100|0|25|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||686|1771 168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|A||0|0|E|0|AGP|0|0|0|100|IKR|31|882|lyfalmen|||00|98|0|98|Actavis|Actavis Group PTC ehf|Lansóprazól||||31|882 168716|N03AF0105|Tegretol Retard|forðatfl|200|mg|50|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1298|2602|lyfalmen|||10|50|0|10|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1298||1298|2602 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3460|5536|lyfalmen|V0789|5536|10|200|0|40|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3460||3460|5536 168815|N03AF0105|Tegretol Retard|forðatfl|400|mg|30|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1359|2685|lyfalmen|||10|30|0|12|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1359||1359|2685 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|6387|9508|lyfalmen|V0713|9508|10|200|0|80|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||6387||6387|9508 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|49860|63943|lyfsjukr|||00|10|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||49860||49860|63943 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|226456|283805|lyfsjukr|||00|50|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||226456||226456|283805 169540|P01BB0101|Paludrin|töflur|100|mg|100|stk|1|glas||P01BB01|01.01.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1500|2876|lyfalmen|||00|100|1|50|Distica|Distica - óskráð lyf|||1500||1500|2876 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|27504|36110|lyfsjukr|||00|5|0|5|Icepharma hf|Roche as|Gancíklóvír||27504||27504|36110 169664|J07BK0101|Varilrix|bóluefni|0| |0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|6145|9179|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluð veira||6145||6145|9179 169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|1168|2425|lyfalmen|V0526|2425|00|20|0|10|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2425 169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|647|1718|lyfalmen|V0522|1718|00|10|0|5|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1718 169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|638|1706|lyfalmen|V0518|1706|00|20|0|5|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1706 169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|393|1374|lyfalmen|V0514|1374|00|10|0|2|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1374 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3176|5150|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3176||3176|5150 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3413|5472|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3413||3413|5472 170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|27541|36156|lyfsjukr|||00|4|0|0|Icepharma hf|Roche Registration Limited|||||27541|36156 170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|68354|86968|lyfsjukr|||00|10|0|0|Icepharma hf|Roche Registration Limited|||||68354|86968 170092|J07BC2001|Twinrix Adult|bóluefni|0| |1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|5627|8476|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|blöndur||5627||5627|8476 170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|136004|171192|lyfsjukr|||00|20|0|0|Icepharma hf|Roche Registration Limited|||||136004|171192 170225|R01AA0702|Otrivin|nefdr|1|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 170233|R01AA0702|Otrivin|nefdr|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|5537|8354|lyfalmen|||59|100|0|50|Vistor hf|Abbott Scandinavia AB|Própafenón||5537||5537|8354 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|10169|14640|lyfalmen|||59|100|0|100|Vistor hf|Abbott Scandinavia AB|Própafenón||10169||10169|14640 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|2288|3945|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||2288||2288|3945 170697|M05BA0406 |Alendronat Actavis|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.06.2009||R|A|2|0|0|E|0|AGP|0|0|0|100|XEU|5369|8126|lyfalmen|V0718|7727|00|12|0|84|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||||5369|8126 170712|A07AA0901|Vancocin|hylki|125|mg|30|stk|1|þpakki|hart hylki|A07AA09|01.10.1988||R|A|2|0|0|E|0|NMA|0|0|1|100|IKR|10000|14411|lyfalmen|||10|30|0|2|Icepharma hf|NordMedica A/S|Vankómýcín||10000||10000|14411 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3351|5388|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||3351||3351|5388 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3610|5739|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||3610||3610|5739 171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|A||0|0|B|0|LDR|0|0|0|100|IKR|732|1834|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||732||732|1834 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4090|6391|lyfalmen|V0709|6391|00|60|0|5|Vistor hf|Janssen-Cilag AB|Tópíramat||4090||4090|6391 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|6733|9977|lyfalmen|V0710|9977|00|60|0|10|Vistor hf|Janssen-Cilag AB|Tópíramat||6733||6733|9977 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|50038|64165|lyfsjukr|||02|75|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||50038||50038|64165 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|42985|55384|lyfsjukr|||02|50|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||42985||42985|55384 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|12160|17324|lyfalmen|V0711|17324|00|60|0|20|Vistor hf|Janssen-Cilag AB|Tópíramat||12160||12160|17324 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|24939|33234|lyfalmen|||00|60|0|40|Vistor hf|Janssen-Cilag AB|Tópíramat||24939||24939|33234 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|74708|94879|lyfsjukr|||02|100|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||74708||74708|94879 172619|L01AB0101|Myleran|töflur|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|A|3|0|0|*|0|GSK|0|0|0|100|GBP|3134|5093|lyfalmen|||00|100|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Búsúlfan||3134||3134|5093 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|13617|19138|lyfalmen|||00|98|0|0|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýst­ings­­lækkandi lyf||13617||13617|19138 172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|7533|11063|lyfalmen|||10|56|0|11|Icepharma hf|Norpharma |Hýdrómorphón||7533||7533|11063 172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|14377|20084|lyfalmen|||10|56|0|22|Icepharma hf|Norpharma |Hýdrómorphón||14377||14377|20084 172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|23911|31954|lyfalmen|||10|56|0|45|Icepharma hf|Norpharma |Hýdrómorphón||23911||23911|31954 172767|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|hgl||J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2600|4369|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2600||2600|4369 172775|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2600|4369|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2600||2600|4369 172825|J07CA0203|DiTeKiPol|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|3702|5864|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|barnaveiki, kíghósti, mænusótt, stífkrampi||3702||3702|5864 172874|D01AC0801|Fungoral|krem|20|mg/g|30|g|1|túpa||D01AC08|01.10.1989|30.06.2009|R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|903|2066|lyfalmen|||00|30|0|30|Vistor hf|Janssen-Cilag AB|Ketókónazól||903||903|2066 172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|27451|36361|lyfalmen|||10|56|0|67|Icepharma hf|Norpharma |Hýdrómorphón||27451||27451|36361 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|888|2045|lyfalmen|V0901|2022|00|50|0|50|Vistor hf|Meda AB|Nítrazepam||888||888|2045 173310|N05BE0107|Buspiron Merck NM|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|2638|4420|lyfalmen|||00|100|0|17|Actavis Group PTC ehf|Merck NM AB (A)|||2638||2638|4420 173344|A06AG1101|Microlax|innhl|0| |5|ml|12|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|60|0|12|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3759 173518|N05BE0107|Buspiron Merck NM|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|5632|8483|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB (A)|||5632||5632|8483 173641|M01AC0202|Tilcotil|töflur|20|mg|10|stk|1|þpakki||M01AC02|01.04.1988||R|A|5|0|0|E|0|MAS|0|0|1|100|SEK|1012|2214|lyfalmen|||00|10|0|10|Vistor hf|Meda AS|Tenoxíkam||1012||1012|2214 173856|N05CF0104|Zopiklon Merck NM|töflur|5|mg|30|stk|1|þpakki||N05CF01|01.10.2001||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|323|1279|lyfalmen|||00|30|0|20|Actavis Group PTC ehf|Merck NM AB|Zópíklón||323||323|1279 173898|N07AA0201|Mestinon|töflur|10|mg|250|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2087|3673|lyfalmen|||00|250|1|14|Distica|Distica - óskráð lyf|||2087||2087|3673 173948|N07AA0201|Mestinon|töflur|60|mg|150|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|9140|13244|lyfalmen|||00|150|1|50|Distica|Distica - óskráð lyf|||9140||9140|13244 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|1561|2235|lyfsjukr|||02|20|0|10|Actavis Group hf|Actavis Group hf|Díazepam||1561||1561|2235 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|618|1679|lyfalmen|||00|14|0|6|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||618||618|1679 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|632|1698|lyfalmen|||00|14|0|7|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||632||632|1698 174433|S01EA0501 |Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|1888|3402|lyfalmen|||00|5|0|25|Vistor hf|Allergan|||||1888|3402 174615|N05CF0104|Zopiklon Merck NM|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.09.1999||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|239|1165|lyfalmen|V0886|1165|00|30|0|30|Actavis Group PTC ehf|Merck NM AB|Zópíklón||||239|1165 174664|S01EA0501 |Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|5537|8354|lyfalmen|||00|15|0|150|Vistor hf|Allergan|||||5537|8354 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|2796|4086|lyfalmen|V0507|4086|00|10|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||2392||2392|4086 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|7513|4983|lyfalmen|V0809|4570|00|28|0|7|Icepharma hf|Eli Lilly Nederland -|Olanzapín||3053||3053|4983 177022|J01MA0101|Tarivid|töflur|200|mg|20|stk|1|þpakki||J01MA01|01.10.1988||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|4497|6943|lyfalmen|||00|20|0|10|Vistor hf|Sanofi-aventis Norge AS|Ófloxacín||4497||4497|6943 177253|N03AG0101|Depakine|sh-tfl|200|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|786|1907|lyfalmen|||43|40|0|5|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||786||786|1907 177295|M02AA1501|Voltaren Emulgel|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|50|0|0|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||| 177311|QJ51RC2202|Nafpenzal vet.|spenalyf|0| |3|g|4|spr||QJ51RC22|01.04.1985||R|A|2|0|0|0|0|INI|0|0|0|100|XEU|717|1415|vetalmen|||16|12|0|0|Icepharma hf|Intervet International B.V.|||717||717|1415 177360|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SPL|0|0|1|100|DKK|830|1967|lyfalmen|||03|1|0|5|Vistor hf|Schering-Plough Europe|Betametasón||830||830|1967 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|A|3|0|0|E|0|PCO|0|0|1|100|IKR|632|1698|lyfalmen|||03|1|1|5|Distica|Distica - óskráð lyf|Tríamcínólón||632||632|1698 179267|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|12|hgl||M03AC09|01.01.1997||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|11945|16739|lyfsjukr|||00|60|0|0|Vistor hf|N.V. Organon|Rókúrón, brómíð||11945||11945|16739 179333|R02AA0304|Strepsils Menthol|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.12.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|A|5|0|0|B|0|UCB|0|0|0|100|DKK|6526|9696|lyfalmen|||10|100|0|25|Vistor hf|U.C.B|Olsalazín||6526||6526|9696 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 180646|C10AA0302|Pravachol|töflur|20|mg|98|stk|1|þpakki||C10AA03|01.08.2008||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|17396|23843|lyfalmen|||00|98|0|65|Vistor hf|Bristol-Myers Squibb|Pravastatín||17396||17396|23843 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|0| |5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|904|2067|lyfalmen|||30|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón og sýkingalyf||904||904|2067 181131|J01EE0103|Primazol|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.04.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|836|1975|lyfalmen|||01|100|0|2|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||836||836|1975 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||23|50|0|5|Vistor hf|Bayer A/S|Klótrímazól||||| 181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DA32|01.10.1995||R|A|1,5|0|0|0|0|PFV|0|0|0|100|DKK|8450|16267|vetalmen|||16|100|0|0|Icepharma hf|Pfizer vet.|||8450||8450|16267 181750|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|11676|16404|lyfsjukr|||00|10|0|0|Icepharma hf|Wyeth AB|Metótrexat||11676||11676|16404 181990|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|44073|56738|lyfsjukr|||00|50|0|0|Icepharma hf|Wyeth AB|Metótrexat||44073||44073|56738 182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|A|2|0|0|0|0|IBV|0|0|0|100|DKK|5535|10715|vetalmen|||16|100|0|0|Vistor hf|Intervet International BV|||5535||5535|10715 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|6117|11823|vetalmen|||27|50|0|0|Vistor hf|Intervet International BV|||6117||6117|11823 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|K|2|0|0|B|0|BRS|0|0|0|100|DKK|1349|2671|lyfalmen|||00|100|0|100|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1349||1349|2671 183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|þpakki||P01AB01|01.10.1995||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|920|2089|lyfalmen|||41|21|0|2|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||920||920|2089 184143|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|2|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|1692|3137|lyfalmen|||00|2|0|2|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||1692||1692|3137 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|437|1433|lyfalmen|||08|100|0|2|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||437||437|1433 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|795|1919|lyfalmen|||08|100|0|5|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||795||795|1919 184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|555|1594|lyfalmen|||00|15|0|4|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||555||555|1594 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|4647|7147|lyfalmen|||98|700|0|5|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||4647||4647|7147 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|26451|35116|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|Letrózól||26451||26451|35116 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|62658|80194|lyfalmen|V0563|80194|00|100|0|100|Vistor hf|Novartis Healthcare A/S-|Letrózól||62658||62658|80194 184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1104|2339|lyfalmen|||00|16|0|8|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1104||1104|2339 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|5097|7757|lyfalmen|||00|6|0|6|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||5097||5097|7757 184671|N06AX0306|Mianserin Merck NM|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|A|3|0|0|B|0|MNA|0|1|0|100|SEK|1094|2325|lyfalmen|V1140|2325|00|90|0|15|Actavis Group PTC ehf|Merck NM AB|Míanserín||1094||1094|2325 187203|B01AA0101|Dicumarol|töflur|20|mg|100|stk|1|glas||B01AA01|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|5152|7832|lyfalmen|||00|100|1|20|Distica|Distica - óskráð lyf|||5152||5152|7832 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3323|5350|lyfalmen|||00|250|0|10|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3323||3323|5350 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|A|4|0|0|*|0|GPL|0|0|0|100|XEU|2307|3971|lyfalmen|||00|100|0|33|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||2307||2307|3971 189126|L02BB0301|Casodex|töflur|150|mg|30|stk|1|þpakki||L02BB03|01.05.2000|30.06.2009|R|A|4|0|0|*|0|ASZ|0|0|0|100|SEK|51875|66769|lyfalmen|||00|30|0|90|Vistor hf|AstraZeneca UK Ltd|Bíkalútamíð||51875||51875|66769 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|A|4|0|0|0|1|NOV|0|0|0|100|DKK|11811|16572|lyfsjukr|||00|10|0|0|Icepharma hf|Novartis Healthcare A/S|Deferoxamín||11811||11811|16572 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|3446|5517|lyfalmen|||03|5|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||3446||3446|5517 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1165|2421|lyfalmen|||03|2|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||1165||1165|2421 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|564|1606|lyfalmen|||03|1|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||564||564|1606 190702|M01AB0101|Confortid|eþ-stil|100|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|915|2082|lyfalmen|||04|10|0|10|Actavis Group hf|Actavis Group hf|Indómetacín||915||915|2082 190728|M01AB0101|Confortid|eþ-stil|50|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|496|1513|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis Group hf|Indómetacín||496||496|1513 190751|M01AB0101|Confortid|hylki|25|mg|100|stk|1|glas||M01AB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|2011|3569|lyfalmen|||10|100|0|25|Actavis Group hf|Actavis Group hf|Indómetacín||2011||2011|3569 191064|B05XC03|Vitalipid Infant|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|5072|7262|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||5072||5072|7262 191247|B05XC02|Vitalipid Adult|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|5173|7406|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||5173||5173|7406 191254|B05XC01|Soluvit|irs|0| |10|ml|10|hgl||B05XC|01.10.1985||R|K||0|0|0|1|FRP|0|0|0|100|DKK|6680|9564|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||6680||6680|9564 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|8|0|5|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|563|1604|lyfalmen|||07|4|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klóramfeníkól||563||563|1604 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |100|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1823|3314|lyfalmen|||10|100|0|100|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1823||1823|3314 192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |25|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|508|1530|lyfalmen|||10|25|0|25|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||508||508|1530 193573|R06AB0201|Polaramin|forðatfl|6|mg|25|stk|1|þpakki||R06AB02|01.10.1991||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|764|1877|lyfalmen|||10|25|0|25|Vistor hf|Schering-Plough|Dexklórfeníramín||764||764|1877 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|A|3|0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen|||14|20|0|22|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2085 193862|A12AA0201|Calcium Sandoz|stl|100|mg/ml|10|ml|5|lykjur||A12AA02|01.12.1972||R|A|5|0|0|0|0|SAN|0|0|0|100|DKK|1277|2573|lyfalmen|||02|50|0|3|Vistor hf|Sandoz A/S|Kalsíumglúbíónat||1277||1277|2573 194076|N02CA5201|Cafergot|töflur|0| |20|stk|1|þpakki||N02CA52|01.03.1999||R|A|3|0|0|E|0|LDR|0|0|0|100|IKR|2645|4430|lyfalmen|||00|20|1|5|Parlogis hf|Parlogis - óskráð lyf|||2645||2645|4430 194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|1271|1820|lyfsjukr|||02|2|0|0|Icepharma hf|Wyeth AB|Metótrexat||1271||1271|1820 194258|A03BB0101|Buscopan|töflur|10|mg|100|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2333|4006|lyfalmen|||00|100|0|17|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2333||2333|4006 194266|A03BB0101|Buscopan|töflur|10|mg|20|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|561|1602|lyfalmen|||00|20|0|3|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||561||561|1602 194720|N03AX0901|Lamictal|dreifit.|5|mg|28|stk|1|þpakki||N03AX09|01.01.1996||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|639|1708|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||639||639|1708 194977|J01MA0202|Ciproxin|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|1949|3485|lyfalmen|V0514|1374|00|10|0|2|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||1949||1949|3485 194985|J01MA0202|Ciproxin|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|4228|6578|lyfalmen|V0518|1706|00|20|0|5|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||4228||4228|6578 195032|J01MA0202|Ciproxin|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|4140|6459|lyfalmen|V0522|1718|00|10|0|5|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||4140||4140|6459 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|1302|2607|lyfalmen|||00|250|0|83|Actavis Group PTC ehf|Mylan AB|Atenólól||||1302|2607 195065|J01MA0202|Ciproxin|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|8031|11739|lyfalmen|V0526|2425|00|20|0|10|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||8031||8031|11739 195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|2185|3806|lyfalmen|||03|5|0|250|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||2185||2185|3806 195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|892|2051|lyfalmen|||03|1|0|50|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||892||892|2051 195354|A07DA0301|Imodium|töflur|2|mg|40|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|952|2132|lyfalmen|||10|40|0|8|Vistor hf|Janssen-Cilag AB|Lóperamíð||952||952|2132 195610|G03AC0801|Implanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2001||R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|24615|32831|lyfalmen|||00|1|0|1015|Vistor hf|N.V. Organon|Etónógestrel||24615||24615|32831 195669|D01AC2002|Pevisone|krem|0| |15|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|735|1838|lyfalmen|||20|15|0|15|Vistor hf|Janssen-Cilag AB|Blöndur||735||735|1838 195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|354|1321|lyfalmen|||10|30|0|15|Vistor hf|Recip AB|Fenýlprópanólamín||354||354|1321 195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|839|1979|lyfalmen|||10|100|0|50|Vistor hf|Recip AB|Fenýlprópanólamín||839||839|1979 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|1626|3047|lyfalmen|||00|250|0|167|Actavis Group PTC ehf|Mylan AB|Atenólól||||1626|3047 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|þp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1337|2655|lyfalmen|||23|63|0|84|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1337||1337|2655 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|2900|5695|vetalmen|||27|10|0|0|Icepharma hf|Intervet International B.V.|||2900||2900|5695 197111|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|5|hgl||QH01CA90|01.07.1986||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|13809|26475|vetalmen|||27|50|0|0|Icepharma hf|Intervet International B.V.|||13809||13809|26475 197343|D11AX0101|Regaine|húðlausn|20|mg/ml|60|ml|1|glas||D11AX01|01.10.1988||L|A|4|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||00|60|0|60|Vistor hf|McNeil Denmark ApS|Mínoxidíl|||||6571 197400|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.03.1981||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|863|2012|lyfalmen|||06|10|0|0|Vistor hf|Novartis Healthcare A/S-|Nafazólín í blöndum með öðrum efnum||863||863|2012 197533|N03AX0901|Lamictal|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.01.1996||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3690|5347|lyfalmen|V0705|5347|00|56|0|19|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||3321||3321|5347 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|966|2151|lyfalmen|V0857|2151|00|20|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||966||966|2151 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|4575|7049|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||4575||4575|7049 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|2612|4385|lyfalmen|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||2612||2612|4385 198432|N02BE5102|Parkodin|eþ-stil|510|mg|10|stk|1|pakki|10+500 mg|N02BE51|01.04.1992|31.07.2009|R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|498|1516|lyfalmen|||04|10|0|2|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||498||498|1516 198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|K|2|0|1|*|0|GSK|0|0|0|100|GBP|1894|3411|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Melphalan||1894||1894|3411 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|11518|16207|lyfsjukr|||02|200|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúóróúracíl||11518||11518|16207 198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|A|5|0|0|0|1|LFS|0|1|0|100|DKK|471|674|lyfsjukr|||02|5|0|2|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||471||471|674 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|42041|54526|lyfalmen|||00|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Estramústín||42041||42041|54526 199307|L01CB0101|Vepesid|stl|20|mg/ml|5|ml|10|hgl||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|17114|23174|lyfsjukr|||00|50|1|0|Distica|Distica - óskráð lyf|||17114||17114|23174 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|A|4|0|0|0|0|PFI|0|0|1|100|DKK|999|2196|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tríazólam||999||999|2196 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|7099|10474|lyfalmen|||44|8|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Kabególín||7099||7099|10474 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|K|3|0|0|0|1|CET|0|0|0|100|XEU|63843|81352|lyfsjukr|||00|5|0|0|Icepharma hf|Centocor -|Abciximab||63843||63843|81352 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4982|7601|lyfalmen|||00|60|1|12|Distica|Distica - óskráð lyf|||4982||4982|7601 327817|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykursaft|A03AA07|01.01.2000||R|A||0|1|E|0|LDR|0|0|0|100|IKR|4615|7103|lyfalmen|||00|100|1|1|Parlogis hf|Parlogis - óskráð lyf|||4615||4615|7103 335968|A04AD0102|Skopolamin|stl|0,3|mg/ml|1|ml|10|lykjur||A04AD01|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|6034|9029|lyfalmen|||00|10|1|0|Parlogis hf|Parlogis - óskráð lyf|Skópólamín||6034||6034|9029 336792|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykurlaus|A03AA07|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2125|3724|lyfalmen|||00|100|1|1|Parlogis hf|Parlogis - óskráð lyf|||2125||2125|3724 338236|C01CA0301|Noradrenalin|stl|1|mg/ml|2|ml|10|lykjur||C01CA03|01.01.2000||R|A||0|0|0|1|LDR|0|0|0|100|IKR|3940|5641|lyfsjukr|||00|20|1|3|Parlogis hf|Parlogis - óskráð lyf|||3940||3940|5641 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|647|926|lyfsjukr|||02|1|0|0|Icepharma hf|Roche|Fýtómenadíón||647||647|926 370353|V08AB0501|Ultravist|stl/irl|300|mg J/ml|20|ml|10|hgl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|19335|25940|lyfsjukr|||02|200|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||19335||19335|25940 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|A|2|0|0|0|1|NOM|0|0|0|100|IKR|544|779|lyfsjukr|||03|1|0|0|Icepharma hf|NordMedica ApS|Cefazólín||544||544|779 371583|A06AG1001|Klyx|innhl|0| |240|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|240|0|1|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum||||| 371609|A06AG1001|Klyx|innhl|0| |120|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|120|0|1|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum||||| 371617|A06AG1001|Klyx|innhl|0| |120|ml|10|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen|||23|1200|0|10|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||8975 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|10|0|5|Actavis Group hf|Actavis hf|Ranitidín||||| 372037|N05AL0501|Solian|töflur|50|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|3080|5020|lyfalmen|||00|30|0|4|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3080||3080|5020 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|8635|12559|lyfalmen|||00|90|0|11|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||8635||8635|12559 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|4665|7171|lyfalmen|||00|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4665||4665|7171 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|42|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|18|0|3|Vistor hf|McNeil Denmark ApS|Nikótín||||| 372714|N05AL0501|Solian|töflur|200|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|10296|14813|lyfalmen|||00|30|0|15|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||10296||10296|14813 372722|B02BD0801|NovoSeven|sts|1,2|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|118097|148898|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||118097||118097|148898 372730|B02BD0801|NovoSeven|sts|2,4|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|235542|295117|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||235542||235542|295117 372748|B02BD0801|NovoSeven|sts|4,8|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|623121|777653|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||623121||623121|777653 373001|G03AB0501|Gracial|töflur|0| |66|stk|1|pakki|þp 3 x (15+7 stk)|G03AB05|01.07.1998||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2828|4678|lyfalmen|||23|66|0|88|Vistor hf|N.V. Organon|Desógestrel og östrógen||2828||2828|4678 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|27302|36176|lyfalmen|||00|90|0|45|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||27302||27302|36176 373324|R03AK0602|Seretide Diskus|innúðadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|4799|7353|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4799||4799|7353 373340|R03AK0602|Seretide Diskus|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|7496|11013|lyfalmen|V0992|11010|23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||7496|11013 373365|R03AK0602|Seretide Diskus|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|9811|14154|lyfalmen|V0993|14153|23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||9811|14154 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|3300|5319|lyfalmen|||44|2|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Kabególín||3300||3300|5319 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|A|5|0|0|*|0|MCK|0|0|0|100|XEU|713|1808|lyfalmen|||00|100|0|25|Icepharma hf|Merck Santé s.a.s.|Metformín||713||713|1808 374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|5596|8434|lyfalmen|||00|30|0|30|Vistor hf|Yamanouchi Europe|Tamsúlósín||5596||5596|8434 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|12605|17878|lyfalmen|||00|60|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||12605||12605|17878 374504|G01AF0502|Pevaryl Depot|krem/sti|0| |15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|15|0|2|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 374520|L02BB0301|Casodex|töflur|50|mg|30|stk|1|þpakki||L02BB03|01.04.1997||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|20603|27836|lyfalmen|V0560|23178|00|30|0|30|Vistor hf|AstraZeneca UK Ltd|Bíkalútamíð||20603||20603|27836 374579|R01AC0101|Lomudal Nasal|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.10.1992||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2779|4612|lyfalmen|||23|15|0|15|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||2779||2779|4612 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|7983|11674|lyfalmen|||00|6|0|30|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7983||7983|11674 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|8878|12888|lyfalmen|||00|8|0|40|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||8878||8878|12888 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|12101|17251|lyfalmen|||00|10|0|50|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||12101||12101|17251 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|5067|7717|lyfalmen|||63|14|0|14|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||5067||5067|7717 377259|J01FA0901|Klacid|töflur|500|mg|100|stk|1|glas||J01FA09|01.04.1992||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|41447|53786|lyfalmen|||63|100|0|100|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||41447||41447|53786 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|12208|14993|lyfalmen|V0508|14993|00|42|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||10429||10429|14993 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|177896|223348|lyfsjukr|||00|2|0|14|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||177896||177896|223348 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|185294|232559|lyfsjukr|||00|2|0|29|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||185294||185294|232559 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|232325|291112|lyfsjukr|||00|2|0|43|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||232325||232325|291112 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1703|3151|lyfalmen|||00|12|0|2|Actavis Group hf|Actavis Group hf|Díazepam||1703||1703|3151 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|2105|3697|lyfalmen|||00|12|0|5|Actavis Group hf|Actavis Group hf|Díazepam||2105||2105|3697 379925|L01CD0201|Taxotere|irs|40|mg/ml|0,5|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|1,5|0|1|0|1|AVS|0|0|0|100|NOK|29085|38078|lyfsjukr|||00|0|0|0|Vistor hf|Aventis Pharma SA|Docetaxel||29085||29085|38078 379933|L01CD0201|Taxotere|irs|40|mg/ml|2|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|2|0|1|0|1|AVS|0|0|0|100|NOK|116785|147265|lyfsjukr|||00|2|0|0|Vistor hf|Aventis Pharma SA|Docetaxel||116785||116785|147265 380642|A10AD0402|Humalog Mix50 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.12.2001||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6767|10024|lyfalmen|||17|15|0|38|Icepharma hf|Eli Lilly Nederland -|Insulín lispro||6767||6767|10024 381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6313|9407|lyfalmen|||00|15|0|38|Icepharma hf|Eli Lilly Nederland -|Insulín lispro||6313||6313|9407 382531|C10AA0101|Zocor|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.07.1995||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|17128|3477|lyfalmen|V0367|3035|00|98|0|131|Icepharma hf|M.S.D.|Simvastatín||1943||1943|3477 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|6401|9527|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca A/S DK|Bambúteról||6401||6401|9527 383075|N02AA5904|Ibukod sterkar|töflur|0| |20|stk|1|glas|30+200 mg|N02AA59|01.02.1999||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|460|1465|lyfalmen|||00|20|0|7|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||460||460|1465 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|||vetorma|||00|2|0|0|Vistor hf|Bayer Animal Health GmbH||||||1933 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|8740|15125|vetorma|||00|20|0|0|Vistor hf|Bayer Animal Health GmbH|||8740||8740|15125 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|60|0|60|Actavis Group hf|Actavis hf|Ketókónazól||||| 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|120|0|120|Actavis Group hf|Actavis hf|Ketókónazól||||| 383737|R06AX1301|Clarityn|freyðit|10|mg|10|stk|1|þpakki||R06AX13|01.10.1995||L|A|2|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Vistor hf|Schering-Plough|Lóratadín||||| 386953|L02BG0301|Arimidex|töflur|1|mg|98|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|57684|74002|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca UK Ltd|Anastrózól||57684||57684|74002 387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|A|3|0|0|0|0|ICE|0|0|0|100|XEU|825|1628|vetalmen|||00|100|0|0|Icepharma hf|Icepharma hf|||825||825|1628 387746|J02AA0101|Abelcet|irþ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|K|2|0|0|0|1|ZPL|0|0|0|100|DKK|253267|317185|lyfsjukr|||00|200|0|29|Zeneus Pharma Limited|Zeneus Pharma Limited|Amfóterícín||253267||253267|317185 388256|N01BB2001|Emla|krem|0| |5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3393|5445|lyfalmen|V2002|5353|00|25|0|5|Vistor hf|AstraZeneca A/S DK|Blöndur||3393||3393|5445 388264|N01BB2001|Emla|krem|0| |30|g|1|túpa||N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3826|6032|lyfalmen|||00|30|0|30|Vistor hf|AstraZeneca A/S DK|Blöndur||3826||3826|6032 388272|N01BB2001|Emla|plástur|0| |2|stk|1|pakki||N01BB20|01.04.1994||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|0|Vistor hf|AstraZeneca A/S DK|Blöndur||||| 388280|N01BB2001|Emla|plástur|0| |20|stk|1|pakki||N01BB20|01.04.1994||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|7141|10531|lyfalmen|||23|20|0|0|Vistor hf|AstraZeneca A/S DK|Blöndur||7141||7141|10531 388660|C09BA0201|Darazið|töflur|22,5|mg|100|stk|1|glas|10+12.5 mg|C09BA02|01.04.1998||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2966|4865|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Enalapríl og þvagræsilyf||2966||2966|4865 389106|G03FA0103|Femanor|töflur|0| |84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2685|4484|lyfalmen|V0388|4484|23|84|0|84|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2685||2685|4484 389122|G03FB0503|Femasekvens|töflur|0| |84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2453|4169|lyfalmen|||23|84|0|84|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2453||2453|4169 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|778|1896|lyfalmen|V0408|1896|00|84|0|84|Vistor hf|BioPhausia AB|Estradíól||778||778|1896 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|720|1817|lyfalmen|||00|84|0|42|Vistor hf|BioPhausia AB|Estradíól||720||720|1817 389361|V08AB0501|Ultravist|stl/irl|300|mg J/ml|500|ml|8|fl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|338727|423583|lyfsjukr|||02|4000|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||338727||338727|423583 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1097|2329|lyfalmen|||00|3|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1097||1097|2329 389577|A04AA0201|Kytril|töflur|2|mg|5|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|13506|19000|lyfalmen|||00|5|0|5|Icepharma hf|Roche as|Granisetrón||13506||13506|19000 389783|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1985|30.06.2009|R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2534|4279|lyfalmen|||00|30|0|8|Vistor hf|Recip AB|Flúkloxacillín||2534||2534|4279 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|K|1|0|0|E|0|BRS|0|0|1|100|DKK|3308|5329|lyfalmen|||01|100|0|7|Vistor hf|Bristol-Myers Squibb|Nýstatín||3308||3308|5329 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|7926|11596|lyfalmen|||00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||7926||7926|11596 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|3130|5088|lyfalmen|||00|20|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||3130||3130|5088 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|15274|21201|lyfalmen|V2140|21201|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||15274||15274|21201 391730|N01BB0203|Xylocain|úðalyf|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.1990||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3090|5034|lyfalmen|||00|50|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||3090||3090|5034 392563|A04AA0103|Zofran|mixtúra|0,8|mg/ml|50|ml|1|flaska||A04AA01|01.08.2009||R|A||0|0|E|0|PCO|0|0|0|100|IKR|12000|17125|lyfalmen|||00|50|1||Distica|Distica - óskráð lyf|Ondansetrón||||12000|17125 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.09.1983||R|S|4|0|0|0|0|PAL|0|0|0|100|XEU|5675|10981|vetalmen|||16|24|0|0|Icepharma hf|Pfizer Oy Animal Health|||5675||5675|10981 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 395715|D10AD0301|Differin|hlaup|0,1|%|30|g|1|túpa||D10AD03|01.07.2001|31.07.2009|R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|1030|2238|lyfalmen|||00|30|0|30|Icepharma hf|Galderma Nordic AB|Adapalen||1030||1030|2238 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|196262|246214|lyfsjukr|||02|300|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||196262||196262|246214 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|12159|17005|lyfsjukr|||00|60|0|0|Icepharma hf|Roche|Capecitabín||12159||12159|17005 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|64577|82266|lyfsjukr|||00|120|0|0|Icepharma hf|Roche|Capecitabín||64577||64577|82266 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2049|3343|lyfalmen|V0703|3343|00|56|0|9|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1844||1844|3343 399527|N03AX0901|Lamictal|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|6434|8873|lyfalmen|V0706|8873|00|56|0|37|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||5919||5919|8873 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|10220|14709|lyfalmen|||02|3|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||10220||10220|14709 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|2|0|2|Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír||||| 400044|S03CA0102|Sofradex|aug.eydr|0| |8|ml|1|glas||S03CA01|01.03.1980||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1714|3166|lyfalmen|||06|8|0|0|Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1714||1714|3166 400101|R05DB2002|Pektolin|mixtúra|0| |150|ml|1|glas||R05DB20|01.06.1981||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|0|Actavis Group hf|Actavis hf|Blöndur||||| 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|6307|9399|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gemfíbrózíl||6307||6307|9399 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|410|1397|lyfalmen|||00|25|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||410||410|1397 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|668|1747|lyfalmen|||00|100|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||668||668|1747 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|291|1235|lyfalmen|||00|25|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||291||291|1235 400804|N07BA0103|Nicorette|forðapl|15|mg/16kls|7|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|8|Vistor hf|McNeil Denmark ApS|Nikótín||||| 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|859|2006|lyfalmen|||00|100|0|13|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||859||859|2006 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|1375|2706|lyfalmen|||00|100|0|33|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1375||1375|2706 401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1246|2531|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|Kaptópríl||1246||1246|2531 401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2000|3554|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Kaptópríl||2000||2000|3554 402651|J07BB0205|Influvac|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|739|1843|lyfalmen|||51|0|0|0|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsaðir mótefnavakar||739||739|1843 402743|QJ01RA0102|Streptocillin, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.11.1979||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1802|3556|vetalmen|||58|100|0|0|Vistor hf|Boehringer Ingelheim Danmark|||1802||1802|3556 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|5820|11257|vetalmen|||27|20|0|0|Vistor hf|Intervet International BV|||5820||5820|11257 403550|C08CA0302|Lomir Retard|forðahlk|2,5|mg|100|stk|1|þpakki||C08CA03|01.10.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|7928|11599|lyfalmen|||10|100|0|50|Vistor hf|Novartis Healthcare A/S-|Ísradipín||7928||7928|11599 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1369|2698|lyfalmen|||06|14|0|0|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1369||1369|2698 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|A|2,5|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|10|0|0|Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar sam­setningar|||||1826 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|A|3|0|0|0|1|BOI|0|0|0|100|DKK|105515|133234|lyfsjukr|||02|1|0|0|Vistor hf|Boehringer Ingelheim|Alteplasi||105515||105515|133234 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|709|1015|lyfsjukr|||02|5|0|2|Icepharma hf|Roche|Fýtómenadíón||709||709|1015 405589|J07BD5203|Priorix|bóluefni|0| |0,5|ml|1|hgl|+ einnota dæla|J07BD52|01.03.1999||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|1963|3504|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||1963||1963|3504 405597|J07BD5203|Priorix|bóluefni|0| |0,5|ml|10|hgl||J07BD52|01.11.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|24215|32333|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||24215||24215|32333 405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|23353|31259|lyfalmen|||00|28|0|21|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||23353||23353|31259 406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27592|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27592 406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|23353|31259|lyfalmen|||00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||23353||23353|31259 406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|23353|31259|lyfalmen|||00|28|0|35|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||23353||23353|31259 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|23586|31550|lyfalmen|||00|100|0|25|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||23586||23586|31550 406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30654|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30654 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|71107|90713|lyfalmen|||00|100|0|75|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||71107||71107|90713 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|77124|98204|lyfalmen|||00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||77124||77124|98204 406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|83140|105694|lyfalmen|||00|100|0|125|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||83140||83140|105694 406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|7881|11535|lyfalmen|||00|30|0|8|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||7881||7881|11535 406751|M01AB0101|Confortid|hylki|25|mg|30|stk|1|þpakki||M01AB01|01.05.1974||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|648|1720|lyfalmen|||10|30|0|8|Actavis Group hf|Actavis Group hf|Indómetacín||648||648|1720 407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|2087|3673|lyfalmen|||00|100|0|50|Vistor hf|Recip AB|Ergotamínlyf í blöndum með geðlyfjum (psycoleptica)||2087||2087|3673 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|1|100|DKK|276|1215|lyfalmen|||00|25|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||276||276|1215 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|0|100|DKK|778|1896|lyfalmen|||00|100|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||778||778|1896 408724|D07AC0104|Diproderm|smyrsli|0,5|mg/g|20|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1202|2472|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|Betametasón||1202||1202|2472 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|5516|8326|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||5516||5516|8326 408757|D07AC0104|Diproderm|áburður|0,5|mg/ml|20|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1202|2472|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|Betametasón||1202||1202|2472 408773|D07AC0104|Diproderm|áburður|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3284|5297|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||3284||3284|5297 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|5905|8854|lyfalmen|||08|35|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||5905||5905|8854 409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|4362|6760|lyfalmen|||00|28|0|56|Vistor hf|Boehringer Ingelheim International |||4362||4362|6760 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|4065|6357|lyfalmen|||23|200|0|100|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4065||4065|6357 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|14090|19727|lyfalmen|||00|98|0|196|Vistor hf|Boehringer Ingelheim International |||14090||14090|19727 409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|3437|5505|lyfalmen|||00|28|0|28|Vistor hf|Boehringer Ingelheim International |||3437||3437|5505 409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|A|3|0|0|0|0|PSW|1|0|0|100|DKK|11991|23012|vetalmen|||27|120|0|0|Vistor hf|Pharmaxim Sweden AB|||11991||11991|23012 409631|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|glas||C07AB03|01.04.1987||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|575|1621|lyfalmen|V0290|1566|00|100|0|33|Actavis Group hf|Actavis hf|Atenólól||||575|1621 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|11417|16334|lyfalmen|||00|98|0|98|Vistor hf|Boehringer Ingelheim International |||11417||11417|16334 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|1213|2486|lyfalmen|||00|20|0|10|Vistor hf|Recip AB|Klórókín||1213||1213|2486 410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|710|1804|lyfalmen|||23|30|0|30|Vistor hf|Janssen-Cilag AB|Tretínóín||710||710|1804 411033|M03BX0104|Baklofen Merck NM|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|621|1683|lyfalmen|||00|50|0|10|Actavis Group PTC ehf|Merck NM AB|Baklófen||621||621|1683 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|8284|11861|lyfsjukr|||02|50|0|17|Icepharma hf|Roche|Mídazólam||8284||8284|11861 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|27805|36485|lyfsjukr|||00|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín||27805||27805|36485 411868|M01AB0505|Voltaren|sh-tfl|25|mg|100|stk|1|þpakki||M01AB05|01.11.1981||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2107|3700|lyfalmen|||67|100|0|25|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2107||2107|3700 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|8464|12326|lyfalmen|||98|6|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||8464||8464|12326 412049|L02AE0301|Zoladex|vefjatfl|3,6|mg|1|stk|1|glas|+ dæla|L02AE03|01.01.1990||R|A|3|0|1|*|0|ASZ|0|0|0|100|SEK|23858|31888|lyfalmen|||00|1|0|28|Vistor hf|AstraZeneca UK Ltd|Góserelín||23858||23858|31888 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|3548|5080|lyfsjukr|||00|3|0|15|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3548||3548|5080 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|1|0|0|100|DKK|11336|21765|vetalmen|||02|100|0|0|Vistor hf|Merial|||11336||11336|21765 412825|L02BA0106|Tamoxifen NM Pharma|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|2060|3636|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Tamoxífen||2060||2060|3636 412833|L02BA0106|Tamoxifen NM Pharma|töflur|20|mg|30|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|1316|2626|lyfalmen|||00|30|0|30|Actavis Group PTC ehf|Merck NM AB|Tamoxífen||1316||1316|2626 413245|J06BA0205|Sandoglobulin|irs|12|g/fl|12|g|1|sett|leys+áhöld|J06BA02|01.04.1993||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|115708|145924|lyfsjukr|||00|12|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||115708||115708|145924 414458|V04CF0102|Tuberkulin|stl|2|TU/0,1ml|1,5|ml|1|hgl||V04CF01|01.01.1998||R|K||0|0|0|0|LDR|0|0|0|100|DKK|2426|4133|lyfalmen|||00|2|1|0|Parlogis hf|Parlogis - óskráð lyf|||2426||2426|4133 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|5143|7820|lyfalmen|||00|90|0|54|Icepharma hf|Servier|Indapamíð||5143||5143|7820 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1643|3070|lyfalmen|||00|300|0|6|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1643||1643|3070 415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|2149|3757|lyfalmen|||5|15|0|15|Vistor hf|Novo-Nordisk|Estradíól||2149||2149|3757 416222|C09DA0101|Cozaar Comp|töflur|62,5|mg|28|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|4052|6339|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||4052||4052|6339 416446|C09DA0101|Cozaar Comp|töflur|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|10734|10450|lyfalmen|V0198|10450|00|98|0|98|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||7081||7081|10450 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|3849|6064|lyfalmen|||00|300|1|15|Distica|Distica - óskráð lyf|Ranitidín||3849||3849|6064 416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|3272|5281|lyfalmen|||23|10|0|0|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||3272||3272|5281 416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|27518|36445|lyfalmen|||23|150|0|0|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||27518||27518|36445 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|A|5|0|0|0|0|IGB|0|0|0|100|SEK|1126|2368|lyfalmen|||00|30|0|30|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1126||1126|2368 417238|QM01AE0301|Romefen, vet.|töflur|10|mg|10|stk|1|þpakki||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|0|0|0|100|XEU|598|1180|vetalmen|||00|10|0|0|Vistor hf|Merial|||598||598|1180 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|45509|58526|lyfsjukr|||00|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|Abacavír||45509||45509|58526 418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|þpakki||A07EC02|01.10.1991||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|4655|7157|lyfalmen|||10|100|0|17|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||4655||4655|7157 418665|D07XC0101|Diprosalic|smyrsli|0| |50|g|1|túpa||D07XC01|01.11.1979||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|1971|3515|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|Betametasón||1971||1971|3515 418731|A07EC0201|Mesasal|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|A|4|0|0|B|0|SNO|0|0|0|100|NOK|9468|13689|lyfalmen|V0299|9931|00|60|0|20|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||9468||9468|13689 418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2206|4353|vetalmen|||13|200|0|0|Vistor hf|Boehringer Ingelheim Danmark|||2206||2206|4353 418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dæla|QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2863|5625|vetalmen|||13|200|0|0|Vistor hf|Boehringer Ingelheim Danmark|||2863||2863|5625 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4624|7115|lyfalmen|||10|100|0|25|Vistor hf|LEO Pharma A/S|Alfakalsídól||4624||4624|7115 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|8055|11771|lyfalmen|||10|100|0|100|Vistor hf|LEO Pharma A/S|Alfakalsídól||8055||8055|11771 419440|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.05.1999||R|K|1,6|0|1|0|1|SCP|0|0|0|100|DKK|71184|90492|lyfsjukr|||00|10|0|0|Vistor hf|Schering-Plough|Doxórúbicín||71184||71184|90492 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|A|3|0|1|0|1|MSD|0|0|0|100|XEU|62718|79951|lyfsjukr|||00|180|0|30|Icepharma hf|M.S.D.|Indínavír||62718||62718|79951 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|A|2|0|1|0|1|ORP|0|0|0|100|DKK|53026|67885|lyfsjukr|||00|100|0|8|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||53026||53026|67885 419945|D07AD0101|Dermovat|áburður|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|919|2088|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||919||919|2088 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|13655|19185|lyfalmen|||02|10|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||13655||13655|19185 420356|B01AB0401|Fragmin|stl|2500|ae/ml|4|ml|10|hgl||B01AB04|01.04.1993||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|13679|18898|lyfsjukr|||00|40|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||13679||13679|18898 420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|4078|6374|lyfalmen|||02|2|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||4078||4078|6374 420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|6959|10284|lyfalmen|||02|2|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||6959||6959|10284 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1823|3314|lyfalmen|V0144|3313|70|30|0|15|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1823||1823|3314 422121|C07AB0205 |Seloken|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.05.2009||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1553|2948|lyfalmen|||00|28|0|33|Vistor hf|AstraZeneca A/S DK|Metóprólól||||1553|2948 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3412|5471|lyfalmen|||43|98|0|62|Vistor hf|AstraZeneca A/S DK|Metóprólól||3412||3412|5471 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|6720|9960|lyfalmen|||43|98|0|124|Vistor hf|AstraZeneca A/S DK|Metóprólól||6720||6720|9960 422402|G03FB0505|Estracomb|forðapl|0| |8|stk|1|pakki|samsett pk|G03FB05|01.04.1993|31.07.2009|R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2861|4723|lyfalmen|||23|8|0|28|Vistor hf|Novartis Healthcare A/S-|Noretísterón og östrógen||2861||2861|4723 422659|G02CB0102|Parlodel|töflur|2,5|mg|100|stk|1|glas||G02CB01|01.11.1979||R|A|3|0|0|E|0|MAS|0|0|0|100|SEK|8733|12691|lyfalmen|||49|100|0|50|Vistor hf|Meda AS|Brómókriptín||8733||8733|12691 424846|M04AA0103|Hexanurat|töflur|100|mg|100|stk|1|glas||M04AA01|01.02.2006||R|A||0|0|E|0|PCO|0|0|0|100|IKR|391|1371|lyfalmen|||00|100|1|25|Distica|Distica - óskráð lyf|||391||391|1371 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dæl||QP52AC13|01.05.1999||L|A|3|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||16|24|0|0|Icepharma hf|Intervet International B.V.||||||2295 425181|N05CD0305|Flunitrazepam Merck NM|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|976|2165|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Flúnítrazepam||976||976|2165 425538|N04BC0102|Parlodel|hylki|10|mg|100|stk|1|þpakki||N04BC01|01.11.1979||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|30303|39912|lyfalmen|||52|100|0|25|Vistor hf|Meda AS|Brómókriptín||30303||30303|39912 426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|0|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 426312|J02AC0101|Diflucan|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.04.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|3873|6096|lyfalmen|V0555|2796|10|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||3873||3873|6096 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|618|1679|lyfalmen|||00|20|0|5|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||618||618|1679 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|806|1934|lyfalmen|||00|30|0|8|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||806||806|1934 427351|N07BA0103|Nicorette|forðapl|5|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|5|Vistor hf|McNeil Denmark ApS|Nikótín||||| 427369|N07BA0103|Nicorette|forðapl|10|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|10|Vistor hf|McNeil Denmark ApS|Nikótín||||| 427377|N07BA0103|Nicorette|forðapl|15|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|15|Vistor hf|McNeil Denmark ApS|Nikótín||||| 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|A|3|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||00|30|0|45|Vistor hf|Boehringer Ingelheim International |Natríum pícós|||||2541 428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1126|2368|lyfalmen|||20|30|0|30|Vistor hf|Schering-Plough|Mómetasón||1126||1126|2368 428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1118|2358|lyfalmen|||20|30|0|30|Vistor hf|Schering-Plough|Mómetasón||1118||1118|2358 428565|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|31847|41517|lyfsjukr|||00|1000|0|4|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||31847||31847|41517 428656|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|49874|63961|lyfsjukr|||00|2000|0|8|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||49874||49874|63961 428672|J01CA0406|Flemoxin Solutab|lausnart|125|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|568|1611|lyfalmen|||23|14|0|2|Vistor hf|Astellas Pharma A/S|Amoxicillín||568||568|1611 428680|J01CA0406|Flemoxin Solutab|lausnart|250|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|937|2112|lyfalmen|||23|14|0|4|Vistor hf|Astellas Pharma A/S|Amoxicillín||937||937|2112 428813|C07AB0309|Atenolol Actavis|töflur|25|mg|30|stk|1|glas||C07AB03|01.01.1992||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|180|1085|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|Atenólól||180||180|1085 429167|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|1|hgl|+ dreifa í dælu|J07CA06|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|6289|9375|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||6289||6289|9375 429225|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|10|hgl||J07CA06|01.12.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|47042|60752|lyfalmen|||AC|5|0|0|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||47042||47042|60752 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|6493|9652|lyfalmen|||00|100|0|133|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Spírónólaktón||6493||6493|9652 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1805|2584|lyfsjukr|||02|50|0|0|Vistor hf|Janssen-Cilag AB|Fentanýl||1805||1805|2584 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|2209|3163|lyfsjukr|||02|50|0|3|Icepharma hf|Roche|Mídazólam||2209||2209|3163 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|4334|8427|vetalmen|||27|100|0|0|Vistor hf|Intervet International BV|||4334||4334|8427 430710|J07AP0301|Typhim Vi|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2875|4742|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefna­vakar||2875||2875|4742 430967|N07BA0105|Nicorette Mint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|862|2010|lyfalmen|||20|15|0|15|Vistor hf|LEO Pharma A/S|Fúsidínsýra||862||862|2010 431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|þpakki||C01DA08|01.07.1989||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1249|2535|lyfalmen|||00|100|0|17|Vistor hf|Recip AB|Ísósorbíð dínítrat||1249||1249|2535 431106|N07BA0105|Nicorette Mint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431122|N07BA0105|Nicorette Mint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431171|N07BA0105|Nicorette Mint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431205|C08DB0107|Korzem|töflur|30|mg|100|stk|1|þpakki||C08DB01|01.01.1989||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|785|1906|lyfalmen|||00|100|0|12|Actavis Group hf|Actavis hf|Diltíazem||785||785|1906 432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|952|2132|lyfalmen|||00|300|0|50|Actavis Group hf|Actavis hf|Paracetamól||952||952|2132 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|12523|17776|lyfalmen|V0729|17776|0|100|0|20|Vistor hf|Orion Corporation|Entakapón||12523||12523|17776 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2809|4652|lyfalmen|||00|28|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||2809||2809|4652 433300|N02AA0106|Contalgin Uno|forðahlk|60|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|5152|7832|lyfalmen|||00|28|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||5152||5152|7832 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|6889|10189|lyfalmen|||00|28|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||6889||6889|10189 433326|N02AA0106|Contalgin Uno|forðahlk|120|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|8625|12545|lyfalmen|||00|28|0|34|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||8625||8625|12545 433342|N02AA0106|Contalgin Uno|forðahlk|150|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|9937|14325|lyfalmen|||00|28|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||9937||9937|14325 433722|J01EE0104|Primazol sterkar|töflur|960|mg|10|stk|1|glas|160+800 mg|J01EE01|01.07.1989|31.07.2009|R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|486|1500|lyfalmen|||00|10|0|5|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||486||486|1500 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||99|10|0|0|Icepharma hf|Intervet International B.V.||||||1461 434670|D01AC2001|Daktacort|krem|0| |50|g|1|túpa||D01AC20|01.10.1988||R|K|3|0|0|0|0|JAS|0|0|1|100|SEK|1515|2896|lyfalmen|||20|50|0|50|Vistor hf|Janssen-Cilag AB|Blöndur||1515||1515|2896 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,7|0|0|B|0|ALK|0|0|1|100|DKK|6568|9753|lyfalmen|||00|1|0|1|Vistor hf|ALK-Abello A/S|Epínefrín (adrenalín)||6568||6568|9753 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,75|0|0|B|0|ALK|0|0|1|100|DKK|6568|9753|lyfalmen|||00|1|0|0|Vistor hf|ALK-Abello A/S|Epínefrín (adrenalín)||6568||6568|9753 434852|N06AB0302|Fontex|lausnart|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|100|XEU|11632|16626|lyfalmen|||00|100|0|100|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||11632||11632|16626 435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|þpakki||N02CC03|01.06.1999||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|6144|9178|lyfalmen|||00|6|0|12|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||6144||6144|9178 435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|þpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|4799|7353|lyfalmen|||00|6|0|6|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||4799||4799|7353 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|7581|9817|lyfalmen|V0725|8528|00|100|0|6|Vistor hf|AstraZeneca UK Ltd|Quetíapín||6615||6615|9817 435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2906|4784|lyfalmen|||00|250|0|42|Vistor hf|Recip AB|Ísósorbíð dínítrat||2906||2906|4784 436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|4215|6560|lyfalmen|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||4215||4215|6560 436030|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|98|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|11114|15923|lyfalmen|V0191|13945|00|98|0|98|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||11114||11114|15923 436071|N04BC0401|Requip|töflur|0,25|mg|210|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|6663|9882|lyfalmen|||00|210|0|9|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||6663||6663|9882 436139|N04BC0401|Requip|töflur|0,5|mg|21|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|1121|2362|lyfalmen|||00|21|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||1121||1121|2362 436147|M01AE0216|Naproxen-E Merck NM|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|A|5|0|0|0|0|MNA|0|0|1|100|IKR|||lyflausa|||10|20|0|10|Actavis Group PTC ehf|Merck NM AB|Naproxen||||| 436238|N04BC0401|Requip|töflur|1|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|7333|10792|lyfalmen|||00|84|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||7333||7333|10792 436279|N04BC0401|Requip|töflur|2|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|13296|18738|lyfalmen|V0728|18389|00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||13296||13296|18738 436295|N04BC0401|Requip|töflur|5|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|28263|37372|lyfalmen|||00|84|0|70|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||28263||28263|37372 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|839|1979|lyfalmen|||20|15|0|15|Vistor hf|LEO Pharma A/S|Fúsidínsýra||839||839|1979 436527|M01AE0216|Naproxen-E Merck NM|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|2032|3598|lyfalmen|||10|100|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||2032||2032|3598 436550|M01AE0211|Naproxen-E NM Pharma|sh-tfl|375|mg|20|stk|1|þpakki||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|814|1945|lyfalmen|||10|20|0|15|Actavis Group PTC ehf|Merck NM AB|Naproxen||814||814|1945 436626|M01AE0216|Naproxen-E Merck NM|sh-tfl|375|mg|100|stk|1|glas||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|3364|5405|lyfalmen|||10|100|0|75|Actavis Group PTC ehf|Merck NM AB|Naproxen||3364||3364|5405 436808|M01AE0216|Naproxen-E Merck NM|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|3847|6061|lyfalmen|||10|100|0|100|Actavis Group PTC ehf|Merck NM AB|Naproxen||3847||3847|6061 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|947|2126|lyfalmen|||00|100|0|12|Vistor hf|Janssen-Cilag AB|Halóperídól||947||947|2126 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|3320|5346|lyfalmen|||00|100|0|50|Vistor hf|Janssen-Cilag AB|Halóperídól||3320||3320|5346 438218|N06AX1602|Efexor Depot|forðahlk|75|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|13662|19194|lyfalmen|V0955|13473|00|100|0|75|Icepharma hf|Wyeth AB|Venlafaxín||13662||13662|19194 438333|N06AX1602|Efexor Depot|forðahlk|150|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|7346|10809|lyfalmen|V0957|6114|00|28|0|42|Icepharma hf|Wyeth AB|Venlafaxín||7346||7346|10809 438374|N07BC0201|Metadon|töflur|5|mg|20|stk|1|glas||N07BC02|01.01.1998||R|A||1|0|0|0|LDR|0|0|0|100|IKR|594|1646|lyfalmen|||00|20|1|4|Parlogis hf|Parlogis - óskráð lyf|||594||594|1646 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|0| |10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|1296|2599|lyfalmen|||00|10|0|0|K.Pétursson hf|Alcon|Hýdrókortisón og sýkingalyf||1296||1296|2599 438424|N06AX1602|Efexor Depot|forðahlk|75|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|3848|6062|lyfalmen|V0954|3888|00|28|0|21|Icepharma hf|Wyeth AB|Venlafaxín||3848||3848|6062 438432|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|13233|18660|lyfalmen|V0955|13204|00|98|0|74|Icepharma hf|Wyeth AB|Venlafaxín||13233||13233|18660 438457|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|25125|33466|lyfalmen|V0956|20953|00|98|0|147|Icepharma hf|Wyeth AB|Venlafaxín||25125||25125|33466 438465|N06AX1602|Efexor Depot|forðahlk|150|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|23162|31022|lyfalmen|V0956|21381|00|100|0|150|Icepharma hf|Wyeth AB|Venlafaxín||23162||23162|31022 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.1989||L|A|4|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Vistor hf|Schering-Plough|Lóratadín||||| 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|2221|3854|lyfalmen|||00|30|0|30|Vistor hf|Schering-Plough|Lóratadín||2221||2221|3854 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|6706|9941|lyfalmen|V0984|3662|00|100|0|100|Vistor hf|Schering-Plough|Lóratadín||6706||6706|9941 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|þpakki||J01DC02|01.10.1990||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|2527|4270|lyfalmen|||66|14|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2527||2527|4270 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|8861|12865|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýst­ings­­lækkandi lyf||8861||8861|12865 439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1066|2287|lyfalmen|||00|70|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1066||1066|2287 440677|J01CE0105|Penicillin Alpharma|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|1677|2401|lyfsjukr|||00|10|0|2|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1677||1677|2401 440693|J01CE0105|Penicillin Alpharma|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|2647|3790|lyfsjukr|||00|10|0|3|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2647||2647|3790 440933|M01AB0507|Vostar|eþ-stil|50|mg|10|stk|1|pakki||M01AB05|01.01.1990||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|548|1584|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis hf|Díklófenak||548||548|1584 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1638|3063|lyfalmen|V0221|2934|00|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Spírónólaktón||1638||1638|3063 441279|D01AC2002|Pevisone|krem|0| |30|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|1312|2621|lyfalmen|||20|30|0|30|Vistor hf|Janssen-Cilag AB|Blöndur||1312||1312|2621 441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|A|2|0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa|||00|59|0|0|Aco Hud Nordic AB|ACO Hud AB|Permetrín||||| 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|913|2079|lyfalmen|||00|30|0|30|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||913||913|2079 442152|J05AF0101|Retrovir|hylki|250|mg|40|stk|1|þpakki||J05AF01|01.07.1995||R|A|5|0|1|0|1|GSK|0|0|0|100|GBP|33457|43521|lyfsjukr|||61|40|0|17|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zídóvúdín||33457||33457|43521 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dæla|H04AA01|01.01.1989||R|K|3|0|0|*|0|NON|0|0|1|100|DKK|4151|6473|lyfalmen|||02|1|0|1|Vistor hf|Novo-Nordisk|Glúkagon||4151||4151|6473 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|35913|46897|lyfalmen|||10|90|0|180|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||35913||35913|46897 444240|J05AF0401|Zerit|hylki|30|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|51099|65486|lyfsjukr|||00|56|0|21|Vistor hf|Bristol-Myers Squibb|Stavúdín||51099||51099|65486 444299|J05AF0401|Zerit|hylki|40|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|51830|66396|lyfsjukr|||00|56|0|28|Vistor hf|Bristol-Myers Squibb|Stavúdín||51830||51830|66396 444315|N06AB0302|Fontex|lausnart|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|100|XEU|3540|5644|lyfalmen|V0914|2128|00|30|0|30|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3540||3540|5644 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3231|5225|lyfalmen|||00|100|0|8|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3231||3231|5225 444927|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|1|hgl||M05BA06|01.04.2006||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|20557|27461|lyfsjukr|||00|2|0|0|Icepharma hf|Roche|||20557||20557|27461 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|A|3|0|0|B|0|LEO|0|0|1|100|DKK|1907|3428|lyfalmen|||00|30|0|30|Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1907||1907|3428 445759|G04CB0101|Proscar|töflur|5|mg|98|stk|1|þpakki||G04CB01|01.04.1993||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|13866|6334|lyfalmen|V0411|5946|10|98|0|98|Icepharma hf|M.S.D.|Fínasteríð||4048||4048|6334 446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1637|3230|vetalmen|||27|50|0|0|Icepharma hf|Intervet International B.V.|||1637||1637|3230 446807|J02AC0101|Diflucan|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|4577|7052|lyfalmen|V0551|3202|10|7|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||4577||4577|7052 446930|J02AC0101|Diflucan|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|1950|3487|lyfalmen|V0554|1864|10|1|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||1950||1950|3487 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|12757|18067|lyfalmen|||00|4|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||12757||12757|18067 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|7277|10716|lyfalmen|||00|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||7277||7277|10716 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|8914|12937|lyfalmen|||00|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||8914||8914|12937 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|10703|15365|lyfalmen|||00|3|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||10703||10703|15365 447912|C08DB0107|Korzem|töflur|60|mg|100|stk|1|þpakki||C08DB01|01.01.1989||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|706|1798|lyfalmen|V0352|1798|00|100|0|25|Actavis Group hf|Actavis hf|Diltíazem||706||706|1798 448217|C05AA0801|Doloproct|eþ-stil|0| |10|stk|1|pakki||C05AA08|01.01.1991||R|A|4|0|0|E|0|IGB|0|0|0|100|SEK|578|1625|lyfalmen|||04|10|0|0|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||578||578|1625 448233|C05AA0801|Doloproct|eþ-krem|0| |30|g|1|túpa||C05AA08|01.01.1991||R|A|3|0|0|E|0|IGB|0|0|0|100|SEK|1130|2374|lyfalmen|||00|30|0|0|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1130||1130|2374 448498|R03DA0503|Aminophylline|stl|30|mg/ml|10|ml|10|lykjur||R03DA05|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|6496|9656|lyfalmen|||02|100|1|5|Parlogis hf|Parlogis - óskráð lyf|||6496||6496|9656 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2669|4462|lyfalmen|V0712|2690|00|50|0|25|Vistor hf|Novartis Healthcare A/S-|Baklófen||2669||2669|4462 449595|C07AB0310|Atenolol Merck NM|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|595|1648|lyfalmen|||00|98|0|65|Actavis Group PTC ehf|Merck NM AB|Atenólól||595||595|1648 449611|C07AB0310|Atenolol Merck NM|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1277|2573|lyfalmen|||00|98|0|131|Actavis Group PTC ehf|Merck NM AB|Atenólól||1277||1277|2573 449819|J01CE0105|Penicillin Alpharma|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|6277|8987|lyfsjukr|||00|10|0|8|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||6277||6277|8987 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|þp 875+125 mg|J01CR02|01.01.1997||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1115|2233|lyfalmen|V0466|2233|00|12|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1026||1026|2233 450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|1196|1786|lyfalmen|V0902|1633|00|20|0|20|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||697||697|1786 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|3770|5201|lyfalmen|V0903|4563|00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||3213||3213|5201 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|45479|58806|lyfalmen|||00|100|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||45479||45479|58806 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|68218|87116|lyfalmen|||00|150|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||68218||68218|87116 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|90958|115428|lyfalmen|||00|200|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||90958||90958|115428 451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|þpakki||N06AB04|01.11.1999||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|6481|8755|lyfalmen|||00|28|0|42|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5832||5832|8755 451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|21498|28003|lyfalmen|||00|100|0|150|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||20737||20737|28003 452268|J02AC0101|Diflucan|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|18784|25571|lyfalmen|V0552|10534|10|30|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||18784||18784|25571 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|A|3|0|0|E|0|ROA|0|0|1|100|DKK|1315|2625|lyfalmen|||00|5|0|5|Icepharma hf|Roche as|Ketórólak||1315||1315|2625 452300|J02AC0101|Diflucan|hylki|50|mg|100|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|62909|80507|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||62909||62909|80507 452482|V07AB09|Sterilt Vann B. Braun|leysir|0||100|ml|10|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0|Actavis Group hf|Braun|||||| 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|A|2|0|0|0|0|LAB|0|0|1|100|SEK|14147|19798|lyfalmen|||00|3000|0|3|Vistor hf|Laboratories 3M Santé|Imikvímóð||14147||14147|19798 452896|A06AD1701|Phosphoral|mixtúra|0| |45|ml|2|fl||A06AD17|01.03.1999||R|A|3|0|0|0|0|LCF|0|0|0|100|DKK|3422|5484|lyfalmen|||00|90|0|0|Vistor hf|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||3422||3422|5484 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2894|4768|lyfalmen|||10|28|0|4|Icepharma hf|Norpharma |Oxýcódon||2894||2894|4768 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|9524|13765|lyfalmen|||10|98|0|13|Icepharma hf|Norpharma |Oxýcódon||9524||9524|13765 452953|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|2832|4684|lyfalmen|||10|100|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Azatíóprín||2832||2832|4684 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|5466|8258|lyfalmen|||10|28|0|7|Icepharma hf|Norpharma |Oxýcódon||5466||5466|8258 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||L|A|3|0|0|0|0|MEF|0|0|0|100|XEU|||vetorma|||16|6|0|0|Vistor hf|Merial (MSD)||||||2888 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|17304|23728|lyfalmen|||10|98|0|26|Icepharma hf|Norpharma |Oxýcódon||17304||17304|23728 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|11010|15781|lyfalmen|||10|28|0|15|Icepharma hf|Norpharma |Oxýcódon||11010||11010|15781 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|27914|36938|lyfalmen|||10|98|0|52|Icepharma hf|Norpharma|Oxýcódon||27914||27914|36938 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|A|3|0|0|0|1|PFI|0|1|0|100|DKK|4088|5853|lyfsjukr|||02|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||4088||4088|5853 453795|J07AL0102|Pneumo 23|bóluefni|0| |0,5|ml|1|dæla||J07AL01|01.09.2003||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2602|4371|lyfalmen|||00|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||2602||2602|4371 454199|C10AA0101|Zocor|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.01.1991||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|11502|9075|lyfalmen|||00|98|0|65|Icepharma hf|M.S.D.|Simvastatín||6068||6068|9075 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|17406|23855|lyfalmen|||00|28|0|19|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||17406||17406|23855 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|49283|63542|lyfalmen|V0375|43136|00|98|0|65|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||49283||49283|63542 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|19638|26634|lyfalmen|||00|28|0|37|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||19638||19638|26634 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|54298|69786|lyfalmen|V0376|48147|00|98|0|131|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||54298||54298|69786 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|A|3|0|1|0|1|GSK|0|0|0|100|GBP|58639|74873|lyfsjukr|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Tópótecan||58639||58639|74873 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1239|2445|vetalmen|||16|100|0|0|Vistor hf|Boehringer Ingelheim Danmark|||1239||1239|2445 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BHC|0|0|0|100|SEK|932|2105|lyfalmen|||00|30|0|5|Vistor hf|Bayer HealthCare AG|Acarbósa||932||932|2105 455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BHC|0|0|0|100|SEK|3347|5382|lyfalmen|||00|120|0|20|Vistor hf|Bayer HealthCare AG|Acarbósa||3347||3347|5382 455428|B03XA0103|NeoRecormon|sts|10000|ae/rörly|1|ml|3|rörlyk|+leysir|B03XA01|01.02.2002|30.06.2009|R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|68777|87495|lyfsjukr|||00|3|0|30|Icepharma hf|Roche|Epóetín||68777||68777|87495 455527|B03XA0103|NeoRecormon|sts|20000|ae/rörly|1|ml|3|rörlyk|+leysir|B03XA01|01.02.2002|30.06.2009|R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|136749|172120|lyfsjukr|||00|3|0|60|Icepharma hf|Roche|Epóetín||136749||136749|172120 455576|B03XA0103|NeoRecormon|sts|100000|ae/hgl|5|ml|1|hgl|+leysir|B03XA01|01.02.2002|30.06.2009|R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|223750|280436|lyfsjukr|||00|5|0|10|Icepharma hf|Roche|Epóetín||223750||223750|280436 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|24836|33106|lyfalmen|||00|21|0|14|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||24836||24836|33106 455717|C05AD0102|Sulgan|eþ-smyr|0| |30|g|1|túpa||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|IKR|||lyflausa|||00|30|0|0|Icepharma hf|Doetsch Grether|Lídókaín||||| 455725|C05AD0102|Sulgan|eþ-stil|0| |10|stk|1|pakki||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|IKR|||lyflausa|||00|10|0|0|Icepharma hf|Doetsch Grether|Lídókaín||||| 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|1129|2372|lyfalmen|||00|10|0|10|Actavis Group hf|Actavis Group hf|Doxýcýklín||1129||1129|2372 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|1232|2512|lyfalmen|||0|15|0|15|Actavis Group hf|Actavis Group hf|Doxýcýklín||1232||1232|2512 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|2699|4503|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis Group hf|Doxýcýklín||2699||2699|4503 456079|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|6000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4477|6410|lyfsjukr|||00|12000|0|12|Icepharma hf|Baxter|||4477||4477|6410 456202|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|6000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4477|6410|lyfsjukr|||00|12000|0|12|Icepharma hf|Baxter|||4477||4477|6410 456277|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|5000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4887|6997|lyfsjukr|||00|10000|0|0|Icepharma hf|Baxter|||4887||4887|6997 456392|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|5000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4887|6997|lyfsjukr|||00|10000|0|0|Icepharma hf|Baxter|||4887||4887|6997 457002|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7317|10476|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||7317||7317|10476 457036|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7317|10476|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||7317||7317|10476 457069|B05DB0001|Dianeal PD1 Glucose|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7317|10476|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||7317||7317|10476 457119|B05DA0002|Dianeal PD1 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|9159|13113|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||9159||9159|13113 457242|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|8928|12783|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||8928||8928|12783 457291|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|11870|16646|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||11870||11870|16646 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|A|2|0|0|0|0|ARA|0|0|1|100|SEK|1075|2299|lyfalmen|||00|25|0|5|Vistor hf|Astra|Clómetíazól||1075||1075|2299 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|1633|3056|lyfalmen|||43|20|0|7|Vistor hf|LEO Pharma A/S|Pívmecillínam||1633||1633|3056 458356|J01CA0801|Selexid|töflur|200|mg|30|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|2374|4062|lyfalmen|||43|30|0|10|Vistor hf|LEO Pharma A/S|Pívmecillínam||2374||2374|4062 458422|J01CA0801|Selexid|töflur|200|mg|100|stk|1|þpakki||J01CA08|01.12.2007||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|9895|14268|lyfalmen|V0456|14268|00|100|0|33|Vistor hf|LEO Pharma A/S|Pívmecillínam||9895||9895|14268 458737|B05DA0003|Dianeal PD4 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|11964|16763|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||11964||11964|16763 458778|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|11964|16763|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||11964||11964|16763 458794|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|11964|16763|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||11964||11964|16763 459214|B05DB0004|Nutrineal PD4 1,1% Amino Acids Clear|kvið.sk|0| |2000|ml|5|pokar||B05DB00|01.06.2004||R|S|2|0|0|0|1|BAM|0|0|0|100|SEK|14234|19589|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||14234||14234|19589 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1611|2307|lyfsjukr|||02|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||1611||1611|2307 459412|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|5|lykjur||M05BA06|01.02.2002||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|96737|122305|lyfsjukr|||00|10|0|2|Icepharma hf|Roche|||96737||96737|122305 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1976|2829|lyfsjukr|||02|4|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||1976||1976|2829 459727|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2288|3945|lyfalmen|||06|15|0|75|Icepharma hf|Santen Oy|Tímólól||2288||2288|3945 459743|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2508|4244|lyfalmen|||06|15|0|75|Icepharma hf|Santen Oy|Tímólól||2508||2508|4244 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|2442|4154|lyfalmen|||00|30|0|8|Vistor hf|Meda AS|Tranexamsýra||2442||2442|4154 459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|4395|6805|lyfalmen|||00|60|0|15|Vistor hf|Meda AS|Tranexamsýra||4395||4395|6805 460071|J01CA0406|Flemoxin Solutab|lausnart|250|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1139|2386|lyfalmen|||23|20|0|5|Vistor hf|Astellas Pharma A/S|Amoxicillín||1139||1139|2386 460170|J07BC0202|Avaxim|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|4806|7362|lyfalmen|||51|0|0|0|Icepharma hf|Aventis Pasteur MSD A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4806||4806|7362 460196|J01CA0406|Flemoxin Solutab|lausnart|500|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1704|3153|lyfalmen|||23|20|0|10|Vistor hf|Astellas Pharma A/S|Amoxicillín||1704||1704|3153 460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|3099|5046|lyfalmen|||23|20|0|15|Vistor hf|Astellas Pharma A/S|Amoxicillín||3099||3099|5046 460618|L01AX0301|Temodal|hylki|5|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|20509|27401|lyfsjukr|||00|20|0|0|Vistor hf|Schering-Plough|Temozolomid||20509||20509|27401 460782|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.10.1992||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyflausa|||23|120|0|120|Vistor hf|Janssen-Cilag AB|Ketókónazól||||| 460972|J07BB0205|Influvac|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|6875|10170|lyfalmen|||51|5|0|0|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsaðir mótefnavakar||6875||6875|10170 461178|L01AX0301|Temodal|hylki|20|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|82031|103996|lyfsjukr|||00|20|0|0|Vistor hf|Schering-Plough|Temozolomid||82031||82031|103996 461335|L01AX0301|Temodal|hylki|100|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|81016|102732|lyfsjukr|||00|5|0|0|Vistor hf|Schering-Plough|Temozolomid||81016||81016|102732 461467|L01AX0301|Temodal|hylki|250|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|201164|252317|lyfsjukr|||00|5|0|0|Vistor hf|Schering-Plough|Temozolomid||201164||201164|252317 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|193|1102|lyfalmen|||00|10|0|2|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||193||193|1102 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|735|1838|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||735||735|1838 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|735|1838|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||735||735|1838 462358|A07EA0601|Entocort|innhl|20|mcg/ml|7|stk|1|pakki|samsett pk|A07EA06|01.04.1993||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7860|11507|lyfalmen|||56|7|0|7|Vistor hf|AstraZeneca A/S DK|Búdesóníð||7860||7860|11507 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|K|3|0|0|0|0|PAL|1|0|0|100|DKK|7594|14637|vetalmen|||02|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||7594||7594|14637 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|6058|11711|vetalmen|||00|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||6058||6058|11711 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|30|0|5|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|A|5|0|0|*|0|OVA|0|1|0|100|DKK|2005|3561|lyfalmen|||00|100|0|8|Swedish Orphan International AB|Ovation Healthcare International Ltd.|Melperón||2005||2005|3561 465203|QJ01RA0103|Depomycine, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.12.1982||R|K|2|0|0|0|0|INI|0|0|0|100|DKK|1346|2656|vetalmen|||58|100|0|0|Icepharma hf|Intervet International B.V.|||1346||1346|2656 465237|QJ01CR5001|Duplocillin L.A., vet.|stl|0| |100|ml|1|hgl||QJ01CR50|01.05.1983||R|S|3|0|0|0|0|INI|1|0|0|100|DKK|1271|2508|vetalmen|||58|100|0|0|Icepharma hf|Intervet International B.V.|||1271||1271|2508 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1362|2688|vetalmen|||27|100|0|0|Icepharma hf|Intervet International B.V.|||1362||1362|2688 465278|QJ51RC2301|Nafpenzal DC, vet.|spenalyf|0| |3|g|4|spr||QJ51RC23|01.04.1985||R|A|3|0|0|0|0|INI|0|0|0|100|XEU|717|1415|vetalmen|||16|12|0|0|Icepharma hf|Intervet International B.V.|||717||717|1415 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|850|1994|lyfalmen|||10|25|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||850||850|1994 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2982|4887|lyfalmen|||10|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||2982||2982|4887 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1808|3294|lyfalmen|||10|25|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||1808||1808|3294 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|7257|10688|lyfalmen|||10|100|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||7257||7257|10688 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|3477|5559|lyfalmen|||10|25|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||3477||3477|5559 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|8967|13009|lyfalmen|||10|50|0|5|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||8967||8967|13009 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|5565|8392|lyfalmen|||10|25|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||5565||5565|8392 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|5282|8008|lyfalmen|||64|100|0|50|Vistor hf|Meda AS|Móklóbemíð||5282||5282|8008 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|17972|24243|lyfsjukr|||00|0|0|1|Vistor hf|Amgen Europe B.V.|Fílgrastím||17972||17972|24243 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|28168|36937|lyfsjukr|||00|0|0|1|Vistor hf|Amgen Europe B.V.|Fílgrastím||28168||28168|36937 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|30499|39839|lyfsjukr|||00|1|0|9|Vistor hf|Schering-Plough|Interferón alfa-2b||30499||30499|39839 467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|49678|63717|lyfsjukr|||00|1|0|15|Vistor hf|Schering-Plough|Interferón alfa-2b||49678||49678|63717 467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|A|2|0|1|*|0|WTE|0|0|0|100|USD|40383|52462|lyfalmen|||00|60|0|20|Icepharma hf|Wyeth Europe|Sirolimus||40383||40383|52462 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|17493|23964|lyfalmen|||10|50|0|10|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||17493||17493|23964 467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|101689|128470|lyfsjukr|||00|1|0|30|Vistor hf|Schering-Plough|Interferón alfa-2b||101689||101689|128470 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|33308|43653|lyfalmen|||10|50|0|20|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||33308||33308|43653 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|A|5|0|0|0|1|JAS|0|1|0|100|SEK|765|1095|lyfsjukr|||00|5|0|3|Vistor hf|Janssen-Cilag AB|Halóperídól||765||765|1095 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|7259|7225|lyfalmen|V0922|4508|00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4705||4705|7225 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|446|639|lyfsjukr|||02|10|0|0|Vistor hf|Janssen-Cilag AB|Fentanýl||446||446|639 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|10570|6872|lyfalmen|V0926|4309|00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4445||4445|6872 468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|26707|14099|lyfalmen|V0930|8459|00|100|0|200|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||9770||9770|14099 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11513|16464|lyfalmen|||00|98|0|49|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gemfíbrózíl||11513||11513|16464 469742|N02AX0206|Nobligan Retard|forðatfl|200|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|3288|5302|lyfalmen|||00|20|0|13|Icepharma hf|Grunenthal|Tramadól||3288||3288|5302 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|13400|18868|lyfalmen|V0738|15020|00|100|0|67|Icepharma hf|Grunenthal|Tramadól||13400||13400|18868 469866|N02AX0206|Nobligan Retard|forðatfl|150|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|2571|4329|lyfalmen|||00|20|0|10|Icepharma hf|Grunenthal|Tramadól||2571||2571|4329 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|10175|14648|lyfalmen|V0736|11610|00|100|0|50|Icepharma hf|Grunenthal|Tramadól||10175||10175|14648 469890|N02AX0206|Nobligan Retard|forðatfl|100|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1747|3211|lyfalmen|V0733|2633|00|20|0|7|Icepharma hf|Grunenthal|Tramadól||1747||1747|3211 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|6950|10272|lyfalmen|V0734|7858|00|100|0|33|Icepharma hf|Grunenthal|Tramadól||6950||6950|10272 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|5932|8890|lyfalmen|||24|120|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5932||5932|8890 470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6223|8910|lyfsjukr|||02|150|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||6223||6223|8910 471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|7625|10917|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||7625||7625|10917 471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6396|9157|lyfsjukr|||02|100|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||6396||6396|9157 471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|9018|12912|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||9018||9018|12912 471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|9600|13745|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||9600||9600|13745 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|2255|3901|lyfalmen|||68|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Glípízíð||2255||2255|3901 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||99|20|0|0|Icepharma hf|Intervet International B.V.||||||2648 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.01.1988||R|A|3|0|0|*|0|BAM|0|0|0|100|SEK|2351|4031|lyfalmen|||00|100|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||2351||2351|4031 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|A|3|0|0|0|0|ORC|1|0|0|100|DKK|5393|10444|vetalmen|||27|10|0|0|Vistor hf|Orion Corporation|||5393||5393|10444 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2262|3910|lyfalmen|V2003|3849|43|98|0|31|Vistor hf|AstraZeneca A/S DK|Metóprólól||2262||2262|3910 472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2747|4568|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||2747||2747|4568 473348|A03AA0402|Spasmerin|töflur|135|mg|50|stk|1|glas||A03AA04|01.07.1990|31.07.2009|R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|957|2139|lyfalmen|||00|50|0|22|Actavis Group hf|Actavis hf|Mebeverín||957||957|2139 473371|A03AA0402|Spasmerin|töflur|135|mg|100|stk|1|glas||A03AA04|01.07.1990|31.07.2009|R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|1680|3120|lyfalmen|||00|100|0|45|Actavis Group hf|Actavis hf|Mebeverín||1680||1680|3120 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|14188|19532|lyfsjukr|||00|400|0|0|Vistor hf|Meda AB|Dextran||14188||14188|19532 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|50|0|0|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen||||| 474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|1018|2222|lyfalmen|||00|30|0|15|Vistor hf|Recip AB|Ergotamínlyf í blöndum með geðlyfjum (psycoleptica)||1018||1018|2222 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|15|0|0|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen||||| 474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|þpakki||J05AG01|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|47196|60627|lyfsjukr|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |Nevírapín||47196||47196|60627 474551|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.05.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|2097|3686|lyfalmen|||00|140|0|35|Vistor hf|Schering-Plough|Mómetasón||2097||2097|3686 475327|N02BE0113|Pinex Junior|eþ-stil|250|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|1|Actavis Group hf|Actavis Group hf|Paracetamól||||| 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|720|1817|lyfalmen|||00|100|0|27|Actavis Group hf|Actavis hf|Warfarín||720||720|1817 475467|G03CA0306|Evorel|forðapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4140|6459|lyfalmen|||23|26|0|91|Vistor hf|Janssen-Cilag AB|Estradíól||4140||4140|6459 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|229|1151|lyfalmen|V0775|1151|00|20|0|7|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||229||229|1151 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|318|1272|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||318||318|1272 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|1|0|0|0|ACA|0|0|1|100|NOK|890|2048|lyfalmen|V0780|2048|00|100|0|33|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||890||890|2048 475756|C09AA0801|Inhibace|töflur|2,5|mg|98|stk|1|þpakki||C09AA08|01.07.1991||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|7065|10428|lyfalmen|||00|98|0|98|Icepharma hf|Roche|Cílazapríl||7065||7065|10428 475798|R03AC1302|Oxis Turbuhaler|innúðadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|3385|5434|lyfalmen|||00|60|0|11|Vistor hf|AstraZeneca A/S DK|Formóteról||3385||3385|5434 475822|R03AC1302|Oxis Turbuhaler|innúðadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|4528|6985|lyfalmen|||00|60|0|22|Vistor hf|AstraZeneca A/S DK|Formóteról||4528||4528|6985 475889|C09AA0801|Inhibace|töflur|5|mg|98|stk|1|þpakki||C09AA08|01.07.1991||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|8375|12206|lyfalmen|||00|98|0|196|Icepharma hf|Roche|Cílazapríl||8375||8375|12206 475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6315|9410|lyfalmen|||00|15|0|38|Icepharma hf|Eli Lilly Nederland -|Insúlín lispró||6315||6315|9410 476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|K|2|0|0|*|0|ELI|0|0|0|100|XEU|5362|8117|lyfalmen|||51|15|0|38|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5362||5362|8117 476580|R03AC0206|Ventoline|lausn|2|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1268|2561|lyfalmen|||00|50|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1268||1268|2561 476648|N05AH0401|Seroquel|töflur|100|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|6905|10211|lyfalmen|||00|30|0|8|Vistor hf|AstraZeneca UK Ltd|Quetíapín||6905||6905|10211 476655|N05AH0401|Seroquel|töflur|200|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|10493|15080|lyfalmen|||00|30|0|15|Vistor hf|AstraZeneca UK Ltd|Quetíapín||10493||10493|15080 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|4976|7593|lyfalmen|||00|12|0|3|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||4976||4976|7593 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Icepharma hf|Fresenius Kabi|||||| 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|500|0|0|Icepharma hf|Fresenius Kabi|||||| 477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0|Icepharma hf|Fresenius Kabi|||||| 477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|500|0|0|Icepharma hf|Fresenius Kabi|||||| 477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|1000|0|0|Icepharma hf|Fresenius Kabi|||||| 479691|C09AA0701|Cibacen|töflur|10|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|B|0|MAS|0|0|0|100|SEK|10131|14589|lyfalmen|||00|98|0|131|Vistor hf|Meda AS|Benazepríl||10131||10131|14589 479717|C09AA0701|Cibacen|töflur|20|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|B|0|MAS|0|0|0|100|SEK|21735|29245|lyfalmen|||00|98|0|261|Vistor hf|Meda AS|Benazepríl||21735||21735|29245 480863|G03XC0101|Evista|töflur|60|mg|28|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|4688|7202|lyfalmen|||00|28|0|28|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||4688||4688|7202 480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|12137|17296|lyfalmen|||00|84|0|84|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||12137||12137|17296 481168|N06AX1201|Zyban|forðatfl|150|mg|60|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|8333|12149|lyfalmen|||00|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||||8333|12149 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|12860|18196|lyfalmen|||00|100|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||12860||12860|18196 481598|M03AX0102|Dysport|sts|500|ein|1|hgl|1|pakki||M03AX01|01.05.2003||R|K|2|0|1|0|1|INP|0|0|0|100|XEU|44860|57718|lyfsjukr|||02|1|0|0|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Clostridium botulinum toxín-A||44860||44860|57718 483552|J02AC0101|Diflucan|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.08.2000||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|70312|89723|lyfalmen|V0557|33109|10|28|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||70312||70312|89723 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|4076|5836|lyfsjukr|||00|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||4076||4076|5836 483636|N07BA0103|Nicorette|tungur.t|2|mg|30|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 483644|N07BA0103|Nicorette|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|5643|8079|lyfsjukr|||00|100|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||5643||5643|8079 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|93216|117921|lyfsjukr|||00|3|0|84|Vistor hf|Ferring|Triptórelín||93216||93216|117921 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|6720|9960|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|Fínasteríð||6720||6720|9960 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|A|3|0|0|E|0|MEB|0|0|1|100|SEK|1337|2655|lyfalmen|||00|300|0|0|Vistor hf|Meda AB (V)|Benzýdamín||1337||1337|2655 486779|M01AE0215|Naproxen Merck NM|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|A|4|0|0|0|0|MNA|0|0|1|100|IKR|||lyflausa|||00|20|0|10|Actavis Group PTC ehf|Merck NM AB|Naproxen||||| 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|718|1815|lyfalmen|||29|5|0|0|K.Pétursson hf|Alcon|Dexametasón||718||718|1815 486886|S01CA0101|Maxitrol|augndr|0| |5|ml|1|glas||S01CA01|01.07.1990||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|706|1798|lyfalmen|||29|5|0|0|K.Pétursson hf|Alcon|Dexametasón||706||706|1798 487264|C09AA0401|Coversyl|töflur|2|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|2819|4666|lyfalmen|||00|30|0|15|Icepharma hf|Servier|Perindópríl||2819||2819|4666 487280|C09AA0401|Coversyl|töflur|4|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|4114|6423|lyfalmen|||00|30|0|30|Icepharma hf|Servier|Perindópríl||4114||4114|6423 487900|J01XE0101|Furadantin|töflur|50|mg|25|stk|1|þpakki||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|810|1940|lyfalmen|||00|25|0|6|Vistor hf|Recip AB|Nítrófúrantóín||810||810|1940 487959|N02BE0113|Pinex Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0|Actavis Group hf|Actavis Group hf|Paracetamól||||| 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|872|2024|lyfalmen|||00|20|0|10|Vistor hf|Meda AB|Nabúmeton||872||872|2024 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|2595|4362|lyfalmen|||00|60|0|30|Vistor hf|Meda AB|Nabúmeton||2595||2595|4362 488114|N02BE0114|Pinex|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|2|Actavis Group hf|Actavis Group hf|Paracetamól||||| 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ACA|0|0|0|100|DKK|11028|15806|lyfalmen|||67|50|0|14|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||11028||11028|15806 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ACA|0|0|0|100|DKK|19907|26969|lyfalmen|||67|50|0|36|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||19907||19907|26969 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|338|1101|lyfalmen|||67|10|0|5|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1101 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|960|1474|lyfalmen|V0609|1424|67|30|0|15|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1474 490417|G03FB0504|Evorel Sequi|forðapl|0| |8|stk|1|pakki||G03FB05|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2439|4150|lyfalmen|||23|8|0|28|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2439||2439|4150 490425|G03FA0104|Evorel Conti|forðapl|0| |8|stk|1|pakki||G03FA01|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2718|4529|lyfalmen|||23|8|0|28|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2718||2718|4529 490557|A04AA0201|Kytril|stl|1|mg/ml|1|ml|5|lykjur||A04AA02|01.10.1999||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|9716|14025|lyfalmen|||00|5|0|2|Icepharma hf|Roche as|Granisetrón||9716||9716|14025 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|5345|8094|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||5345||5345|8094 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12262|11630|lyfalmen|V0337|6756|00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||7951||7951|11630 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|8296|12098|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||8296||8296|12098 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|17402|15859|lyfalmen|V0338|9234|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||11067||11067|15859 490839|C10AA0501|Zarator|töflur|40|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12877|18217|lyfalmen|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||12877||12877|18217 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|22132|19566|lyfalmen|V0339|11516|00|100|0|200|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||13961||13961|19566 491639|N06DA0301|Exelon|mixtúra|2|mg/ml|120|ml|1|fl||N06DA03|01.05.2003||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|24967|33269|lyfalmen|||00|120|0|27|Vistor hf|Novartis Europharm Ltd|Rívastigmín||24967||24967|33269 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|K|1|0|1|0|1|ORG|0|0|0|100|DKK|54825|70125|lyfsjukr|||00|3|0|21|Vistor hf|N.V. Organon|BCG bóluefni||54825||54825|70125 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|hylki|100+25 mg|N04BA02|01.01.1991||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3844|6057|lyfalmen|||10|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3844||3844|6057 492520|A02BC0105|Losec MUPS|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|11522|16476|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca A/S DK|Ómeprazól||11522||11522|16476 492546|A02BC0102 |Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|A|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|14|0|7|Vistor hf|AstraZeneca A/S DK|Ómeprazól||||| 492587|N06AX0303|Mianserin NM Pharma|töflur|10|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|1434|2786|lyfalmen|V1140|2583|00|100|0|17|Actavis Group PTC ehf|Merck NM AB|Míanserín||1434||1434|2786 493148|C10AA0302|Pravachol|töflur|20|mg|28|stk|1|þpakki||C10AA03|01.07.1989||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|4851|7423|lyfalmen|||00|28|0|19|Vistor hf|Bristol-Myers Squibb|Pravastatín||4851||4851|7423 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|A|5|0|0|B|0|SNO|0|1|0|100|NOK|1629|3051|lyfalmen|||00|100|0|17|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1629||1629|3051 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|4448|6877|lyfalmen|||00|100|0|33|Vistor hf|Novartis Healthcare A/S-|Pízótífen||4448||4448|6877 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|96166|121594|lyfsjukr|||00|20|0|0|Icepharma hf|Roche Registration Limited|Rítúxímab||96166||96166|121594 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|240415|301184|lyfsjukr|||00|50|0|0|Icepharma hf|Roche Registration Limited|Rítúxímab||240415||240415|301184 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburður, fleyti|D10AF01|01.10.1995||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2569|4327|lyfalmen|||00|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2569||2569|4327 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2931|4818|lyfalmen|V0408|1896|23|84|0|84|Vistor hf|Novo-Nordisk|Estradíól||2931||2931|4818 494724|G03FA0102|Kliogest|töflur|0| |84|stk|1|skífup||G03FA01|01.10.1986||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|3718|5886|lyfalmen|V0388|4484|23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3718||3718|5886 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|2489|4218|lyfalmen|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||2489||2489|4218 495259|A02BA0205|Zantac|freyðit|150|mg|15|stk|2|stauk|2 x 15 stk.|A02BA02|01.04.1990||L|A|2|0|0|0|0|GSK|0|0|0|100|IKR|||lyfalmen|||14|30|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín|||||4097 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|20420|27608|lyfalmen|||00|15|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||20420||20420|27608 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7942|11618|lyfalmen|V1088|7729|02|10|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||7942||7942|11618 495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|11347|16239|lyfalmen|V1089|12111|02|20|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||11347||11347|16239 495572|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.04.2002|30.06.2009|R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|18457|25164|lyfalmen|||00|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||18457||18457|25164 495580|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.04.2002|30.06.2009|R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|31112|40919|lyfalmen|||00|100|0|44|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||31112||31112|40919 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|3116|5069|lyfalmen|||00|20|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||3116||3116|5069 496174|QJ01M0001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4785|9286|vetalmen|||0|10|0|0|Vistor hf|Bayer Animal Health GmbH|||||4785|9286 496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|4501|6948|lyfalmen|||02|100|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||4501||4501|6948 496554|C07AG0101|Trandate|töflur|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|1136|2382|lyfalmen|||00|50|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||1136||1136|2382 496752|C07AG0101|Trandate|töflur|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|3566|5680|lyfalmen|||00|100|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||3566||3566|5680 496935|N02AG0201|Ketogan|eþ-stil|0| |10|stk|1|pakki||N02AG02|01.07.1994||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|632|1698|lyfalmen|||04|10|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||632||632|1698 496950|N02AG0201|Ketogan|töflur|0| |20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|960|2143|lyfalmen|||00|20|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||960||960|2143 497099|N02AG0201|Ketogan|töflur|0| |100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|3655|5800|lyfalmen|||00|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3655||3655|5800 497263|N06BA0103|Amfetamin Actavis|töflur|5|mg|30|stk|1|glas||N06BA01|01.07.1991||R|A|3|1|0|0|0|ACA|0|0|0|100|IKR|1036|2246|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|Amfetamín||1036||1036|2246 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|419|1409|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|Enalapríl||419||419|1409 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|802|1929|lyfalmen|V0167|1929|00|100|0|50|Actavis Group hf|Actavis hf|Enalapríl||802||802|1929 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2725|4538|lyfalmen|V0169|4538|00|100|0|200|Actavis Group hf|Actavis hf|Enalapríl||2725||2725|4538 497511|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.12.1983||L|A|3|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|250|0|250|Icepharma hf|Bioglan AB|Klórhexidín||||| 497818|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3|0|0|B|0|BIG|0|0|1|100|SEK|806|1934|lyfalmen|||20|30|0|30|Icepharma hf|Bioglan AB|Flúócínólón||806||806|1934 498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1541|2932|lyfalmen|||03|2|0|35|Vistor hf|Schering-Plough|Betametasón||1541||1541|2932 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|20738|28004|lyfalmen|||00|56|0|14|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||20738||20738|28004 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|20483|27686|lyfalmen|||00|56|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||20483||20483|27686 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|30251|39847|lyfalmen|||00|56|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||30251||30251|39847 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|30824|40561|lyfalmen|||00|56|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||30824||30824|40561 500314|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3,5|0|0|B|0|BIG|0|0|1|100|SEK|806|1934|lyfalmen|||20|30|0|30|Icepharma hf|Bioglan AB|Flúócínólón||806||806|1934 501734|M01AB0508|Vostar-R|forðatfl|75|mg|100|stk|1|glas||M01AB05|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|3199|5182|lyfalmen|||67|100|0|75|Actavis Group hf|Actavis hf|Díklófenak||3199||3199|5182 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|4012|6285|lyfalmen|||10|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4012||4012|6285 502187|D07AB0201|Locoid|lausn|1|mg/ml|100|ml|1|glas||D07AB02|01.03.1977||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2385|4077|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2385||2385|4077 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|þpakki||N06AA21|01.06.1977||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|3379|5426|lyfalmen|||00|100|0|25|Vistor hf|Amdipharm Ltd|Maprótilín||3379||3379|5426 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|34973|45409|lyfsjukr|||00|1|0|28|Vistor hf|Ferring|Triptórelín||34973||34973|45409 503961|D07AC0301|Ibaril|krem|2,5|mg/g|50|g|1|túpa||D07AC03|01.10.1976||R|A|5|0|0|B|0|SNO|0|0|1|100|NOK|2270|3921|lyfalmen|||20|50|0|50|Vistor hf|Sanofi-aventis Norge AS|Desoxímetasón||2270||2270|3921 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.01.1988||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|2516|4255|lyfalmen|||00|90|0|45|Vistor hf|N.V. Organon|Estríól||2516||2516|4255 504746|R06AB0201|Polaramin|forðatfl|6|mg|50|stk|1|þpakki||R06AB02|01.01.1977|31.05.2009|R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1324|2637|lyfalmen|||10|50|0|50|Vistor hf|Schering-Plough|Dexklórfeníramín||1324||1324|2637 504753|R06AB0201|Polaramin|töflur|2|mg|50|stk|1|pakki|þp|R06AB02|01.06.2007|31.05.2009|R|A|5|0|0|E|0|SCP|0|0|0|100|DKK|617|1678|lyfalmen|||00|50|0|0|Vistor hf|Schering-Plough|Dexklórfeníramín||617||617|1678 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|A|5|0|0|0|0|ROC|0|0|1|100|DKK|1446|2803|lyfalmen|||00|100|0|30|Icepharma hf|Roche|Brómazepam||1446||1446|2803 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|þpakki||N06AA21|01.05.1978||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|9297|13457|lyfalmen|||00|100|0|75|Vistor hf|Amdipharm Ltd|Maprótilín||9297||9297|13457 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|3742|5358|lyfsjukr|||02|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxórúbicín||3742||3742|5358 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|7284|10429|lyfsjukr|||02|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxórúbicín||7284||7284|10429 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|11232|15851|lyfsjukr|||02|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxórúbicín||11232||11232|15851 506774|J01GB0301|Garamycin|stl|10|mg/ml|2|ml|10|lykjur||J01GB03|01.11.1977||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|3538|5066|lyfsjukr|||02|20|0|1|Vistor hf|Schering-Plough|Gentamícín||3538||3538|5066 506949|N01AB0601|Forene|innönd.l|0| |250|ml|1|stauk||N01AB06|01.10.1993||R|A|5|0|0|0|1|ABS|0|0|0|100|DKK|32801|42705|lyfsjukr|||00|250|0|0|Vistor hf|Abbott Scandinavia AB|Ísóflúran||32801||32801|42705 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|2773|4603|lyfalmen|||10|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxepín||2773||2773|4603 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|þpakki||A06AB02|01.12.1975||L|A|3|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||10|25|0|12|Vistor hf|Orion Pharma|Bisakódýl||||| 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|þpakki||A06AB02|01.12.1975||R|A|3|0|0|0|0|ERC|0|0|0|100|DKK|453|1455|lyfalmen|||10|100|0|50|Vistor hf|Orion Pharma|Bisakódýl||453||453|1455 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|24|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||1291 507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|120|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||5489 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|10293|17813|vetorma|||13|1000|0|0|Icepharma hf|Intervet International B.V.|||10293||10293|17813 507582|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|50|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.06.1999||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|2847|5594|vetalmen|||27|50|0|0|Vistor hf|Intervet International BV|||2847||2847|5594 508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|2895|4769|lyfalmen|||10|98|0|98|Vistor hf|Abbott Scandinavia AB|Verapamíl||2895||2895|4769 508671|QJ01M0001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|5786|11193|vetalmen|||0|100|0|0|Vistor hf|Bayer Animal Health GmbH|||||5786|11193 508689|QJ01M0001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4640|9010|vetalmen|||0|50|0|0|Vistor hf|Bayer Animal Health GmbH|||4640||4640|9010 508705|QJ01M0001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|14356|27517|vetalmen|||0|100|0|0|Vistor hf|Bayer Animal Health GmbH|||14356||14356|27517 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|A|3|0|0|*|0|LBK|0|1|0|100|DKK|11301|16176|lyfalmen|||02|10|0|133|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||11301||11301|16176 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||00|15|0|75|Vistor hf|N.V. Organon|Estríól|||||2909 509448|D10AE0102|Panoxyl|hlaup|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|465|1471|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||465||465|1471 509455|D10AE0102|Panoxyl|hlaup|100|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|524|1551|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||524||524|1551 509463|D10AE0102|Panoxyl|áburður|50|mg/ml|30|ml|1|fl||D10AE01|01.12.1982||R|A|3|0|0|0|0|STI|0|0|0|100|XEU|384|1361|lyfalmen|||23|30|0|30|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||384||384|1361 509471|D10AE0102|Panoxyl|krem|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|465|1471|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||465||465|1471 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|52816|67623|lyfsjukr|||00|60|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Zídóvúdín og lamívúdín||52816||52816|67623 510248|B03XA0103|NeoRecormon|stl|1000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|14880|20393|lyfsjukr|||00|2|0|6|Icepharma hf|Roche|Epóetín||14880||14880|20393 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|27071|35571|lyfsjukr|||00|2|0|12|Icepharma hf|Roche|Epóetín||27071||27071|35571 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|34742|45121|lyfsjukr|||00|2|0|18|Icepharma hf|Roche|Epóetín||34742||34742|45121 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|56997|72829|lyfsjukr|||00|2|0|30|Icepharma hf|Roche|Epóetín||56997||56997|72829 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|110440|139365|lyfsjukr|||00|4|0|60|Icepharma hf|Roche|Epóetín||110440||110440|139365 510321|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|278304|348356|lyfsjukr|||00|4|0|120|Icepharma hf|Roche|Epóetín||278304||278304|348356 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|4717|5946|lyfalmen|V0411|5946|00|98|0|98|Actavis Group hf|Actavis hf|Fínasteríð||3762||3762|5946 511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|þpakki||C09CA07|01.03.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|3228|5221|lyfalmen|||00|28|0|14|Vistor hf|Boehringer Ingelheim International |||3228||3228|5221 511303|G03FB0501|Trisekvens|töflur|0| |84|stk|1|skífup||G03FB05|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|3048|4977|lyfalmen|V0385|4875|23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3048||3048|4977 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|21343|28440|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||21343||21343|28440 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|13352|18491|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||13352||13352|18491 512608|B05XA3101|Peditrace|irþ|0| |10|ml|10|hgl||B05XA31|01.07.1993||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|10767|15272|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||10767||10767|15272 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|A|5|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|35|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||||| 514265|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|2004|3560|lyfalmen|||23|200|0|25|Vistor hf|AstraZeneca A/S DK|Terbútalín||2004||2004|3560 515031|N06AX1801|Edronax|töflur|4|mg|20|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|2377|4066|lyfalmen|||00|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2377||2377|4066 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|5002|7628|lyfalmen|||00|60|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5002||5002|7628 516476|A02BC0105|Losec MUPS|sh-tfl|10|mg|14|stk|1|glas||A02BC01|01.01.1999||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|1843|3341|lyfalmen|||00|14|0|7|Vistor hf|AstraZeneca A/S DK|Ómeprazól||1843||1843|3341 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|4464|6898|lyfalmen|||00|90|0|11|Vistor hf|Novo-Nordisk|Repaglíníð||4464||4464|6898 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|5239|7950|lyfalmen|||00|90|0|22|Vistor hf|Novo-Nordisk|Repaglíníð||5239||5239|7950 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|6444|9585|lyfalmen|||00|90|0|45|Vistor hf|Novo-Nordisk|Repaglíníð||6444||6444|9585 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|1039|2250|lyfalmen|||00|20|0|15|Actavis Group hf|Actavis Group hf|Díklófenak||1039||1039|2250 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|4940|7544|lyfalmen|||00|100|0|75|Actavis Group hf|Actavis Group hf|Díklófenak||4940||4940|7544 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2360|4043|lyfalmen|||23|84|0|84|Vistor hf|N.V. Organon|Desógestrel||2360||2360|4043 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1011|2212|lyfalmen|||08|125|0|3|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1011||1011|2212 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|9368|13553|lyfalmen|||02|2|0|6|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||9368||9368|13553 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5450|8236|lyfalmen|||00|4|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||5450||5450|8236 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|6154|9192|lyfalmen|||00|4|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||6154||6154|9192 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|17341|23775|lyfalmen|||00|12|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||17341||17341|23775 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|6600|9797|lyfalmen|V1300|9391|00|4|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||6600||6600|9797 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|18263|24922|lyfalmen|||00|12|0|24|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||18263||18263|24922 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1623|3043|lyfalmen|V0308|3043|00|100|0|100|Actavis Group hf|Actavis hf|Amlódipín||1623||1623|3043 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2644|4428|lyfalmen|V0310|4428|00|100|0|200|Actavis Group hf|Actavis hf|Amlódipín||2644||2644|4428 520759|M03BC5101|Norgesic|töflur|0| |30|stk|1|þpakki||M03BC51|01.03.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|408|1394|lyfalmen|||00|30|0|9|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||408||408|1394 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|36300|47378|lyfalmen|||00|100|0|28|Vistor hf|Boehringer Ingelheim International|Pramipexól||36300||36300|47378 521757|L01XX0501|Hydrea|hylki|500|mg|100|stk|1|glas||L01XX05|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|8676|12422|lyfsjukr|||00|100|1|0|Distica|Distica - óskráð lyf|||8676||8676|12422 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|0| |8|g|40|spr||QJ51RC23|01.12.1982||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|9045|17401|vetalmen|||16|320|0|0|Vistor hf|Boehringer Ingelheim Danmark|||9045||9045|17401 522599|J07CA0202|Tetravac|bóluefni|0| |0,5|ml|1|spr|einnota dæla|J07CA02|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|3761|5944|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mænusótt, stífkrampi||3761||3761|5944 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|K|1,5|0|1|0|1|NOE|0|0|0|100|DKK|300764|376319|lyfsjukr|||00|1|0|0|Vistor hf|Novartis Europharm Ltd|Basiliximab||300764||300764|376319 522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|446|1446|lyfalmen|||00|20|0|3|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||446||446|1446 522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|1841|3339|lyfalmen|||00|100|0|17|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||1841||1841|3339 522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|11024|15800|lyfalmen|||00|250|0|208|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||11024||11024|15800 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|975|2163|lyfalmen|V0732|2163|02|10|0|2|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||975||975|2163 522839|D05AX0201|Daivonex|lausn|50|mcg/ml|120|ml|1|glas|í hársvörð|D05AX02|01.12.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|10062|14495|lyfalmen|||00|120|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól||10062||10062|14495 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|407|1393|lyfalmen|||00|40|0|13|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||407||407|1393 523274|S01XA2008|Artelac|augndr|0| |10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|A|3|0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen|||00|10|0|0|Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar sam­setningar|||||1253 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|1240|2523|lyfalmen|||00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1240||1240|2523 523886|L02BB0101|Eulexin|töflur|250|mg|84|stk|1|þpakki||L02BB01|01.01.1993||R|A|5|0|0|*|0|SCP|0|0|0|100|DKK|27017|35821|lyfalmen|||00|84|0|28|Vistor hf|Schering-Plough|Flútamíð||27017||27017|35821 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1025|2231|lyfalmen|||43|28|0|21|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||1025||1025|2231 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2606|4377|lyfalmen|||43|98|0|74|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||2606||2606|4377 524694|C01DA0204|Nitromex|tungur.t|0,25|mg|30|stk|1|glas||C01DA02|01.12.1983||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|3|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1163 524710|C01DA0204|Nitromex|tungur.t|0,5|mg|30|stk|1|glas||C01DA02|01.11.1981||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|6|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1142 525014|M03BC5101|Norgesic|töflur|0| |100|stk|1|þpakki||M03BC51|01.06.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|1119|2359|lyfalmen|||00|100|0|29|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||1119||1119|2359 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|1144|2393|lyfalmen|||00|15|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1144||1144|2393 525147|M01AB0504|Klofen-L|forðahlk|100|mg|30|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|1532|2919|lyfalmen|||10|30|0|30|Actavis Group hf|Actavis hf|Díklófenak||1532||1532|2919 525170|M01AB0504|Klofen-L|forðahlk|100|mg|100|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|5105|7768|lyfalmen|||10|100|0|100|Actavis Group hf|Actavis hf|Díklófenak||5105||5105|7768 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.03.2002||R|A|5|0|0|0|0|CPA|0|0|0|100|DKK|11453|16383|lyfalmen|||00|30|0|10|Vistor hf|Cephalon France (V)|Modafinil||11453||11453|16383 525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0|0|Actavis Group hf|Braun|||||| 526004|V07AB09|Sterilt Vann B. Braun|leysir|0||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0|Actavis Group hf|Braun|||||| 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|8256|12044|lyfalmen|||00|100|0|33|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||8256||8256|12044 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|5203|7901|lyfalmen|||10|100|0|20|Vistor hf|Desitin Artzneimittel|Valpróínsýra||5203||5203|7901 526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|A|5|0|0|0|0|IBV|0|0|0|100|DKK|7544|14541|vetalmen|||16|188|0|0|Vistor hf|Intervet International BV|||7544||7544|14541 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4616|7105|lyfalmen|||10|100|0|40|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4616||4616|7105 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|A|3|0|0|0|1|SNO|0|0|0|100|NOK|14893|20409|lyfsjukr|||00|2000|0|7|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||14893||14893|20409 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|A|2,5|0|0|E|0|ALC|0|0|0|100|USD|1308|2615|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|Emedastín||1308||1308|2615 529263|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|2171|3108|lyfsjukr|||00|7|0|2|Vistor hf|Schering-Plough|Búprenorfín||2171||2171|3108 529289|R02AA0301|Strepsils|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 529438|QJ51RC2002|Ampiclox vet.|spenalyf|0| |3|g|24|spr|spenadælur|QJ51RC20|01.06.1998||R|A|1.5|0|0|0|0|PAL|0|0|0|100|DKK|4841|9393|vetalmen|||16|72|0|0|Icepharma hf|Pfizer Oy Animal Health|||4841||4841|9393 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|4169|8113|vetalmen|||16|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||4169||4169|8113 529586|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|5551|7948|lyfsjukr|||00|7|0|7|Vistor hf|Schering-Plough|Búprenorfín||5551||5551|7948 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|K|2|0|0|0|1|PFI|0|0|0|100|DKK|90472|114505|lyfsjukr|||00|100|0|11|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Fosfenýtóín||90472||90472|114505 530030|J06BA0205|Sandoglobulin|irs|1|g/fl|1|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|10668|15149|lyfsjukr|||00|1|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||10668||10668|15149 530048|J06BA0205|Sandoglobulin|irs|3|g/fl|3|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|28927|37882|lyfsjukr|||00|3|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||28927||28927|37882 530055|J06BA0205|Sandoglobulin|irs|6|g/fl|6|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|57854|73896|lyfsjukr|||00|6|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||57854||57854|73896 530741|G03FA0105|Activelle|töflur|0| |84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3509|5602|lyfalmen|||23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3509||3509|5602 531459|R03CC0303|Bricanyl Retard|forðatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2728|4542|lyfalmen|||43|100|0|50|Vistor hf|AstraZeneca A/S DK|Terbútalín||2728||2728|4542 531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|A|0,5|0|1|0|1|BII|0|0|0|100|DKK|10255|14635|lyfsjukr|||00|240|0|6|Vistor hf|Boehringer Ingelheim International |Nevírapín||10255||10255|14635 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|815|1946|lyfalmen|||01|30|0|3|Vistor hf|Janssen-Cilag AB|Mebendazól||815||815|1946 533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1842|3340|lyfalmen|||43|100|0|33|Vistor hf|AstraZeneca A/S DK|Terbútalín||1842||1842|3340 534537|J01EE0103|Primazol|töflur|480|mg|20|stk|1|glas|80+400 mg|J01EE01|01.10.1995|31.07.2009|R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|476|1486|lyfalmen|||00|20|0|5|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||476||476|1486 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|K|3|0|0|0|0|BPA|0|0|0|100|IKR|||lyflausa|||00|100|0|0|Icepharma hf|Bioglan Pharma AB|Dísúlfíram í blöndum||||| 535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|þpakki||G04BD04|01.06.1998||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|6272|9352|lyfalmen|||00|84|0|28|Vistor hf|Sanofi-aventis Norge AS|Oxýbútýnín||6272||6272|9352 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|461|1466|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|Pílókarpín||461||461|1466 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|588|1638|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|Pílókarpín||588||588|1638 536938|N04BC0102|Parlodel|hylki|5|mg|100|stk|1|þpakki||N04BC01|01.05.1983||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|15715|21750|lyfalmen|||52|100|0|12|Vistor hf|Meda AS|Brómókriptín||15715||15715|21750 537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|A|3|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||710 537811|G03CA0401|Ovestin|sk-stil|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||05|15|0|38|Vistor hf|N.V. Organon|Estríól|||||2447 538181|A02AD0106|Rennie|sog/tugg|0| |24|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|24|0|2|Icepharma hf|Bayer AB|Blöndur saltsambanda||||| 538199|A02AD0106|Rennie|sog/tugg|0| |48|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|48|0|5|Icepharma hf|Bayer AB|Blöndur saltsambanda||||| 538207|A02AD0106|Rennie|sog/tugg|0| |96|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|96|0|10|Icepharma hf|Bayer AB|Blöndur saltsambanda||||| 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|137502|173057|lyfsjukr|||00|6|0|61|Gróco ehf|Serono Nordic|Interferón beta-1a||137502||137502|173057 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|A|5|0|1|E|0|SNO|0|0|0|100|NOK|10388|14937|lyfalmen|||00|100|0|25|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||10388||10388|14937 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|198|1109|lyfalmen|||00|25|0|5|Actavis Group hf|Actavis Group hf|Díazepam||198||198|1109 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|0|100|DKK|432|1427|lyfalmen|||00|100|0|20|Actavis Group hf|Actavis Group hf|Díazepam||432||432|1427 539783|D01AC2001|Daktacort|krem|0| |15|g|1|túpa||D01AC20|01.04.1986||L|K|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||20|15|0|15|Vistor hf|Janssen-Cilag AB|Blöndur||||| 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|2879|4747|lyfalmen|||23|40|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2879||2879|4747 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|3155|5122|lyfalmen|||00|250|0|250|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||3155||3155|5122 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.07.2000||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|6645|9858|lyfalmen|||06|15|0|0|Icepharma hf|M.S.D.|Tímólól í blöndum||6645||6645|9858 541060|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|1951|3488|lyfalmen|||23|200|0|50|Vistor hf|AstraZeneca A/S DK|Terbútalín||1951||1951|3488 541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|10761|15444|lyfalmen|||10|200|0|60|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||10761||10761|15444 541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|17431|23887|lyfalmen|||10|200|0|100|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||17431||17431|23887 541169|R02AA0302|Strepsils med honning og citron|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 542803|C08DA0103|Isoptin retard|forðatfl|240|mg|28|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|1693|3138|lyfalmen|||10|28|0|28|Vistor hf|Abbott Scandinavia AB|Verapamíl||1693||1693|3138 542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1638|3063|lyfalmen|||00|100|1|100|Parlogis hf|Parlogis - óskráð lyf|||1638||1638|3063 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|þpakki||C07AA03|01.12.1983||R|A|5|0|0|B|0|NOH|0|0|0|100|DKK|4981|7600|lyfalmen|||00|98|0|65|Vistor hf|Novartis Healthcare A/S-|Pindólól||4981||4981|7600 543413|R06AA5201|Koffinatin|töflur|0| |10|stk|1|þpakki||R06AA52|01.12.1982||L|A|4|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|2|Actavis Group hf|Actavis hf|Dífenhýdramín í blöndum||||| 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||42|250|0|22|Vistor hf|Recip AB|Semen psyllii (ispaghula)||||| 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|8|0|9|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 543926|D11AC0302|Selsun Blue|hársápa|10|mg/ml|120|ml|1|glas||D11AC03|01.08.1984||L|A|3|0|0|0|0|CHT|0|0|0|100|IKR|||lyflausa|||01|120|0|120|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|Selensambönd||||| 544502|G03GA0501|Gonal-F|sts|37,5|ae/lykju|10|lyk|1|pakki|+ leysir 1 ml|G03GA05|01.02.2002||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|25444|33863|lyfalmen|||00|10|0|5|Gróco ehf|Serono Nordic|Follitrópín alfa||25444||25444|33863 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|808|1937|lyfalmen|||00|15|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||808||808|1937 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1347|2668|lyfalmen|||00|100|0|7|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||1347||1347|2668 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|3580|5699|lyfalmen|||00|100|0|33|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||3580||3580|5699 545996|V01AA0507|Alutard SQ, birkifrjo|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|34204|44769|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||34204||34204|44769 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|27577|36518|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||27577||27577|36518 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|34405|45019|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||34405||34405|45019 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|29229|38575|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||29229||29229|38575 546143|N02BE0108|Paratabs Retard|forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|30|0|5|Actavis Group hf|Actavis hf|Paracetamól||||| 546168|N02BE0108|Paratabs Retard|forðatfl|500|mg|100|stk|1|þpakki||N02BE01|01.10.1993||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|521|1547|lyfalmen|||10|100|0|17|Actavis Group hf|Actavis hf|Paracetamól||521||521|1547 546531|N06AF0101|Marplan|töflur|10|mg|56|stk|1|glas||N06AF01|01.10.2001||R|A||0|0|E|0|LDR|0|0|0|100|DKK|9347|13525|lyfalmen|||00|56|1|37|Parlogis hf|Parlogis - óskráð lyf|||9347||9347|13525 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|A|5|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||23|60|0|15|Vistor hf|Orion Corporation|Súkralfat|||||4622 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|11278|15909|lyfsjukr|||00|100|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||11278||11278|15909 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|3717|5322|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||3717||3717|5322 547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|9701|14005|lyfalmen|||63|0|0|1|Vistor hf|N.V. Organon|Follitrópín beta||9701||9701|14005 547869|G03GA0601|Puregon|stl|150|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|60312|77273|lyfalmen|||63|2|0|5|Vistor hf|N.V. Organon|Follitrópín beta||60312||60312|77273 547893|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|4982|7601|lyfalmen|||63|0|0|0|Vistor hf|N.V. Organon|Follitrópín beta||4982||4982|7601 547901|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|24251|32377|lyfalmen|||63|2|0|2|Vistor hf|N.V. Organon|Follitrópín beta||24251||24251|32377 548297|A08AA1001|Reductil|hylki|10|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|18490|25205|lyfalmen|||00|98|0|98|Vistor hf|Abbott Laboratories A/S|Sibutramin||18490||18490|25205 548347|A08AA1001|Reductil|hylki|15|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|18490|25205|lyfalmen|||00|98|0|147|Vistor hf|Abbott Laboratories A/S|Sibutramin||18490||18490|25205 548511|J01CF0101|Diclocil|sts/irs|500|mg|1|stk|10|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2375|3400|lyfsjukr|||03|10|0|2|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2375||2375|3400 548776|M05BA0701|Optinate|filmhtfl|5|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|5869|8805|lyfalmen|||00|28|0|28|Vistor hf|Sanofi-aventis Norge AS|||5869||5869|8805 548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|16021|22131|lyfalmen|||00|84|0|84|Vistor hf|Sanofi-aventis Norge AS|||16021||16021|22131 548792|M05BA0701|Optinate|filmhtfl|30|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|41067|53313|lyfalmen|||00|28|0|168|Vistor hf|Sanofi-aventis Norge AS|||41067||41067|53313 549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|117398|148028|lyfsjukr|||17|1|0|0|Vistor hf|Abbott Laboratories Ltd|Palivisumab||117398||117398|148028 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|8681|12621|lyfalmen|||02|5|0|152|Vistor hf|Janssen-Cilag AB|Halóperídól||8681||8681|12621 549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|167450|210343|lyfsjukr|||17|1|0|0|Vistor hf|Abbott Laboratories Ltd|Palivisumab||167450||167450|210343 550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|2355|4036|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsaðir mótefna­vakar||2355||2355|4036 550061|N02BE0102|Panodil Brus|freyðit|500|mg|24|stk|1|þpakki||N02BE01|01.04.1992||L|A|4|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||00|24|0|4|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||1448 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|60|0|0|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 550731|N02BE0103|Panodil Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|0|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|10040|14465|lyfalmen|||00|12|0|12|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||10040||10040|14465 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|1673|3111|lyfalmen|||03|1|0|3|Vistor hf|Meda AB|Tríamcínólón||1673||1673|3111 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|3815|6018|lyfalmen|||00|100|0|50|Vistor hf|Meda AB|Nabúmeton||3815||3815|6018 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|S||1|0|E|0|LDR|0|0|0|100|IKR|905|2069|lyfalmen|||00|20|1|2|Parlogis hf|Parlogis - óskráð lyf|Morfín||905||905|2069 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|2157|1904|lyfalmen|||00|28|0|14|Vistor hf|Eisai Ltd|Rabeprazól||784||784|1904 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|3931|3808|lyfalmen|||00|56|0|28|Vistor hf|Eisai Ltd|Rabeprazól||2187||2187|3808 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|2488|4217|lyfalmen|||00|14|0|14|Vistor hf|Eisai Ltd|Rabeprazól||2488||2488|4217 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|928|2100|lyfalmen|||00|28|0|28|Vistor hf|Eisai Ltd|Rabeprazól||928||928|2100 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|7916|3975|lyfalmen|||00|56|0|56|Vistor hf|Eisai Ltd|Rabeprazól||2310||2310|3975 552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.04.1985||R|A|5|0|0|B|0|BHC|0|0|0|100|SEK|3933|6178|lyfalmen|||63|100|0|67|Vistor hf|Bayer HealthCare AG|Nífedipín||3933||3933|6178 552703|M01AB0509|Modifenac|forðahlk|75|mg|10|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|679|1762|lyfalmen|||00|10|0|8|Actavis Group hf|Actavis Group hf|Díklófenak||679||679|1762 552877|N05CF0104|Zopiklon Merck NM|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|4604|7088|lyfalmen|||00|500|0|500|Actavis Group PTC ehf|Merck NM AB|Zópíklón||4604||4604|7088 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3954|6206|lyfalmen|||00|100|0|15|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3954||3954|6206 552919|N03AF0201|Trileptal|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3925|6167|lyfalmen|||00|50|0|15|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3925||3925|6167 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|A||0|0|E|0|PFI|0|0|0|100|DKK|13583|19096|lyfalmen|||00|18|0|18|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eletriptan||||13583|19096 553313|N02CC0601|Relpax|töflur|40|mg|3|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2696|4499|lyfalmen|||00|3|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eletriptan||2696||2696|4499 553339|N02CC0601|Relpax|töflur|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|4645|7144|lyfalmen|||00|6|0|6|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eletriptan||4645||4645|7144 554154|QA12CE9902|Selevitan, vet.|stl|0| |100|ml|5|hgl||QA12CE99|01.05.1983||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|8200|15791|vetalmen|||27|500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||8200||8200|15791 555607|N06AB0601|Zoloft|mixtúruþ|20|mg/ml|60|ml|1|fl||N06AB06|01.03.2001||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|5526|8339|lyfalmen|||00|60|0|24|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||5526||5526|8339 556589|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3573|5116|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Elektrólýtar||3573||3573|5116 556654|B05BA0313|Glucos 500 mg/ml Fresenius Kabi|irl|500|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.05.2004||R|A|1|0|0|0|1|FRP|0|0|0|100|DKK|6874|9842|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Kolvetni||6874||6874|9842 556662|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|5829|8346|lyfsjukr|||00|6000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||5829||5829|8346 556738|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4294|6148|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Kolvetni||4294||4294|6148 556753|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3992|5716|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Kolvetni||3992||3992|5716 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5517|8327|lyfalmen|V2150|8326|00|100|0|30|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||5517||5517|8327 556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|7612|11170|lyfalmen|||00|50|0|30|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||7612||7612|11170 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|10756|15437|lyfalmen|||00|100|0|60|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||10756||10756|15437 557546|D10AF0202|Zineryt|áburður|0| |30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|A|2|0|0|0|0|ASP|0|0|0|100|XEU|1806|3291|lyfalmen|||38|30|0|30|Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1806||1806|3291 558585|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|10|hgl|röntgenskuggaefni|V08CA01|01.07.1992||R|A|5|0|0|0|1|SAG|0|0|0|100|SEK|166857|209604|lyfsjukr|||02|200|0|0|Icepharma hf|Schering AG|Gadópentetat||166857||166857|209604 559013|C08DA0103|Isoptin retard|forðatfl|120|mg|28|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|1108|2344|lyfalmen|||10|28|0|14|Vistor hf|Abbott Scandinavia AB|Verapamíl||1108||1108|2344 559021|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|2199|3825|lyfalmen|||10|98|0|49|Vistor hf|Abbott Scandinavia AB|Verapamíl||2199||2199|3825 559062|N02AX0201|Nobligan|hylki|50|mg|100|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1110|2347|lyfalmen|V0731|1524|10|100|0|17|Icepharma hf|Grunenthal|Tramadól||1110||1110|2347 559070|N02AX0201|Nobligan|hylki|50|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|664|1741|lyfalmen|V0730|1238|10|20|0|3|Icepharma hf|Grunenthal|Tramadól||664||664|1741 559104|N02AX0201|Nobligan|eþ-stil|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1852|3354|lyfalmen|||04|20|0|7|Icepharma hf|Grunenthal|Tramadól||1852||1852|3354 559120|N02AX0201|Nobligan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1065|2286|lyfalmen|V0732|2163|02|10|0|2|Icepharma hf|Grunenthal|Tramadól||1065||1065|2286 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|100|Icepharma hf|STADA Arzneimittel AG|Heparínóíð||||| 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2743|4563|lyfalmen|||06|5|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||2743||2743|4563 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|0|Icepharma hf|STADA Arzneimittel AG|Heparínóíð||||| 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|6478|9631|lyfalmen|||23|1|0|90|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Estradíól||6478||6478|9631 559963|C01DA0201|Discotrine|forðapl|5|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|2894|4768|lyfalmen|||23|30|0|30|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||2894||2894|4768 559971|C01DA0201|Discotrine|forðapl|10|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3196|5178|lyfalmen|||23|30|0|60|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3196||3196|5178 559989|N01AB0701|Suprane|innönd.l|0| |240|ml|1|fl||N01AB07|01.01.1995||R|A|3|0|0|0|1|BAX|0|0|0|100|DKK|11229|15848|lyfsjukr|||00|240|0|0|Icepharma hf|Baxter|Desflúran||11229||11229|15848 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|A|3|0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen|||07|10|0|0|Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar sam­setningar|||||1337 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|3360|5400|lyfalmen|||00|25|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||3360||3360|5400 560334|J05AB0102|Zovir|töflur|200|mg|100|stk|1|þpakki||J05AB01|01.07.1994|30.06.2009|R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|12083|17228|lyfalmen|||00|100|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||12083||12083|17228 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||20|2|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Acíklóvír||||| 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|1916|3440|lyfalmen|||07|4|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1916||1916|3440 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|6404|9531|lyfalmen|||00|125|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6404||6404|9531 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|6944|10264|lyfalmen|||00|100|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6944||6944|10264 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|K|3|0|1|0|1|ABS|0|0|0|100|DKK|113419|143074|lyfsjukr|||00|5|0|1|Vistor hf|Abbott Scandinavia AB|Levosimendan||113419||113419|143074 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|K|3|0|1|0|1|ABS|0|0|0|100|DKK|645681|606265|lyfsjukr|||00|20|0|5|Vistor hf|Abbott Scandinavia AB|Levosimendan||485460||485460|606265 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2749|4571|lyfalmen|||06|5|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||2749||2749|4571 561571|N06AX1101|Remeron|töflur|30|mg|250|stk|1|glas|til notkunar vélskömmtun lyfja|N06AX11|01.11.2002||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|37690|49109|lyfalmen|||00|250|0|250|Vistor hf|N.V. Organon|Mirtazapín||37690||37690|49109 563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|28166|37252|lyfalmen|||02|6|0|17|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||28166||28166|37252 563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|43359|56167|lyfalmen|||02|10|0|29|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||43359||43359|56167 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|747|1854|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||747||747|1854 563387|D07AC1701|Cutivat|krem|0,5|mg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2319|3987|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2319||2319|3987 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|747|1854|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||747||747|1854 563403|D07AC1701|Cutivat|smyrsli|50|mcg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2319|3987|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2319||2319|3987 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1834|3329|lyfalmen|||10|100|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||1834||1834|3329 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|232924|292175|lyfalmen|||02|60|0|172|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||232924||232924|292175 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|5368|8125|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||5368||5368|8125 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|5654|8513|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||5654||5654|8513 563684|C10AA0401|Lescol|hylki|20|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|9992|14400|lyfalmen|||00|98|0|33|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||9992||9992|14400 563700|C10AA0401|Lescol|hylki|40|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|12651|17935|lyfalmen|||00|98|0|65|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||12651||12651|17935 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|171769|215720|lyfsjukr|||00|168|0|34|Vistor hf|Schering-Plough|Ribavirin||171769||171769|215720 565275|C07AG0202|Dimitone|töflur|12,5|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|6003|8987|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||6003||6003|8987 565325|C07AG0202|Dimitone|töflur|25|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|9009|13066|lyfalmen|||00|100|1|67|Parlogis hf|Parlogis - óskráð lyf|||9009||9009|13066 565374|C07AG0202|Dimitone|töflur|6,25|mg|28|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|1593|3002|lyfalmen|||00|28|1|5|Parlogis hf|Parlogis - óskráð lyf|||1593||1593|3002 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|A|4|0|0|B|0|UCB|0|0|0|100|DKK|13069|18456|lyfalmen|||00|100|0|50|Vistor hf|U.C.B|Olsalazín||13069||13069|18456 566018|D01BA0201|Lamisil|töflur|125|mg|14|stk|1|þpakki||D01BA02|01.07.1995||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|3141|2835|lyfalmen|||00|14|0|7|Vistor hf|Novartis Healthcare A/S-|Terbínafín||1470||1470|2835 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|1460|2822|lyfalmen|||06|5|0|25|K.Pétursson hf|Alcon|Brinzólamíð||1460||1460|2822 566661|L04AB0101|Enbrel|sts|0| |25|mg|4|hgl|+ leysir|L04AB01|01.11.2000||R|K|3|0|1|0|1|WTE|0|0|0|100|USD|87908|111313|lyfsjukr|||00|100|0|14|Icepharma hf|Wyeth Europe|Etanercept||87908||87908|111313 566992|J02AC0101|Diflucan|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.10.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|6542|9718|lyfalmen|V0556|4233|10|4|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||6542||6542|9718 567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1618|3036|lyfalmen|||00|100|0|4|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1618||1618|3036 567073|A10BG0201|Avandia|töflur|4|mg|56|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|8776|12750|lyfalmen|||00|56|0|37|GlaxoSmithKline ehf|SmithKline Beecham PLC|Rósíglítazón||||8776|12750 567149|A10BG0201|Avandia|töflur|8|mg|28|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|6948|10269|lyfalmen|||00|28|0|37|GlaxoSmithKline ehf|SmithKline Beecham PLC|Rósíglítazón||6948||6948|10269 567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|5945|8908|lyfalmen|V0791|4040|00|60|0|12|Vistor hf|Janssen-Cilag AB|Risperídón||5945||5945|8908 567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|13714|19259|lyfalmen|V0793|8270|00|60|0|24|Vistor hf|Janssen-Cilag AB|Risperídón||13714||13714|19259 567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|22793|30562|lyfalmen|V0794|11709|00|60|0|36|Vistor hf|Janssen-Cilag AB|Risperídón||22793||22793|30562 567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|30201|39785|lyfalmen|V0795|18331|00|60|0|48|Vistor hf|Janssen-Cilag AB|Risperídón||30201||30201|39785 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|A|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||24|15|0|12|Vistor hf|Janssen-Cilag AB|Levókabastín||||| 567636|N05BA1205|Alprazolam Mylan|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|A||0|0|0|0|RAN|0|0|0|100|SEK|1055|2272|lyfalmen|V0857|2151|00|20|0|20|Actavis Group PTC ehf|Mylan AB|Alprazólam||||1055|2272 567990|V08AB0901|Visipaque|stl|150|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996|31.07.2009|R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|14023|19326|lyfsjukr|||02|1200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||14023||14023|19326 568022|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|fl||V08AB09|01.01.1996|31.07.2009|R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|27452|36045|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||27452||27452|36045 568030|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|fl||V08AB09|01.01.1996|31.07.2009|R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5568|7972|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||5568||5568|7972 568055|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|fl||V08AB09|01.01.1996|31.07.2009|R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|28937|37894|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||28937||28937|37894 568238|A02BC0401|Pariet|sh-tfl|20|mg|120|stk|1|þpakki||A02BC04|01.05.2002||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|16169|8520|lyfalmen|||00|120|0|120|Vistor hf|Eisai Ltd|Rabeprazól||5659||5659|8520 568519|N05AB0301|Trilafon|töflur|8|mg|100|stk|1|þpakki||N05AB03|01.01.1986|31.07.2009|R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|2245|3887|lyfalmen|||00|100|0|27|Vistor hf|Schering-Plough|Perfenazín||2245||2245|3887 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1201|2470|lyfalmen|||00|3|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1201||1201|2470 568790|N02AA5902|Parkodin forte|eþ-stil|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.07.1993||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|489|1504|lyfalmen|||04|10|0|3|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||489||489|1504 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|1463|2826|lyfalmen|V0316|2826|10|100|0|100|Actavis Group hf|Actavis hf|Felódipín||1463||1463|2826 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|2318|3986|lyfalmen|V0324|3986|10|100|0|200|Actavis Group hf|Actavis hf|Felódipín||2318||2318|3986 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|20123|26921|lyfsjukr|||02|5|0|18|Vistor hf|Novartis Healthcare A/S-|Baklófen||20123||20123|26921 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|20123|26921|lyfsjukr|||02|20|0|18|Vistor hf|Novartis Healthcare A/S-|Baklófen||20123||20123|26921 569897|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|án nálar|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2600|4369|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2600||2600|4369 569913|J07CA0203|DiTeKiPol|bóluefni|0| |0,5|ml|1|spr|án nálar|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|3702|5864|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|barnaveiki, kíghósti, mænusótt, stífkrampi||3702||3702|5864 572768|B02BC1001|Tisseel Duo Quick|vefjalím|0| |0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|136247|171495|lyfsjukr|||00|5|0|0|Icepharma hf|Baxter|Fíbrínógen manna||136247||136247|171495 572776|B02BC1001|Tisseel Duo Quick|vefjalím|0| |1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|178339|223900|lyfsjukr|||00|10|0|0|Icepharma hf|Baxter|Fíbrínógen manna||178339||178339|223900 572784|B02BC1001|Tisseel Duo Quick|vefjalím|0| |2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|335501|419566|lyfsjukr|||00|20|0|0|Icepharma hf|Baxter|Fíbrínógen manna||335501||335501|419566 573287|G03CA0306|Evorel|forðapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3705|5868|lyfalmen|||23|26|0|46|Vistor hf|Janssen-Cilag AB|Estradíól||3705||3705|5868 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|110117|138963|lyfsjukr|||00|1|0|0|Icepharma hf|Roche|Trastuzumab||110117||110117|138963 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|SEK|28879|37822|lyfsjukr|||00|5000|0|2|Vistor hf|AstraZeneca UK Ltd|Meropenem||28879||28879|37822 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|SEK|56521|72236|lyfsjukr|||00|10|0|5|Vistor hf|AstraZeneca UK Ltd|Meropenem||56521||56521|72236 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|2756|2507|lyfalmen|V0610|2451|67|100|0|50|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2507 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|3356|3736|lyfalmen|V0931|2428|00|28|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||2134||2134|3736 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|8721|10296|lyfalmen|V0933|6361|00|98|0|98|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||6968||6968|10296 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|6979|5696|lyfalmen|V0935|3559|00|28|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||3578||3578|5696 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|15536|16822|lyfalmen|V0937|10351|00|98|0|196|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||11777||11777|16822 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|K|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|40|0|0|Icepharma hf|Norpharma |Malatíón||||| 575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|A|3|0|0|0|1|SAA|0|0|0|100|NOK|6260|8963|lyfsjukr|||00|12|0|0|Vistor hf|Sanofi - Aventis|Adenósín||6260||6260|8963 575787|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.12.2000||R|K|3|0|1|0|1|CEO|0|0|0|100|DKK|101434|128153|lyfsjukr|||00|1|0|27|Vistor hf|Centocor B.V.|Infliximab||101434||101434|128153 577494|M05BA0101|Didronate|töflur|200|mg|28|stk|1|þpakki||M05BA01|01.04.1996|30.06.2009|R|A|4|0|0|E|0|PGA|0|0|0|100|DKK|6854|10142|lyfalmen|||00|28|0|14|Sofus Consulting AB|Procter & Gamble-|Etídrónsýra||6854||6854|10142 577668|C07FB0201|Logimax|forðatfl|55|mg|28|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3079|5019|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýst­ings­­lækkandi lyf||3079||3079|5019 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1199|2467|lyfalmen|||02|10|0|0|Vistor hf|AstraZeneca A/S DK|Terbútalín||1199||1199|2467 579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|A|3|0|0|*|0|WAB|0|0|0|100|USD|891|2050|lyfalmen|||00|30|0|30|Icepharma hf|Wyeth AB|Metótrexat||891||891|2050 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|34719|45093|lyfsjukr|||02|1|0|9|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||34719||34719|45093 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|69124|87927|lyfsjukr|||02|1|0|18|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||69124||69124|87927 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|132475|166799|lyfsjukr|||02|1|0|36|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||132475||132475|166799 582213|R01AA0503|Nezeril|nefúði|0,1|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|8|0|2|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|5620|9726|vetorma|||16|50|0|0|Icepharma hf|Pfizer Oy Animal Health|||5620||5620|9726 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|21178|36650|vetorma|||16|200|0|0|Icepharma hf|Pfizer Oy Animal Health|||21178||21178|36650 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|39554|51112|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||39554||39554|51112 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|70812|90028|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||70812||70812|90028 582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|þpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|747|1854|lyfalmen|||00|28|0|19|Vistor hf|AstraZeneca A/S DK|Metóprólól||747||747|1854 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|27452|36045|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||27452||27452|36045 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|53298|68224|lyfsjukr|||02|2000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||53298||53298|68224 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1087|2315|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Sótalól||1087||1087|2315 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|82356|104401|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||82356||82356|104401 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|28937|37894|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||28937||28937|37894 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|61388|78296|lyfsjukr|||02|2000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||61388||61388|78296 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|92841|117455|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||92841||92841|117455 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4302|6159|lyfsjukr|||00|5000|0|5|Icepharma hf|Fresenius Kabi|Elektrólýtar||4302||4302|6159 583856|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2240|3207|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Elektrólýtar||2240||2240|3207 583914|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|8273|11845|lyfsjukr|||00|1500|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||8273||8273|11845 583922|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6787|9717|lyfsjukr|||00|5000|0|5|Icepharma hf|Fresenius Kabi|Kolvetni||6787||6787|9717 583930|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3297|4720|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Kolvetni||3297||3297|4720 584011|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9423|13491|lyfsjukr|||00|3000|0|3|Icepharma hf|Fresenius Kabi|Kolvetni||9423||9423|13491 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3728|5338|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Kolvetni||3728||3728|5338 584102|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4444|6363|lyfsjukr|||00|9000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||4444||4444|6363 584276|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2513|3598|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Elektrólýtar||2513||2513|3598 584284|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |100|ml|30|pokar|excel umbúðir|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|3000|0|0|Icepharma hf|Fresenius Kabi|||||| 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|þpakki||N06AG02|01.07.1995||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|3741|5917|lyfalmen|||64|30|0|30|Vistor hf|Meda AS|Móklóbemíð||3741||3741|5917 585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|11249|15873|lyfsjukr|||02|20|0|50|Vistor hf|LEO Pharma A/S|Heparín||11249||11249|15873 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|4098|5867|lyfsjukr|||02|25|0|12|Vistor hf|LEO Pharma A/S|Heparín||4098||4098|5867 585844|J01DH5101|Tienam|irs|500|mg|12|hgl|1|pakki|monovial|J01DH51|01.04.1988||R|A|2|0|0|0|1|MSD|0|0|0|100|XEU|40249|51978|lyfsjukr|||00|12|0|3|Icepharma hf|M.S.D.|Imipenem og ensímhemill||40249||40249|51978 585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3987|6251|lyfalmen|||02|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3987||3987|6251 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|39016|50760|lyfalmen|||00|50|0|20|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||39016||39016|50760 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|2966|4865|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2966||2966|4865 587667|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB02|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3492|5000|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3492||3492|5000 588152|S01GX0401|Tilavist|augndr|20|mg/ml|5|ml|1|glas||S01GX04|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1505|2883|lyfalmen|||06|5|0|0|Vistor hf|Sanofi-aventis Norge AS|Nedókrómíl||1505||1505|2883 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|2474|4198|lyfalmen|V0426|4129|43|20|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2474||2474|4198 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|13282|18721|lyfalmen|||00|100|0|50|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||13282||13282|18721 588723|B03AA0702|Ferlen-R|forðatfl|100|mg|60|stk|1|glas||B03AA07|01.01.1994|31.07.2009|L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|60|0|30|Actavis Group hf|Actavis hf|Ferrósúlfat||||| 588772|H05BA0103|Miacalcic Nasal|nefúði|200|ae/sk|2|ml|1|úðagl|14 skammt|H05BA01|01.03.2002||R|K|3|0|0|E|0|NOH|0|0|0|100|DKK|9902|14278|lyfalmen|||23|2|0|14|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||9902||9902|14278 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6864|11878|vetorma|||16|3|0|0|Icepharma hf|Pfizer Animal Health|||6864||6864|11878 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2660|4603|vetorma|||16|1|0|0|Icepharma hf|Pfizer Animal Health|||2660||2660|4603 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6623|11461|vetorma|||16|6|0|0|Icepharma hf|Pfizer Animal Health|||6623||6623|11461 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3577|6190|vetorma|||16|1|0|0|Icepharma hf|Pfizer Animal Health|||3577||3577|6190 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3716|6431|vetorma|||16|2|0|0|Icepharma hf|Pfizer Animal Health|||3716||3716|6431 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2878|4981|vetorma|||16|2|0|0|Icepharma hf|Pfizer Animal Health|||2878||2878|4981 589497|D11AF0102|Canthacur|lausn|0,7|%|7,5|ml|1|glas||D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2566|4323|lyfalmen|||00|8|1|8|Parlogis hf|Parlogis - óskráð lyf|||2566||2566|4323 589500|D11AF0103|Canthacur-PS|lausn|36|%|7,5|ml|1|glas|1%+30%+5%|D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5480|8277|lyfalmen|||00|8|1|8|Parlogis hf|Parlogis - óskráð lyf|||5480||5480|8277 589911|L01BB0501|Fludara|sts|50|mg/hgl|50|mg|5|hgl||L01BB05|01.01.1996||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|150457|189186|lyfsjukr|||00|250|0|0|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||150457||150457|189186 590315|J05AE0301|Norvir|hylki|100|mg|84|stk|4|glös|mjúk hylki|J05AE03|01.08.2003||R|K|2|0|1|0|1|ABL|0|0|0|100|DKK|96820|122408|lyfsjukr|||00|336|0|28|Vistor hf|Abbott Laboratories A/S|Ritonavír||96820||96820|122408 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|1|100|IKR|||lyflausa|||00|20|0|20|Vistor hf|Bayer A/S|Klótrímazól||||| 590539|A01AD1101|Bonjela|hlaup|0| |15|g|1|túpa|hlaup í munn|A01AD11|01.01.1996||L|A|3|0|0|0|0|REB|0|0|1|100|IKR|||lyflausa|||00|15|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Ýmis lyf||||| 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.10.1999||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1404|2746|lyfalmen|V0139|2746|10|98|0|147|Actavis Group hf|Actavis hf|Ísósorbíð mónónítrat||1404||1404|2746 590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|29901|39412|lyfalmen|||02|10|0|250|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||29901||29901|39412 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|A|2|0|0|0|1|BOI|0|0|0|100|DKK|220501|276391|lyfsjukr|||00|1|0|1|Vistor hf|Boehringer Ingelheim|Tenekteplasi||220501||220501|276391 591131|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996|31.07.2009|R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|31979|41681|lyfsjukr|||00|1200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||31979||31979|41681 591149|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996|31.07.2009|R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|36833|47725|lyfsjukr|||00|1200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||36833||36833|47725 592097|N01AF0301|Pentothal Natrium|sts|500|mg|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|3669|5253|lyfsjukr|||02|12|0|0|Vistor hf|Hospira Enterprises B.V.|Tíópentalnatríum||3669||3669|5253 592147|D05AX0301|Silkis|smyrsli|3|mcg/g|100|g|1|túpa||D05AX03|01.06.2001||R|A|3|0|0|B|0|GAN|0|0|0|100|XEU|7070|10435|lyfalmen|||00|100|0|0|Icepharma hf|Galderma Nordic AB|Kalcítríól||7070||7070|10435 592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Vistor hf|Regent Medical Overseas Limited|Klórhexidín||||| 592469|N02BE0107|Paratabs|lausnart|160|mg|30|stk|1|þpakki||N02BE01|01.01.1995||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||09|30|0|2|Actavis Group hf|Actavis hf|Paracetamól||||| 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|731|1832|lyfalmen|||00|50|0|3|Icepharma hf|Roche|Klónazepam||731||731|1832 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1012|2214|lyfalmen|||00|150|0|9|Icepharma hf|Roche|Klónazepam||1012||1012|2214 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1939|3472|lyfalmen|||00|100|0|25|Icepharma hf|Roche|Klónazepam||1939||1939|3472 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|19610|26599|lyfalmen|||03|12|0|32|Vistor hf|Meda AB|Tríamcínólón||19610||19610|26599 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||659 594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||5489 594903|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3219|4609|lyfsjukr|||02|9000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3219||3219|4609 594945|QA12CE9903|Selenevit, vet.|stl|26|mg/ml|100|ml|1|hgl|1+25 mg/ml|QA12CE99|01.09.1982||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1155|2279|vetalmen|||27|100|0|0|Icepharma hf|Intervet International B.V.|||1155||1155|2279 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|9824|14066|lyfsjukr|||02|5|0|5|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||9824||9824|14066 595991|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|680|1763|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||680||680|1763 596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|250|0|250|Vistor hf|Regent Medical Overseas Limited|Klórhexidín||||| 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|4383|6788|lyfalmen|||43|24|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||4383||4383|6788 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 597575|D01AC0301|Pevaryl|húðduft|10|mg/g|30|g|1|stauk||D01AC03|01.07.1991|30.06.2009|L|A|5|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|1002|2200|lyfalmen|||00|150|0|25|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||1002||1002|2200 801120|A11HA0503|Biotin Bayer|töflur|5|mg|20|stk|1|glas||A11HA05|01.12.2005||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1218|2493|lyfalmen|||00|20|1|0|Distica|Distica - óskráð lyf|||1218||1218|2493 908048|J07AM5201|Tetagam P/Tetanogamma P|bóluefni|250|ae|1,2|ml|1|hgl||J07AM52|01.01.1998||R|K||0|0|0|0|LDR|0|0|1|100|IKR|19419|26362|lyfalmen|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|||19419||19419|26362 912792|N07CA0301|Sibelium|hylki|5|mg|50|stk|1|glas||N07CA03|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4276|6643|lyfalmen|||00|50|1|25|Distica|Distica - óskráð lyf|||4276||4276|6643 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2314|3981|lyfalmen|||00|100|1|33|Distica|Distica - óskráð lyf|||2314||2314|3981 922866|N05BA0602|Ativan|stl|4|mg/ml|1|ml|4|lykjur||N05BA06|01.11.2005||R|A||0|0|0|1|LDR|0|0|0|100|USD|3310|4739|lyfsjukr|||00|4|1|0|Parlogis hf|Parlogis - óskráð lyf|||3310||3310|4739 923351|S01XA2006|Lacri - Lube|augnsm|0| |3,5|g|1|túpa||S01XA20|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|480|1492|lyfalmen|||00|4|1|0|Distica|Distica - óskráð lyf|Gervitár og aðrar óvirkar sam­setningar||480||480|1492 923608|C03BA0801|Metenix|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|4460|6893|lyfalmen|||00|100|1|100|Distica|Distica - óskráð lyf|||4460||4460|6893 924698|G03DA0402|Gestone|stl|50|mg/ml|2|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|8792|12772|lyfalmen|||00|20|1|200|Distica|Distica - óskráð lyf|||8792||8792|12772 927361|A12AA1201|Phos-Ex|töflur|167|mg|180|stk|1|glas||A12AA12|01.01.1998||R|A||0|1|0|0|LDR|0|0|0|100|IKR|1768|3240|lyfalmen|||00|180|1|15|Parlogis hf|Parlogis - óskráð lyf|||1768||1768|3240 937980|C01CA2403|Adrenalin|stl|0,1|mg/ml|10|ml|1|spr||C01CA24|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|2064|2955|lyfsjukr|||02|10|1|2|Parlogis hf|Parlogis - óskráð lyf|Epínefrín (adrenalín)||2064||2064|2955 938376|N07BC0201|Metadon|hylki|40|mg|100|stk|1|glas||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|8233|12013|lyfalmen|||00|100|1|160|Parlogis hf|Parlogis - óskráð lyf|||8233||8233|12013 938417|N07BC0201|Metadon|stl|10|mg/ml|1,1|ml|10|lykjur||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|1770|3242|lyfalmen|||00|11|1|4|Parlogis hf|Parlogis - óskráð lyf|||1770||1770|3242 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|A||0|0|E|0|LDR|0|0|0|100|GBP|5114|7780|lyfalmen|||00|100|1|50|Parlogis hf|Parlogis - óskráð lyf|||5114||5114|7780 938524|G04BE0201|Papaverin|stl|40|mg/ml|1|ml|10|lykjur||G04BE02|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|3002|4914|lyfalmen|||00|10|1|4|Parlogis hf|Parlogis - óskráð lyf|||3002||3002|4914 938649|C05BA0401|Elmiron|hylki|100|mg|100|stk|1|glas||C05BA04|01.05.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|35415|46277|lyfalmen|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||35415||35415|46277 938665|A12CX0001|K-Phos Neutral|töflur|0| |100|stk|1|glas||A12CX00|01.03.2001||R|A||0|0|0|0|LDR|0|0|0|100|IKR|4071|6365|lyfalmen|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||4071||4071|6365 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|7401|10884|lyfalmen|||00|100|1|2|Parlogis hf|Parlogis - óskráð lyf|Kaptópríl||7401||7401|10884 939366|G03DA0402|Gestone|stl|50|mg/ml|1|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|11596|16577|lyfalmen|||00|10|1|100|Distica|Distica - óskráð lyf|||11596||11596|16577 940256|G03CA0313|Oestradiol|vefjatfl|25|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|2245|3887|lyfalmen|||00|1|1|83|Distica|Distica - óskráð lyf|Estradíól||2245||2245|3887 940264|G03CA0313|Oestradiol|vefjatfl|50|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4490|6934|lyfalmen|||00|1|1|167|Distica|Distica - óskráð lyf|Estradíól||4490||4490|6934 940272|G03CA0313|Oestradiol|vefjatfl|100|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|8395|12233|lyfalmen|||00|1|1|333|Distica|Distica - óskráð lyf|Estradíól||8395||8395|12233 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|1837|3333|lyfalmen|||00|1|1|1|Distica|Distica - óskráð lyf|Testósterón||1837||1837|3333 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|A||0|0|E|0|PCO|0|0|1|100|IKR|4544|7007|lyfalmen|||00|100|1|13|Distica|Distica - óskráð lyf|||4544||4544|7007 944745|G03BA0302|Testosteron|vefjatfl|25|mg|1|stk|1|pakki||G03BA03|01.01.2002||R|A||0|0|E|0|PCO|0|0|0|100|IKR|1061|2280|lyfalmen|||00|1|1|8|Distica|Distica - óskráð lyf|Testósterón||1061||1061|2280 944852|A06AX0102|Glycerol infant|eþ-stil|0| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1304|lyfalmen|||00|12|1|0|Parlogis hf|Parlogis - óskráð lyf|||342||342|1304 944886|H02AB0601|Prednisolon|töflur|1|mg|28|stk|1|pakki||H02AB06|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|122|1006|lyfalmen|||00|28|1|3|Parlogis hf|Parlogis - óskráð lyf|Prednisólón||122||122|1006 944985|A06AX0103|Glycerol adult|eþ-stil|0| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1304|lyfalmen|||00|12|1|0|Parlogis hf|Parlogis - óskráð lyf|||342||342|1304 944993|V03AB1702|Methylen Blue|stl|10|mg/ml|10|ml|10|lykjur||V03AB17|01.11.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|10030|14355|lyfsjukr|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||10030||10030|14355 945602|A11EA08|Vitamin B-komplex|stl|0| |2|ml|10|lykjur||A11EA|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1533|2921|lyfalmen|||00|20|1|0|Parlogis hf|Parlogis - óskráð lyf|||1533||1533|2921 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2293|3952|lyfalmen|||00|10|1|10|Distica|Distica - óskráð lyf|Prómetazín||2293||2293|3952 947236|N06BC0101|Koffein|töflur|200|mg|50|stk|1|glas||N06BC01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1558|2955|lyfalmen|||00|50|1|25|Parlogis hf|Parlogis - óskráð lyf|||1558||1558|2955 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|3625|5760|lyfalmen|||00|100|1|67|Parlogis hf|Parlogis - óskráð lyf|||3625||3625|5760 947822|H02AB0203|Dexamethason|töflur|4|mg|50|stk|1|glas||H02AB02|01.11.2001||R|A||0|0|E|0|LDR|0|0|1|100|IKR|8756|12723|lyfalmen|||00|50|1|133|Parlogis hf|Parlogis - óskráð lyf|||8756||8756|12723 947913|A11HA0203|Vitamin B6 Heve|stl|12,5|mg/ml|2|ml|10|lykjur||A11HA02|01.06.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|582|1630|lyfalmen|||00|20|1|2|Parlogis hf|Parlogis - óskráð lyf|||582||582|1630 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2071|3651|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||2071||2071|3651 949620|G03DA0401|Utrogestan|hylki|100|mg|30|stk|1|pakki||G03DA04|01.01.1999||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2001|3556|lyfalmen|||00|30|1|10|Parlogis hf|Parlogis - óskráð lyf|||2001||2001|3556 950742|H02AB0204|Dexa-Ratiopharm|stl|4|mg/ml|1|ml|10|hgl||H02AB02|01.01.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1307|1871|lyfsjukr|||55|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||1307||1307|1871 951005|G03CA0102|Etinylestradiol|töflur|25|mcg|21|stk|1|pakki||G03CA01|01.09.2002||R|A||0|0|E|0|LDR|0|0|0|100|IKR|755|1865|lyfalmen|||00|21|1|21|Parlogis hf|Parlogis - óskráð lyf|||755||755|1865 951287|J01CA0101|Ampicillin|sts|0| |1|g|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|4952|7090|lyfsjukr|||00|10|1|5|Parlogis hf|Parlogis - óskráð lyf|||4952||4952|7090 951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|A||0|0|E|0|PCO|0|0|1|100|IKR|4851|7423|lyfalmen|||00|100|1||Distica|Distica - óskráð lyf|Hýdrókortisón||||4851|7423 952251|J01CA0101|Ampicillin|sts|0| |500|mg|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|4403|6304|lyfsjukr|||00|5000|1|2|Parlogis hf|Parlogis - óskráð lyf|||4403||4403|6304 952855|N02AA0102|Morfin|eþ-stil|10|mg|12|stk|1|pakki||N02AA01|01.10.2004||R|S||1|0|E|0|LDR|0|0|0|100|IKR|3127|5084|lyfalmen|||00|12|1|4|Parlogis hf|Parlogis - óskráð lyf|Morfín||3127||3127|5084 952929|A03AA0403|Duspatalin|töflur|135|mg|100|stk|1|glas||A03AA04|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|5186|7878|lyfalmen|||00|100|1|45|Parlogis hf|Parlogis - óskráð lyf|Mebeverín||||5186|7878 953374|N05AB0602|Stelazine|töflur|1|mg|112|stk|1|glas||N05AB06|01.06.2007||R|A||0|0|*|0|LDR|0|0|0|100|IKR|1410|2754|lyfalmen|||00|112|1|6|Parlogis hf|Parlogis - óskráð lyf|||1410||1410|2754 953621|R03DA0504|Theofyllamin EDA Ratiopharm|stl|120|mg/ml|1|ml|5|lykja||R03DA05|01.09.2004||R|A||0|0|0|0|LDR|0|0|0|100|IKR|289|1233|lyfalmen|||00|5|1|1|Parlogis hf|Parlogis - óskráð lyf|||289||289|1233 954421|C03CA0109|Furosemid|mixtúra|10|mg/ml|60|ml|1|glas||C03CA01|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1870|3378|lyfalmen|||00|60|1||Parlogis hf|Parlogis - óskráð lyf|Fúrósemíð||||1870|3378 954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5690|8562|lyfalmen|||00|150|1||Parlogis hf|Parlogis - óskráð lyf|Própranólól||||5690|8562 954645|N03AB0207|Phenyntoin|mixtúra|25|mg/ml|237|ml|1|glas||N03AB02|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2953|4848|lyfalmen|||00|237|1||Parlogis hf|Parlogis - óskráð lyf|Fenýtóín||||2953|4848 955239|A11GA0108|Vitamin C 500|stl|100|mg/ml|5|ml|5|lykjur||A11GA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|551|1588|lyfalmen|||00|25|1|12|Parlogis hf|Parlogis - óskráð lyf|||551||551|1588 955578|A03AA0403|Duspatalin|töflur|135|mg|50|stk|1|glas||A03AA04|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2593|4359|lyfalmen|||00|50|1|22|Parlogis hf|Parlogis - óskráð lyf|Mebeverín||||2593|4359 956302|N07AA0101|Neostigmin|stl|0,5|mg/ml|1|ml|10|lykjur||N07AA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|848|1991|lyfalmen|||00|10|1|2|Parlogis hf|Parlogis - óskráð lyf|||848||848|1991 958613|V03AB1503|Naloxon|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.01.2009||R|A||0|0|0|1|LDR|0|0|0|100|IKR|12107|16941|lyfsjukr|||00|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||12107||12107|16941 958829|A06AD0002|Miralax|lausnduf|0| |238|g|1|stauk||A06AD00|01.05.2007||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2093|3681|lyfalmen|||00|238|1|0|Parlogis hf|Parlogis - óskráð lyf|||2093||2093|3681 959132|J01XE0103|Nitrofurantoin|mixtúra|5|mg/ml|300|ml|1|glas||J01XE01|01.08.2009||R|A||0|0|0|0|LDR|0|0|0|100|IKR|23718|31714|lyfalmen|||00|300|1||Parlogis hf|Parlogis - óskráð lyf|Nítrófúrantóín||||23718|31714 960999|L02AB0101|Megace|töflur|160|mg|30|stk|1|glas||L02AB01|01.01.2009||R|A||0|1|0|1|PCO|0|0|0|100|IKR|12918|17950|lyfsjukr|||00|30|1|112|Distica|Distica - óskráð lyf|||12918||12918|17950 961202|A03AA0405|Mebaverin|töflur|135|mg|100|stk|1|glas||A03AA04|01.08.2009||R|A||0|0|E|0|PCO|0|0|0|100|GBP|1720|3175|lyfalmen|||00||1||Distica|Distica - óskráð lyf|Mebeverín||||1720|3175 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2108|3701|lyfalmen|||00|20|1|20|Parlogis hf|Parlogis - óskráð lyf|||||2108|3701 961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|glas||H02AB09|01.08.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2150|3758|lyfalmen|||00|20|1||Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||||2150|3758 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|4400|6811|lyfalmen|||00|25|1|17|Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||4400||4400|6811 962466|H02AB0203|Dexamethason|töflur|4|mg|100|stk|1|glas||H02AB02|01.08.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|3451|5524|lyfalmen|||00|100|1|267|Parlogis hf|Parlogis - óskráð lyf|||||3451|5524 962523|B05BB0118|Natrium Bicarbonat|irl|50|mg/ml|100|ml|10|fl||B05BB01|01.05.2009||R|A||0|0|0|1|LDR|0|0|0|100|IKR|5430|7774|lyfsjukr|||0|1000|1|0|Parlogis hf|Parlogis - óskráð lyf|Elektrólýtar||5430||5430|7774